
<html lang="en"     class="pb-page"  data-request-id="f2c7efd4-8b8a-46a4-95cd-26a9c12f8afb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm2006222;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-20;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase" /></meta><meta name="dc.Creator" content="Vito  Guagnano" /></meta><meta name="dc.Creator" content="Pascal  Furet" /></meta><meta name="dc.Creator" content="Carsten  Spanka" /></meta><meta name="dc.Creator" content="Vincent  Bordas" /></meta><meta name="dc.Creator" content="Mickaël  Le Douget" /></meta><meta name="dc.Creator" content="Christelle  Stamm" /></meta><meta name="dc.Creator" content="Josef  Brueggen" /></meta><meta name="dc.Creator" content="Michael R.  Jensen" /></meta><meta name="dc.Creator" content="Christian  Schnell" /></meta><meta name="dc.Creator" content="Herbert  Schmid" /></meta><meta name="dc.Creator" content="Markus  Wartmann" /></meta><meta name="dc.Creator" content="Joerg  Berghausen" /></meta><meta name="dc.Creator" content="Peter  Drueckes" /></meta><meta name="dc.Creator" content="Alfred  Zimmerlin" /></meta><meta name="dc.Creator" content="Dirksen  Bussiere" /></meta><meta name="dc.Creator" content="Jeremy  Murray" /></meta><meta name="dc.Creator" content="Diana  Graus Porta" /></meta><meta name="dc.Description" content="A novel series of N-aryl-N′-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally des..." /></meta><meta name="Description" content="A novel series of N-aryl-N′-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally des..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 21, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2006222" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2006222" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2006222" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2006222" /></link>
        
    
    

<title>Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2006222" /></meta><meta property="og:title" content="Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0020.jpeg" /></meta><meta property="og:description" content="A novel series of N-aryl-N′-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring. On the basis of its in vitro profile, compound 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3. These results support the potential therapeutic use of 1h as a new anticancer agent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2006222"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2006222">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2006222&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2006222&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2006222&amp;href=/doi/10.1021/jm2006222" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7066-7083</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2005404" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200636z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vito++Guagnano">Vito Guagnano</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Furet">Pascal Furet</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carsten++Spanka">Carsten Spanka</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Bordas">Vincent Bordas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Micka%C3%ABl++Le+Douget">Mickaël Le Douget</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christelle++Stamm">Christelle Stamm</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josef++Brueggen">Josef Brueggen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Jensen">Michael R. Jensen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Schnell">Christian Schnell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Herbert++Schmid">Herbert Schmid</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Wartmann">Markus Wartmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joerg++Berghausen">Joerg Berghausen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Drueckes">Peter Drueckes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alfred++Zimmerlin">Alfred Zimmerlin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dirksen++Bussiere">Dirksen Bussiere</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Murray">Jeremy Murray</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Graus+Porta">Diana Graus Porta</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff2"><span class="aff-text">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div><div class="corresp-info">For V.G.: phone, 41 61 696 24 60; fax, 41 61 696 24 55; E-mail, <a href="/cdn-cgi/l/email-protection#85f3ecf1eaabe2f0e4e2ebe4ebeac5ebeaf3e4f7f1ecf6abe6eae8"><span class="__cf_email__" data-cfemail="7f09160b1051180a1e18111e11103f1110091e0d0b160c511c1012">[email protected]</span></a>. For D.G.P.: phone, 41 61 696 50 93; fax, 41 61 696 70 96; E-mail, <a href="/cdn-cgi/l/email-protection#c5a1aca4aba4eba2b7a4b0b69ab5aab7b1a485abaab3a4b7b1acb6eba6aaa8"><span class="__cf_email__" data-cfemail="395d50585758175e4b584c4a6649564b4d587957564f584b4d504a175a5654">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2006222&amp;href=/doi/10.1021%2Fjm2006222" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7066–7083</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 21, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 May 2011</li><li><span class="item_label"><b>Published</b> online</span>21 September 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 October 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2006222" title="DOI URL">https://doi.org/10.1021/jm2006222</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7066%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVito%2BGuagnano%252C%2BPascal%2BFuret%252C%2BCarsten%2BSpanka%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D20%26contentID%3Djm2006222%26title%3DDiscovery%2Bof%2B3-%25282%252C6-Dichloro-3%252C5-dimethoxy-phenyl%2529-1-%257B6-%255B4-%25284-ethyl-piperazin-1-yl%2529-phenylamino%255D-pyrimidin-4-yl%257D-1-methyl-urea%2B%2528NVP-BGJ398%2529%252C%2BA%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2Bthe%2BFibroblast%2BGrowth%2BFactor%2BReceptor%2BFamily%2Bof%2BReceptor%2BTyrosine%2BKinase%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7083%26publicationDate%3DOctober%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2006222"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">9170</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">281</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2006222" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vito&quot;,&quot;last_name&quot;:&quot;Guagnano&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Furet&quot;},{&quot;first_name&quot;:&quot;Carsten&quot;,&quot;last_name&quot;:&quot;Spanka&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Bordas&quot;},{&quot;first_name&quot;:&quot;Mickaël&quot;,&quot;last_name&quot;:&quot;Le Douget&quot;},{&quot;first_name&quot;:&quot;Christelle&quot;,&quot;last_name&quot;:&quot;Stamm&quot;},{&quot;first_name&quot;:&quot;Josef&quot;,&quot;last_name&quot;:&quot;Brueggen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Jensen&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Schnell&quot;},{&quot;first_name&quot;:&quot;Herbert&quot;,&quot;last_name&quot;:&quot;Schmid&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Wartmann&quot;},{&quot;first_name&quot;:&quot;Joerg&quot;,&quot;last_name&quot;:&quot;Berghausen&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Drueckes&quot;},{&quot;first_name&quot;:&quot;Alfred&quot;,&quot;last_name&quot;:&quot;Zimmerlin&quot;},{&quot;first_name&quot;:&quot;Dirksen&quot;,&quot;last_name&quot;:&quot;Bussiere&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Graus Porta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7066-7083&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2006222&quot;},&quot;abstract&quot;:&quot;A novel series of N-aryl-N′-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring. On the basis of its in vitro profile, compound 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3. These results support the potential therapeutic use of 1h as a new anticancer agent.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2006222&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2006222" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2006222&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2006222" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2006222&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2006222" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2006222&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2006222&amp;href=/doi/10.1021/jm2006222" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2006222" /></input><a href="/doi/pdf/10.1021/jm2006222" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2006222%26sid%3Dliteratum%253Aachs%26pmid%3D21936542%26genre%3Darticle%26aulast%3DGuagnano%26date%3D2011%26atitle%3DDiscovery%2Bof%2B3-%25282%252C6-Dichloro-3%252C5-dimethoxy-phenyl%2529-1-%257B6-%255B4-%25284-ethyl-piperazin-1-yl%2529-phenylamino%255D-pyrimidin-4-yl%257D-1-methyl-urea%2B%2528NVP-BGJ398%2529%252C%2BA%2BPotent%2Band%2BSelective%2BInhibitor%2Bof%2Bthe%2BFibroblast%2BGrowth%2BFactor%2BReceptor%2BFamily%2Bof%2BReceptor%2BTyrosine%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D20%26spage%3D7066%26epage%3D7083%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jmcmar.2011.54.issue-20/production/jmcmar.2011.54.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel series of <i>N</i>-aryl-<i>N</i>′-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring. On the basis of its in vitro profile, compound <b>1h</b> (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3. These results support the potential therapeutic use of <b>1h</b> as a new anticancer agent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>†</span> Author Present Address</h4><p class="last">Genentech, Inc., South San Francisco, CA, United States</p></div><div class="extra-info-sec articleNote"><h4><span>‡</span> Author Present Address</h4><p class="last">Novartis Pharma AG, CH-4002 Basel, Switzerland</p></div><div class="extra-info-sec articleNote"><h4><span>§</span> Author Present Address</h4><p class="last">Novartis Institute for BioMedical Research, Emeryville, CA, United States</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During the past 15 years, the pharmaceutical industry has shown an ever-growing interest in the field of tyrosine kinases. Among this class of enzymes, the fibroblast growth factor receptor (FGFR) family represents an attractive therapeutic target in oncology that is gaining increasing attention. The fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases (RTKs) comprises four members (FGFR1, FGFR2, FGFR3, and FGFR4) that share significant sequence homology. Each receptor consists of an extracellular ligand-binding domain containing three immunoglobulin-like repeats, a single transmembrane domain, and a cytosolic region with a split tyrosine kinase domain and tyrosine autophosphorylation sites. This family of RTKs serves as high affinity receptors for the fibroblast growth factors (FGFs) that control cell proliferation, migration, apoptosis, and differentiation and are involved in both developmental and adult tissue homeostasis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">A variety of genetic alterations, including deregulated expression and/or abnormal activation of FGFs and FGFR family members, has been found in diverse tumor types.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Translocation and fusion of FGFR1 to other genes resulting in constitutive activation of its kinase by oligomerization is responsible for 8p11 myeloproliferative disorder (MPD).<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7 ref8">(3-8)</a> PKC412,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> a compound which inhibits the growth of ZNF198–FGFR1-transformed BaF3 cells with an IC<sub>50</sub> of 200 nM, proved efficacious when administered to one patient with MPD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Similar translocations and fusions for FGFR3 are associated with peripheral T-cell lymphoma.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In multiple myeloma, recurrent chromosomal translocations of 14q32 into the immunoglobuline heavy chain switch region result in deregulated overexpression of FGFR3.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Further, somatic activating mutations in FGFR3 in solid tumors, being particularly high in bladder carcinomas,<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> and activating point mutations of FGFR2 in gastric cancer<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> and in endometrial carcinomas<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> have been described. Recently, frequent and focal FGFR1 amplification has been identified in squamous cell lung cancer and found to be associated with tumor growth and survival.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Gene amplification and protein overexpression have been reported for FGFR1, FGFR2, and FGFR4 in breast cancer.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23-28)</a> Specifically for FGFR1, the amplification of the locus was significantly more prevalent in tumors that lacked HER2 and proved to be an independent prognostic factor for poor overall survival in estrogen receptor (ER) positive breast cancer patients.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In breast tumors, the 11q13 amplicon containing three different FGFs (FGF3, FGF4, and FGF19) has been found amplified.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30-33)</a> Interestingly, FGF3 and FGF4 are two of the most commonly activated oncogenes upon mouse mammary tumor virus (MMTV) insertion in the mouse genome, leading to mammary tumors. Other tumor types in which this amplicon is altered include ovarian tumors,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> oral squamous cell carcinomas,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and hepatocellular carcinomas.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a></div><div class="NLM_p">While there are a number of low molecular weight compounds in clinical development (such as BIBF-1120,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> TKI258,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> BMS-582664,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> AZD-2171,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> AB-1010,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> TSU-68,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> AP-24534,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and E-7080,<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) that are reported to target FGFR, they have multitarget specificity with respect to other kinases.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of nonspecific FGFR inhibitors in clinical development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The quest for highly selective small molecule inhibitors of specific kinases is still a significant challenge for medicinal chemists. However, the discovery of such inhibitors can be very advantageous to assess the relevance of the alterations of the target protein to cancer dependence. In addition to their use as tool compounds for target validation, these compounds could become superior therapeutic agents owing to a potentially more favorable toxicity profile compared to more promiscuous drugs. Considering the prominent role of FGFRs in cancer development, it would be desirable to evaluate clinically the therapeutic benefit of potent and selective FGFR inhibitors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">We have established a new and nonconventional strategy to mimic documented lead compounds which consists in the replacement of real rings by stable pseudo six-membered rings resulting from the formation of an intramolecular hydrogen bond in a planar conjugated system. More recently, we have reported an example of the application of such a strategy to the design of a new class of protein kinase inhibitors featuring an <i>N</i>-pyrimidin-4-yl-urea motif as an alternative to the pyrido[2,3-<i>d</i>]pyrimidin-7-one core structure of a well-known class of protein kinase inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). In this context, we have described a prototype compound (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) showing submicromolar activity against several tyrosine kinases including FGFR1 (IC<sub>50</sub> 570 nM).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The present report describes the optimization process that led to the identification of compound <b>1h</b> (NVP-BGJ398), a potent and selective inhibitor of the FGFR family of tyrosine kinase receptors, currently in phase I clinical trial.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Pseudo ring concept applied to the design of the <i>N</i>-pyrimidin-4-yl-urea motif. (B) Prototype compound <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Identification of Compound <b>1h</b></h3><div class="NLM_p">Encouraged by the promising starting point represented by <b>2</b>, we initiated a lead optimization process with the support of three main tools: a biochemical assay utilizing constitutively active FGFR3, a proliferation assay using a FGFR3-dependent BaF3 cell line, and a homology model of the FGFR3 kinase domain. Taking into account the high level of sequence homology among the four members of the FGFR family,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> FGFR3 was selected for screening purposes owing to the interesting epidemiological data available at the beginning of this program which demonstrated the critical role of this receptor in the pathogenesis of bladder cancer.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> Importantly, we considered the published information concerning known inhibitors of FGFRs and focused on compound <b>3</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> (PD173074, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), an inhibitor displaying selectivity for these receptors that had been crystallized bound to the ATP binding site of the FGFR1 tyrosine kinase domain.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structure of compound <b>3</b> (PD173074).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This compound, which belongs to the pyrido[2,3-<i>d</i>]pyrimidine class, exhibits nanomolar and submicromolar inhibitory activity at the cellular level against FGFR1 and VEGFR2, respectively.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Its high affinity and selectivity for FGFR1 stem from the presence at the C(3) and C(5) positions of the phenyl ring of two methoxy groups that fill optimally a complementary hydrophobic pocket in the cocrystal structure. As an entry to our lead optimization process, we took advantage of this finding and introduced the 3,5-dimethoxy-phenyl pharmacophore in the pyrimidinyl urea scaffold by preparing compound <b>1a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and FGFR3 Biochemical and Cellular Potencies of <i>N</i>-Aryl-<i>N</i>′-pyrimidin-4-yl Ureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0017.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0018.gif" alt="" id="_i8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Radiometric kinase assay.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Single measurement.</p></div></div><div></div></div><div class="NLM_p">We expected that <b>1a</b> would exhibit lower potency than <b>3</b> due to the significantly higher deconjugation energy barrier that the dimethoxy-phenyl moiety of the former compound has to overcome to adopt an almost perpendicular orientation required for binding to the kinase ATP pocket as revealed by the <b>3</b>-FGFR1 cocrystal structure. Ab initio calculations (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) indicate that this deconjugation has an energy cost of 1.5 kcal/mol in <b>1a</b>, taking the relaxed conformation of the compound in water as reference. In contrast, this cost amounts to only 0.5 kcal/mol for <b>3</b> because higher intramolecular steric hindrance in this compound causes its reference minimum energy conformation to be closer to the perpendicular, kinase bound conformation.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Difference in Energy between the Constrained and Unconstrained Minimized Structure of <b>3</b>, <b>1a</b>, <b>1b</b>, and <b>1h</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0019.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">compd</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>1a</b></th><th class="colsep0 rowsep0" align="center"><b>1b</b></th><th class="colsep0 rowsep0" align="center"><b>1h</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Φ<sub>low</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">127</td><td class="colsep0 rowsep0" align="center">180</td><td class="colsep0 rowsep0" align="center">180</td><td class="colsep0 rowsep0" align="center">109</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Δ<i>E</i><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Torsion angle (Φ) value in degrees in the unconstrained minimized structure.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Difference in energy (Δ<i>E</i>) in kcal/mol between the constrained (kinase bound) and unconstrained minimized structure.</p></div></div></div><div class="NLM_p last">Indeed, <b>1a</b> showed only moderate submicromolar inhibitory activity (IC<sub>50</sub> 505 nM) against the FGFR3 kinase in the biochemical assay and inhibited the proliferation of the BaF3-Tel-FGFR3 cell line with an IC<sub>50</sub> value of 1.5 μM. To lower the deconjugation energy penalty in <b>1a</b>, we envisaged the introduction of chlorine atoms in the ortho positions of the dimethoxy-phenyl ring. Modeling based on the <b>3</b>–FGFR1 cocrystal structure suggested that, in addition to stabilizing the perpendicular conformation, the chlorine atoms would form favorable hydrophobic contacts with the kinase ATP pocket. This was supported by the significant FGFR1 inhibitory activity (570 nM) displayed by our initial <i>ortho</i>-dichloro-prototype compound <b>2</b>. On the basis of these considerations, compound <b>1b</b> was synthesized which showed improved biochemical and cellular potency (4- and 2.5-fold, respectively), in agreement with the reduction in the calculated deconjugation energy (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Exchange of the methyl on the urea nitrogen in <b>1b</b> by either a hydrogen atom (compound <b>1c</b>) or an ethyl group (compound <b>1d)</b> had a neutral effect on potency. Consistent with the binding hypothesis, removal of the methoxy group at the C(3) position of the urea aniline to give compound <b>1e</b> resulted in a decrease of potency. Addition of the second ortho chlorine atom afforded derivatives (<b>1f</b>–<b>g</b>) showing double-digit nanomolar activity in the biochemical assay while for the first time approaching the 100 nM level in the proliferation assay. Finally, the most potent compounds (<b>1h</b>–<b>n</b>) were obtained when we introduced the optimal 2,6-dichloro-3,5-dimethoxy-phenyl moiety, which is associated to the lowest deconjugation energy and modified the pyrimidinyl aniline to modulate the pharmacological profile.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Evaluation of Compounds <b>1h</b>–<b>n</b> in a Cytochrome P450 Panel</h3><div class="NLM_p">Inhibition of cytochrome P450 (CYP450) drug metabolizing enzymes may alter the metabolism of coadministered compounds, leading to a change in drug exposure and possible toxicity. Thus, the potential for drug–drug interactions of compounds <b>1h</b>–<b>n</b> was assessed by monitoring their impact on the metabolic activity of a panel of five major human CYP450 isoforms (3A4, 2C9, 2C19, 2D6, and 1A2) in the presence of a known substrate for each of the isoforms. CYP3A4 inhibition was determined in two assays using two distinct substrates to account for the existence of two substrate binding sites. The results of these six assays, one for each specific isoform/substrate combination, are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profile of Compounds <b>1h</b>–<b>n</b> in a Panel of Human Cytochrome P450 Isozymes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">IC<sub>50</sub> (μM) for CYP450/substrate<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">3A4/BFC</th><th class="colsep0 rowsep0" align="center" char=".">3A4/DBF</th><th class="colsep0 rowsep0" align="center" char=".">2C9/MFC</th><th class="colsep0 rowsep0" align="center" char=".">2C19/CEC</th><th class="colsep0 rowsep0" align="center" char=".">2D6/AMMC</th><th class="colsep0 rowsep0" align="center" char=".">1A2/CEC</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1h</b></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1i</b></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1j</b></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1k</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1l</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1m</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1n</b></td><td class="colsep0 rowsep0" align="char" char="."><0.1</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">7-Benzyloxy-4-(trifluoromethyl)-coumarin (BFC), dibenzylfluorescein (DBF), 7-methoxy-4-trifluoromethylcoumarin (MFC), 3-cyano-7-ethoxycoumarin (CEC), 3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin (AMMC).</p></div></div></div><div class="NLM_p last">Whereas compounds <b>1i</b>–<b>n</b> inhibited between one and three of the CYP isozymes at single-digit micromolar or submicromolar concentrations, compound <b>1h</b> did not show inhibitory activity against any of the isoforms up to the 10 μM concentration and was selected for further profiling.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Activity and Selectivity Profile of Compound <b>1h</b></h3><div class="NLM_p">The selectivity of <b>1h</b> was first evaluated by testing it against our in-house panel of 76 protein kinases. Compound <b>1h</b> inhibited FGFR1, FGFR2, and FGFR3 with IC<sub>50</sub> = 1 nM, FGFR3-K650E with IC<sub>50</sub> = 4.9 nM, and FGFR4 with IC<sub>50</sub> = 60 nM. IC<sub>50</sub> values for all other kinases were greater than 10 μM (see <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>) or in the μM range (FYN, LCK, YES, and ABL) except for VEGFR2, KIT, and LYN, which were inhibited at submicromolar concentrations of the compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selectivity of <b>1h</b> in a Panel of Kinases<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="char" char=".">0.0010</td><td class="colsep0 rowsep0" align="left">ABL</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3-K650E</td><td class="colsep0 rowsep0" align="char" char=".">0.0049</td><td class="colsep0 rowsep0" align="left">FYN</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="char" char=".">0.0009</td><td class="colsep0 rowsep0" align="left">KIT</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR2</td><td class="colsep0 rowsep0" align="char" char=".">0.0014</td><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR4</td><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="left">LYN</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR2</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="left">YES</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">All assays were performed with purified recombinant enzymes under optimized conditions using peptidic substrates and a microfluidic mobility shift readout (Caliper lifesciences, Moutain View, CA, USA). The concentrations for ATP were adjusted to the respective <i>K</i><sub>m</sub> values of the kinase.</p></div></div></div><div class="NLM_p">At the cellular level, the selectivity of <b>1h</b> was determined by measuring its ability to inhibit the proliferation of a panel of 31 BaF3 cell lines. The data summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> show that <b>1h</b> inhibited the proliferation of the FGFR1-, FGFR2-, and FGFR3-dependent BaF3 cells with IC<sub>50</sub> values which were in the low nanomolar range and comparable to those observed for the inhibition of the receptors kinase activity in the enzymatic assay. For the remaining cells, all IC<sub>50</sub> values were greater than 1.5 μM (see <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>) except for VEGFR2 (IC<sub>50</sub> 1449 and 938 nM), for which there was at least a 400-fold selectivity versus FGFR1, FGFR2, and FGFR3.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity of <b>1h</b> in a Panel of BaF3 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">BaF3 cells</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">BaF3 cells</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">VEGFR2-Q<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">938</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3-Q<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="left">VEGFR1-Q<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1510</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3-K650E</td><td class="colsep0 rowsep0" align="char" char=".">52.2</td><td class="colsep0 rowsep0" align="left">VEGFR3-Q<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">2072</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="left">BCR-ABL</td><td class="colsep0 rowsep0" align="char" char=".">2192</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR2-Q<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="left">KIT-Q<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">2501</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR2</td><td class="colsep0 rowsep0" align="char" char=".">1449</td><td class="colsep0 rowsep0" align="left">LYN</td><td class="colsep0 rowsep0" align="char" char=".">3019</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Q indicates presence of juxtamembrane domain in the TEL-kinase construct.</p></div></div></div><div class="NLM_p">Because activation of FGFRs results in autophosphorylation on specific tyrosine residues, the ability of <b>1h</b> to interfere with FGFR kinase activity at the cellular level was determined by monitoring changes in the phosphotyrosine content of the receptor by means of a capture ELISA assay. Four cell capture ELISA assays that detect pFGFR1, pFGFR2, pFGFR3, and pFGFR4, respectively, were developed using HEK293 cells transfected with expression vectors encoding for the indicated FGFRs. The data summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> show that <b>1h</b> inhibited FGFR1, FGFR2, and FGFR3 with a 5 nM IC<sub>50</sub> and to a lesser extent FGFR4, in agreement with the trend observed in the biochemical assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Cellular Activity of <b>1h</b> in Cell Capture ELISA Assay for pFGFR1-4</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">receptor</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">FGFR1-WT</th><th class="colsep0 rowsep0" align="center" char=".">FGFR2-WT</th><th class="colsep0 rowsep0" align="center" char=".">FGFR3-K650E</th><th class="colsep0 rowsep0" align="center" char=".">FGFR3-S249C</th><th class="colsep0 rowsep0" align="center" char=".">FGFR4-WT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">168</td></tr></tbody></table></div></div><div class="NLM_p">With the aim of developing a disease model to assess the efficacy of <b>1h</b>, we tested the compound against a panel of eight human bladder cancer cell lines. In accordance to the observed selectivity profile, <b>1h</b> suppressed proliferation of the cancer cells with wild-type (WT) FGFR3 overexpression but not those lacking this receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Owing to their ability to grow in vivo, the RT112 cells were used to establish disease models in rodents.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Cellular Activity of <b>1h</b> in a Panel of Bladder Cancer Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center" char=".">cell line</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">RT112<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">RT4<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">SW780<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">JMSU1<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HT1197</th><th class="colsep0 rowsep0" align="center" char=".">VMCUB1</th><th class="colsep0 rowsep0" align="center" char=".">UMUC3</th><th class="colsep0 rowsep0" align="center" char=".">J82</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">1157</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Bladder cancer cell lines overexpressing WT FGFR3.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Pharmacokinetics of Compound <b>1h</b> in Rodents</h3><div class="NLM_p">Compound <b>1h</b> was administered to athymic nude mice implanted subcutaneously with RT112/luc1 tumors: either as a 5 mg/kg intravenous bolus in NMP/PEG200 (1:9, v/v) or orally by gavage as a suspension in PEG300/D5W (2:1, v/v) at a 20 mg/kg dose. The relevant pharmacokinetic (PK) parameters reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a> indicate that the oral bioavailability of <b>1h</b> in this study was 32%. After intravenous dosing, the compound showed a rapid distribution from the vascular compartment into the peripheral tissues, translating into a high volume of distribution (26 L/kg). The plasma clearance was high at 3.3 L/h/kg (61% of liver blood flow). The ratio of tumor to plasma after oral dosing based on AUC was determined to be 10.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetic Properties of <b>1h</b> in RT112 Tumor-Bearing Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">iv dose (5 mg/kg)</th><th class="rowsep1 colsep0" colspan="2" align="center">po dose (20 mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">unit</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">tumor</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">tumor</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">μM or nmol/g<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.86</td><td class="colsep0 rowsep0" align="left">1.68</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">1.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">9.3</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">μM·h or h·nmol/g<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">1.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL</td><td class="colsep0 rowsep0" align="left">L/h/kg</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub></td><td class="colsep0 rowsep0" align="left">L/kg</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">%</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Plasma in μM, tissues in nmol/g.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Dose normalized to 1 mg/kg.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Plasma in μM·h, tissues in h·nmol/g.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Bioavailability (<i>F</i><sub>po</sub>) is calculated as dose-normalized AUC<sub>po</sub> /AUC<sub>iv</sub> extrapolated to infinity.</p></div></div></div><div class="NLM_p">Compound <b>1h</b> was administered intravenously to the femoral vein of female Wistar rats as a 5 mg/kg intravenous bolus in NMP/PEG200 (1:9, v/v). The monophosphate salt of <b>1h</b> was dosed as an oral solution in acetic acid–acetate buffer pH 4.6/PEG300 (1:1, v/v) at 10 mg/kg. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>, the estimated mean systemic plasma clearance of <b>1h</b> was high (3.6 L/h/kg) as compared to the hepatic blood flow (3.3 L/h/kg), while the estimated volume of distribution at steady state (<i>V</i><sub>ss</sub>, 9.6 L/kg) was very high compared to the total body water volume in rats (0.66 L/kg). The apparent terminal elimination half-life in plasma was around 5 h after both intravenous and oral administration. The oral bioavailability of <b>1h</b> in this study was 51%.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Properties of <b>1h</b> in Wistar Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">unit</th><th class="colsep0 rowsep0" align="center">iv dose (5 mg/kg)</th><th class="colsep0 rowsep0" align="center">po dose (10 mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">μM or nmol/g<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.97<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">μM·h</td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL</td><td class="colsep0 rowsep0" align="left">L/h/kg</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub></td><td class="colsep0 rowsep0" align="left">L/kg</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>po</sub><a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">%</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Plasma in μM, tissues in nmol/g.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Determined 5 min postadministration.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Dose normalized to 1 mg/kg.</p></div><div class="footnote" id="t9fn4"><sup>d</sup><p class="last">Bioavailability (<i>F</i><sub>po</sub>) is calculated as dose-normalized AUC<sub>po</sub> /AUC<sub>iv</sub> extrapolated to infinity.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Antitumor Activity of Compound <b>1h</b></h3><div class="NLM_p">The antitumor activity of <b>1h</b> was evaluated in an orthotopic xenograft bladder cancer model based on the human bladder cancer cell line RT112 which overexpresses FGFR3. To establish this model, the parental RT112 cell line was stably infected with a retrovirus that constitutively expresses luciferase (pLNCX2/luc1) to generate RT112/luc1 cells which were suspended in 50% Matrigel and injected into the bladder lumen of female HsdNpa: Athymic Nude-nu mice (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Growth kinetics of orthotopically growing RT112/luc1 bladder cancer cells. Tumor burden was monitored by measuring light emission after intravenous injection of <span class="smallcaps smallerCapital">d</span>-luciferin. Representative Xenogen IVIS images from 1, 5, 13, 22, 29, and 34 days after inoculation. One animal (top right in each frame) was inoculated subcutaneously for comparison. The pseudocolor gradient of each image has been adjusted to the same scale (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At 34 days after inoculation, the bladders of the tumor bearing animals were increased in size due to the tumor mass compared with a normal bladder. Histological analysis demonstrated that the tumors invade through the bladder wall during the late stages of the study (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Orthotopically growing RT112/luc1 bladder tumors dissected 34 days after inoculation. Left: Three tumor-filled bladders dissected from RT112/luc1 bladder tumor carrying mice. A noninoculated normal bladder (WT) is shown for comparison. Right: Histology of a representative tumor invading through the bladder wall.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When tested in this orthotopic xenograft bladder cancer model, <b>1h</b> induced tumor growth inhibition and stasis after oral administration for 12 consecutive days at the doses of 10 and 30 mg/kg, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The experiment was terminated prematurely at treatment day 12 due to a 15% body weight loss observed in the vehicle treated animals as a consequence of the disease progression. Interestingly, the animals that received <b>1h</b> exhibited either no body weight loss (10 mg/kg) or 10% body weight gain (30 mg/kg), a further indication of efficacy.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tumors were established in female HsdNpa: Athymic Nude-nu  mice by orthotopic inoculation of 5 × 10<sup>5</sup> cells per animal. Daily treatment with compound <b>1h</b> administered orally as a suspension in PEG300/D5W (2:1, v/v) at 0, 10, and 30 mg/kg was initiated 14 days after inoculation. (A) Light emission from tumor bearing animals during 12 days treatment as a measure of tumor burden. (B) Body weight measurements during the treatment. Data are presented as means ± SEM *<i>p</i> < 0.05; ANOVA post hoc Dunnett’s versus vehicle treated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A subcutaneous tumor model using the RT112 human bladder cancer xenograft in rats was established with the aim to determine the correlation between efficacy and tolerability of <b>1h</b> in this species. The monophosphate salt of <b>1h</b> was orally administered to juvenile, immunocompromised, female Rowett rats (<i>n</i> = 8) for 20 consecutive days (20 administrations) at the doses of 5, 10, and 15 mg/kg/qd (free base equivalents). Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> shows the mean tumor growth and mean body weight changes in the course of treatment. Nearly complete tumor stasis was achieved at the lowest dose while no overt toxicity (morbidity or body weight loss) was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The doses of 10 and 15 mg/kg provided tumor regression (66% and 73%, respectively) which was accompanied by a dose-dependent decrease of body weight (4% and 9%, respectively).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Antitumor activity of compound <b>1h</b> against RT112 human bladder cancer xenografts implanted subcutaneously in immuno-compromised, female Rowett rats. (B) Body weight measurements during the treatment. Data are presented as means ± SEM *<i>p</i> < 0.05, ***<i>p</i> < 0.001; ANOVA post hoc Dunnett’s versus vehicle treated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The relationship between antitumor efficacy and inhibition of the molecular target in vivo was assessed in an independent study. Thus, RT112 tumor-bearing, female Rowett rats (<i>n</i> = 4) received a single oral administration of the monophosphate salt of <b>1h</b> at the doses of 4.25 and 8.51 mg/kg (free base equivalents) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Tumors were collected at various time points post-therapy for compound concentration determination and pharmacodynamic (PD) analysis. Because FGFRs mediate several cellular responses via phosphorylation of the membrane-anchored docking protein FRS2 which links the activated RTK to intracellular pathways (e.g., Ras-MAPK pathway),<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> pFRS2 and the downstream pMAPK were used as PD markers. Compound <b>1h</b> significantly decreased the levels of pFRS2 and pMAPK in a dose-dependent manner. Whereas only partial inhibition of the two markers was observed at the lower dose, their phosphorylation was almost completely abolished up to 16 h in the group treated with the 8.51 mg/kg dose. The inhibitory effect diminished in a time-dependent manner and was completely relieved 24 h postdosing, correlating with compound elimination from the tumor tissue.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. RT112 xenograft tumors were dissected at the indicated time points postdosing (<i>n</i> = 4), lysed, and analyzed by Western blot for concentration of <b>1h</b>, FRS2 Tyr-phosphorylation (pFRS2), and MAPK activation (pMAPK). Protein loading was monitored by analyzing the lysates for total FRS2 protein, total MAPK protein, or β-tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vivo Antiangiogenic Activity of Compound <b>1h</b></h3><div class="NLM_p">The ability of <b>1h</b> to inhibit angiogenesis induced by either bFGF or VEGF was tested in vivo in an agar chamber model. Compound <b>1h</b> was administered orally in doses of 10, 30, and 50 mg/kg daily for 4 consecutive days to female FVB mice implanted subcutaneously with either bFGF or VEGF containing chambers. Upon removal of the chambers 24 h after the last dose, the angiogenic response was quantified by measuring the weight and the Tie-2 (a receptor tyrosine kinase specifically expressed on endothelial cells) levels of the vascularized tissue grown around the chamber (capsule). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, compound <b>1h</b> inhibited significantly bFGF-stimulated angiogenesis in a dose-dependent manner. However, it did not impair VEGF-induced blood vessel formation. This result demonstrates the selectivity of <b>1h</b> for FGFR versus VEGFR.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of <b>1h</b> treatment on the capsule weight and Tie-2 levels in bFGF (A) or VEGF (B) containing porous chambers implanted subcutaneously in the flank of FVB mice. Animals were treated orally either with <b>1h</b> at 10, 30, and 50 mg/kg or vehicle (NMP/PEG300 10%, 5 mL/kg) starting 4–6 h before implantation of the chambers and daily for 3 additional days. Values are mean ± SEM *<i>p</i> < 0.05, statistical significance of inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Docking of <b>1h</b> to FGFR3 Kinase Domain Model and X-ray Structure of the FGFR1–Compound <b>1h</b> Complex</h3><div class="NLM_p">The proposed binding mode of <b>1h</b> in the FGFR3 catalytic site and a summary of the interactions of the inhibitor with the enzyme are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Binding model of <b>1h</b> to the FGFR3 kinase domain homology model showing interacting residues. Hydrogen bonds are indicated by turquoise dashes. (B) Summary of the interactions of <b>1h</b> within the ATP binding site of FGFR3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">According to this model, the 4-(4-ethyl-piperazin-1-yl)-phenylamine NH and the adjacent pyrimidine nitrogen of <b>1h</b> are involved in critical H-bonds with the carbonyl and the amino group of alanine 558 (an amino acid residue located in the hinge region of the ATP-binding pocket), respectively. An additional H-bond occurs between the backbone carbonyl group of glutamic acid 556 (hinge region) and the pyrimidine C(2)-H, which behaves as a H-bond donor by virtue of the polarization induced by the two adjacent nitrogen atoms. It is noteworthy that the urea carbonyl group might also be engaged in a water-mediated H-bond (not shown) with the side chain amino group of lysine 508, whereas the aryl ring of the 4-(4-ethyl-piperazin-1-yl)-phenylamine is in contact with the hydrophobic side chains of two amino acid residues glycine 561 and leucine 478 (the latter not represented for clarity) in a sandwich-like manner.</div><div class="NLM_p">The optimized substitution pattern of the urea aniline is responsible for productive interactions such as the H-bond between the methoxy oxygen and the NH of aspartate 635 in addition to further hydrophobic contacts. The optimal fitting of the tetra-substituted phenyl ring in the complementary hydrophobic cavity results from the perpendicular orientation of this ring with respect to the plane of the pseudobicyclic system. Such a rigid orthogonal arrangement is enforced by the two chlorine atoms which prevent aromatic conjugation. These atoms are involved in favorable contacts with the gate keeper valine 555 and with alanine 634, respectively. Interestingly, the latter amino acid is replaced by a cysteine residue in VEGFR2. The increased steric hindrance of cysteine compared to alanine might account for an energy penalty in order for the VEGF receptor to accommodate <b>1h</b> in its ATP binding site, thus providing a potential rationale for the selectivity of the compound against this receptor.</div><div class="NLM_p">More generally, the model suggests that the specificity of <b>1h</b> for the FGFR kinases originates in an optimal fit of the dichloro-dimethoxy phenyl moiety to the particular shape of the ATP site back pocket observed in the available crystal structures of these enzymes (FGFR1 and FGFR2). This stems from the conjunction of a small valine gate keeper residue, a small alanine residue preceding the DFG motif (A634 in FGFR3), and a particular rotameric state of the side chain of the phenylalanine residue in the DFG motif (F636 in FGFR3). This unusual side chain conformation having only been observed in the crystal structures of FGFR kinases.</div><div class="NLM_p">The above binding model could be validated by the determination of the crystal structure of the FGFR1 kinase domain in complex with <b>1h</b> at 2.8 Å resolution. All the putative interactions, described in Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, between the inhibitor and the equivalent residues in FGFR1 which are all conserved (as well as in FGFR2 and FGFR4) are indeed observed in this crystal structure. In particular, the speculated water mediated hydrogen bond between the urea carbonyl group of the inhibitor and the side chain of lysine 508 (K514 in FGFR1) exists in the X-ray structure. A representation of the ATP site region of the cocrystal structure is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. X-ray structure of the <b>1h</b>–FGFR1 complex (RCSB ID: rcsb067881. PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI">3TT0</a>). Hydrogen bonds are indicated by pale cyan circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of Compounds <b>1a</b>–<b>n</b></h3><div class="NLM_p">Compounds <b>1a</b>–<b>n</b> were prepared by addition of pyrimidine-4,6-diamines <b>16</b>–<b>25</b> to the isocyanates obtained by treatment of anilines <b>26</b>–<b>30</b> with phosgene (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of <i>N</i>-Aryl-<i>N</i>′-pyrimidin-4-yl Ureas<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>NH<sub>2</sub>, 25% NH<sub>3</sub> in H<sub>2</sub>O, 33% MeNH<sub>2</sub> in EtOH or 70% EtNH<sub>2</sub> in H<sub>2</sub>O, <i>i</i>-PrOH, RT; (b) R<sub>2</sub>NH<sub>2</sub> (<b>8</b>–<b>15</b>), CH<sub>3</sub>COOH/H<sub>2</sub>O, 100 °C or 4 N HCl in dioxane, 150 °C; (c) 20% COCl<sub>2</sub> in toluene, dioxane, reflux; (d) toluene, 70 °C or reflux.</p></p></figure><div class="NLM_p">Treatment of 4,6-dichloropyrimidine (<b>4</b>) with either aqueous ammonia, ethanolic methylamine, or aqueous ethylamine afforded 4-amino-6-chloropyrimidines <b>5</b>, <b>6</b>, and <b>7</b>, respectively, which underwent subsequent reaction with aniline <b>8</b> to provide the corresponding diaminopyrimidines <b>16</b>, <b>17</b>, and <b>18</b>. The pyrimidine-4,6-diamine analogues <b>19</b>–<b>25</b> were prepared similarly from compound <b>6</b> and amines <b>9</b>–<b>15</b>. These reactions were carried out using either aqueous acetic acid or 4 N hydrochloric acid in dioxane, the latter being a convenient alternative to acetic acid when the acetylation of the aniline is predominant to the desired substitution of the chlorine atom. The structures of commercially available anilines <b>8</b>, <b>10</b>, <b>15</b>, and <b>28</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>.</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of anilines <b>8</b>, <b>10</b>, <b>15</b>, and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Anilines <b>9</b>, <b>11</b>–<b>14</b> were prepared according to the synthetic routes described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Anilines <b>9</b>, <b>11</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (A) (a) 80 °C, 15 h (89%); (b) Raney Ni, H<sub>2</sub>, MeOH, 25 °C, 7 h (98%). (B) (a) NaOH, DMF, 75 °C, 2 h (92%). (C) (a) (<i>t</i>-Bu)<sub>3</sub>P, Pd(PhCN)<sub>2</sub>Cl<sub>2</sub>, CuI, dioxane, 25 °C, 22 h (90%); (b) 10% Pd on carbon, H<sub>2</sub>, EtOH, 25 °C, 22 h (68%). (D) (a) H<sub>2</sub>SO<sub>4</sub>, HNO<sub>3</sub>, CH<sub>3</sub>COOH (47%); (b) CH<sub>3</sub>CHO, Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, 5 °C, 1 h (70%); (c) 10% Pd on carbon, H<sub>2</sub>, EtOH, 25 °C, 3 h (33%). (E) (a) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 15 h (100%); (b) Raney Ni, H<sub>2</sub>, MeOH, 25 °C, 5 h (84%).</p></p></figure><div class="NLM_p">With the exception of <b>11</b>, these anilines were prepared from the corresponding nitrobenzene precursors. Thus, amine <b>9</b> was the product of the Raney nickel-catalyzed hydrogenation of 1-ethyl-4-(4-nitro-phenyl)-piperazine <b>31</b>, obtained by reacting 1-bromo-4-nitrobenzene and 1-ethylpiperazine at 80 °C for 15 h (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>A). Aniline <b>11</b> could instead be synthesized by etherification of 4-aminophenol with 1-(2-chloroethyl)-pyrrolidine hydrochloride using finely powdered sodium hydroxide in DMF (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>B). It is noteworthy that an efficient mechanical stirring of the suspension was critical in order to ensure the high-yielding formation of the desired product. Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>C illustrates the preparation of aniline <b>12</b> by Sonogashira coupling of 3-dimethylamino-1-propyne with 1-bromo-4-nitrobenzene and subsequent hydrogenation of the resulting product (<b>32</b>) in the presence of palladium on carbon. Compound <b>13</b> was synthesized according to a three-step protocol involving the nitration of 4-phenylpiperidine, the reductive ethylation of <b>33</b>, and the catalytic hydrogenation of the corresponding nitro derivative <b>34</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>D). Nitrobenzene <b>35</b>, derived from the alkylation of 3-nitrobenzylchloride with 1-methylpiperazine in the presence of potassium carbonate, was reduced to aniline <b>14</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>E) in analogy to the protocol used for the synthesis of amine <b>9</b>.</div><div class="NLM_p">The preparation of anilines <b>27</b> and <b>30</b> was carried out according to a two-step protocol starting from acetamide <b>36</b>, readily accessible by acetylation of 3,5-dimethoxyaniline (<b>26</b>) (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Anilines <b>27</b> and <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) acetic anhydride, toluene, 25 °C (97%); (b) sodium chlorate, acetic acid, 32% HCl (in H<sub>2</sub>O), 0 °C (47%); (c) SO<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, 0 °C (58%); (d) 2 N KOH, ethanol (<b>27</b>, 100%; <b>30</b>, 92%).</p></p></figure><div class="NLM_p">The extent of the chlorination of <b>36</b> could be modulated by the appropriate selection of the ratio between <b>36</b> and the reagent utilized as the chlorine source. While compound <b>36</b> reacted with a substoichiometric amount of sodium chlorate to afford 2-chloro-substituted amide <b>37</b>, the use of an excess of sulfuryl chloride provided the 2,6-dichloro analogue (<b>38</b>). Conversion of <b>37</b> and <b>38</b> to the corresponding anilines (<b>27</b> and <b>30</b>, respectively) was accomplished by hydrolytic deacetylation under basic conditions (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_p">Aniline <b>29</b> was synthesized by treatment of commercially available 2,4-dichloro-3-aminophenol hydrochloride (<b>39</b>) with potassium hydroxide in acetone and subsequent methylation with dimethyl sulfate (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aniline <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) dimethyl sulfate, KOH, acetone, 25 °C (91%).</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Following an original scaffold morphing concept and exploiting crystallographic information, we have identified <i>N</i>-aryl-<i>N</i>′-pyrimidin-4-yl-urea compounds as a new class of potent and selective FGFR inhibitors. Evaluation of reversible inhibition of a panel of human CYP450 enzymes by the most potent derivatives in this series indicated <b>1h</b> as the one exhibiting the least likelihood for drug–drug interactions. Preliminary assessment of the pharmacokinetic properties of <b>1h</b> in mice and rats revealed that the compound was orally bioavailable in rodents, thus justifying additional studies to determine its anticancer efficacy in vivo. Compound <b>1h</b> potently inhibited the proliferation of bladder cancer cells overexpressing wild-type FGFR3 and demonstrated significant dose-dependent antitumor activity in RT112 bladder cancer xenografts correlating with the inhibition of the pharmacodynamic markers, pFRS2 and pMAPK, in the tumor. These results support further evaluation of this novel inhibitor with the aim to assess its therapeutic potential in those malignancies characterized by FGF/FGFR genetic alterations.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemistry</h3><div class="NLM_p last">Proton magnetic resonance spectra were recorded on either a Varian Mercury 400 MHz or a Bruker Avance 600 MHz spectrometer. Carbon magnetic resonance spectra were recorded on a Bruker Avance 600 MHz spectrometer. High-resolution mass spectra were recorded on a THERMO LTQ Orbitrap XL mass spectrometer. Column chromatography was performed on Merck silica gel 60 (particle size of 40–63 μm). Analytical high-pressure liquid chromatography (HPLC) analyses were conducted using: (i) a Hewlett-Packard 1100 series system, UV detection at 215 nm; a column Nucleosil 100–3 C18 4 mm × 70 mm, a linear gradient from 20% to 100% A over 5 min and then 100% B for 1.5 min (A = CH<sub>3</sub>CN + 0.1% CF<sub>3</sub>COOH and B = H<sub>2</sub>O + 0.1% CF<sub>3</sub>COOH), flow rate 1 mL/min, temperature 30 °C (HPLC 1); (ii) a Waters system equipped with a CTC Analytics HTS PAL autosampler, 515 pumps, UV detection at 210 nm, a column Nucleosil 100–3 C18 3 mm × 70 mm, a linear gradient from 0% to 95% A over 6.6 min and then 95% A for 4.4 min (A = CH<sub>3</sub>CN + 20% H<sub>2</sub>O + 0.1% H<sub>3</sub>PO<sub>4</sub> (85%) + 1% (CH<sub>3</sub>)<sub>4</sub>NOH (10%) and B = H<sub>2</sub>O + 0.2% H<sub>3</sub>PO<sub>4</sub> (85%) + 2% (CH<sub>3</sub>)<sub>4</sub>NOH (10%)), flow rate 1.2 mL/min, temperature, 45 °C (HPLC 2). Purities for final compounds were measured by analytical HPLC and are ≥95.0%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (<b>1h</b>): Procedure A</h3><div class="NLM_p last">To a stirred solution of <b>30</b> (2.03 g, 9.2 mmol) in dioxane (25 mL) was added 20% phosgene in toluene (8.1 mL, 15.3 mmol), under an argon atmosphere. The resulting mixture was heated to reflux for 1 h, allowed to cool to room temperature, and concentrated in vacuo. The solid residue was added portionwise to a solution of <b>19</b> (2.39 g, 7.7 mmol) in toluene (70 mL), under argon. After the end of the addition, the reaction mixture was heated to reflux, stirred for 1.5 h, allowed to cool to room temperature, and diluted with CH<sub>2</sub>Cl<sub>2</sub> and a saturated aqueous solution of NaHCO<sub>3</sub>. The aqueous layer was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Purification of the crude product by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aqueous NH<sub>3</sub>, 96:3:1), followed by trituration of the resulting material with MeOH, provided 1.79 g of the desired product (batch 1). Mixed fractions were combined and concentrated. The residue was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/aqueous NH<sub>3</sub>, 94:5:1), followed by trituration of the resulting material with MeOH, to give additional 1.26 g of pure product (batch 2). The two batches were combined to afford <b>1h</b> (3.05 g, 71%) as a colorless solid. HPLC <i>t</i><sub>R</sub> = 3.53 min (HPLC 1). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.02 (t, <i>J</i> = 7.1 Hz, 3 H), 2.35 (q, <i>J</i> = 7.2 Hz, 2 H), 2.41–2.50 (m, 4 H), 3.03–3.12 (m, 4 H), 3.29 (s, 3 H), 3.93 (s, 6 H), 6.39 (s, 1 H), 6.89 (s, 1 H), 6.91 (d, <i>J</i> = 9.2 Hz, 2 H), 7.39 (d, <i>J</i> = 8.3 Hz, 2 H), 8.37 (s, 1 H), 9.44 (s, 1 H), 12.05 (s, 1 H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.0, 31.7, 48.6 (2 C), 51.6, 52.4 (2 C), 56.7 (2 C), 89.8, 96.6, 112.6 (2 C), 115.8 (2 C), 122.0 (2 C), 134.5, 147.3, 152.8, 154.2 (3 C), 155.9, 159.2, 161.7. HRMS for C<sub>26</sub>H<sub>32</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>3</sub> (M + H)<sup>+</sup> calcd 560.1937, found 560.1938.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Preparation of the Monophosphate Salt of Compound <b>1h</b></h3><div class="NLM_p last">A suspension of <b>1h</b> (134 g, 240 mmol) in 2-propanol (2000 mL) was heated to 50 °C with stirring. To this suspension was added portionwise a solution of phosphoric acid (73.5 g, 750 mmol) in water (2000 mL). The mixture was stirred at 60 °C for 30 min and filtered through a polypropylene pad. The pad was washed with warm 2-propanol/water (1:1, 200 mL). The filtrates were combined to provide a clear solution to which 2-propanol (6000 mL) was added. The resulting mixture was stirred under reflux for 20 min, cooled slowly to room temperature, and stirred for 24 h. The white salt product was collected by filtration, washed with 2-propanol (2 × 500 mL), and dried in the oven at 60 °C under reduced pressure over two days to give the monophosphate salt of compound <b>1h</b> (110 g, 70%): Anal. Calcd for C<sub>26</sub>H<sub>34</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>7</sub>P (658.49): C, 47.42; H, 5.20; Cl, 10.77; N, 14.89; O, 17.01; P, 4.70. Found: C, 47.40; H, 5.11; Cl, 10.73; N, 14.71; O, 17.18; P, 4.87.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (6-Chloro-pyrimidin-4-yl)-methyl-amine (<b>6</b>)</h3><div class="NLM_p last">To a suspension of 4,6-dichloropyrimidine (<b>4</b>, 20 g, 132 mmol) in 2-propanol (60 mL) was added 33% methylamine in ethanol (40 mL, 329 mmol) at such a rate that the internal temperature did not rise above 50 °C. After completion of the addition, the reaction mixture was stirred for 1 h at room temperature. Water (50 mL) was added, and the resulting suspension was cooled in an ice bath to 5 °C. The precipitated product was filtered off and washed with cold 2-propanol/water (2:1, 45 mL) and water. The collected material was dried in vacuo at 45 °C overnight to afford <b>6</b> (16.2 g, 86%) as colorless powder. HPLC <i>t</i><sub>R</sub> = 3.57 min (HPLC 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.99 (d, <i>J</i> = 4.3 Hz, 3 H), 5.31 (br s, 1 H), 6.39 (s, 1 H), 8.38 (s, 1 H). ESI-MS: 144.3 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(4-Ethylpiperazin-1-yl)-phenylamine (<b>9</b>)</h3><div class="NLM_p last">A mixture of <b>31</b> (6.2 g, 26.35 mmol) and Raney nickel (2 g) in MeOH (120 mL) was stirred for 7 h at room temperature, under a hydrogen atmosphere. The reaction mixture was filtered through a pad of Celite. The filtrate was concentrated to afford <b>9</b> (5.3 g, 98%) as a violet solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.03 (t, <i>J</i> = 7.23 Hz, 3 H), 2.37 (q, <i>J</i> = 7.3 Hz, 2 H), 2.45–2.55 (m, 4 H), 2.85–2.95 (m, 4 H), 4.59 (br s, 2 H), 6.47–6.53 (m, 2 H), 6.66–6.72 (m, 2 H). ESI-MS: 206.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-[4-(4-Ethyl-piperazin-1-yl)-phenyl]-<i>N</i>′-methyl-pyrimidine-4,6-diamine (<b>19</b>)</h3><div class="NLM_p last">A mixture of <b>6</b> (1.81 g, 12.7 mmol) and <b>9</b> (2 g, 9.8 mmol) in a mixture of water (4 mL) and glacial acetic acid (20 mL) was heated to 100 °C for 16 h. After further addition of <b>6</b> (0.5 g, 3.5 mmol), the reaction mixture was stirred for additional 24 h at 100 °C, cooled, and concentrated. The resulting aqueous residue was made basic by addition of a saturated aqueous solution of NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was triturated in ethyl acetate to afford <b>19</b> (2.13 g, 70%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05 (t, <i>J</i> = 7.23 Hz, 3 H), 2.39 (q, <i>J</i> = 7.0 Hz, 2 H), 2.65–2.75 (m, 4 H), 3.05–3.15 (m, 4 H), 3.30–3.35 (m, 3 H), 5.60 (s, 1 H), 6.70 (d, <i>J</i> = 4.7 Hz, 1 H), 6.89 (d, <i>J</i> = 9.0 Hz, 2 H), 7.31 (d, <i>J</i> = 8.6 Hz, 2 H), 8.02 (s, 1 H), 8.60 (br s, 1 H). ESI-MS: 313.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2,6-Dichloro-3,5-dimethoxy-phenylamine (<b>30</b>)</h3><div class="NLM_p last">To a solution of <b>38</b> (34.5 g, 264 mmol) in ethanol (1300 mL) was added 2 N KOH (720 mL). The reaction mixture was heated to reflux, stirred for 44 h, and allowed to cool to room temperature. The resulting suspension was cooled to 0 °C, stirred for 1 h, and filtered. The residue was washed with a small portion of cold ethanol/water (1:1) and with cold water until neutrality and dried to provide <b>30</b> (26.7 g, 92%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.85 (s, 6 H), 5.44 (s, 2 H), 6.24 (s, 1 H). ESI-MS: 222.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-Ethyl-4-(4-nitro-phenyl)-piperazine (<b>31</b>)</h3><div class="NLM_p last">A mixture of 1-bromo-4-nitrobenzene (6 g, 29.7 mmol) and 1-ethylpiperazine (7.6 mL, 59.4 mmol) was heated to 80 °C and stirred for 15 h. The reaction mixture was allowed to cool to room temperature and diluted with water and CH<sub>2</sub>Cl<sub>2</sub>/MeOH (9:1). The aqueous layer was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (9:1). The organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH + 1% of aqueous NH<sub>3</sub>, 9:1) to afford <b>31</b> (6.2 g, 89%) as a yellow solid: HPLC <i>t</i><sub>R</sub> = 2.35 min (HPLC 1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05 (t, <i>J</i> = 7.2 Hz, 3 H), 2.39 (q, <i>J</i> = 7.0 Hz, 2 H), 2.44–2.57 (m, 4 H), 3.45–3.50 (m, 4 H), 7.05 (d, <i>J</i> = 9.4 Hz, 2 H), 8.07 (d, <i>J</i> = 9.4 Hz, 2 H). ESI-MS: 236.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(3,5-Dimethoxy-phenyl)-acetamide (<b>36</b>)</h3><div class="NLM_p last">Acetic anhydride (13 mL, 137 mmol, 1.05 equiv) was added in 15 min to a suspension of 3,5-dimethoxyaniline (<b>26</b>, 20 g, 131 mmol) in toluene (110 mL), keeping the internal temperature in the range of 35–45 °C. The reaction mixture was allowed to stir for 20 h at room temperature. The resulting thick, gray suspension was diluted with hexane (55 mL) and filtered. The residue in the filter was washed with toluene/hexane (2:1, 70 mL) and hexane and dried to provide <b>36</b> (24.8 g, 97%) as a colorless solid. HPLC <i>t</i><sub>R</sub> = 3.03 min (HPLC 1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.03 (s, 3 H), 3.71 (s, 6 H), 6.21 (t, <i>J</i> = 2.1 Hz, 1 H), 6.84 (d, <i>J</i> = 2.3 Hz, 2 H), 9.89 (s, 1 H). ESI-MS: 196.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(2,6-Dichloro-3,5-dimethoxy-phenyl)-acetamide (<b>38</b>)</h3><div class="NLM_p last">Sulfuryl chloride (26.9 mL, 325 mmol) was added in 7 min to a cold (0 °C) suspension of <b>36</b> (32.9 g, 169 mmol) in CH<sub>3</sub>CN (500 mL), under an argon atmosphere. The resulting yellowish mixture was allowed to stir for 30 min and quenched by dropwise addition of a saturated aqueous solution of NaHCO<sub>3</sub> (250 mL). The resulting precipitate was collected by vacuum filtration, washed with H<sub>2</sub>O (300 mL), and dried to afford 20 g of the desired product (batch 1). The filtrate was diluted with a saturated aqueous solution of NaHCO<sub>3</sub> (300 mL) and extracted with ethyl acetate (2 × 300 mL). The organic phase was washed with H<sub>2</sub>O and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue is purified by silica gel column chromatography (ethyl acetate/hexanes, 1:1 → 2:1) to provide 8.8 g of product (batch 2). Batch 1 and 2 were combined and stirred in hexane. The solid was collected by filtration, washed with hexane, and dried to afford <b>38</b> (25.8 g, 58%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.05 (s, 3 H), 3.94 (s, 6 H), 6.90 (s, 1 H), 9.76 (s, 1 H). ESI-MS: 264.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Radiometric Kinase Assay</h3><div class="NLM_p last">The enzymatic kinase activity was assessed by measuring the phosphorylation of a synthetic substrate by the purified GST-fusion FGFR3-K650E kinase domain, in the presence of radiolabeled ATP. Enzyme activities were measured by mixing 10 μL of a 3-fold concentrated compound solution or control with 10 μL of the corresponding substrate mixture (peptidic substrate, ATP and [γ<sup>33</sup>P]ATP). The reactions were initiated by addition of 10 μL of a 3-fold concentrated solution of the enzyme in assay buffer. The final concentrations of the assay components were as following: 10 ng of GST-FGFR3-K650E, 20 mM Tris-HCl, pH 7.5, 3 mM MnCl<sub>2</sub>, 3 mM MgCl<sub>2</sub>, 1 mM DTT, 250 μg/mL PEG 20000, 2 μg/mL poly(EY) 4:1, 1% DMSO and 0.5 μM ATP (γ-[<sup>33</sup>P]-ATP 0.1 μCi). The assay was carried out according to the filter binding (FB) method in 96-well plates at room temperature for 10 min in a final volume of 30 μL including the components as indicated above. The enzymatic reactions were stopped by the addition of 20 μL of 125 mM EDTA, and the incorporation of <sup>33</sup>P into the polypeptidic substrates was quantified as following: 30 μL of the stopped reaction mixture were transferred onto Immobilon-PVDF membranes previously soaked for 5 min with methanol, rinsed with water, soaked for 5 min with 0.5% H<sub>3</sub>PO<sub>4</sub>, and mounted on vacuum manifold with disconnected vacuum source. After spotting, vacuum was connected, and each well rinsed with 0.5% H<sub>3</sub>PO<sub>4</sub> (200 μL). Free membranes were removed and washed four times on a shaker with 1% H<sub>3</sub>PO<sub>4</sub> and once with ethanol. Membranes were dried and overlaid with addition of 10 μL/well of a scintillation fluid. The plates were eventually sealed and counted in a microplate scintillation counter. IC<sub>50</sub> values were calculated by linear regression analysis of the percentage inhibition of the compound.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> BaF3 Cell Lines Proliferation Assays</h3><div class="NLM_p last">Murine BaF3 cell lines, whose proliferation and survival has been rendered IL-3-independent by stable transduction with tyrosine kinases activated either by mutation or fusion with a dimerizing partner, were cultured in RPMI-1640 media (Gibco Cat. no. 11875093, Carlsbad, CA) supplemented with 10% FBS (Hyclone Cat no. SV30014.03, Logan, UT), 4.5 g/L glucose (Sigma no. G5400, St.Louis, MO), 1.5 g/L sodium bicarbonate (Biowhittaker no. 17–613E, Walkersville, MD), and Pen/Strep (Gibco no. 10378–016, Carlsbad, CA). Cells were passaged twice weekly. Compound-mediated inhibition of BaF3 cell proliferation and viability was assessed using a Luciferase bioluminescent assay (Bright-Glo, Promega, Madison, WI, USA). Exponentially growing BaF3 or BaF3 Tel-TK cells were seeded into 384-well plates (4250 cells/well) at 50 μL/well using a μFill liquid dispenser (BioTek, Winooski, VT, USA) in fresh medium. Compound <b>1h</b> was serially diluted in DMSO and arrayed in a polypropylene 384-well plate. Then 50 nL of compound were transferred into the plates containing the cells by using the pintool transfer device, and the plates incubated at 37 °C (5% CO<sub>2</sub>) for 48 h. Then 25 μL of Bright-Glo were added, and luminescence was quantified using an Analyst-GT (Molecular Devices, Sunnyvale, CA, USA). Custom curve-fitting software was used to produce a logistic fit of percent cell viability as a function of the logarithm of inhibitor concentration. The IC<sub>50</sub> value was determined as the concentration of compound needed to reduce cell viability to 50% of a DMSO control.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> FGFR1–4 Cellular Autophosphorylation Assays</h3><div class="NLM_p last">HEK293 cells seeded in 96-well plates were transiently transfected with pcDNA3.1 vectors encoding for FGFR1, FGFR2, FGFR3-K650E, FGFR3-S249C, FGFR4, or pcDNA3.1 empty vector using Fugene-6-reagent (Roche no. 11814443001). At 24 h post-transfection, cells were treated in triplicates with serial dilutions of the compound, prepared in DMSO, or DMSO for 40 min at 37 °C. The final concentration of DMSO in the cells was 0.2%. Cells were lysed in 100 μL/well of lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EGTA, 5 mM EDTA, 1% Triton, 2 mM NaVanadate, 1 mM PMSF, and protease inhibitors cocktail Roche no. 11873580001), and 50 μL of cell lysate were transferred to the FluoroNunc plates coated with FGFR capturing antibodies (α-FGFR1 antibody: R&D Systems no. MAB766; α-FGFR2 antibody, R&D Systems no. MAB665; α-FGFR3 antibody, R&D Systems no. MAB766; α-FGFR4 antibody, R&D Systems no. MAB685. Capturing was allowed to proceed for 5 h at 4 °C. The plate was washed with PBS/O containing 0.05% Tween. α-pTyr-antibody coupled to alkaline phosphates (Zymed PY20 no. 03–7722) was added overnight at 4 °C. The signal was revealed by adding CDP-Star substrate (Applied Biosystems no. MS1000RY) for 45 min, and the luminescence was next measured using TOP Count NXT luminometer (Packard Bioscience). The inhibitory activity of the compound was calculated as the percentage of the DMSO-treated samples, and IC<sub>50</sub> values were determined as the concentration of compound needed to inhibit the signal by 50%.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Bladder Cancer Cell lines Proliferation Assays</h3><div class="NLM_p last">Bladder cancer cell lines were obtained either from ATCC or DSMZ. Bladder cancer cell proliferation was measured in 96-well plates. 8500 cells/well (RT4, RT112) or 5000 cells/well (J82, HT1197, VMCUB1, JMSU1, SW780, UMUC3) were seeded in a volume of 100 μL/well in growth media. Media containing compound dilutions or DMSO was added 24 h thereafter. After 72 h, cells were fixed by addition of 25 μL/well glutaraldehyde (20%) for 10 min at room temperature. Cells were washed twice with 200 μL/well H<sub>2</sub>O, and 100 μL of Methylene Blue (0.05%) were added. After incubation for 10 min at room temperature, cells were washed three times with 200 μL/well H<sub>2</sub>O. Upon addition of 200 μL/well HCl (3%) and incubation for 30 min at room temperature on a plate shaker, OD650 nm was measured. The concentration of compound providing 50% of proliferation inhibition was calculated using Excel Fit.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Cytochrome P450 Assay</h3><div class="NLM_p last">Six probe substrates, each specific for a particular CYP450, were used as follows: 7-benzyloxy-4-(trifluoromethyl)-coumarin (CYP3A4), dibenzylfluorescein (CYP3A4), 7-methoxy-4-trifluoromethylcoumarin (CYP2C9), 3-cyano-7-ethoxycoumarin (CYP2C19, CYP1A2), and 3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin (CYP2D6). Assays were conducted at 37 °C in the presence of a NADPH regenerating system using a 384-well format. Probe substrate metabolites were quantified by fluorescence detection. The IC<sub>50</sub> values were determined using ExcelFit curve-fitting software.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Pharmacokinetic Parameters in Rodents</h3><div class="NLM_p">The pharmacokinetic properties of compound <b>1h</b> were determined in RT112/luc1-tumor bearing mice. The parental RT112 cell line was stably infected with a retrovirus that constitutively expresses luciferase (pLNCX2/luc1) to generate RT112/luc1 cells. RT112/luc1 tumors were established by subcutaneous injection of 5 × 10<sup>6</sup> cells in 100 μL of HBSS (Sigma no. H8264) containing 50% Matrigel (BD no. 356234) into the right flank of female HsdNpa:Athymic Nude-nu mice. Appropriately sized tumors (ca. 300–400 mm<sup>3</sup>) developed 20–26 days following cell injection.</div><div class="NLM_p">Compound <b>1h</b> was administered either as a solution in NMP/PEG200 (1:9, v/v) by tail vein injection (5 mg/kg) or as a suspension in PEG300/D5W (2:1, v/v) by oral gavage (20 mg/kg). At the allotted times (0.083, 0.25, 0.5, 1, 2, 6, 8, 24 h), the groups of mice (<i>n</i> = 4) were sacrificed, blood and tumors removed, extracted, and the concentration of compound determined by high pressure liquid chromatography/tandem mass spectrometry (LC-MS/MS) using the positive electrospray mode. Limit of quantification (LOQ) for plasma and tumors was set to 5 ng/mL and 10 ng/g, respectively. Relevant pharmacokinetic parameters were derived by noncompartmental analysis (WinNonlin version 4.0, Pharsight). Area under the concentration versus time curve (AUC) was calculated by linear trapezoidal rule.</div><div class="NLM_p last">The pharmacokinetic properties of <b>1h</b> in rats were determined as follows. The compound was administered intravenously to the femoral vein of female Wistar rats as a solution in NMP/PEG200 (1:9, v/v) at 5 mg/kg. The monophosphate salt of compound <b>1h</b> was administered as a solution in acetic acid–acetate buffer pH 4.6/PEG300 at 10 mg/kg. Dosing with the salt forms was based on free base equivalents. Serial plasma samples were collected by sublingual vein bleeding for 24 h (0.083, 0.25, 0.5, 1, 2, 6, 8, 24 h) either from two separate groups of rats (<i>n</i> = 4), using a staggered sampling design, or by sequential bleeding of one group (<i>n</i> = 3–4). Samples were extracted and the concentration of compound determined by LC-MS/MS. Pharmacokinetic parameters were derived in analogy to the method described above. LOQ was set to 10 ng/mL.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> In Vivo Antitumor Activity in Mouse Model</h3><div class="NLM_p">Female HsdNpa: Athymic Nude-nu mice were obtained from Laboratory Animal Services, Novartis Pharma AG, Basel. The animals were kept under optimized hygienic conditions (OHC) in Makrolon type III cages (maximum of 10 animals/cage) and were provided with food and water ad libitum.</div><div class="NLM_p">The parental RT112 cell line was stably infected with the retroviral vector pLNCX2/luc1. Each mouse was inoculated with approximately 25–50 μL of cell suspension (∼1–2 × 10<sup>5</sup> cells) directly in the bladder lumen. Tumor growth measurements were done by noninvasive imaging using a Xenogen IVIS imaging system. Measurements were performed 10 min after intravenous injection of 10 mL/kg (50 mg/mL in PBS) <span class="smallcaps smallerCapital">d</span>-luciferin.</div><div class="NLM_p last">Compound <b>1h</b> was formulated as a suspension in PEG300/D5W (2:1, v/v) and administered orally for 12 consecutive days at the doses of 10 and 30 mg/kg/qd. Tumor and body weight data were analyzed by ANOVA with post hoc Dunnett’s test for comparison of treatment versus control group. The post hoc Tukey test was used for intragroup comparison. Statistical analysis was performed using GraphPad prism 4.02 (GraphPad Software). As a measure of efficacy, the <i>T</i>/<i>C</i> (%) value was calculated at a certain number of days after treatment start according to:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/jm-2011-006222_m001.gif" alt="" /></img></span>Δ light emission represents the mean light emission on the evaluation day minus the mean light emission at the start of the experiment.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> In Vivo Antitumor Activity in Rat Model</h3><div class="NLM_p">Female nude Rowett rats 6–9 weeks of age were obtained from Harlan (The Netherlands). The animals were kept under optimized hygienic conditions (OHC) in Makrolon type III cages (maximum of 2 animals per cage) and were provided with food and water ad libitum. RT112 tumors were established by subcutaneous injection of 1 × 10<sup>6</sup> cells in 100 μL of HBSS containing 50% Matrigel into the right flank of nude rats. Treatments were initiated when the mean tumor volumes were approximately 100 mm<sup>3</sup>. The monophosphate salt of compound <b>1h</b> was formulated as a solution in acetic acid–acetate buffer pH 4.6/PEG300 (1:1, v/v) and applied daily by gavage to the tumor-bearing rats (<i>n</i> = 8) for 20 consecutive days at doses of 5, 10, and 15 mg/kg/qd (free base equivalents). The application volume was 5 mL/kg.</div><div class="NLM_p">Tumor volumes were measured with calipers and determined according to the formula: length × width × height × π/6.</div><div class="NLM_p">Antitumor activity was expressed as <i>T</i>/<i>C</i> (%): (mean change of tumor volume of treated animals/mean change of tumor volume of control animals) × 100.</div><div class="NLM_p">Regressions (%) were calculated according to the formula: [(mean tumor volume at end of treatment – mean tumor volume at start of treatment)/mean tumor volume at start of treatment] × 100.</div><div class="NLM_p last">In the pharmacodynamic study, RT112 tumor-bearing rats (<i>n</i> = 4) received a single oral administration of the monophosphate salt of compound <b>1h</b>, formulated as described above, at the doses of 4.25 and 8.51 mg/kg (free base equivalents). Tumors were collected at various time points post-therapy, frozen, minced, and homogenized in an equal volume of ice-cold phosphate buffered saline (PBS) using a Polytron homogenizer (TP18–10, IKA, Staufen, Germany), keeping the material cold during the homogenization. Concentrations of <b>1h</b> in tumors were determined by LC-MS/MS. LOQ was set to 3 ng/mL. Aliquots of tumor powder were weighted (50 mg) and resuspended immediately in a ratio of 1:10 (w/v) of ice-chilled lysis buffer containing 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EGTA, 5 mM EDTA, 1% Triton, 2 mM NaVanadate, 1 mM PMSF, and protease inhibitors cocktail Roche no. 11873580001). Lysates were clarified by centrifugation at 12000<i>g</i> for 15 min, and protein concentration was determined using the DC protein assay reagents (Bio Rad no. 500–0116) and a BSA standard. Total cell lysates were subjected to SDS-PAGE, and proteins were blotted onto PVDF membranes. Filters were blocked in 5% BSA and further incubated with the primary antibodies (pFRS2(Tyr196), Cell Signaling no. 3864; pMAPK, Cell Signaling no. 9101; β-tubulin, Sigma no. T4026) overnight at 40 °C. Proteins were visualized with peroxidase-coupled antimouse or antirabbit AB using the SuperSignalWest Dura Extended Duration Substrate Detection System (Pierce no. 34075).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> In Vivo Antiangiogenic Activity in VEGF/bFGF Agar Chamber Model</h3><div class="NLM_p">Female FVB mice were implanted with sterile tissue chambers made of perfluoro-alkoxy-Teflon (21 mm × 8 mm diameter, with 80 regularly spaced 0.8 mm perforations) filled with 500 μL of molten 0.8% w/v agar containing 20 U/mL heparin and with or without growth factor (dog VEGF 2 μg/mL or bFGF 0.3 μg/mL). Compound <b>1h</b> was administered orally in doses of 10, 30, and 50 mg/kg daily in a vehicle of 10% NMP in PEG300 (dose volume 5 mL/kg). Treatment was started 4–6 h before implantation of the chambers and continued for 3 days. The implants were removed 24 h after the last dose. The angiogenic response was quantified by measuring the weight and the receptor tyrosine kinase Tie-2 levels of the vascularized tissue grown around the chamber (capsule). Tie-2 measurements were performed by an ELISA assay utilizing the capture antibody anti-Tie-2 AB33. The percentage inhibition of the angiogenic response (increase in capsule weight or total Tie-2) was calculated in individual animals as follows:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/jm-2011-006222_m002.gif" alt="" /></img></span></div><ul class="NLM_list-list_type-label"><li><p class="inline"><i>A</i> = capsule weight or total Tie-2 from a drug-treated mouse with a chamber containing growth factor.</p></li><li><p class="inline"><i>B</i> = capsule weight or total Tie-2 from the group of vehicle-treated mice with chambers containing growth factor.</p></li><li><p class="inline"><i>C</i> = mean background capsule weight or total Tie-2 from the group of vehicle-treated mice with chambers not containing growth factor.</p></li></ul><div class="NLM_p last">The statistical comparisons between groups (compound-treated versus nontreated animals) were made using the absolute values for capsule weight and Tie-2 levels (Rank Sums Test, JANDEL SigmaStat 2.0). The significance level was set at <i>p</i> < 0.05.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Conformational Calculations</h3><div class="NLM_p last">The initial conformations of the compounds were generated in MacroModel<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and minimized by molecular mechanics using the AMBER*/H<sub>2</sub>O/GBSA force field. The ab initio calculations were performed in the Jaguar module of Maestro (Schrödinger Inc., New York, NY, USA) The quantum mechanics method used was DFT(b3lyp) with the 6-31G**+ basis set and the Poisson–Boltzmann method for water solvation energy calculations. The lowest energy molecular mechanics minimized conformations of the compounds were input in Jaguar and were fully minimized without constraints applying the water solvation model. This gave the reference energy of the isolated compound. For each compound, a second minimization was performed constraining the torsion angle defining the orientation of the dimethoxy-phenyl moiety with respect to the plane of the core structure to adopt the value of 110° observed in the FGFR1–compound <b>3</b> cocrystal structure. The difference in energy obtained from these two calculations gave an estimate of the deconjugation energy penalty paid by the compound for binding to the kinase.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Homology Model</h3><div class="NLM_p last">The sequence of the human FGFR3 kinase was obtained from SWISS-PROT,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> entry P22607. The crystallographic structure of the FGFR1 kinase in complex with compound <b>3</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI">2FGI</a> from the Protein Data Bank) was chosen as template. The sequences were aligned using T-Coffe.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> On the basis of the resulting alignment, the 3D structure of the FGFR3 kinase was modeled using the What If program<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> with the default parameters (PIRPSQ module, BLDPIR command). It should be noted that aside from one residue, A559 (FGFR3), pointing toward the exterior of the pocket, FGFR1 and FGFR3 have identical residues in their ATP binding sites. Thus, we considered the FGFR3 homology model as reliable for docking compounds in the ATP pocket.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Docking</h3><div class="NLM_p last">Using MacroModel,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> the inhibitors were constructed, manually docked in the ATP binding site of the FGFR3 kinases model (assuming the same binding mode as that of compound <b>3</b> in the FGFR1 crystal structure), and the resulting ligand–protein complexes energy-minimized (AMBER*/H<sub>2</sub>O/GBSA force field).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Purification, Crystallization, and Structure of the FGFR1–Compound <b>1h</b> Complex</h3><div class="NLM_p">Human FGFR1 protein was expressed in TN5 insect cells using a construct with an N-terminal His-tag, a spacer, and a TEV cleavage site (comprising a sequence of MGYYHHHHHH-DYDIPTT-ENLYFQG−) followed by amino acids 456–765 of FGFR1; potentially reactive Cys residues were removed from the construct by incorporating two point mutations: C488A and C584S. The cell pellet was lysed using JPER, and the soluble lysate was obtained after centrifugation and removal of cell debris. A 5 mL IMAC column was equilibrated with buffer A (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% (v/v) glycerol, 10 mM imidazole, 5 mM β-mercaptoethanol, 1 tablet of EDTA-free complete protease inhibitor cocktail (Roche), 10 μg/mL leupeptin), the cell lysate was loaded onto the column, and the column was washed with buffer until an A280 baseline was reached. The bound protein was then eluted by instituting a gradient where the buffer A imidazole concentration was slowly increased to 250 mM (hereafter, buffer B) during which 5 mL fractions were collected. IMAC fractions were selected for pooling by SDS-PAGE analysis. EDTA was added to pooled IMAC fractions to a final concentration of 1 mM. The pooled IMAC fractions were concentrated to a volume and loaded onto a SEC Superdex 200 2660 column, and the protein was eluted with buffer B while 10 mL fractions were collected. The fractions were selected by SDS-PAGE and pooled. The pooled fractions were diluted with two volumes of buffer C (20 mM Tri-HCl, pH 7.5, 5% (v/v) glycerol, and 5 mM DTT). A 5 mL QHP column was equilibrated with buffer C supplemented with 50 mM NaCl, the pooled fractions were loaded onto the column, and the column was washed. The protein was then eluted using a gradient where the NaCl concentration was gradually increased to a final concentration of 1 M NaCl while 10 mL fractions were collected. The fractions were analyzed by SDS-PAGE and mass spectrometry and pooled. The His-tag was removed by TEV protease digestion overnight at 4 °C. A second IMAC column was run as delineated previously to remove cleaved His-tag and TEV protease, and fractions were analyzed by SDS-PAGE and pooled. The pooled fractions were dialyzed against 2 L of buffer D (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% (v/v) glycerol, 5 mM dithiothreitol, and 0.5 mM EDTA) overnight at 4 °C. The protein was concentrated to approximately 10 mg/mL.</div><div class="NLM_p">Prior to crystallization, the protein was spun at 10000 rpm in a microfuge at 4 °C for 15 min. The protein was crystallized by the hanging drop vapor diffusion method: 1 μL of protein solution was mixed with 1 μL of mother liquor, which consisted of a grid of 18–28% (v/v) PEG-MME 5000 with 0.2 M ammonium sulfate and 0.1 M sodium cacodylate. The resulting drop was suspended over a reservoir of 0.5 mL of mother liquor and sealed with vacuum grease. The apo-crystals grew at 4 °C. The FGFR1–<b>1h</b> costructure was obtained by a soaking protocol where apo-crystals of FGFR1 were transferred into a large drop of mother liquor supplemented with 2 mM of compound <b>1h</b> and stored overnight at 4 °C. Crystals were transferred into a cryoprotectant consisting of mother liquor supplemented with 2 mM of <b>1h</b> and 25% (v/v) of glycerol. Crystals were then cryocooled in liquid nitrogen for data collection.</div><div class="NLM_p">The X-ray diffraction data was collected at Stanford Synchrotron Research Laboratory. Data integration and scaling were performed by using the programs MOSFLM and SCALA.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Data were reduced in the <i>C</i>2 space group, with unit cell dimensions <i>a</i> = 209.11 Å, <i>b</i> = 50.60 Å, <i>c</i> = 66.90 Å, and <i>b</i> = 104.7°. There are two monomers in the asymmetric unit. The data set is 99.2% complete in the resolution range of 100.0–2.8 Å and has an <i>R</i><sub>merge</sub> of 15.1% with a multiplicity of 3.4; approximately 6% of the data was flagged for cross-validation of the refinement via the calculation of an <i>R</i><sub>free</sub> factor. The costructure was determined using molecular replacement with an apo-structure of FGFR1 as the search model. The structure was refined by executing several iterations of manual rebuilding after inspection of <i>2F</i><sub>o</sub> – <i>F</i><sub>c</sub>, and <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> difference maps followed by refinement by the program AUTOBUSTER.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Data from a resolution range of 25.92–2.8 Å was used in the refinement. Refinement parameter files for compound <b>1h</b> were generated by the program AFITT (Openeye Scientific Software). The final structure has an <i>R</i>-factor of 20.41% and an <i>R</i><sub>free</sub> factor of 26.07%.</div><div class="NLM_p last">The active site and compound <b>1h</b> are well-represented in the electron density contoured at 1σ, as are adjacent structural waters. The density for the ethyl piperazine group of <b>1h</b> is only approximately represented in density, suggesting that it is flexible and/or oscillating, leading to a disordering of the electron density in this region and the adoption of a high-energy conformer for this group during refinement. A low-energy conformation for the ethyl piperazine group was modeled in by hand after the end of the refinement procedure.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/jm2006222">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details (including analytical data) for the final compounds <b>1a</b>–<b>g</b>, <b>1i</b>–<b>n</b>, and intermediates <b>5</b>, <b>7</b>, <b>11</b>–<b>14</b>, <b>16</b>–<b>18</b>, <b>20</b>–<b>25</b>, <b>27</b>, <b>29</b>, <b>32</b>–<b>35</b>, <b>37</b>; complete data set of Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2006222/suppl_file/jm2006222_si_001.pdf">jm2006222_si_001.pdf (254.94 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2006222" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vito Guagnano</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a6c736e75347d6f7b7d747b74755a74756c7b686e7369347975773a7e737b747b347d687b6f69456a75686e7b5a74756c7b686e736934797577"><span class="__cf_email__" data-cfemail="c3b5aab7aceda4b6a2a4ada2adac83adacb5a2b1b7aab0eda0acae">[email protected]</span> <span class="__cf_email__" data-cfemail="88ece1e9e6e9a6effae9fdfbd7f8e7fafce9c8e6e7fee9fafce1fba6ebe7e5">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Graus Porta</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a3d5cad7cc8dc4d6c2c4cdc2cdcce3cdccd5c2d1d7cad08dc0ccce83c7cac2cdc28dc4d1c2d6d0fcd3ccd1d7c2e3cdccd5c2d1d7cad08dc0ccce"><span class="__cf_email__" data-cfemail="ea9c839e85c48d9f8b8d848b8485aa84859c8b989e8399c4898587">[email protected]</span> <span class="__cf_email__" data-cfemail="0e6a676f606f20697c6f7b7d517e617c7a6f4e6061786f7c7a677d206d6163">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Furet</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carsten Spanka</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Bordas</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mickaël Le Douget</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christelle Stamm</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josef Brueggen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Jensen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Schnell</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herbert Schmid</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Wartmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joerg Berghausen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Drueckes</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alfred Zimmerlin</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirksen Bussiere</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Murray</span> - <span class="hlFld-Affiliation affiliation">Novartis Institute for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Novartis Analytical Science Department, Juergen Koeppler, Sandra Molle, Timothy Smith, Wei Gao, Kelly Yan, Wei Shu, the Oncology Protein Sciences Group for technical support, and Robin Fairhurst for proofreading the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> Abbreviations Used</h2><tr><td class="NLM_term">ABL</td><td class="NLM_def"><p class="first last">Abelson</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BCR-ABL</td><td class="NLM_def"><p class="first last">breakpoint cluster region–Abelson</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">Ci</td><td class="NLM_def"><p class="first last">curie</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">D5W</td><td class="NLM_def"><p class="first last">5% glucose in water</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol tetraacetic acid</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FGF</td><td class="NLM_def"><p class="first last">fibroblast growth factor</p></td></tr><tr><td class="NLM_term">FGFR</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor</p></td></tr><tr><td class="NLM_term">FRS2</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor substrate 2</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank’s Balanced Salt Solution</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectra</p></td></tr><tr><td class="NLM_term">LCK</td><td class="NLM_def"><p class="first last">lymphocyte-specific protein tyrosine kinase</p></td></tr><tr><td class="NLM_term">LOQ</td><td class="NLM_def"><p class="first last">limit of quantification</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MPD</td><td class="NLM_def"><p class="first last">myeloproliferative disorder</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidinone</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">PEG-MME</td><td class="NLM_def"><p class="first last">polyethylene glycol monomethyl ether</p></td></tr><tr><td class="NLM_term">PMSF</td><td class="NLM_def"><p class="first last">phenylmethanesulfonyl fluoride</p></td></tr><tr><td class="NLM_term">PVDF</td><td class="NLM_def"><p class="first last">polyvinylidene fluoride</p></td></tr><tr><td class="NLM_term">qd</td><td class="NLM_def"><p class="first last">quaque die (daily)</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SDS-PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">TEV</td><td class="NLM_def"><p class="first last">tobacco etch virus</p></td></tr><tr><td class="NLM_term">TK</td><td class="NLM_def"><p class="first last">tyrosine kinase</p></td></tr><tr><td class="NLM_term">Tris</td><td class="NLM_def"><p class="first last">tris(hydroxymethyl)aminomethane</p></td></tr><tr><td class="NLM_term">VEGFR2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor 2</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41138" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41138" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Beenken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span> </span><span class="NLM_article-title">The FGF family: biology, pathophysiology and therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=235-253&author=A.+Beenkenauthor=M.+Mohammadi&title=The+FGF+family%3A+biology%2C+pathophysiology+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeenken%26aufirst%3DA.%26aulast%3DMohammadi%26aufirst%3DM.%26atitle%3DThe%2520FGF%2520family%253A%2520biology%252C%2520pathophysiology%2520and%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D235%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Turner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grose, R.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor signalling: from development to cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1038%2Fnrc2780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=20094046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Gktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=116-129&author=N.+Turnerauthor=R.+Grose&title=Fibroblast+growth+factor+signalling%3A+from+development+to+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor signalling: from development to cancer</span></div><div class="casAuthors">Turner, Nicholas; Grose, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fibroblast growth factors (FGFs) and their receptors control a wide range of biol. functions, regulating cellular proliferation, survival, migration and differentiation.  Although targeting FGF signalling as a cancer therapeutic target has lagged behind that of other receptor tyrosine kinases, there is now substantial evidence for the importance of FGF signalling in the pathogenesis of diverse tumor types, and clin. reagents that specifically target the FGFs or FGF receptors are being developed.  Although FGF signalling can drive tumorigenesis, in different contexts FGF signalling can mediate tumor protective functions; the identification of the mechanisms that underlie these differential effects will be important to understand how FGF signalling can be most appropriately therapeutically targeted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUBfz6uAu97bVg90H21EOLACvtfcHk0lhxTmsVqxD8Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Gktg%253D%253D&md5=7963bc75c149981560dffc8d91b4aaf1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2780%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DN.%26aulast%3DGrose%26aufirst%3DR.%26atitle%3DFibroblast%2520growth%2520factor%2520signalling%253A%2520from%2520development%2520to%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D116%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Walz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt-Graeff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hehlmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, A.</span><span> </span><span class="NLM_article-title">The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1005-1009&author=C.+Walzauthor=A.+Chaseauthor=C.+Schochauthor=A.+Weisserauthor=F.+Schlegelauthor=A.+Hochhausauthor=R.+Fuchsauthor=A.+Schmitt-Graeffauthor=R.+Hehlmannauthor=N.+C.+P.+Crossauthor=A.+Reiter&title=The+t%288%3B17%29%28p11%3Bq23%29+in+the+8p11+myeloproliferative+syndrome+fuses+MYO18A+to+FGFR1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalz%26aufirst%3DC.%26aulast%3DChase%26aufirst%3DA.%26aulast%3DSchoch%26aufirst%3DC.%26aulast%3DWeisser%26aufirst%3DA.%26aulast%3DSchlegel%26aufirst%3DF.%26aulast%3DHochhaus%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DR.%26aulast%3DSchmitt-Graeff%26aufirst%3DA.%26aulast%3DHehlmann%26aufirst%3DR.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26aulast%3DReiter%26aufirst%3DA.%26atitle%3DThe%2520t%25288%253B17%2529%2528p11%253Bq23%2529%2520in%2520the%25208p11%2520myeloproliferative%2520syndrome%2520fuses%2520MYO18A%2520to%2520FGFR1%26jtitle%3DLeukemia%26date%3D2005%26volume%3D19%26spage%3D1005%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Belloni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trubia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapinassi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuciforo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Coco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, P. P.</span><span> </span><span class="NLM_article-title">8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.20144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=15609342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=320-325&author=E.+Belloniauthor=M.+Trubiaauthor=P.+Gaspariniauthor=C.+Micucciauthor=C.+Tapinassiauthor=S.+Confalonieriauthor=P.+Nuciforoauthor=B.+Martinoauthor=F.+Lo-Cocoauthor=P.+G.+Pelicciauthor=P.+P.+Di+Fiore&title=8p11+myeloproliferative+syndrome+with+a+novel+t%287%3B8%29+translocation+leading+to+fusion+of+the+FGFR1+and+TIF1+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes</span></div><div class="casAuthors">Belloni, Elena; Trubia, Maurizio; Gasparini, Patrizia; Micucci, Carla; Tapinassi, Cinzia; Confalonieri, Stefano; Nuciforo, Paolo; Martino, Bruno; Lo-Coco, Francesco; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-325</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">8P11 myeloproliferative syndrome (EMS) is a clin.-pathol. entity characterized by rearrangements involving the FGFR1 gene, which encodes a receptor tyrosine kinase.  These rearrangements invariably lead to aberrant fusion proteins in which the kinase activity is constitutively turned on, with resulting oncogenic properties.  In this article, authors describe a new translocation in EMS, t(7;8)(q34;p11), in which the FGFR1 gene is fused to a previously unidentified partner, the TIF1 gene.  Authors show that both the TIF1-FGFR1 and FGFR1-TIF1 fusion proteins have the potential to be translated as a result of the translocation.  Thus, these data extend the involvement of FGFR1 in EMS and lend support to the concept that there is a precise correlation between genotype and phenotype in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJAFwc0c3bmbVg90H21EOLACvtfcHk0lhxTmsVqxD8Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cnsb8%253D&md5=10eed7238eb11f51f1de9a926058aa0d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20144%26sid%3Dliteratum%253Aachs%26aulast%3DBelloni%26aufirst%3DE.%26aulast%3DTrubia%26aufirst%3DM.%26aulast%3DGasparini%26aufirst%3DP.%26aulast%3DMicucci%26aufirst%3DC.%26aulast%3DTapinassi%26aufirst%3DC.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DNuciforo%26aufirst%3DP.%26aulast%3DMartino%26aufirst%3DB.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26aulast%3DDi%2BFiore%26aufirst%3DP.%2BP.%26atitle%3D8p11%2520myeloproliferative%2520syndrome%2520with%2520a%2520novel%2520t%25287%253B8%2529%2520translocation%2520leading%2520to%2520fusion%2520of%2520the%2520FGFR1%2520and%2520TIF1%2520genes%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2005%26volume%3D42%26spage%3D320%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Roumiantsev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitri, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asiedu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span> </span><span class="NLM_article-title">Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=287-298&author=S.+Roumiantsevauthor=D.+S.+Krauseauthor=C.+A.+Neumannauthor=C.+A.+Dimitriauthor=F.+Asieduauthor=N.+C.+P.+Crossauthor=R.+A.+Van+Etten&title=Distinct+stem+cell+myeloproliferative%2FT+lymphoma+syndromes+induced+by+ZNF198-FGFR1+and+BCR-FGFR1+fusion+genes+from+8p11+translocations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoumiantsev%26aufirst%3DS.%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DNeumann%26aufirst%3DC.%2BA.%26aulast%3DDimitri%26aufirst%3DC.%2BA.%26aulast%3DAsiedu%26aufirst%3DF.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DDistinct%2520stem%2520cell%2520myeloproliferative%252FT%2520lymphoma%2520syndromes%2520induced%2520by%2520ZNF198-FGFR1%2520and%2520BCR-FGFR1%2520fusion%2520genes%2520from%25208p11%2520translocations%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D287%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Grand, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscier, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span> </span><span class="NLM_article-title">Identification of a novel gene, FGFR10P2, fused to FGFR1 in 8p11 myeloproliferative syndrome</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.20023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=15034873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslCqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=78-83&author=E.+K.+Grandauthor=F.+H.+Grandauthor=A.+J.+Chaseauthor=F.+M.+Rossauthor=M.+M.+Corcoranauthor=D.+G.+Oscierauthor=N.+C.+P.+Cross&title=Identification+of+a+novel+gene%2C+FGFR10P2%2C+fused+to+FGFR1+in+8p11+myeloproliferative+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel gene, FGFR10P2, fused to FGFR1 in 8p11 myeloproliferative syndrome</span></div><div class="casAuthors">Grand, Effie K.; Grand, Francis H.; Chase, Andrew J.; Ross, Fiona M.; Corcoran, Martin M.; Oscier, David G.; Cross, Nicholas C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-83</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The 8p11 myeloproliferative syndrome (EMS) is an aggressive hematol. malignancy caused by the fusion of diverse partner genes to fibroblast growth factor receptor 1 (FGFR1).  The partner proteins promote dimerization and ligand-independent activation of FGFR1-encoded tyrosine kinase, deregulating hemopoiesis in a manner analogous to BCR-ABL in chronic myeloid leukemia.  Here, the authors describe the identification of a new FGFR1 fusion gene in a patient who presented with T-cell lymphoblastic lymphoma in conjunction with an acquired ins(12;8)(p11;p11p22).  Initial FISH anal. and Southern :blotting confirmed that FGFR1 was disrupted.  Using 5'-RACE PCR, we identified part of a novel gene, FGFR1OP, at chromosome band 12p11 that was fused to exon 9 of FGFR1.  FGFR1OP2 is predicted to be translated into an evolutionarily conserved protein contg. coiled-coil domains but no other recognizable motifs.  The presence of the chimeric gene was confirmed by RT-PCR, genomic DNA PCR, and FISH.  These data further support the central role of deregulated FGFR1 in the pathogenesis of EMS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMM7rk-elQQLVg90H21EOLACvtfcHk0lhtZvt8XYnfkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslCqtL0%253D&md5=dd9d52bfb44a018bbc898699bb09bc65</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20023%26sid%3Dliteratum%253Aachs%26aulast%3DGrand%26aufirst%3DE.%2BK.%26aulast%3DGrand%26aufirst%3DF.%2BH.%26aulast%3DChase%26aufirst%3DA.%2BJ.%26aulast%3DRoss%26aufirst%3DF.%2BM.%26aulast%3DCorcoran%26aufirst%3DM.%2BM.%26aulast%3DOscier%26aufirst%3DD.%2BG.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26atitle%3DIdentification%2520of%2520a%2520novel%2520gene%252C%2520FGFR10P2%252C%2520fused%2520to%2520FGFR1%2520in%25208p11%2520myeloproliferative%2520syndrome%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2004%26volume%3D40%26spage%3D78%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sohal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mould, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welborn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montefusco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Berg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanstraelen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span> </span><span class="NLM_article-title">Identification of four new translocations involving FGFRI in myeloid disorders</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.1177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=11550283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Skt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=155-163&author=J.+Sohalauthor=A.+Chaseauthor=S.+Mouldauthor=M.+Corcoranauthor=D.+Oscierauthor=S.+Iqbalauthor=S.+Parkerauthor=J.+Welbornauthor=R.+I.+Harrisauthor=G.+Martinelliauthor=V.+Montefuscoauthor=P.+Sinclairauthor=B.+S.+Wilkinsauthor=H.+Van+Den+Bergauthor=D.+Vanstraelenauthor=J.+M.+Goldmanauthor=N.+C.+P.+Cross&title=Identification+of+four+new+translocations+involving+FGFRI+in+myeloid+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of four new translocations involving FGFRI in myeloid disorders</span></div><div class="casAuthors">Sohal, Jastinder; Chase, Andrew; Mould, Sarah; Corcoran, Martin; Oscier, David; Iqbal, Sameena; Parker, Sally; Welborn, Jeanna; Harris, Richard I.; Martinelli, Giovanni; Montefusco, Vittorio; Sinclair, Paul; Wilkins, Bridget S.; Van Den Berg, Henk; Vanstraelen, Danny; Goldman, John M.; Cross, Nicholas C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The 8p11 myeloproliferative syndrome (EMS) is assocd. with three translocations, t(8;13)(p11;q12), t(8;9)(p11;q33), and t(6;8)(q27;p11), that fuse unrelated genes (ZNF198, CEP110, and FOP, resp.) to the entire tyrosine kinase domain of FGFRI.  In all cases thus far examd. (n = 10), the t(8;13) results in an identical mRNA fusion between ZNF198 exon 17 and FGFRI exon 9.  To det. if consistent fusions are also seen in the variant translocations, the authors performed RT-PCR on four cases and sequenced the products.  For two patients with a t(8;9), the authors found that CEP110 exon 15 was fused to FGFRI exon 9.  For two patients with a t(6;8), the authors found that FOP exon 5 (n = 1) or exon 7 (n = 1) was fused to FGFRI exon 9.  To det. if FGFRI might be involved in other myeloid disorders with translocations of 8p, the authors developed a two-color FISH assay using two differentially labeled PAC clones that flank FGFRI.  Disruption of this gene was indicated in a patient with a t(8;17)(p11;q25) and Ph-neg. chronic myeloid leukemia in assocn. with systemic malignant mast cell disease, a patient with acute myeloid leukemia with a t(8;11)(p11;p15), and two cases with T-cell lymphoma, myeloproliferative disorder, and marrow eosinophilia with a t(8;12)(p11;q15) and ins(12;8)(p11;p11p21), resp.  For the patient with the t(8;11), the chromosome 11 breakpoint was detd. to be in the vicinity of NUP98.  The authors conclude that 1) all mRNA fusions in EMS result in splicing to FGFRI exon 9 but breakpoints in FOP are variable, 2) two-color FISH can identify patients with EMS, and 3) the t(8;17)(p11;q25).  T(8;11)(p11;p15), t(8;12)(p11;q15), and ins(12;8)(p11;p11p21) are novel karyotypic changes that most likely involve FGFRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6aAENbhw7LVg90H21EOLACvtfcHk0lhtZvt8XYnfkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Skt7g%253D&md5=2303ea2f1ccacce9f3ebce78b1e72242</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fgcc.1177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.1177%26sid%3Dliteratum%253Aachs%26aulast%3DSohal%26aufirst%3DJ.%26aulast%3DChase%26aufirst%3DA.%26aulast%3DMould%26aufirst%3DS.%26aulast%3DCorcoran%26aufirst%3DM.%26aulast%3DOscier%26aufirst%3DD.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DS.%26aulast%3DWelborn%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DR.%2BI.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DMontefusco%26aufirst%3DV.%26aulast%3DSinclair%26aufirst%3DP.%26aulast%3DWilkins%26aufirst%3DB.%2BS.%26aulast%3DVan%2BDen%2BBerg%26aufirst%3DH.%26aulast%3DVanstraelen%26aufirst%3DD.%26aulast%3DGoldman%26aufirst%3DJ.%2BM.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26atitle%3DIdentification%2520of%2520four%2520new%2520translocations%2520involving%2520FGFRI%2520in%2520myeloid%2520disorders%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2001%26volume%3D32%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Popovici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ollendorff, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaffanet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guasch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacrot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pebusque, M.-J.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">5712</span><span class="NLM_x">–</span> <span class="NLM_lpage">5717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=5712-5717&author=C.+Popoviciauthor=J.+Adelaideauthor=V.+Ollendorffauthor=M.+Chaffanetauthor=G.+Guaschauthor=M.+Jacrotauthor=D.+Lerouxauthor=D.+Birnbaumauthor=M.-J.+Pebusque&title=Fibroblast+growth+factor+receptor+1+is+fused+to+FIM+in+stem-cell+myeloproliferative+disorder+with+t%288%3B13%29%28p12%3Bq12%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici%26aufirst%3DC.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DOllendorff%26aufirst%3DV.%26aulast%3DChaffanet%26aufirst%3DM.%26aulast%3DGuasch%26aufirst%3DG.%26aulast%3DJacrot%26aufirst%3DM.%26aulast%3DLeroux%26aufirst%3DD.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DPebusque%26aufirst%3DM.-J.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25201%2520is%2520fused%2520to%2520FIM%2520in%2520stem-cell%2520myeloproliferative%2520disorder%2520with%2520t%25288%253B13%2529%2528p12%253Bq12%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D5712%26epage%3D5717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Regenass, U; Caravatti, G.; Fredenhagen, A.; Wacker, O.</span>Patent WO9532975,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Regenass%2C+U%3B+Caravatti%2C+G.%3B+Fredenhagen%2C+A.%3B+Wacker%2C+O.Patent+WO9532975%2C+1995."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRegenass%26aufirst%3DU%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">14479</span><span class="NLM_x">–</span> <span class="NLM_lpage">14484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=14479-14484&author=J.+Chenauthor=D.+J.+DeAngeloauthor=J.+L.+Kutokauthor=I.+R.+Williamsauthor=B.+H.+Leeauthor=M.+Wadleighauthor=N.+Duclosauthor=S.+Cohenauthor=J.+Adelspergerauthor=R.+Okabeauthor=A.+Coburnauthor=I.+Galinskyauthor=B.+Huntlyauthor=P.+S.+Cohenauthor=T.+Meyerauthor=D.+Fabbroauthor=J.+Roeselauthor=L.+Banerjiauthor=J.+D.+Griffinauthor=S.+Xiaoauthor=J.+A.+Fletcherauthor=R.+M.+Stoneauthor=D.+G.+Gilliland&title=PKC412+inhibits+the+zinc+finger+198-fibroblast+growth+factor+receptor+1+fusion+tyrosine+kinase+and+is+active+in+treatment+of+stem+cell+myeloproliferative+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DDuclos%26aufirst%3DN.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DCoburn%26aufirst%3DA.%26aulast%3DGalinsky%26aufirst%3DI.%26aulast%3DHuntly%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DP.%2BS.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DBanerji%26aufirst%3DL.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DPKC412%2520inhibits%2520the%2520zinc%2520finger%2520198-fibroblast%2520growth%2520factor%2520receptor%25201%2520fusion%2520tyrosine%2520kinase%2520and%2520is%2520active%2520in%2520treatment%2520of%2520stem%2520cell%2520myeloproliferative%2520disorder%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D14479%26epage%3D14484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Yagasaki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murohashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniwaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, M.</span><span> </span><span class="NLM_article-title">Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8371</span><span class="NLM_x">–</span> <span class="NLM_lpage">8374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8371-8374&author=F.+Yagasakiauthor=D.+Wakaoauthor=Y.+Yokoyamaauthor=Y.+Uchidaauthor=I.+Murohashiauthor=H.+Kayanoauthor=M.+Taniwakiauthor=A.+Matsudaauthor=M.+Bessho&title=Fusion+of+ETV6+to+fibroblast+growth+factor+receptor+3+in+peripheral+T-cell+lymphoma+with+a+t%284%3B12%29%28p16%3Bp13%29+chromosomal+translocation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYagasaki%26aufirst%3DF.%26aulast%3DWakao%26aufirst%3DD.%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DUchida%26aufirst%3DY.%26aulast%3DMurohashi%26aufirst%3DI.%26aulast%3DKayano%26aufirst%3DH.%26aulast%3DTaniwaki%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DBessho%26aufirst%3DM.%26atitle%3DFusion%2520of%2520ETV6%2520to%2520fibroblast%2520growth%2520factor%2520receptor%25203%2520in%2520peripheral%2520T-cell%2520lymphoma%2520with%2520a%2520t%25284%253B12%2529%2528p16%253Bp13%2529%2520chromosomal%2520translocation%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8371%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brents, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrock, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ried, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehl, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span> </span><span class="NLM_article-title">Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1038%2Fng0797-260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=9207791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK2sXktFGjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=260-264&author=M.+Chesiauthor=E.+Nardiniauthor=L.+A.+Brentsauthor=E.+Schrockauthor=T.+Riedauthor=W.+M.+Kuehlauthor=P.+L.+Bergsagel&title=Frequent+translocation+t%284%3B14%29%28p16.3%3Bq32.3%29+in+multiple+myeloma+is+associated+with+increased+expression+and+activating+mutations+of+fibroblast+growth+factor+receptor+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3</span></div><div class="casAuthors">Chesi, Marta; Nardini, Elena; Brents, Leslie A.; Schrock, Evelin; Ried, Thomas; Kuehl, W. Michael; Bergsagel, P. Leif</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">260-264</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Dysregulation of oncogenes by translocation to the IgH locus (14q32) is a seminal event in the pathogenesis of B-cell tumors.  In multiple myeloma (MM), translocations to the IgH locus have been reported at an incidence of 20-60%.  For most translocations, the partner chromosome is unknown (14q+); for the others, a diverse array of chromosomal partners have been identified, with 11q13 (cyclin D1) the only chromosome that is frequently involved.  Recently, we developed a Southern-blot assay that detects translocation breakpoint fragments in most MM tumors, including those with no translocation detected by conventional karyotyping.  In a continuing anal. of translocations in 21 myeloma cell lines and primary tumors, we show that the novel, karyotypically silent translocation t(4;14)(p16.3;q32.3) is present in five lines and at least three of ten primary tumors.  The chromosome-4 breakpoints are clustered in a 70-kb region centromeric to the fibroblast growth factor receptor 3 gene (FGFR3), the apparent dysregulated oncogene.  Two lines and one primary tumor with this translocation selectively express an FGFR3 allele contg. activating mutations identified previously in thanatophoric dwarfism.  We propose that after the t(4;14) translocation, somatic mutation during tumor progression frequently generates an FGFR3 protein that is active in the absence of ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojH58PJMxq5bVg90H21EOLACvtfcHk0lixwKMopFKmVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFGjsrc%253D&md5=edb81448dfdac30ce0be3b67686bd5b6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fng0797-260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0797-260%26sid%3Dliteratum%253Aachs%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DNardini%26aufirst%3DE.%26aulast%3DBrents%26aufirst%3DL.%2BA.%26aulast%3DSchrock%26aufirst%3DE.%26aulast%3DRied%26aufirst%3DT.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26atitle%3DFrequent%2520translocation%2520t%25284%253B14%2529%2528p16.3%253Bq32.3%2529%2520in%2520multiple%2520myeloma%2520is%2520associated%2520with%2520increased%2520expression%2520and%2520activating%2520mutations%2520of%2520fibroblast%2520growth%2520factor%2520receptor%25203%26jtitle%3DNature%2520Genet.%26date%3D1997%26volume%3D16%26spage%3D260%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Richelda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronchetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viggiano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiolo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, A.</span><span> </span><span class="NLM_article-title">A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">4062</span><span class="NLM_x">–</span> <span class="NLM_lpage">4070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=4062-4070&author=R.+Richeldaauthor=D.+Ronchettiauthor=L.+Baldiniauthor=L.+Croauthor=L.+Viggianoauthor=R.+Marzellaauthor=M.+Rocchiauthor=T.+Otsukiauthor=L.+Lombardiauthor=A.+T.+Maioloauthor=A.+Neri&title=A+novel+chromosomal+translocation+t%284%3B14%29%28p16.3%3Bq32%29+in+multiple+myeloma+involves+the+fibroblast+growth-factor+receptor+3+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichelda%26aufirst%3DR.%26aulast%3DRonchetti%26aufirst%3DD.%26aulast%3DBaldini%26aufirst%3DL.%26aulast%3DCro%26aufirst%3DL.%26aulast%3DViggiano%26aufirst%3DL.%26aulast%3DMarzella%26aufirst%3DR.%26aulast%3DRocchi%26aufirst%3DM.%26aulast%3DOtsuki%26aufirst%3DT.%26aulast%3DLombardi%26aufirst%3DL.%26aulast%3DMaiolo%26aufirst%3DA.%2BT.%26aulast%3DNeri%26aufirst%3DA.%26atitle%3DA%2520novel%2520chromosomal%2520translocation%2520t%25284%253B14%2529%2528p16.3%253Bq32%2529%2520in%2520multiple%2520myeloma%2520involves%2520the%2520fibroblast%2520growth-factor%2520receptor%25203%2520gene%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D4062%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Intini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiolo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, A.</span><span> </span><span class="NLM_article-title">Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1046%2Fj.1365-2141.2001.02957.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=11529856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVyhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2001&pages=362-364&author=D.+Intiniauthor=L.+Baldiniauthor=S.+Fabrisauthor=L.+Lombardiauthor=G.+Ciceriauthor=A.+T.+Maioloauthor=A.+Neri&title=Analysis+of+FGFR3+gene+mutations+in+multiple+myeloma+patients+with+t%284%3B14%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)</span></div><div class="casAuthors">Intini, Daniela; Baldini, Luca; Fabris, Sonia; Lombardi, Luigia; Ciceri, Gabriella; Maiolo, Anna Teresa; Neri, Antonino</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">362-364</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The t(4;14)(p16.3;q32) in multiple myeloma (MM) leads to an apparent deregulation of the FGFR3 and WHSC1/MMSET genes.  FGFR3 mutations, known to be assocd. with genetic skeletal disorders, have also been identified in a few cases of MM (mainly cell lines) with t(4;14).  We investigated FGFR3 mutations in a series of 53 MM cases; 11 cases with t(4;14) and FGFR3 overexpression were analyzed using reverse transcription polymerase chain reaction, while the remaining cases were studied at DNA level.  The Arg248Cys mutation, which is assocd. with some lethal forms of skeletal disorders, was found in one case with t(4;14).  Our results indicate that FGFR3 mutations occur in only a small fraction of MM cases with t(4;14).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRMVl9Xjk57Vg90H21EOLACvtfcHk0lhiJx-LELellA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVyhu7o%253D&md5=66b3052d3f7a6909381b35cc8bb49cab</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2141.2001.02957.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2141.2001.02957.x%26sid%3Dliteratum%253Aachs%26aulast%3DIntini%26aufirst%3DD.%26aulast%3DBaldini%26aufirst%3DL.%26aulast%3DFabris%26aufirst%3DS.%26aulast%3DLombardi%26aufirst%3DL.%26aulast%3DCiceri%26aufirst%3DG.%26aulast%3DMaiolo%26aufirst%3DA.%2BT.%26aulast%3DNeri%26aufirst%3DA.%26atitle%3DAnalysis%2520of%2520FGFR3%2520gene%2520mutations%2520in%2520multiple%2520myeloma%2520patients%2520with%2520t%25284%253B14%2529%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2001%26volume%3D114%26spage%3D362%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cappellen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Medina, S. G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre-Garau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radvanyi, F.</span><span> </span><span class="NLM_article-title">Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10471491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=18-20&author=D.+Cappellenauthor=C.+De+Oliveiraauthor=D.+Ricolauthor=S.+G.+D.+De+Medinaauthor=J.+Bourdinauthor=X.+Sastre-Garauauthor=D.+Chopinauthor=J.+P.+Thieryauthor=F.+Radvanyi&title=Frequent+activating+mutations+of+FGFR3+in+human+bladder+and+cervix+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas</span></div><div class="casAuthors">Cappellen, David; De Oliveira, Catherine; Ricol, David; De Medina, Sixtina Gil Diez; Bourdin, Jerome; Sastre-Garau, Xavier; Chopin, Dominique; Thiery, Jean Paul; Radvanyi, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-20</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The authors assessed transcript levels of the two FGFR3 variants, FGFR3b and FGFR3c, by semi-quant. PCR in 76 primary bladder carcinomas, 6 normal urothelial, 29 primary cervical carcinomas, and 6 normal cervical epithelia.  As expected, the FGFR3b variant was the only form expressed in both malignant and non malignant epithelial tissues.  PCR-SSCP anal. of the coding region of FGFR3 on reverse-transcribed RNA from a representative subset of 26 bladder and 12 cervix tumor samples was performed.  The sequences of abnormally migrating bands revealed single nucleotide substitutions in 9 of 26 bladder carcinomas, and 3 of 12 cervix carcinomas.  These same changes were obsd. in corresponding tumor genomic sequences.  Matched constitutional DNA, available in the nine bladder tumor cases with mutations, contained wild-type sequences, demonstrating the somatic nature of these mutations.  FGFR3 missense somatic mutations identified include R248C, S249C, G372C, and K652E.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYzbQ2LS6my7Vg90H21EOLACvtfcHk0lhiJx-LELellA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWhs7s%253D&md5=2873c55650dd0179ea565c2f981b0a5d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCappellen%26aufirst%3DD.%26aulast%3DDe%2BOliveira%26aufirst%3DC.%26aulast%3DRicol%26aufirst%3DD.%26aulast%3DDe%2BMedina%26aufirst%3DS.%2BG.%2BD.%26aulast%3DBourdin%26aufirst%3DJ.%26aulast%3DSastre-Garau%26aufirst%3DX.%26aulast%3DChopin%26aufirst%3DD.%26aulast%3DThiery%26aufirst%3DJ.%2BP.%26aulast%3DRadvanyi%26aufirst%3DF.%26atitle%3DFrequent%2520activating%2520mutations%2520of%2520FGFR3%2520in%2520human%2520bladder%2520and%2520cervix%2520carcinomas%26jtitle%3DNature%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D18%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Billerey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubriot-Lorton, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil Diez de Medina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rhijn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bralet, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefrere-Belda, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahaye, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafrani, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Kwast, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radvanyi, F.</span><span> </span><span class="NLM_article-title">Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1955</span><span class="NLM_x">–</span> <span class="NLM_lpage">1959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2FS0002-9440%2810%2964665-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=11395371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFyksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1955-1959&author=C.+Billereyauthor=D.+Chopinauthor=M.-H.+Aubriot-Lortonauthor=D.+Ricolauthor=S.+Gil+Diez+de+Medinaauthor=B.+Van+Rhijnauthor=M.-P.+Braletauthor=M.-A.+Lefrere-Beldaauthor=J.-B.+Lahayeauthor=C.+C.+Abbouauthor=J.+Bonaventureauthor=E.+S.+Zafraniauthor=T.+Van+Der+Kwastauthor=J.+P.+Thieryauthor=F.+Radvanyi&title=Frequent+FGFR3+mutations+in+papillary+non-invasive+bladder+%28pTa%29+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors</span></div><div class="casAuthors">Billerey, Claude; Chopin, Dominique; Aubriot-Lorton, Marie-Helene; Ricol, David; Gil Diez de Medina, Sixtina; Van Rhijn, Bas; Bralet, Marie-Pierre; Lefrere-Belda, Marie-Aude; Lahaye, Jean-Baptiste; Abbou, Claude C.; Bonaventure, Jacky; Zafrani, Elie Serge; Van Der Kwast, Theo; Thiery, Jean Paul; Radvanyi, Francois</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1955-1959</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The authors recently identified activating mutations of fibroblast growth factor receptor 3 (FGFR3) in bladder carcinoma.  In this study they assessed the incidence of FGFR3 mutations in a series of 132 bladder carcinomas: 20 carcinoma in situ (CIS), 50 pTa, 19 pT1, and 43 pT2-4.  All 48 mutations identified were identical to the germinal activating mutations that cause thanatophoric dysplasia, a lethal form of dwarfism.  The S249C mutation, found in 33 of the 48 mutated tumors, was the most common.  The frequency of mutations was higher in pTa tumors (37 of 50, 74%) than in CIS (0 of 20, 0%; P < 0.0001), pT1 (4 of 19, 21%; P < 0.0001) and pT2-4 tumors (7 of 43, 16%; P < 0.0001).  FGFR3 mutations were detected in 27 of 32 (84%) G1, 16 of 29 (55%) G2, and 5 of 71 (7%) G3 tumors.  This assocn. between FGFR3 mutations and low grade was highly significant (P < 0.0001).  FGFR3 is the first gene found to be mutated at a high frequency in pTa tumors.  The absence of FGFR3 mutations in CIS and the low frequency of FGFR3 mutations in pT1 and pT2-4 tumors are consistent with the model of bladder tumor progression in which the most common precursor of pT1 and pT2-4 tumors is CIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cEtqTlSTK7Vg90H21EOLACvtfcHk0lhiJx-LELellA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFyksLg%253D&md5=d721e057bb97ab766c990b803cb3a874</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2964665-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252964665-2%26sid%3Dliteratum%253Aachs%26aulast%3DBillerey%26aufirst%3DC.%26aulast%3DChopin%26aufirst%3DD.%26aulast%3DAubriot-Lorton%26aufirst%3DM.-H.%26aulast%3DRicol%26aufirst%3DD.%26aulast%3DGil%2BDiez%2Bde%2BMedina%26aufirst%3DS.%26aulast%3DVan%2BRhijn%26aufirst%3DB.%26aulast%3DBralet%26aufirst%3DM.-P.%26aulast%3DLefrere-Belda%26aufirst%3DM.-A.%26aulast%3DLahaye%26aufirst%3DJ.-B.%26aulast%3DAbbou%26aufirst%3DC.%2BC.%26aulast%3DBonaventure%26aufirst%3DJ.%26aulast%3DZafrani%26aufirst%3DE.%2BS.%26aulast%3DVan%2BDer%2BKwast%26aufirst%3DT.%26aulast%3DThiery%26aufirst%3DJ.%2BP.%26aulast%3DRadvanyi%26aufirst%3DF.%26atitle%3DFrequent%2520FGFR3%2520mutations%2520in%2520papillary%2520non-invasive%2520bladder%2520%2528pTa%2529%2520tumors%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2001%26volume%3D158%26spage%3D1955%26epage%3D1959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gomez-Roman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saenz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escuredo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santa Cruz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junquera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez Banos, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Brea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esparza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Val-Bernal, J. F.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=15701828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=459-465&author=J.+J.+Gomez-Romanauthor=P.+Saenzauthor=J.+Cuevas+Gonzalezauthor=K.+Escuredoauthor=S.+Santa+Cruzauthor=C.+Junqueraauthor=L.+Simonauthor=A.+Martinezauthor=J.+L.+Gutierrez+Banosauthor=M.+Lopez-Breaauthor=C.+Esparzaauthor=J.+F.+Val-Bernal&title=Fibroblast+growth+factor+receptor+3+is+overexpressed+in+urinary+tract+carcinomas+and+modulates+the+neoplastic+cell+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth</span></div><div class="casAuthors">Gomez-Roman, J. Javier; Saenz, Pilar; Cuevas Gonzalez, Jorge; Escuredo, Kepa; Santa Cruz, Simon; Junquera, Corina; Simon, Laureano; Martinez, Antonio; Gutierrez Banos, J. Luis; Lopez-Brea, Marta; Esparza, Clara; Val-Bernal, J. Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">459-465</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Fibroblast growth factor receptor 3 (FGFR3) mutations have been assocd. with achondroplastic syndromes and urinary bladder carcinomas.  Here we describe changes in FGFR3 mRNA and protein expression in transitional carcinomas and det. the effect of monoclonal antibodies against FGFR3 in RT-112 cell line proliferation.  We used microarray tools to evaluate FGFR3 mRNA expression in 22 urinary bladder carcinomas at different stages (noninvasive pTa, lamina propria invasive pT1, and muscular invasive pT2) and 7 nonneoplastic tissue controls.  FGFR3 protein expression was evaluated by Western blotting in 15 different carcinomas and 3 nonneoplastic controls.  Two hundred thirty-seven urinary bladder and renal pelvis carcinomas and 21 neg. controls were tested on tissue microarrays by immunohistochem.  The effect on cell proliferation in the RT-112 bladder cancer cell line of monoclonal antibodies against FGFR3 was also evaluated.  Overexpression of FGFR3 mRNA was found in pTa and pT1 stage carcinomas (fold change >8) and in pT2 carcinomas (fold change >4).  Nonneoplastic urinary bladder samples do not express FGFR3 protein.  However, 83% of pTa, 100% of pT1, and 50% of pT2 carcinomas expressed FGFR3 as detd. by Western blotting.  By immunohistochem., FGFR3 was pos. in 71.4% of pTa, 72% of pT1, and 49.2% of pT2 cases as well as 61.5% of upper urinary tract carcinomas.  Proliferation of the RT-112 cell line was inhibited with monoclonal antibodies against FGFR3.  FGFR3 seems to play an important role in transitional cell carcinoma development.  Our results suggest that FGFR3 antagonists could be developed as possible therapeutics for treatment of urinary tract carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoykdI_zOzaobVg90H21EOLACvtfcHk0lhlkEl1FCU-oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWgtrY%253D&md5=4f877dd65a2af3c9203174b6b98a751c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Roman%26aufirst%3DJ.%2BJ.%26aulast%3DSaenz%26aufirst%3DP.%26aulast%3DCuevas%2BGonzalez%26aufirst%3DJ.%26aulast%3DEscuredo%26aufirst%3DK.%26aulast%3DSanta%2BCruz%26aufirst%3DS.%26aulast%3DJunquera%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DL.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGutierrez%2BBanos%26aufirst%3DJ.%2BL.%26aulast%3DLopez-Brea%26aufirst%3DM.%26aulast%3DEsparza%26aufirst%3DC.%26aulast%3DVal-Bernal%26aufirst%3DJ.%2BF.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25203%2520is%2520overexpressed%2520in%2520urinary%2520tract%2520carcinomas%2520and%2520modulates%2520the%2520neoplastic%2520cell%2520growth%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D459%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Jang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. G.</span><span> </span><span class="NLM_article-title">Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3541</span><span class="NLM_x">–</span> <span class="NLM_lpage">3543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=3541-3543&author=J.+H.+Jangauthor=K.+H.+Shinauthor=J.+G.+Park&title=Mutations+in+fibroblast+growth+factor+receptor+2+and+fibroblast+growth+factor+receptor+3+genes+associated+with+human+gastric+and+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DJ.%2BH.%26aulast%3DShin%26aufirst%3DK.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BG.%26atitle%3DMutations%2520in%2520fibroblast%2520growth%2520factor%2520receptor%25202%2520and%2520fibroblast%2520growth%2520factor%2520receptor%25203%2520genes%2520associated%2520with%2520human%2520gastric%2520and%2520colorectal%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D3541%26epage%3D3543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokote, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saijo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, K.</span><span> </span><span class="NLM_article-title">AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3051</span><span class="NLM_x">–</span> <span class="NLM_lpage">3057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1158%2F1078-0432.CCR-06-2743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17505008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3051-3057&author=M.+Takedaauthor=T.+Araoauthor=H.+Yokoteauthor=T.+Komatsuauthor=K.+Yanagiharaauthor=H.+Sasakiauthor=Y.+Yamadaauthor=T+Tamuraauthor=K.+Fukuokaauthor=H.+Kimuraauthor=N.+Saijoauthor=K.+Nishio&title=AZD2171+shows+potent+antitumor+activity+against+gastric+cancer+over-expressing+fibroblast+growth+factor+receptor+2%2Fkeratinocyte+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor</span></div><div class="casAuthors">Takeda, Masayuki; Arao, Tokuzo; Yokote, Hideyuki; Komatsu, Teruo; Yanagihara, Kazuyoshi; Sasaki, Hiroki; Yamada, Yasuhide; Tamura, Tomohide; Fukuoka, Kazuya; Kimura, Hiroshi; Saijo, Nagahiro; Nishio, Kazuto</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3051-3057</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">AZD2171 is an oral, highly potent, and selective vascular endothelial growth factor signaling inhibitor that inhibits all vascular endothelial growth factor receptor tyrosine kinases.  The purpose of this study was to investigate the activity of AZD2171 in gastric cancer.  We examd. the antitumor effect of AZD2171 on the eight gastric cancer cell lines in vitro and in vivo.  AZD2171 directly inhibited the growth of two gastric cancer cell lines (KATO-III and OCUM2M), with an IC50 of 0.15 and 0.37 μmol/L, resp., more potently than the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib.  Reverse transcription-PCR expts. and immunoblotting revealed that sensitive cell lines dominantly expressed COOH terminus-truncated fibroblast growth factor receptor 2 (FGFR2) splicing variants that were constitutively phosphorylated and spontaneously dimerized.  AZD2171 completely inhibited the phosphorylation of FGFR2 and downstream signaling proteins (FRS2, AKT, and mitogen-activated protein kinase) in sensitive cell lines at a 10-fold lower concn. (0.1 μmol/L) than in the other cell lines.  An in vitro kinase assay showed that AZD2171 inhibited kinase activity of immunopptd. FGFR2 with submicromolar Ki values (∼0.05 μmol/L).  Finally, we assessed the antitumor activity of AZD2171 in human gastric tumor xenograft models in mice.  Oral administration of AZD2171 (1.5 or 6 mg/kg/d) significantly and dose-dependently inhibited tumor growth in mice bearing KATO-III and OCUM2M tumor xenografts.  AZD2171 exerted potent antitumor activity against gastric cancer xenografts overexpressing FGFR2.  The results of these preclin. studies indicate that AZD2171 may provide clin. benefit in patients with certain types of gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0qvLkeUog7LVg90H21EOLACvtfcHk0lhlkEl1FCU-oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KrtLs%253D&md5=015f1e899f602818fd92f9d2679e5db7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2743%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DArao%26aufirst%3DT.%26aulast%3DYokote%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DT.%26aulast%3DYanagihara%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTamura%26aufirst%3DT%26aulast%3DFukuoka%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DSaijo%26aufirst%3DN.%26aulast%3DNishio%26aufirst%3DK.%26atitle%3DAZD2171%2520shows%2520potent%2520antitumor%2520activity%2520against%2520gastric%2520cancer%2520over-expressing%2520fibroblast%2520growth%2520factor%2520receptor%25202%252Fkeratinocyte%2520growth%2520factor%2520receptor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3051%26epage%3D3057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorenstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span> </span><span class="NLM_article-title">FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 Signaling for Growth and Survival</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2340</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2340-2348&author=K.+Kuniiauthor=L.+Davisauthor=J.+Gorensteinauthor=H.+Hatchauthor=M.+Yashiroauthor=A.+Di+Baccoauthor=C.+Elbiauthor=B.+Lutterbach&title=FGFR2-amplified+gastric+cancer+cell+lines+require+FGFR2+and+Erbb3+Signaling+for+Growth+and+Survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DGorenstein%26aufirst%3DJ.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DYashiro%26aufirst%3DM.%26aulast%3DDi%2BBacco%26aufirst%3DA.%26aulast%3DElbi%26aufirst%3DC.%26aulast%3DLutterbach%26aufirst%3DB.%26atitle%3DFGFR2-amplified%2520gastric%2520cancer%2520cell%2520lines%2520require%2520FGFR2%2520and%2520Erbb3%2520Signaling%2520for%2520Growth%2520and%2520Survival%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2340%26epage%3D2348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pollock, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartside, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejeza, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodfellow, P. J.</span><span> </span><span class="NLM_article-title">Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">7158</span><span class="NLM_x">–</span> <span class="NLM_lpage">7162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=7158-7162&author=P.+M.+Pollockauthor=M.+G.+Gartsideauthor=L.+C.+Dejezaauthor=M.+A.+Powellauthor=M.+A.+Mallonauthor=H.+Daviesauthor=M.+Mohammadiauthor=P.+A.+Futrealauthor=M.+R.+Strattonauthor=J.+M.+Trentauthor=P.+J.+Goodfellow&title=Frequent+activating+FGFR2+mutations+in+endometrial+carcinomas+parallel+germline+mutations+associated+with+craniosynostosis+and+skeletal+dysplasia+syndromes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollock%26aufirst%3DP.%2BM.%26aulast%3DGartside%26aufirst%3DM.%2BG.%26aulast%3DDejeza%26aufirst%3DL.%2BC.%26aulast%3DPowell%26aufirst%3DM.%2BA.%26aulast%3DMallon%26aufirst%3DM.%2BA.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DTrent%26aufirst%3DJ.%2BM.%26aulast%3DGoodfellow%26aufirst%3DP.%2BJ.%26atitle%3DFrequent%2520activating%2520FGFR2%2520mutations%2520in%2520endometrial%2520carcinomas%2520parallel%2520germline%2520mutations%2520associated%2520with%2520craniosynostosis%2520and%2520skeletal%2520dysplasia%2520syndromes%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D7158%26epage%3D7162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Weiss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltermann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöttle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leenders, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabow, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Querings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heukamp, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balke-Want, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansén, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baessmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmüller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainer, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorimier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustugun, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel-Riedel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sänger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timens, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sietsma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heideman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligorio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoelben, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nürnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span> </span><span class="NLM_article-title">Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1126%2Fscitranslmed.3001451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=62-93&author=J.+M.+Weissauthor=M.+L.+Sosauthor=D.+Seidelauthor=M.+Peiferauthor=T.+Zanderauthor=J.+M.+Heuckmannauthor=R.+T.+Ullrichauthor=R.+Menonauthor=S.+Maierauthor=A.+Soltermannauthor=H.+Mochauthor=P.+Wagenerauthor=F.+Fischerauthor=S.+Heynckauthor=M.+Kokerauthor=J.+Sch%C3%B6ttleauthor=F.+Leendersauthor=F.+Gablerauthor=I.+Dabowauthor=S.+Queringsauthor=L.+C.+Heukampauthor=H.+Balke-Wantauthor=S.+Ans%C3%A9nauthor=D.+Rauhauthor=I.+Baessmannauthor=J.+Altm%C3%BCllerauthor=Z.+Wainerauthor=M.+Conronauthor=G.+Wrightauthor=O.+Russellauthor=B.+Solomonauthor=E.+Brambillaauthor=C.+Brambillaauthor=P.+Lorimierauthor=S.+Sollbergauthor=O.+T.+Brustugunauthor=W.+Engel-Riedelauthor=C.+Ludwigauthor=I.+Petersenauthor=J.+S%C3%A4ngerauthor=J.+Clementauthor=H.+Groenauthor=W.+Timensauthor=H.+Sietsmaauthor=E.+Thunnissenauthor=E.+Smitauthor=D.+Heidemanauthor=F.+Cappuzzoauthor=C.+Ligorioauthor=S.+Damianiauthor=M.+Hallekauthor=R.+Beroukhimauthor=W.+Paoauthor=B.+Kleblauthor=M.+Baumannauthor=R.+Buettnerauthor=K.+Ernestusauthor=E.+Stoelbenauthor=J.+Wolfauthor=P.+N%C3%BCrnbergauthor=S.+Pernerauthor=R.+K.+Thomas&title=Frequent+and+Focal+FGFR1+Amplification+Associates+with+Therapeutically+Tractable+FGFR1+Dependency+in+Squamous+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer</span></div><div class="casAuthors">Weiss, Jonathan; Sos, Martin L.; Seidel, Danila; Peifer, Martin; Zander, Thomas; Heuckmann, Johannes M.; Ullrich, Roland T.; Menon, Roopika; Maier, Sebastian; Soltermann, Alex; Moch, Holger; Wagener, Patrick; Fischer, Florian; Heynck, Stefanie; Koker, Mirjam; Schoettle, Jakob; Leenders, Frauke; Gabler, Franziska; Dabow, Ines; Querings, Silvia; Heukamp, Lukas C.; Balke-Want, Hyatt; Ansen, Sascha; Rauh, Daniel; Baessmann, Ingelore; Altmueller, Janine; Wainer, Zoe; Conron, Matthew; Wright, Gavin; Russell, Prudence; Solomon, Ben; Brambilla, Elisabeth; Brambilla, Christian; Lorimier, Philippe; Sollberg, Steinar; Brustugun, Odd Terje; Engel-Riedel, Walburga; Ludwig, Corinna; Petersen, Iver; Saenger, Joerg; Clement, Joachim; Groen, Harry; Timens, Wim; Sietsma, Hannie; Thunnissen, Erik; Smit, Egbert; Heideman, Danielle; Cappuzzo, Federico; Ligorio, Claudia; Damiani, Stefania; Hallek, Michael; Beroukhim, Rameen; Pao, William; Klebl, Bert; Baumann, Matthias; Buettner, Reinhard; Ernestus, Karen; Stoelben, Erich; Wolf, Juergen; Nuernberg, Peter; Perner, Sven; Thomas, Roman K.</div><div class="citationInfo"><span class="NLM_cas:title">Science Translational Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">62</span>),
    <span class="NLM_cas:pages">62ra93</span>CODEN:
                <span class="NLM_cas:coden">STMCBQ</span>;
        ISSN:<span class="NLM_cas:issn">1946-6242</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Lung cancer remains one of the leading causes of cancer-related death in developed countries.  Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to treatment by epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) inhibition, resp., squamous cell lung cancer currently lacks therapeutically exploitable genetic alterations.  We conducted a systematic search in a set of 232 lung cancer specimens for genetic alterations that were therapeutically amenable and then performed high-resoln. gene copy no. analyses.  We identified frequent and focal fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell lung cancer (n = 155), but not in other lung cancer subtypes, and, by fluorescence in situ hybridization, confirmed the presence of FGFR1 amplifications in an independent cohort of squamous cell lung cancer samples (22% of cases).  Using cell-based screening with the FGFR inhibitor PD173074 in a large (n = 83) panel of lung cancer cell lines, we demonstrated that this compd. inhibited growth and induced apoptosis specifically in those lung cancer cells carrying amplified FGFR1.  We validated the FGFR1 dependence of FGFR1-amplified cell lines by FGFR1 knockdown and by ectopic expression of an FGFR1-resistant allele (FGFR1V561M), which rescued FGFR1-amplified cells from PD173074-mediated cytotoxicity.  Finally, we showed that inhibition of FGFR1 with a small mol. led to significant tumor shrinkage in vivo.  Thus, focal FGFR1 amplification is common in squamous cell lung cancer and assocd. with tumor growth and survival, suggesting that FGFR inhibitors may be a viable therapeutic option in this cohort of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9iQRgbnlWiLVg90H21EOLACvtfcHk0libLvR9x6JpHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWisLc%253D&md5=1d088ffa078b4bf37ee43100d91fee6e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001451%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%2BM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DSeidel%26aufirst%3DD.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DZander%26aufirst%3DT.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DUllrich%26aufirst%3DR.%2BT.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DMaier%26aufirst%3DS.%26aulast%3DSoltermann%26aufirst%3DA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DWagener%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DF.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DSch%25C3%25B6ttle%26aufirst%3DJ.%26aulast%3DLeenders%26aufirst%3DF.%26aulast%3DGabler%26aufirst%3DF.%26aulast%3DDabow%26aufirst%3DI.%26aulast%3DQuerings%26aufirst%3DS.%26aulast%3DHeukamp%26aufirst%3DL.%2BC.%26aulast%3DBalke-Want%26aufirst%3DH.%26aulast%3DAns%25C3%25A9n%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DBaessmann%26aufirst%3DI.%26aulast%3DAltm%25C3%25BCller%26aufirst%3DJ.%26aulast%3DWainer%26aufirst%3DZ.%26aulast%3DConron%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DRussell%26aufirst%3DO.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DBrambilla%26aufirst%3DE.%26aulast%3DBrambilla%26aufirst%3DC.%26aulast%3DLorimier%26aufirst%3DP.%26aulast%3DSollberg%26aufirst%3DS.%26aulast%3DBrustugun%26aufirst%3DO.%2BT.%26aulast%3DEngel-Riedel%26aufirst%3DW.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DI.%26aulast%3DS%25C3%25A4nger%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DJ.%26aulast%3DGroen%26aufirst%3DH.%26aulast%3DTimens%26aufirst%3DW.%26aulast%3DSietsma%26aufirst%3DH.%26aulast%3DThunnissen%26aufirst%3DE.%26aulast%3DSmit%26aufirst%3DE.%26aulast%3DHeideman%26aufirst%3DD.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DLigorio%26aufirst%3DC.%26aulast%3DDamiani%26aufirst%3DS.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DM.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DErnestus%26aufirst%3DK.%26aulast%3DStoelben%26aufirst%3DE.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DP.%26aulast%3DPerner%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26atitle%3DFrequent%2520and%2520Focal%2520FGFR1%2520Amplification%2520Associates%2520with%2520Therapeutically%2520Tractable%2520FGFR1%2520Dependency%2520in%2520Squamous%2520Cell%2520Lung%2520Cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D62%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarrio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iravani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardisson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6652</span><span class="NLM_x">–</span> <span class="NLM_lpage">6662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1158%2F1078-0432.CCR-06-1164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17121884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1elsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=6652-6662&author=J.+S.+Reis-Filhoauthor=P.+T.+Simpsonauthor=N.+C.+Turnerauthor=M.+B.+Lambrosauthor=C.+Jonesauthor=A.+Mackayauthor=A.+Grigoriadisauthor=D.+Sarrioauthor=K.+Savageauthor=T.+Dexterauthor=M.+Iravaniauthor=K.+Fenwickauthor=B.+Weberauthor=D.+Hardissonauthor=F.+C.+Schmittauthor=J.+Palaciosauthor=S.+R.+Lakhaniauthor=A.+Ashworth&title=FGFR1+emerges+as+a+potential+therapeutic+target+for+lobular+breast+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">FGFR1 Emerges as a potential therapeutic target for lobular breast crcinomas</span></div><div class="casAuthors">Reis-Filho, Jorge Sergio; Simpson, Pete T.; Turner, Nicholas C.; Lambros, Maryou Ballo; Jones, Chris; Mackay, Alan; Grigoriadis, Anita; Sarrio, David; Savage, Kay; Dexter, Tim; Iravani, Marjan; Fenwick, Kerry; Weber, Barbara; Hardisson, David; Schmitt, Fernando Carlos; Palacios, Jose; Lakhani, Sunil R.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6652-6662</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Classic lobular carcinomas (CLC) account for 10% to 15% of all breast cancers.  At the genetic level, CLCs show recurrent phys. loss of chromosome16q coupled with the lack of E-cadherin (CDH1 gene) expression.  However, little is known about the putative therapeutic targets for these tumors.  The aim of this study was to characterize CLCs at the mol. genetic level and identify putative therapeutic targets.  We subjected 13 cases of CLC to a comprehensive mol. anal. including immunohistochem. for E-cadherin, estrogen and progesterone receptors, HER2/neu and p53; high-resoln. comparative genomic hybridization (HR-CGH); microarray-based CGH (aCGH); and fluorescent and chromogenic in situ hybridization for CCND1 and FGFR1.  All cases lacked the expression of E-cadherin, p53, and HER2, and all but one case was pos. for estrogen receptors.  HR-CGH revealed recurrent gains on 1q and losses on 16q (both, 85%). aCGH showed a good agreement with but higher resoln. and sensitivity than HR-CGH.  Recurrent, high level gains at 11q13 (CCND1) and 8p12-p11.2 were identified in seven and six cases, resp., and were validated with in situ hybridization.  Examn. of aCGH and the gene expression profile data of the cell lines, MDA-MB-134 and ZR-75-1, which harbor distinct gains of 8p12-p11.2, identified FGFR1 as a putative amplicon driver of 8p12-p11.2 amplification in MDA-MB-134.  Inhibition of FGFR1 expression using small interfering RNA or a small-mol. chem. inhibitor showed that FGFR1 signaling contributes to the survival of MDA-MB-134 cells.  The findings suggest that receptor FGFR1 inhibitors may be useful as therapeutics in a subset of CLCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3HfEguTUcVbVg90H21EOLACvtfcHk0ljrcq2-qcBk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1elsL%252FO&md5=3b036c4129974b6386214ede47292d73</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1164%26sid%3Dliteratum%253Aachs%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DSimpson%26aufirst%3DP.%2BT.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DSarrio%26aufirst%3DD.%26aulast%3DSavage%26aufirst%3DK.%26aulast%3DDexter%26aufirst%3DT.%26aulast%3DIravani%26aufirst%3DM.%26aulast%3DFenwick%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DHardisson%26aufirst%3DD.%26aulast%3DSchmitt%26aufirst%3DF.%2BC.%26aulast%3DPalacios%26aufirst%3DJ.%26aulast%3DLakhani%26aufirst%3DS.%2BR.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFGFR1%2520emerges%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520lobular%2520breast%2520carcinomas%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D6652%26epage%3D6662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Penault-Llorca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deLapeyriere, O.</span><span> </span><span class="NLM_article-title">Expression of FGF and FGF receptor genes in human breast cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.2910610205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7705943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1995&pages=170-176&author=F.+Penault-Llorcaauthor=F.+Bertucciauthor=J.+Adelaideauthor=P.+Parcauthor=F.+Coulierauthor=J.+Jacquemierauthor=D.+Birnbaumauthor=O.+deLapeyriere&title=Expression+of+FGF+and+FGF+receptor+genes+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of FGF and FGF receptor genes in human breast cancer</span></div><div class="casAuthors">Penault-Llorca, Frederique; Bertucci, Francois; Adelaiede, Jose; Parc, Patricia; Coulier, Francois; Jacquemier, Jocelyne; Birnbaum, Daniel; DeLapeyriere, Odile</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-6</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The family of FGF growth factors is involved in several biol. processes and might play an important role in tumorigenesis.  The authors have studied the resp. expression of 8 of the 9 characterized FGF genes, and of the 4 known FGF receptor genes, in a panel of 10 tumor-cell lines and 103 breast-tumor samples, using RT-PCR and Northern-blot analyses.  FGF1 and FGF2 were expressed in almost all samples, whereas expression of FGF5, FGF6, FGF7 and FGF9 was more restricted.  FGFR1, FGFR2, and FGFR4 were expressed at high levels in resp. 22%, 4%, and 32% of tumors.  FGFR3 expression was not detected.  The transcript encoding an FGFR1 isoform with 2 Ig-like domains was the most prevalent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM4Ndkn4BdcLVg90H21EOLACvtfcHk0ljrcq2-qcBk0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D&md5=ce0eda6c49f3504d032c36d6cfb805e5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910610205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910610205%26sid%3Dliteratum%253Aachs%26aulast%3DPenault-Llorca%26aufirst%3DF.%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DParc%26aufirst%3DP.%26aulast%3DCoulier%26aufirst%3DF.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DdeLapeyriere%26aufirst%3DO.%26atitle%3DExpression%2520of%2520FGF%2520and%2520FGF%2520receptor%2520genes%2520in%2520human%2520breast%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1995%26volume%3D61%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penault-Llorca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deLapeyriere, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span> </span><span class="NLM_article-title">Expression of the FGFR1 gene in human breast-carcinoma cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.2910590314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7927944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fht1yqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=373-378&author=J.+Jacquemierauthor=J.+Adelaideauthor=P.+Parcauthor=F.+Penault-Llorcaauthor=J.+Plancheauthor=O.+deLapeyriereauthor=D.+Birnbaum&title=Expression+of+the+FGFR1+gene+in+human+breast-carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the FGFR1 gene in human breast-carcinoma cells</span></div><div class="casAuthors">Jacquemier J; Adelaide J; Parc P; Penault-Llorca F; Planche J; deLapeyriere O; Birnbaum D</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-8</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Fibroblast growth factors (FGF) constitute a family of at least 9 members which act through high-affinity tyrosine-kinase receptors encoded by 4 distinct genes.  In humans, the FGFR1 gene is located in chromosomal region 8p12.  Its amplification and expression were examined in a panel of 110 breast carcinoma samples by Southern- and Northern-blot analyses.  FGFR1 was amplified in 9% and overexpressed in about 15% of the tumors studied.  In situ hybridization experiments were performed on tissue sections of normal breast and tumors with a high level of FGFR1 expression.  In both normal and tumoral tissues, FGFR1 RNA was detected in the epithelial cells.  Overexpression of FGFR1 seems to be associated with small, well-differentiated diploid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj08CCzyP00w5nADWVYHg1fW6udTcc2ebbP9n6XYffq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fht1yqtw%253D%253D&md5=28a3af0a2b6fb24f844e5dce70eb0d18</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910590314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910590314%26sid%3Dliteratum%253Aachs%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DParc%26aufirst%3DP.%26aulast%3DPenault-Llorca%26aufirst%3DF.%26aulast%3DPlanche%26aufirst%3DJ.%26aulast%3DdeLapeyriere%26aufirst%3DO.%26aulast%3DBirnbaum%26aufirst%3DD.%26atitle%3DExpression%2520of%2520the%2520FGFR1%2520gene%2520in%2520human%2520breast-carcinoma%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1994%26volume%3D59%26spage%3D373%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmikangas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyrhonen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtovirta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanlinna, H.</span><span> </span><span class="NLM_article-title">Amplification of fgfr4 gene in human breast and gynecological cancers</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.2910540305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=8099571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK3sXmt1aqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1993&pages=378-382&author=S.+Jaakkolaauthor=P.+Salmikangasauthor=S.+Nylundauthor=J.+Partanenauthor=E.+Armstrongauthor=S.+Pyrhonenauthor=P.+Lehtovirtaauthor=H.+Nevanlinna&title=Amplification+of+fgfr4+gene+in+human+breast+and+gynecological+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of fgfr4 gene in human breast and gynecological cancers</span></div><div class="casAuthors">Jaakkola, Susanna; Salmikangas, Paula; Nylund, Stella; Partanen, Juha; Armstrong, Elina; Pyrhonen, Seppo; Lehtovirta, Pentti; Nevanlinna, Heli</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">378-82</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The authors have investigated gene amplification of fibroblast growth factor receptor-4 (FGFR4) gene in 30 primary breast tumor samples and 15 gynecol. tumor samples.  Ten percent of the breast tumors showed 2- to 4-fold amplification.  Amplification was found more frequently in estrogen- and progesterone-receptor-pos. tumors and in tumors with high lymph-node involvement.  Breast tumor samples were also analyzed for the amplification of fgfr4 and erbB2 genes and the chromosome 11q13 located genes hst1/int2/bcl1/sea.  ErbB2 gene was amplified 2- to 13-fold in 13% of the cases, but no amplification of int2/hst1/bcl1/sea amplicon was found.  Gynecol. tumors were also analyzed for the amplification of fgfr4 and fgfr3 genes and for int2 and hst1 oncogenes.  Eleven of the 15 gynecol. tumors were ovarian neoplasms including 2 benign tumors; the remainder comprised 1 ovarian metastasis of breast cancer; I endometrial cancer; 1 uterine leiomyosarcoma and 1 carcinosarcoma of the fallopian tube.  In gynecol. tumors, fgfr4 gene was found to be amplified in 2 ovarian tumors.  Amplification of hstI was found in 1 benign ovarian tumor.  Thus, the fgfr4 gene may be involved in breast and ovarian tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8SaHJN93yLVg90H21EOLACvtfcHk0lhJ9e87pDd3iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmt1aqu70%253D&md5=6109469c784e655644ddc8ed3106bf1b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910540305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910540305%26sid%3Dliteratum%253Aachs%26aulast%3DJaakkola%26aufirst%3DS.%26aulast%3DSalmikangas%26aufirst%3DP.%26aulast%3DNylund%26aufirst%3DS.%26aulast%3DPartanen%26aufirst%3DJ.%26aulast%3DArmstrong%26aufirst%3DE.%26aulast%3DPyrhonen%26aufirst%3DS.%26aulast%3DLehtovirta%26aufirst%3DP.%26aulast%3DNevanlinna%26aufirst%3DH.%26atitle%3DAmplification%2520of%2520fgfr4%2520gene%2520in%2520human%2520breast%2520and%2520gynecological%2520cancers%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1993%26volume%3D54%26spage%3D378%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Theillet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louason, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet-Dorion, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsaros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sismondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudray, P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.2870070407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7692948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK2cXhs1Shtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=219-226&author=C.+Theilletauthor=J.+Adelaideauthor=G.+Louasonauthor=F.+Bonnet-Dorionauthor=J.+Jacquemierauthor=J.+Adnaneauthor=M.+Longyauthor=D.+Katsarosauthor=P.+Sismondiauthor=P.+Gaudray&title=FGFRI+and+PLAT+genes+and+DNA+amplification+at+8p12+in+breast+and+ovarian+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers</span></div><div class="casAuthors">Theillet, Charles; Adelaide, Jose; Louason, Genevieve; Bonnet-Dorion, Francoise; Jacquemier, Jocelyne; Adnane, Jalila; Longy, Michel; Katsaros, Dionisi; Sismondi, Piero; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-26</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    </div><div class="casAbstract">Several chromosomal regions are found to be consistently amplified in human breast cancers.  For two of these regions, 8p 12 and 10q26, the authors previously reported the amplification of genes encoding FGF receptors, FGFRI/FLG and FGFR2/BEK, in about 12% of breast tumors.  The PLAT gene, encoding the tissue-type plasminogen activator, is also located close to or within the 8p 12 region.  In the present study, the authors show that both FGFRI and PLAT can be amplified in breast as well as ovarian carcinomas.  FGFRI amplification was detected in 14.5% of breast and 7.8% of ovarian tumors, whereas PLAT was found to be amplified in 15.6% and 19.4% of the tumors, resp.  Each gene could be amplified independently of the other.  These data raised the question of which gene is selected for amplification at 8p 12.  In most cases, the levels of expression of FGFRI and PLAT in breast tumors were comparable to their level of expression in normal mammary tissue.  However, FGFRI was expressed above the normal level in a certain no. of cases.  This gene could be a good candidate as "driver" of the 8p12 amplification, but it cannot account for all complex mol. events taking place in this region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKI0BCYkSi_bVg90H21EOLACvtfcHk0lhJ9e87pDd3iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhs1Shtrs%253D&md5=d8eaa381591a324bd7d42e8a50a075b4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fgcc.2870070407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.2870070407%26sid%3Dliteratum%253Aachs%26aulast%3DTheillet%26aufirst%3DC.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DLouason%26aufirst%3DG.%26aulast%3DBonnet-Dorion%26aufirst%3DF.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DAdnane%26aufirst%3DJ.%26aulast%3DLongy%26aufirst%3DM.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DSismondi%26aufirst%3DP.%26aulast%3DGaudray%26aufirst%3DP.%26atitle%3DFGFRI%2520and%2520PLAT%2520genes%2520and%2520DNA%2520amplification%2520at%25208p12%2520in%2520breast%2520and%2520ovarian%2520cancers%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D1993%26volume%3D7%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Adnane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionne, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanteur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theillet, C.</span><span> </span><span class="NLM_article-title">BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=659-663&author=J.+Adnaneauthor=P.+Gaudrayauthor=C.+A.+Dionneauthor=G.+Crumleyauthor=M.+Jayeauthor=J.+Schlessingerauthor=P.+Jeanteurauthor=D.+Birnbaumauthor=C.+Theillet&title=BEK+and+FLG%2C+two+receptors+to+members+of+the+FGF+family%2C+are+amplified+in+subsets+of+human+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdnane%26aufirst%3DJ.%26aulast%3DGaudray%26aufirst%3DP.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26aulast%3DCrumley%26aufirst%3DG.%26aulast%3DJaye%26aufirst%3DM.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DJeanteur%26aufirst%3DP.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DTheillet%26aufirst%3DC.%26atitle%3DBEK%2520and%2520FLG%252C%2520two%2520receptors%2520to%2520members%2520of%2520the%2520FGF%2520family%252C%2520are%2520amplified%2520in%2520subsets%2520of%2520human%2520breast%2520cancers%26jtitle%3DOncogene%26date%3D1991%26volume%3D6%26spage%3D659%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Elsheikh, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grainge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span> </span><span class="NLM_article-title">FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">R23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=R23&author=S.+E.+Elsheikhauthor=A.+R.+Greenauthor=M.+B.+K.+Lambrosauthor=N.+C.+Turnerauthor=M.+J.+Graingeauthor=D.+Poweauthor=I.+O.+Ellisauthor=J.+S.+Reis-Filho&title=FGFR1+amplification+in+breast+carcinomas%3A+a+chromogenic+in+situ+hybridisation+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElsheikh%26aufirst%3DS.%2BE.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DLambros%26aufirst%3DM.%2BB.%2BK.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DGrainge%26aufirst%3DM.%2BJ.%26aulast%3DPowe%26aufirst%3DD.%26aulast%3DEllis%26aufirst%3DI.%2BO.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26atitle%3DFGFR1%2520amplification%2520in%2520breast%2520carcinomas%253A%2520a%2520chromogenic%2520in%2520situ%2520hybridisation%2520analysis%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2007%26volume%3D9%26spage%3DR23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Valladares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Hernandez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamanca Gomez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curiel-Quezada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrigal-Bujaidar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra Martinez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenas Aranda, D. J.</span><span> </span><span class="NLM_article-title">Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women</span> <span class="citation_source-journal">Cancer Genet. Cytogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2Fj.cancergencyto.2006.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17011986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWqtrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2006&pages=147-151&author=A.+Valladaresauthor=N.+Garcia+Hernandezauthor=F.+Salamanca+Gomezauthor=E.+Curiel-Quezadaauthor=E.+Madrigal-Bujaidarauthor=M.+D.+Vergaraauthor=M.+Sierra+Martinezauthor=D.+J.+Arenas+Aranda&title=Genetic+expression+profiles+and+chromosomal+alterations+in+sporadic+breast+cancer+in+Mexican+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women</span></div><div class="casAuthors">Valladares, Adan; Garcia Hernandez, Normand; Salamanca Gomez, Fabio; Curiel-Quezada, Everardo; Madrigal-Bujaidar, Eduardo; Vergara, Ma. Dolores; Sierra Martinez, Monica; Arenas Aranda, Diego J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Genetics and Cytogenetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-151</span>CODEN:
                <span class="NLM_cas:coden">CGCYDF</span>;
        ISSN:<span class="NLM_cas:issn">0165-4608</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Breast cancer is the second-leading cause of death among Mexican women >35 years of age.  At the mol. level, changes in many genetic pathways have been reported to be assocd. with this neoplasm.  To analyze these changes, we detd. gene expression profiles and chromosomal structural alterations in tumors from Mexican women.  We obtained mRNA to identify expression profiles with microarray technol., and DNA to det. amplifications and deletions, in 10 fresh sporadic breast tumor biopsies without treatment, as well as in 10 nonaffected breast tissues.  Expression profiles were compared with genetic changes obsd. by comparative genomic hybridization (CGH).  We compared the expression profiles against the structural alterations from the studied genes by means of microarrays; at least 17 of these genes correlated with DNA copy no. alterations.  We found that the following genes were overexpressed: LAMC1, PCTK3, CCNC, CCND1, FGF3, PCTK2, L1CAM, BGN, and PLXNB3 (alias PLEXR).  Underexpressed genes included CASP9, FGR, TP73, HSPG2, and ERCC1; genes turned off included FRAP1, EPHA2 (previously ECK), IL12A, E2F5, TNFRSF10B, TNFRSF10A, EFNB3, and BCL2.  The results will allow us, in the near future, to outline genes that could serve as diagnostic, prognostic, or target therapy markers for the Mexican population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmHhQPSzIowrVg90H21EOLACvtfcHk0lh05exl1s3f2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWqtrvM&md5=61cefaa234d059279b82b169ebba0bbe</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergencyto.2006.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergencyto.2006.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DValladares%26aufirst%3DA.%26aulast%3DGarcia%2BHernandez%26aufirst%3DN.%26aulast%3DSalamanca%2BGomez%26aufirst%3DF.%26aulast%3DCuriel-Quezada%26aufirst%3DE.%26aulast%3DMadrigal-Bujaidar%26aufirst%3DE.%26aulast%3DVergara%26aufirst%3DM.%2BD.%26aulast%3DSierra%2BMartinez%26aufirst%3DM.%26aulast%3DArenas%2BAranda%26aufirst%3DD.%2BJ.%26atitle%3DGenetic%2520expression%2520profiles%2520and%2520chromosomal%2520alterations%2520in%2520sporadic%2520breast%2520cancer%2520in%2520Mexican%2520women%26jtitle%3DCancer%2520Genet.%2520Cytogenet.%26date%3D2006%26volume%3D170%26spage%3D147%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Fioravanti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelletti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coradini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miodini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fronzo, G.</span><span> </span><span class="NLM_article-title">int-2 oncogene amplification and prognosis in node-negative breast carcinoma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2F%28SICI%291097-0215%2819971219%2974%3A6%3C620%3A%3AAID-IJC11%3E3.0.CO%3B2-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=9421359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A280%3ADyaK1c%252FotFOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1997&pages=620-624&author=L.+Fioravantiauthor=V.+Cappellettiauthor=D.+Coradiniauthor=P.+Miodiniauthor=G.+Borsaniauthor=M.+G.+Daidoneauthor=G.+Di+Fronzo&title=int-2+oncogene+amplification+and+prognosis+in+node-negative+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">int-2 oncogene amplification and prognosis in node-negative breast carcinoma</span></div><div class="casAuthors">Fioravanti L; Cappelletti V; Coradini D; Miodini P; Borsani G; Daidone M G; Di Fronzo G</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-4</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The role of int-2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node-negative primary breast cancers given first-line local-regional treatments until relapse and with a median follow-up of 65 months.  Tumours had been previously characterised for oestrogen (ER) and progesterone receptor (PgR) status and proliferative activity (3H-thymidine labelling index).  Amplification of the int-2 oncogene occurred in 18% of cases and was significantly related to the presence of hormone receptors and to menopausal status or age, but not to proliferative status.  Patients with tumours exhibiting int-2 amplification had a lower probability of disease-free survival than patients with non-amplified tumours and frequently developed local-regional recurrence.  Disease-free survival analysis, adjusted for the prognostic contribution provided by tumour size, steroid receptors and proliferative rate, indicated that the association between int-2 amplification and risk of relapse was maintained and remained constant even in the presence of the other co-variates.  Interestingly, int-2 amplification was a further prognostic discriminant within subsets of patients with a putatively good (i.e., tumour size <20 mm, ER+ and PgR+) or poor prognosis (i.e., high labelling index).  Our exploratory study suggests that within node-negative patients, int-2 amplification could be a valuable and independent prognosticator, useful to identify patients at high risk of local-regional recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAFFsDZPhrMEg6wdEZmT2rfW6udTcc2eZGyiM75znAEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252FotFOisA%253D%253D&md5=deffd5e262f0abb1097675c56aeb8147</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819971219%2974%3A6%3C620%3A%3AAID-IJC11%3E3.0.CO%3B2-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819971219%252974%253A6%253C620%253A%253AAID-IJC11%253E3.0.CO%253B2-9%26sid%3Dliteratum%253Aachs%26aulast%3DFioravanti%26aufirst%3DL.%26aulast%3DCappelletti%26aufirst%3DV.%26aulast%3DCoradini%26aufirst%3DD.%26aulast%3DMiodini%26aufirst%3DP.%26aulast%3DBorsani%26aufirst%3DG.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DDi%2BFronzo%26aufirst%3DG.%26atitle%3Dint-2%2520oncogene%2520amplification%2520and%2520prognosis%2520in%2520node-negative%2520breast%2520carcinoma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1997%26volume%3D74%26spage%3D620%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaul, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsfall, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musgrove, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshadri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span> </span><span class="NLM_article-title">EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1617</span><span class="NLM_x">–</span> <span class="NLM_lpage">1623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=1617-1623&author=R.+Huiauthor=D.+H.+Campbellauthor=C.+S.+L.+Leeauthor=K.+McCaulauthor=D.+J.+Horsfallauthor=E.+A.+Musgroveauthor=R.+J.+Dalyauthor=R.+Seshadriauthor=R.+L.+Sutherland&title=EMS1+amplification+can+occur+independently+of+CCND1+or+INT-2+amplification+at+11q13+and+may+identify+different+phenotypes+in+primary+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BS.%2BL.%26aulast%3DMcCaul%26aufirst%3DK.%26aulast%3DHorsfall%26aufirst%3DD.%2BJ.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DSeshadri%26aufirst%3DR.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26atitle%3DEMS1%2520amplification%2520can%2520occur%2520independently%2520of%2520CCND1%2520or%2520INT-2%2520amplification%2520at%252011q13%2520and%2520may%2520identify%2520different%2520phenotypes%2520in%2520primary%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D1997%26volume%3D15%26spage%3D1617%26epage%3D1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Berns, E. M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foekens, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staveren, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Putten, W. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Koning, H. Y. W. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portengen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klijn, J. G. M.</span><span> </span><span class="NLM_article-title">Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1995&pages=11-18&author=E.+M.+J.+J.+Bernsauthor=J.+A.+Foekensauthor=I.+L.+van+Staverenauthor=W.+L.+J.+van+Puttenauthor=H.+Y.+W.+C.+M.+de+Koningauthor=H.+Portengenauthor=J.+G.+M.+Klijn&title=Oncogene+amplification+and+prognosis+in+breast+cancer%3A+relationship+with+systemic+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerns%26aufirst%3DE.%2BM.%2BJ.%2BJ.%26aulast%3DFoekens%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2BStaveren%26aufirst%3DI.%2BL.%26aulast%3Dvan%2BPutten%26aufirst%3DW.%2BL.%2BJ.%26aulast%3Dde%2BKoning%26aufirst%3DH.%2BY.%2BW.%2BC.%2BM.%26aulast%3DPortengen%26aufirst%3DH.%26aulast%3DKlijn%26aufirst%3DJ.%2BG.%2BM.%26atitle%3DOncogene%2520amplification%2520and%2520prognosis%2520in%2520breast%2520cancer%253A%2520relationship%2520with%2520systemic%2520treatment%26jtitle%3DGene%26date%3D1995%26volume%3D159%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Mayr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanitz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderegg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthardt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohrs, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, J.</span><span> </span><span class="NLM_article-title">Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1309%2FN6X5MB24BP42KP20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=16753589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFWisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=101-109&author=D.+Mayrauthor=V.+Kanitzauthor=B.+Andereggauthor=B.+Luthardtauthor=J.+Engelauthor=U.+Lohrsauthor=G.+Amannauthor=J.+Diebold&title=Analysis+of+gene+amplification+and+prognostic+markers+in+ovarian+cancer+using+comparative+genomic+hybridization+for+microarrays+and+immunohistochemical+analysis+for+tissue+microarrays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays</span></div><div class="casAuthors">Mayr, Doris; Kanitz, Veronika; Anderegg, Birgit; Luthardt, Beate; Engel, Jutta; Lohrs, Udo; Amann, Gudrun; Diebold, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">AJCPAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Pathology</span>)
        </div><div class="casAbstract">To identify oncogens amplification involved in ovarian carcinogenesis, we studied 21 ovarian carcinomas and 5 serous borderline tumors using conventional comparative genomic hybridization (CGH) and CGH to a genomic DNA microarray.  Immunohistochem. anal. of the proteins encoded by the genes that were amplified frequently (FGF3/4, FGFR1, CCNE1, PAK1, JUNB, and MDM2) was performed on a tissue microarray comprising 254 cases of ovarian neoplasms.  Regarding histol. type, characteristic patterns of copy no. changes were revealed.  They correlated with histol. tumor type and with intratumoral heterogeneity.  Gain of FGF3/4 and CCNE1 was found in all serous carcinomas.  Endometrioid carcinomas most frequently showed gain of JUNB (83%), KRAS2 (67%), MYCN (50%), ESR (50%), and CCND2 (50%).  Of the serous borderline tumors, 80% harbored amplification of FGFR1 and MDM2 and a 75% gain of PIK3CA.  Only CCNE1 immunoreactivity was significantly correlated with CGH results (P < .05) and postoperative survival (P < .05).  Microarray-based genomic anal. in combination with immunohistochem. anal. was found to be a powerful technique for identification of clin. relevant gene amplification in human ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSaV-Jzj09aLVg90H21EOLACvtfcHk0lgZ6-7wo3xyHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFWisb4%253D&md5=5612e9b0a96e4a2c7ce08a05acf44d00</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1309%2FN6X5MB24BP42KP20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FN6X5MB24BP42KP20%26sid%3Dliteratum%253Aachs%26aulast%3DMayr%26aufirst%3DD.%26aulast%3DKanitz%26aufirst%3DV.%26aulast%3DAnderegg%26aufirst%3DB.%26aulast%3DLuthardt%26aufirst%3DB.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DLohrs%26aufirst%3DU.%26aulast%3DAmann%26aufirst%3DG.%26aulast%3DDiebold%26aufirst%3DJ.%26atitle%3DAnalysis%2520of%2520gene%2520amplification%2520and%2520prognostic%2520markers%2520in%2520ovarian%2520cancer%2520using%2520comparative%2520genomic%2520hybridization%2520for%2520microarrays%2520and%2520immunohistochemical%2520analysis%2520for%2520tissue%2520microarrays%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2006%26volume%3D126%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Seki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, T.</span><span> </span><span class="NLM_article-title">Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10853025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksV2ru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2000&pages=103-106&author=A.+Sekiauthor=M.+Yoshinouchiauthor=N.+Sekiauthor=J.+Kodamaauthor=Y.+Miyagiauthor=T.+Kudo&title=Detection+of+c-erbB-2+and+FGF-3+%28INT-2%29+gene+amplification+in+epithelial+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer</span></div><div class="casAuthors">Seki, Akihiko; Yoshinouchi, Mitsuo; Seki, Noriko; Kodama, Junichi; Miyagi, Yasunari; Kudo, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-106</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">We examd. gene amplifications of the c-erbB-2 and FGF-3 gene in 48 epithelial ovarian cancers by differential PCR and addressed their assocn. with clinico-pathol. features including clin. outcome.  Overall, 25.0 and 20.8% of ovarian cancers displayed amplified c-erbB-2 or FGF-3 gene, resp.  Amplification of the c-erbB-2 gene was significantly assocd. with particular histol. cell types, higher histol. grade, and low levels of serous CA125.  However, there was no correlation between c-erbB-2 gene amplification and patient outcome.  No correlation was obsd. between FGF-3 gene amplification and any clinicopathol. features including overall survival.  These findings suggested that c-erbB-2 or FGF-3 gene amplification might be one of the oncogenic events implicated in the development of ovarian cancers, yet is not a useful prognostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwoWQcmp_GU7Vg90H21EOLACvtfcHk0lgZ6-7wo3xyHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksV2ru7o%253D&md5=eaf374a5551ed5f62987506ad0266fff</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeki%26aufirst%3DA.%26aulast%3DYoshinouchi%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DKodama%26aufirst%3DJ.%26aulast%3DMiyagi%26aufirst%3DY.%26aulast%3DKudo%26aufirst%3DT.%26atitle%3DDetection%2520of%2520c-erbB-2%2520and%2520FGF-3%2520%2528INT-2%2529%2520gene%2520amplification%2520in%2520epithelial%2520ovarian%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2000%26volume%3D17%26spage%3D103%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rubin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etkind, P.</span><span> </span><span class="NLM_article-title">Amplification of the Int-2 gene in head and neck squamous cell carcinoma</span> <span class="citation_source-journal">J. Laryngol. Otol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7876747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A280%3ADyaK2M7ot1Sisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1995&pages=72-76&author=J.+S.+Rubinauthor=L.+Qiuauthor=P.+Etkind&title=Amplification+of+the+Int-2+gene+in+head+and+neck+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of the Int-2 gene in head and neck squamous cell carcinoma</span></div><div class="casAuthors">Rubin J S; Qiu L; Etkind P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of laryngology and otology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-6</span>
        ISSN:<span class="NLM_cas:issn">0022-2151</span>.
    </div><div class="casAbstract">Cellular oncogenes have been implicated in head and neck cancer development since 1986.  More recently interest has focused on chromosome 11q13; oncogenes therein undergoing ongoing investigation include Bcl-1/Prad-1, Hst-1 and Int-2.  Our laboratory has studied the Int-2 oncogene for several years, primarily in the breast.  This paper presents our investigations of Int-2 in the head and neck.  Thirty-four paraffin-embedded primary squamous cell carcinomas were studied for Int-2 gene amplification using a carefully controlled method of sequence quantification by DNA dot blots.  Amplification, mostly low level, was identified in 62 per cent of samples studied.  No clinical correlation to amplification could be found.  Further studies are underway looking for evidence of expression of Int-2 in fresh tissues and for amplification and expression of other oncogenes on this amplicon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN78q5fDugwBfKb6ELK8t0fW6udTcc2eZqshCl5RxlQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7ot1Sisw%253D%253D&md5=91de349c313d4985ea76ece9a99562c2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DEtkind%26aufirst%3DP.%26atitle%3DAmplification%2520of%2520the%2520Int-2%2520gene%2520in%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DJ.%2520Laryngol.%2520Otol.%26date%3D1995%26volume%3D109%26spage%3D72%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, J. S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, X.-Y.</span><span> </span><span class="NLM_article-title">Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2Fj.canlet.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17215076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2ks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2007&pages=36-42&author=L.+Huauthor=J.+S.+T.+Shamauthor=D.+Xieauthor=J.-M.+Wenauthor=W.-S.+Wangauthor=Y.+Wangauthor=X.-Y.+Guan&title=Up-regulation+of+fibroblast+growth+factor+3+is+associated+with+tumor+metastasis+and+recurrence+in+human+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma</span></div><div class="casAuthors">Hu, Liang; Sham, Jonathan S. T.; Xie, Dan; Wen, Jian-Ming; Wang, Wei-Sheng; Wang, Yi; Guan, Xin-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-42</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently, we established a hepatocellular carcinoma (HCC) cell line (named H4-M) from a metastatic HCC tumor.  In H4-M, a marker chromosome contg. a homogeneously staining region (hsr) was identified by cytogenetic anal.  The hsr was characterized by chromosome microdissection and the result showed that the hsr was composed of DNA sequence from 11q13.  Oncogenes CCND1 and FGF3 were localized within the complicon and overexpressions of CCND1 and FGF3 were confirmed by Northern blot anal.  Clin. significance of FGF3 overexpression was studied by immunohistochem. (IHC) using an HCC tissue microarray (TMA) contg. 60 pairs of primary/metastatic HCCs and 30 pairs of primary/recurrent HCCs.  TMA study showed that overexpression of FGF3 was significantly assocd. with HCC metastasis and recurrence (p < 0.01) , suggesting that up-regulation of FGF3 may play an important role in HCC metastasis and recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvXmjWrs7XbVg90H21EOLACvtfcHk0ljdgZuMVqA94g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2ks7s%253D&md5=4f5ed1eb2b83f5f867f9083a7b892051</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSham%26aufirst%3DJ.%2BS.%2BT.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DJ.-M.%26aulast%3DWang%26aufirst%3DW.-S.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DX.-Y.%26atitle%3DUp-regulation%2520of%2520fibroblast%2520growth%2520factor%25203%2520is%2520associated%2520with%2520tumor%2520metastasis%2520and%2520recurrence%2520in%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D252%26spage%3D36%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tsou, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsen, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. F.</span><span> </span><span class="NLM_article-title">Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=331-340&author=A.+P.+Tsouauthor=K.+M.+Wuauthor=T.+Y.+Tsenauthor=C.+W.+Chiauthor=J.+H.+Chiuauthor=W.+Y.+Luiauthor=C.+P.+Huauthor=C.+Changauthor=C.+K.+Chouauthor=S.+F.+Tsai&title=Parallel+hybridization+analysis+of+multiple+protein+kinase+genes%3A+identification+of+gene+expression+patterns+characteristic+of+human+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DA.%2BP.%26aulast%3DWu%26aufirst%3DK.%2BM.%26aulast%3DTsen%26aufirst%3DT.%2BY.%26aulast%3DChi%26aufirst%3DC.%2BW.%26aulast%3DChiu%26aufirst%3DJ.%2BH.%26aulast%3DLui%26aufirst%3DW.%2BY.%26aulast%3DHu%26aufirst%3DC.%2BP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DC.%2BK.%26aulast%3DTsai%26aufirst%3DS.%2BF.%26atitle%3DParallel%2520hybridization%2520analysis%2520of%2520multiple%2520protein%2520kinase%2520genes%253A%2520identification%2520of%2520gene%2520expression%2520patterns%2520characteristic%2520of%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DGenomics%26date%3D1998%26volume%3D50%26spage%3D331%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gerald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colbatzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handschuh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann-Lintz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4466</span><span class="NLM_x">–</span> <span class="NLM_lpage">4480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4466-4480&author=J.+Geraldauthor=A.+Heckelauthor=F.+Colbatzkyauthor=S.+Handschuhauthor=J.+Kleyauthor=T.+Lehmann-Lintzauthor=R.+Lotzauthor=U.+Tontsch-Gruntauthor=R.+Walterauthor=F.+Hilberg&title=Design%2C+Synthesis%2C+and+Evaluation+of+Indolinones+as+Triple+Angiokinase+Inhibitors+and+the+Discovery+of+a+Highly+Specific+6-Methoxycarbonyl-Substituted+Indolinone+%28BIBF+1120%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerald%26aufirst%3DJ.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3DColbatzky%26aufirst%3DF.%26aulast%3DHandschuh%26aufirst%3DS.%26aulast%3DKley%26aufirst%3DJ.%26aulast%3DLehmann-Lintz%26aufirst%3DT.%26aulast%3DLotz%26aufirst%3DR.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DHilberg%26aufirst%3DF.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Indolinones%2520as%2520Triple%2520Angiokinase%2520Inhibitors%2520and%2520the%2520Discovery%2520of%2520a%2520Highly%2520Specific%25206-Methoxycarbonyl-Substituted%2520Indolinone%2520%2528BIBF%25201120%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4466%26epage%3D4480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machajewski, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonios-McCrea, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menezes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aardalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernette-Hammond, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">Design, Structure–Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800790t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=278-292&author=P.+A.+Renhoweauthor=S.+Pecchiauthor=C.+M.+Shaferauthor=T.+D.+Machajewskiauthor=E.+M.+Jazanauthor=C.+Taylorauthor=W.+Antonios-McCreaauthor=C.+M.+McBrideauthor=K.+Frazierauthor=M.+Wiesmannauthor=G.+R.+Lapointeauthor=P.+H.+Feuchtauthor=R.+L.+Warneauthor=C.+C.+Heiseauthor=D.+Menezesauthor=K.+Aardalenauthor=H.+Yeauthor=M.+Heauthor=V.+Leauthor=J.+Voraauthor=J.+M.+Jansenauthor=M.+E.+Wernette-Hammondauthor=A.+L.+Harris&title=Design%2C+Structure%E2%80%93Activity+Relationships+and+in+Vivo+Characterization+of+4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones%3A+A+Novel+Class+of+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm800790t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800790t%26sid%3Dliteratum%253Aachs%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DMachajewski%26aufirst%3DT.%2BD.%26aulast%3DJazan%26aufirst%3DE.%2BM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DAntonios-McCrea%26aufirst%3DW.%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DFrazier%26aufirst%3DK.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DLapointe%26aufirst%3DG.%2BR.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DWarne%26aufirst%3DR.%2BL.%26aulast%3DHeise%26aufirst%3DC.%2BC.%26aulast%3DMenezes%26aufirst%3DD.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DWernette-Hammond%26aufirst%3DM.%2BE.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DDesign%252C%2520Structure%25E2%2580%2593Activity%2520Relationships%2520and%2520in%2520Vivo%2520Characterization%2520of%25204-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones%253A%2520A%2520Novel%2520Class%2520of%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D278%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaseelan, R.,  Sr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span> </span><span class="NLM_article-title">Discovery and preclinical studies of (<i>R</i>)-1-(4-(4-fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propanol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2143</span><span class="NLM_x">–</span> <span class="NLM_lpage">2146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051106d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2143-2146&author=R.+S.+Bhideauthor=Z.-W.+Caiauthor=Y.-Z.+Zhangauthor=L.+Qianauthor=D.+Weiauthor=S.+Barbosaauthor=L.+J.+Lombardoauthor=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+I.+Wuauthor=J.+C.+Barrishauthor=S.-H.+Kimauthor=K.+Leavittauthor=A.+Mathurauthor=L.+Leithauthor=S.+Chaoauthor=B.+Wautletauthor=S.+Mortilloauthor=R.+Jayaseelanauthor=D.+Kukralauthor=J.+Huntauthor=A.+Kamathauthor=A.+Furaauthor=V.+Vyasauthor=P.+Maratheauthor=C.+D%E2%80%99Arienzoauthor=G.+Derbinauthor=J.+Fargnoli&title=Discovery+and+preclinical+studies+of+%28R%29-1-%284-%284-fluoro-2-methyl-1H-indol-5-yloxy%29-5-methylpyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-6-yloxy%29propanol+%28BMS-540215%29%2C+an+in+vivo+active+potent+VEGFR-2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm051106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051106d%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DZhang%26aufirst%3DY.-Z.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DBarbosa%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BI.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DLeavitt%26aufirst%3DK.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJayaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DJ.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDerbin%26aufirst%3DG.%26aulast%3DFargnoli%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520studies%2520of%2520%2528R%2529-1-%25284-%25284-fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propanol%2520%2528BMS-540215%2529%252C%2520an%2520in%2520vivo%2520active%2520potent%2520VEGFR-2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2143%26epage%3D2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Hennequin, L. F. A.; Ple, P.; Stokes, E. S. E.; Mckerrecher, D.</span><span> </span><span class="NLM_article-title">Quinazoline derivatives as angiogenesis inhibitors</span>. Patent WO2000047212,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=L.+F.+A.+Hennequin&author=P.+Ple&author=E.+S.+E.+Stokes&author=D.+Mckerrecher&title=Quinazoline+derivatives+as+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%2BA.%26atitle%3DQuinazoline%2520derivatives%2520as%2520angiogenesis%2520inhibitors%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wedge, S. R.; K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brave, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilburn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgensmeier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span> </span><span class="NLM_article-title">AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4389-4400&author=S.+R.%3B+K.+J.+Wedgeauthor=L.+F.+Hennequinauthor=P.+J.+Valentineauthor=S.+T.+Barryauthor=S.+R.+Braveauthor=N.+R.+Smithauthor=N.+H.+Jamesauthor=M.+Dukesauthor=J.+O.+Curwenauthor=R.+Chesterauthor=J.+A.+Jacksonauthor=S.+J.+Boffeyauthor=L.+L.+Kilburnauthor=S.+Barnettauthor=G.+H.+P.+Richmondauthor=P.+F.+Wadsworthauthor=M.+Walkerauthor=A.+L.+Bigleyauthor=S.+T.+Taylorauthor=L.+Cooperauthor=S.+Beckauthor=J.+M.+Jurgensmeierauthor=D.+J.+Ogilvie&title=AZD2171%3A+a+highly+potent%2C+orally+bioavailable%2C+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%253B%2BK.%2BJ.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DValentine%26aufirst%3DP.%2BJ.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DBrave%26aufirst%3DS.%2BR.%26aulast%3DSmith%26aufirst%3DN.%2BR.%26aulast%3DJames%26aufirst%3DN.%2BH.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DChester%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DJ.%2BA.%26aulast%3DBoffey%26aufirst%3DS.%2BJ.%26aulast%3DKilburn%26aufirst%3DL.%2BL.%26aulast%3DBarnett%26aufirst%3DS.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%2BP.%26aulast%3DWadsworth%26aufirst%3DP.%2BF.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DBigley%26aufirst%3DA.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%2BT.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DJurgensmeier%26aufirst%3DJ.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DAZD2171%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4389%26epage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Moussy, A.; Kinet, J.-P.</span><span> </span><span class="NLM_article-title">Use of dual C-KIT/FGFR3 inhibitors for treating multiple myeloma</span>. Patent WO2007026251,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Moussy&author=J.-P.+Kinet&title=Use+of+dual+C-KIT%2FFGFR3+inhibitors+for+treating+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoussy%26aufirst%3DA.%26atitle%3DUse%2520of%2520dual%2520C-KIT%252FFGFR3%2520inhibitors%2520for%2520treating%2520multiple%2520myeloma%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawver, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Cho.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5120</span><span class="NLM_x">–</span> <span class="NLM_lpage">5130</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5120-5130&author=L.+Sunauthor=N.+Tranauthor=C.+Liangauthor=F.+Tangauthor=A.+Riceauthor=R.+Schreckauthor=K.+Waltzauthor=L.+K.+Shawverauthor=G.+McMahonauthor=Cho.+Tang&title=Design%2C+Synthesis%2C+and+Evaluations+of+Substituted+3-%5B%283-+or+4-Carboxyethylpyrrol-2-yl%29methylidenyl%5Dindolin-2-ones+as+Inhibitors+of+VEGF%2C+FGF%2C+and+PDGF+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm9904295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904295%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DA.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DWaltz%26aufirst%3DK.%26aulast%3DShawver%26aufirst%3DL.%2BK.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DCho.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluations%2520of%2520Substituted%25203-%255B%25283-%2520or%25204-Carboxyethylpyrrol-2-yl%2529methylidenyl%255Dindolin-2-ones%2520as%2520Inhibitors%2520of%2520VEGF%252C%2520FGF%252C%2520and%2520PDGF%2520Receptor%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5120%26epage%3D5130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Huang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentini, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broudy, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commodore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narasimhan, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohemmad, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuliucci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span> </span><span class="NLM_article-title">Discovery of 3-[2-(Imidazo[1,2-<i>b</i>]pyridazin-3-yl)ethynyl]-4-methyl-<i>N</i>-[4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl]benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region–Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4719</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100395q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4701-4719&author=W.-S.+Huangauthor=C.+A.+Metcalfauthor=R.+Sundaramoorthiauthor=Y.+Wangauthor=D.+Zouauthor=R.+M.+Thomasauthor=X.+Zhuauthor=L.+Caiauthor=D.+Wenauthor=S.+Liuauthor=J.+Romeroauthor=J.+Qiauthor=I.+Chenauthor=G.+Bandaauthor=S.+P.+Lentiniauthor=S.+Dasauthor=Q.+Xuauthor=J.+Keatsauthor=F.+Wangauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+T.+Snodgrassauthor=M.+I.+Broudyauthor=K.+Russianauthor=T.+Zhouauthor=L.+Commodoreauthor=N.+I.+Narasimhanauthor=Q.+K.+Mohemmadauthor=J.+Iuliucciauthor=V.+M.+Riveraauthor=D.+C.+Dalgarnoauthor=T.+K.+Sawyerauthor=T.+Clacksonauthor=W.+C.+Shakespeare&title=Discovery+of+3-%5B2-%28Imidazo%5B1%2C2-b%5Dpyridazin-3-yl%29ethynyl%5D-4-methyl-N-%5B4-%28%284-methylpiperazin-1-yl%29methyl%29-3-%28trifluoromethyl%29phenyl%5Dbenzamide+%28AP24534%29%2C+a+Potent%2C+Orally+Active+Pan-Inhibitor+of+Breakpoint+Cluster+Region%E2%80%93Abelson+%28BCR-ABL%29+Kinase+Including+the+T315I+Gatekeeper+Mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100395q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100395q%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DBanda%26aufirst%3DG.%26aulast%3DLentini%26aufirst%3DS.%2BP.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DSnodgrass%26aufirst%3DJ.%2BT.%26aulast%3DBroudy%26aufirst%3DM.%2BI.%26aulast%3DRussian%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DNarasimhan%26aufirst%3DN.%2BI.%26aulast%3DMohemmad%26aufirst%3DQ.%2BK.%26aulast%3DIuliucci%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26atitle%3DDiscovery%2520of%25203-%255B2-%2528Imidazo%255B1%252C2-b%255Dpyridazin-3-yl%2529ethynyl%255D-4-methyl-N-%255B4-%2528%25284-methylpiperazin-1-yl%2529methyl%2529-3-%2528trifluoromethyl%2529phenyl%255Dbenzamide%2520%2528AP24534%2529%252C%2520a%2520Potent%252C%2520Orally%2520Active%2520Pan-Inhibitor%2520of%2520Breakpoint%2520Cluster%2520Region%25E2%2580%2593Abelson%2520%2528BCR-ABL%2529%2520Kinase%2520Including%2520the%2520T315I%2520Gatekeeper%2520Mutant%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4701%26epage%3D4719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Funahashi, Y.; Tsuruoka, A.; Matsukura, M.; Haneda, T.; Fukuda, Y.; Kamata, J.; Takahashi, K.; Matsushima, T.; Miyazaki, K.; Nomoto, K.; Watanabe, T.; Obaishi, H.; Yamaguchi, A.; Suzuki, S.; Nakamura, K.; Mimura, F.; Yamamoto, Y.; Matsui, J.; Matsui, K.; Yoshiba, T.; Suzuki, Y.; Arimoto, I.</span><span> </span><span class="NLM_article-title">Nitrogenous aromatic ring compounds</span>. Patent WO2002032872,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=Y.+Funahashi&author=A.+Tsuruoka&author=M.+Matsukura&author=T.+Haneda&author=Y.+Fukuda&author=J.+Kamata&author=K.+Takahashi&author=T.+Matsushima&author=K.+Miyazaki&author=K.+Nomoto&author=T.+Watanabe&author=H.+Obaishi&author=A.+Yamaguchi&author=S.+Suzuki&author=K.+Nakamura&author=F.+Mimura&author=Y.+Yamamoto&author=J.+Matsui&author=K.+Matsui&author=T.+Yoshiba&author=Y.+Suzuki&author=I.+Arimoto&title=Nitrogenous+aromatic+ring+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFunahashi%26aufirst%3DY.%26atitle%3DNitrogenous%2520aromatic%2520ring%2520compounds%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Matsui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uenaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, M.</span><span> </span><span class="NLM_article-title">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.23131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2007&pages=664-671&author=J.+Matsuiauthor=Y.+Yamamotoauthor=Y.+Funahashiauthor=A.+Tsuruokaauthor=T.+Watanabeauthor=T.+Wakabayashiauthor=T.+Uenakaauthor=M.+Asada&title=E7080%2C+a+novel+inhibitor+that+targets+multiple+kinases%2C+has+potent+antitumor+activities+against+stem+cell+factor+producing+human+small+cell+lung+cancer+H146%2C+based+on+angiogenesis+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span></div><div class="casAuthors">Matsui, Junji; Yamamoto, Yuji; Funahashi, Yasuhiro; Tsuruoka, Akihiko; Watanabe, Tatsuo; Wakabayashi, Toshiaki; Uenaka, Toshimitsu; Asada, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">664-671</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">E7080 is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.  In this study, we show the inhibitory activity of E7080 against SCF-induced angiogenesis in vitro and tumor growth of SCF-producing human small cell lung carcinoma H146 cells in vivo.  E7080 inhibits SCF-driven tube formation of HUVEC, which express SCF receptor, KIT at the IC50 value of 5.2 nM and it was almost identical for VEGF-driven one (IC50 = 5.1 nM).  To assess the role of SCF/KIT signaling in tumor angiogenesis, we evaluated the effect of imatinib, a selective KIT kinase inhibitor, on tumor growth of H146 cells in nude mice.  Imatinib did not show the potent antitumor activity in vitro (IC50 = 2,200 nM), because H146 cells did not express KIT.  However, oral administration of imatinib at 160 mg/kg clearly slowed tumor growth of H146 cells in nude mice, accompanied by decreased microvessel d.  Oral administration of E7080 inhibited tumor growth of H146 cells at doses of 30 and 100 mg/kg in a dose-dependent manner and caused tumor regression at 100 mg/kg.  While anti-VEGF antibody also slowed tumor growth, it did not cause tumor regression.  These results indicate that KIT signaling has a role in tumor angiogenesis of SCF-producing H146 cells, and E7080 causes regression of H146 tumors as a result of antiangiogenic activity mediated by inhibition of both KIT and VEGF receptor signaling.  E7080 may provide therapeutic benefits in the treatment of SCF-producing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPTQ6ba_AUe7Vg90H21EOLACvtfcHk0lhTsHD3kYCV0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeltg%253D%253D&md5=6e9eb70f79fe324167a0b87efadfe563</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fijc.23131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23131%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DT.%26aulast%3DUenaka%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DM.%26atitle%3DE7080%252C%2520a%2520novel%2520inhibitor%2520that%2520targets%2520multiple%2520kinases%252C%2520has%2520potent%2520antitumor%2520activities%2520against%2520stem%2520cell%2520factor%2520producing%2520human%2520small%2520cell%2520lung%2520cancer%2520H146%252C%2520based%2520on%2520angiogenesis%2520inhibition%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D122%26spage%3D664%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><div class="note"><p class="first last">During the preparation of this manuscript, AstraZeneca disclosed the FGFR inhibitor AZD4547</p></div>.<span class="NLM_contrib-group">Gavine, P. R.; Mooney, L.; Kilgour, E.; Thomas, A. P.; Al-Kadhimi, K.; Beck, S.; Coleman, T.; Baker, D.; Mellor, M. J.; Brooks, A. N.; Klinowska, T.</span><span> </span><span class="NLM_article-title">Characterization of AZD4547: An orally bioavailable, potent and selective inhibitor of FGFR tyrosine kinases 1, 2 and 3</span>. <span class="NLM_conf-name">American Association for Cancer Research (AACR) 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2–6, 2011</span>, <div class="note"><p class="first last">Abstract 3568</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=During+the+preparation+of+this+manuscript%2C+AstraZeneca+disclosed+the+FGFR+inhibitor+AZD4547.Gavine%2C+P.+R.%3B+Mooney%2C+L.%3B+Kilgour%2C+E.%3B+Thomas%2C+A.+P.%3B+Al-Kadhimi%2C+K.%3B+Beck%2C+S.%3B+Coleman%2C+T.%3B+Baker%2C+D.%3B+Mellor%2C+M.+J.%3B+Brooks%2C+A.+N.%3B+Klinowska%2C+T.+Characterization+of+AZD4547%3A+An+orally+bioavailable%2C+potent+and+selective+inhibitor+of+FGFR+tyrosine+kinases+1%2C+2+and+3.+American+Association+for+Cancer+Research+%28AACR%29+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2%E2%80%936%2C+2011%2C+Abstract+3568."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGavine%26aufirst%3DP.%2BR.%26atitle%3DCharacterization%2520of%2520AZD4547%253A%2520An%2520orally%2520bioavailable%252C%2520potent%2520and%2520selective%2520inhibitor%2520of%2520FGFR%2520tyrosine%2520kinases%25201%252C%25202%2520and%25203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Entry into a new class of protein kinase inhibitors by pseudo ring design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=897-900&author=P.+Furetauthor=G.+Caravattiauthor=V.+Guagnanoauthor=M.+Langauthor=T.+Meyerauthor=J.+Schoepfer&title=Entry+into+a+new+class+of+protein+kinase+inhibitors+by+pseudo+ring+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520inhibitors%2520by%2520pseudo%2520ring%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D897%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="note"><p class="first last">The kinase domains of FGFR2, FGFR3 and FGFR4 have a sequence identity to that of FGFR1 of 87%, 84%, and 75%, respectively. In the ATP binding site, all the residues are conserved within the different isoforms with the exception of two of them located in the hinge region and corresponding to FGFR3 residues Y557 and A559. In FGFR1 and FGFR2, Y557 is conserved while it is mutated into a cysteine in FGFR4. A559 is conserved in FGFR4 but is a serine in FGFR1 and FGFR2. The latter residue points towards the exterior of the ATP pocket and cannot make contact with inhibitors. In contrast, Y557 and its cysteine equivalent in FGFR4 can make van der Waals contacts with inhibitors.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoon, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationships of Soluble 7-Substituted 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridin-2-amines and Related Ureas as Dual Inhibitors of the Fibroblast Growth Factor Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4653</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0500931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4628-4653&author=A.+M.+Thompsonauthor=A.+M.+Delaneyauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=T.+A.+Spoonauthor=S.+M.+Creanauthor=H.+D.+H.+Showalterauthor=W.+A.+Denny&title=Synthesis+and+Structure%E2%80%93Activity+Relationships+of+Soluble+7-Substituted+3-%283%2C5-Dimethoxyphenyl%29-1%2C6-naphthyridin-2-amines+and+Related+Ureas+as+Dual+Inhibitors+of+the+Fibroblast+Growth+Factor+Receptor-1+and+Vascular+Endothelial+Growth+Factor+Receptor-2+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0500931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500931%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DSpoon%26aufirst%3DT.%2BA.%26aulast%3DCrean%26aufirst%3DS.%2BM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520Soluble%25207-Substituted%25203-%25283%252C5-Dimethoxyphenyl%2529-1%252C6-naphthyridin-2-amines%2520and%2520Related%2520Ureas%2520as%2520Dual%2520Inhibitors%2520of%2520the%2520Fibroblast%2520Growth%2520Factor%2520Receptor-1%2520and%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4628%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseenkova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5896</span><span class="NLM_x">–</span> <span class="NLM_lpage">5904</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1093%2Femboj%2F17.20.5896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=9774334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=5896-5904&author=M.+Mohammadiauthor=S.+Froumauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=R.+L.+Panekauthor=G.+H.+Luauthor=A.+V.+Eliseenkovaauthor=D.+Greenauthor=J.+Schlessingerauthor=S.+R.+Hubbard&title=Crystal+structure+of+an+angiogenesis+inhibitor+bound+to+the+FGF+receptor+tyrosine+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span></div><div class="casAuthors">Mohammadi, Moosa; Froum, Scott; Hamby, James M.; Schroeder, Mel C.; Panek, Robert L.; Lu, Gina H.; Eliseenkova, Anna V.; Green, David; Schlessinger, Joseph; Hubbard, Stevan R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5896-5904</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is an essential physiol. process in development, yet also plays a major role in the progression of human diseases such as diabetic retinopathy, atherosclerosis and cancer.  The effects of the most potent angiogenic factors, vascular endothelial growth factor (VEGF), angiopoietin and fibroblast growth factor (FGF) are mediated through cell surface receptors that possess intrinsic protein tyrosine kinase activity.  In this report, the authors describe a synthetic compd. of the pyrido[2,3-d]pyrimidine class, designated PD 173074, that selectively inhibits the tyrosine kinase activities of the FGF and VEGF receptors.  The authors show that systemic administration of PD 173074 in mice can effectively block angiogenesis induced by either FGF or VEGF with no apparent toxicity.  To elucidate the determinants of selectivity, the authors have detd. the crystal structure of PD 173074 in complex with the tyrosine kinase domain of FGF receptor 1 at 2.5 Å resoln.  A high degree of surface complementarity between PD 173074 and the hydrophobic, ATP-binding pocket of FGF receptor 1 underlies the potency and selectivity of this inhibitor.  PD 173074 is thus a promising candidate for a therapeutic angiogenesis inhibitor to be used in the treatment of cancer and other diseases whose progression is dependent upon new blood vessel formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zdEklzyMx7Vg90H21EOLACvtfcHk0liYxnqiOPYUlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D&md5=a76b085ddc9d352878a2c6bc9d1cd6ff</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.20.5896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.20.5896%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DFroum%26aufirst%3DS.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DEliseenkova%26aufirst%3DA.%2BV.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DCrystal%2520structure%2520of%2520an%2520angiogenesis%2520inhibitor%2520bound%2520to%2520the%2520FGF%2520receptor%2520tyrosine%2520kinase%2520domain%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D5896%26epage%3D5904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ong, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadari, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lax, I.</span><span> </span><span class="NLM_article-title">FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1128%2FMCB.20.3.979-989.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10629055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Snuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=979-989&author=S.+H.+Ongauthor=G.+R.+Guyauthor=Y.+R.+Hadariauthor=S.+Laksauthor=N.+Gotohauthor=J.+Schlessingerauthor=I.+Lax&title=FRS2+proteins+recruit+intracellular+signaling+pathways+by+binding+to+diverse+targets+on+fibroblast+growth+factor+and+nerve+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors</span></div><div class="casAuthors">Ong, S. H.; Guy, G. R.; Hadari, Y. R.; Laks, S.; Gotoh, N.; Schlessinger, J.; Lax, I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">979-989</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The docking protein FRS2 was implicated in the transmission of extracellular signals from the fibroblast growth factor (FGF) or nerve growth factor (NGF) receptors to the Ras/mitogen-activated protein kinase signaling cascade.  The two members of the FRS2 family, FRS2α and FRS2β, are structurally very similar.  Each is composed of an N-terminal myristoylation signal, a phosphotyrosine-binding (PTB) domain, and a C-terminal tail contg. multiple binding sites for the SH2 domains of the adapter protein Grb2 and the protein tyrosine phosphatase Shp2.  The PTB domains of both the α and β isoforms of FRS2 bind directly to the FGF or NGF receptors.  The PTB domains of the FRS2 proteins bind to a highly conserved sequence in the juxtamembrane region of FGFR1.  While FGFR1 interacts with FRS2 constitutively, independent of ligand stimulation and tyrosine phosphorylation, NGF receptor (TrkA) binding to FRS2 is strongly dependent on receptor activation.  Complex formation with TrkA is dependent on phosphorylation of Y490, a canonical PTB domain binding site that also functions as a binding site for Shc (NPXpY).  Using deletion and alanine scanning mutagenesis as well as peptide competition assays, the authors demonstrate that the PTB domains of the FRS2 proteins specifically recognize two different primary structures in two different receptors in a phosphorylation-dependent or -independent manner.  In addn., NGF-induced tyrosine phosphorylation of FRS2α is diminished in cells that overexpress a kinase-inactive mutant of FGFR1.  This expt. suggests that FGFR1 may regulate signaling via NGF receptors by sequestering a common key element which both receptors utilize for transmitting their signals.  The multiple interactions mediated by FRS2 appear to play an important role in target selection and in defining the specificity of several families of receptor tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorUBiLcOTfcbVg90H21EOLACvtfcHk0liYxnqiOPYUlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Snuw%253D%253D&md5=c87b5e18ba3b12a836070ea2378e2593</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.3.979-989.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.3.979-989.2000%26sid%3Dliteratum%253Aachs%26aulast%3DOng%26aufirst%3DS.%2BH.%26aulast%3DGuy%26aufirst%3DG.%2BR.%26aulast%3DHadari%26aufirst%3DY.%2BR.%26aulast%3DLaks%26aufirst%3DS.%26aulast%3DGotoh%26aufirst%3DN.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DLax%26aufirst%3DI.%26atitle%3DFRS2%2520proteins%2520recruit%2520intracellular%2520signaling%2520pathways%2520by%2520binding%2520to%2520diverse%2520targets%2520on%2520fibroblast%2520growth%2520factor%2520and%2520nerve%2520growth%2520factor%2520receptors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D979%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Mohamadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caufield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">MacroModel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+J.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=MacroModel%E2%80%94an+integrated+software+system+for+modeling+organic+and+bioorganic+molecules+using+molecular+mechanics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%2BJ.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacroModel%25E2%2580%2594an%2520integrated%2520software%2520system%2520for%2520modeling%2520organic%2520and%2520bioorganic%2520molecules%2520using%2520molecular%2520mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, B.</span><span> </span><span class="NLM_article-title">The SWISS-PROT protein sequence data bank: current status</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3578</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=3578-3580&author=A.+Bairochauthor=B.+Boeckmann&title=The+SWISS-PROT+protein+sequence+data+bank%3A+current+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DBoeckmann%26aufirst%3DB.%26atitle%3DThe%2520SWISS-PROT%2520protein%2520sequence%2520data%2520bank%253A%2520current%2520status%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D3578%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Notredame, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D.; G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heringa, J.</span><span> </span><span class="NLM_article-title">T-Coffee: A novel method for fast and accurate multiple sequence alignment</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1006%2Fjmbi.2000.4042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10964570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2000&pages=205-217&author=C.+Notredameauthor=D.%3B+G.+Higginsauthor=J.+Heringa&title=T-Coffee%3A+A+novel+method+for+fast+and+accurate+multiple+sequence+alignment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">T-Coffee: A Novel Method for Fast and Accurate Multiple Sequence Alignment</span></div><div class="casAuthors">Notredame, Cedric; Higgins, Desmond G.; Heringa, Jaap</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-217</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">We describe a new method (T-Coffee) for multiple sequence alignment that provides a dramatic improvement in accuracy with a modest sacrifice in speed as compared to the most commonly used alternatives.  The method is broadly based on the popular progressive approach to multiple alignment but avoids the most serious pitfalls caused by the greedy nature of this algorithm.  With T-Coffee we pre-process a data set of all pair-wise alignments between the sequences.  This provides us with a library of alignment information that can be used to guide the progressive alignment.  Intermediate alignments are then based not only on the sequences to be aligned next but also on how all of the sequences align with each other.  This alignment information can be derived from heterogeneous sources such as a mixt. of alignment programs and/or structure superposition.  Here, we illustrate the power of the approach by using a combination of local and global pair-wise alignments to generate the library.  The resulting alignments are significantly more reliable, as detd. by comparison with a set of 141 test cases, than any of the popular alternatives that we tried.  The improvement, esp. clear with the more difficult test cases, is always visible, regardless of the phylogenetic spread of the sequences in the tests.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraooGHJVZRYrVg90H21EOLACvtfcHk0ljYFnS0Mnww_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVGntr8%253D&md5=62c7b0c4e224acf1b172810571d5755d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2000.4042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2000.4042%26sid%3Dliteratum%253Aachs%26aulast%3DNotredame%26aufirst%3DC.%26aulast%3DHiggins%26aufirst%3DD.%253B%2BG.%26aulast%3DHeringa%26aufirst%3DJ.%26atitle%3DT-Coffee%253A%2520A%2520novel%2520method%2520for%2520fast%2520and%2520accurate%2520multiple%2520sequence%2520alignment%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D302%26spage%3D205%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Vriend, G.</span><span> </span><span class="NLM_article-title">WHAT IF: A molecular modeling and drug design program</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2F0263-7855%2890%2980070-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=2268628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=52-56&author=G.+Vriend&title=WHAT+IF%3A+A+molecular+modeling+and+drug+design+program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">WHAT IF:  a molecular modeling and drug design program</span></div><div class="casAuthors">Vriend, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-6, 29</span>CODEN:
                <span class="NLM_cas:coden">JMGRDV</span>;
        ISSN:<span class="NLM_cas:issn">0263-7855</span>.
    </div><div class="casAbstract">A FORTRAN 77 computer program has been written to aid with macromol. modeling and drug design.  Called WHAT IF, it provides an intelligent and flexible environment for displaying, manipulating, and analyzing small mols., proteins, nucleic acids, and their interactions.  A relational protein structure database is incorporated to be queried.  The program is suitable for most common crystallog. work.  The menu-driven operation of WHAT IF, combined with the use of default values wherever user input is required, makes it very easy to use for a novice user while keeping full flexibility for more sophisticated studies.  Although there are not too many unique features in WHAT IF, the fact that everything is integrated in one program makes if a unique tool for many purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ64OrfsqnR7Vg90H21EOLACvtfcHk0ljYFnS0Mnww_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D&md5=a764dc42ba008577f0076092ab4e6024</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0263-7855%2890%2980070-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0263-7855%252890%252980070-V%26sid%3Dliteratum%253Aachs%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DWHAT%2520IF%253A%2520A%2520molecular%2520modeling%2520and%2520drug%2520design%2520program%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1990%26volume%3D8%26spage%3D52%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bailey, S.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr, Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">D50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D50&publication_year=1994&pages=760-763&author=S.+Bailey&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DS.%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3DD50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="ref60_1"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, P.; Roversi, P.; Sharff, A.; Smart, O.; Vonrhein, C.; Woman, T.</span>Buster 2.9; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, UK</span><span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=P.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+Smart&author=C.+Vonrhein&author=T.+Woman&title=Buster+2.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref60_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%25202.9%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':[],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['ref60_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 281 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yujiao Wei, Yanting Tang, Yunyun Zhou, Yuyu Yang, Yetong Cui, Xuan Wang, Yubo Wang, Yulin Liu, Ning Liu, Qianqian Wang, Chong Li, Hao Ruan, Honggang Zhou, Mingming Wei, Guang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Cheng Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of a Novel 2H-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9078-9099. <a href="https://doi.org/10.1021/acs.jmedchem.1c00174" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00174%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252Ba%252BNovel%252B2H-Pyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252BDerivative%252Bas%252Ba%252BPotent%252BIrreversible%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitor%26aulast%3DWei%26aufirst%3DYujiao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D31012021%26date%3D15062021%26volume%3D64%26issue%3D13%26spage%3D9078%26epage%3D9099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ryan A. Brawn, Andrew Cook, Kiyoyuki Omoto, Jiyuan Ke, Craig Karr, Federico Colombo, Milena Virrankoski, Sudeep Prajapati, Dominic Reynolds, David M. Bolduc, Tuong-Vi Nguyen, Patricia Gee, Deanna Borrelli, Benjamin Caleb, Shihua Yao, Sean Irwin, Nicholas A. Larsen, Anand Selvaraj, Xuesong Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Stephanos Ioannidis</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 93-98. <a href="https://doi.org/10.1021/acsmedchemlett.0c00517" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00517%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BAminopyrazole%252BDerivatives%252Bas%252BPotent%252BInhibitors%252Bof%252BWild-Type%252Band%252BGatekeeper%252BMutant%252BFGFR2%252Band%252B3%26aulast%3DBrawn%26aufirst%3DRyan%2BA.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25092020%26date%3D25112020%26date%3D02122020%26volume%3D12%26issue%3D1%26spage%3D93%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian Gampe, <span class="NLM_string-name hlFld-ContribAuthor">Vishal A. Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14357-14381. <a href="https://doi.org/10.1021/acs.jmedchem.0c01177" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01177%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurse%252Bor%252BCure%25253F%252BA%252BPerspective%252Bon%252Bthe%252BDevelopability%252Bof%252BAldehydes%252Bas%252BActive%252BPharmaceutical%252BIngredients%26aulast%3DGampe%26aufirst%3DChristian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D29092020%26date%3D11092020%26volume%3D63%26issue%3D23%26spage%3D14357%26epage%3D14381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann, Catherine Leblanc, Robert Mah, Milen Todorov, Pierre Nimsgern, Sebastien Ripoche, Michel Niklaus, Nicolas Warin, Van Huy Luu, Mario Madoerin, Jasmin Wirth, Diana Graus-Porta, Andreas Weiss, Michael Kiffe, Markus Wartmann, Jacqueline Kinyamu-Akunda, Dario Sterker, Christelle Stamm, Flavia Adler, Alexandra Buhles, Heiko Schadt, Philippe Couttet, Jutta Blank, Inga Galuba, Jörg Trappe, Johannes Voshol, Nils Ostermann, Chao Zou, Jörg Berghausen, Alberto Del Rio Espinola, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Pascal Furet</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12542-12573. <a href="https://doi.org/10.1021/acs.jmedchem.0c01019" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BRoblitinib%252B%252528FGF401%252529%252Bas%252Ba%252BReversible-Covalent%252BInhibitor%252Bof%252Bthe%252BKinase%252BActivity%252Bof%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B4%26aulast%3DFairhurst%26aufirst%3DRobin%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15062020%26date%3D01102020%26date%3D15092020%26volume%3D63%26issue%3D21%26spage%3D12542%26epage%3D12573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Megan Egbert, Adrian Whitty, György M. Keserű, <span class="NLM_string-name hlFld-ContribAuthor">Sandor Vajda</span>. </span><span class="cited-content_cbyCitation_article-title">Why Some Targets Benefit from beyond Rule of Five Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10005-10025. <a href="https://doi.org/10.1021/acs.jmedchem.8b01732" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01732%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhy%252BSome%252BTargets%252BBenefit%252Bfrom%252Bbeyond%252BRule%252Bof%252BFive%252BDrugs%26aulast%3DEgbert%26aufirst%3DMegan%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13112018%26date%3D26062019%26date%3D12062019%26volume%3D62%26issue%3D22%26spage%3D10005%26epage%3D10025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yulan Wang, Yang Dai, Xiaowei Wu, Fei Li, Bo Liu, Chunpu Li, Qiufeng Liu, Yuanyang Zhou, Bao Wang, Mingrui Zhu, Rongrong Cui, Xiaoqin Tan, Zhaoping Xiong, Jia Liu, Minjia Tan, Yechun Xu, Meiyu Geng, Hualiang Jiang, Hong Liu, Jing Ai, <span class="NLM_string-name hlFld-ContribAuthor">Mingyue Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7473-7488. <a href="https://doi.org/10.1021/acs.jmedchem.9b00510" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00510%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252Ba%252BSeries%252Bof%252BPyrazolo%25255B3%25252C4-d%25255Dpyridazinone%252BCompounds%252Bas%252Bthe%252BNovel%252BCovalent%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bby%252Bthe%252BRational%252BDrug%252BDesign%26aulast%3DWang%26aufirst%3DYulan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22032019%26date%3D09082019%26date%3D23072019%26volume%3D62%26issue%3D16%26spage%3D7473%26epage%3D7488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuming Wang, Lijun Li, Jun Fan, Yang Dai, Alan Jiang, Meiyu Geng, Jing Ai, <span class="NLM_string-name hlFld-ContribAuthor">Wenhu Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9085-9104. <a href="https://doi.org/10.1021/acs.jmedchem.7b01843" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01843%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BIrreversible%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptor%252B%252528FGFR%252529%252BInhibitors%26aulast%3DWang%26aufirst%3DYuming%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D14122017%26date%3D16032018%26date%3D09032018%26volume%3D61%26issue%3D20%26spage%3D9085%26epage%3D9104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hanna Cho, Injae Shin, Eunhye Ju, Seunghye Choi, Wooyoung Hur, Haelee Kim, Eunmi Hong, Nam Doo Kim, Hwan Geun Choi, Nathanael S. Gray, <span class="NLM_string-name hlFld-ContribAuthor">Taebo Sim</span>. </span><span class="cited-content_cbyCitation_article-title">First SAR Study for Overriding NRAS Mutant Driven Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8353-8373. <a href="https://doi.org/10.1021/acs.jmedchem.8b00882" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00882%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BSAR%252BStudy%252Bfor%252BOverriding%252BNRAS%252BMutant%252BDriven%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DCho%26aufirst%3DHanna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04062018%26date%3D11092018%26date%3D28082018%26volume%3D61%26issue%3D18%26spage%3D8353%26epage%3D8373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Floriana  Morgillo</span>, <span class="hlFld-ContribAuthor ">Giorgio  Amendola</span>, <span class="hlFld-ContribAuthor ">Carminia Maria  Della Corte</span>, <span class="hlFld-ContribAuthor ">Chiara  Giacomelli</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Botta</span>, <span class="hlFld-ContribAuthor ">Salvatore  Di Maro</span>, <span class="hlFld-ContribAuthor ">Anna  Messere</span>, <span class="hlFld-ContribAuthor ">Vincenza  Ciaramella</span>, <span class="hlFld-ContribAuthor ">Sabrina  Taliani</span>, <span class="hlFld-ContribAuthor ">Luciana  Marinelli</span>, <span class="hlFld-ContribAuthor ">Maria Letizia  Trincavelli</span>, <span class="hlFld-ContribAuthor ">Claudia  Martini</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Fortunato  Ciardiello</span>, and <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7447-7458. <a href="https://doi.org/10.1021/acs.jmedchem.7b00794" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00794%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BMET%252Band%252BSMO%252BNegative%252BModulators%252BOvercome%252BResistance%252Bto%252BEGFR%252BInhibitors%252Bin%252BHuman%252BNonsmall%252BCell%252BLung%252BCancer%26aulast%3DMorgillo%26aufirst%3DFloriana%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D31052017%26date%3D22082017%26date%3D14092017%26date%3D08082017%26volume%3D60%26issue%3D17%26spage%3D7447%26epage%3D7458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ken A.  Brameld</span>, <span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>, <span class="hlFld-ContribAuthor ">Erik  Verner</span>, <span class="hlFld-ContribAuthor ">Eleni  Venetsanakos</span>, <span class="hlFld-ContribAuthor ">J. Michael  Bradshaw</span>, <span class="hlFld-ContribAuthor ">Vernon T.  Phan</span>, <span class="hlFld-ContribAuthor ">Danny  Tam</span>, <span class="hlFld-ContribAuthor ">Kwan  Leung</span>, <span class="hlFld-ContribAuthor ">Jin  Shu</span>, <span class="hlFld-ContribAuthor ">Jacob  LaStant</span>, <span class="hlFld-ContribAuthor ">David G.  Loughhead</span>, <span class="hlFld-ContribAuthor ">Tony  Ton</span>, <span class="hlFld-ContribAuthor ">Dane E.  Karr</span>, <span class="hlFld-ContribAuthor ">Mary E.  Gerritsen</span>, <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, and <span class="hlFld-ContribAuthor ">Jens Oliver  Funk</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6516-6527. <a href="https://doi.org/10.1021/acs.jmedchem.7b00360" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00360%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BIrreversible%252BCovalent%252BFGFR%252BInhibitor%252B8-%2525283-%2525284-Acryloylpiperazin-1-yl%252529propyl%252529-6-%2525282%25252C6-dichloro-3%25252C5-dimethoxyphenyl%252529-2-%252528methylamino%252529pyrido%25255B2%25252C3-d%25255Dpyrimidin-7%2525288H%252529-one%252B%252528PRN1371%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BSolid%252BTumors%26aulast%3DBrameld%26aufirst%3DKen%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07032017%26date%3D25072017%26date%3D10082017%26date%3D30062017%26volume%3D60%26issue%3D15%26spage%3D6516%26epage%3D6527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Xianjie  Chen</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Chunpu  Li</span>, <span class="hlFld-ContribAuthor ">Yulong  He</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6018-6035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00076" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BNovel%252BMultisubstituted%252BPyridin-3-amine%252BDerivatives%252Bas%252BMultitargeted%252BProtein%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DZhu%26aufirst%3DWei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23012017%26date%3D17072017%26date%3D27072017%26date%3D22062017%26volume%3D60%26issue%3D14%26spage%3D6018%26epage%3D6035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaomeng  Shen</span>, <span class="hlFld-ContribAuthor ">Shichen  Shen</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Hu</span>, <span class="hlFld-ContribAuthor ">Lei  Nie</span>, <span class="hlFld-ContribAuthor ">Chengjian  Tu</span>, <span class="hlFld-ContribAuthor ">Xue  Wang</span>, <span class="hlFld-ContribAuthor ">Benjamin  Orsburn</span>, <span class="hlFld-ContribAuthor ">Jianmin  Wang</span>, and <span class="hlFld-ContribAuthor ">Jun  Qu</span>  . </span><span class="cited-content_cbyCitation_article-title">An IonStar Experimental Strategy for MS1 Ion Current-Based Quantification Using Ultrahigh-Field Orbitrap: Reproducible, In-Depth, and Accurate Protein Measurement in Large Cohorts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2017,</strong> <em>16 </em>
                                    (7)
                                     , 2445-2456. <a href="https://doi.org/10.1021/acs.jproteome.7b00061" title="DOI URL">https://doi.org/10.1021/acs.jproteome.7b00061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jproteome.7b00061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jproteome.7b00061%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DAn%252BIonStar%252BExperimental%252BStrategy%252Bfor%252BMS1%252BIon%252BCurrent-Based%252BQuantification%252BUsing%252BUltrahigh-Field%252BOrbitrap%25253A%252BReproducible%25252C%252BIn-Depth%25252C%252Band%252BAccurate%252BProtein%252BMeasurement%252Bin%252BLarge%252BCohorts%26aulast%3DShen%26aufirst%3DXiaomeng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06022017%26date%3D25052017%26date%3D07072017%26date%3D16042017%26volume%3D16%26issue%3D7%26spage%3D2445%26epage%3D2456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hirosato  Ebiike</span>, <span class="hlFld-ContribAuthor ">Naoki  Taka</span>, <span class="hlFld-ContribAuthor ">Masayuki  Matsushita</span>, <span class="hlFld-ContribAuthor ">Masayuki  Ohmori</span>, <span class="hlFld-ContribAuthor ">Kyoko  Takami</span>, <span class="hlFld-ContribAuthor ">Ikumi  Hyohdoh</span>, <span class="hlFld-ContribAuthor ">Masami  Kohchi</span>, <span class="hlFld-ContribAuthor ">Tadakatsu  Hayase</span>, <span class="hlFld-ContribAuthor ">Hiroki  Nishii</span>, <span class="hlFld-ContribAuthor ">Kenji  Morikami</span>, <span class="hlFld-ContribAuthor ">Yoshito  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Nukinori  Akiyama</span>, <span class="hlFld-ContribAuthor ">Hidetoshi  Shindoh</span>, <span class="hlFld-ContribAuthor ">Nobuya  Ishii</span>, <span class="hlFld-ContribAuthor ">Takehito  Isobe</span>, and <span class="hlFld-ContribAuthor ">Hiroharu  Matsuoka</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of [5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone (CH5183284/Debio 1347), An Orally Available and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10586-10600. <a href="https://doi.org/10.1021/acs.jmedchem.6b01156" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01156%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25255B5-Amino-1-%2525282-methyl-3H-benzimidazol-5-yl%252529pyrazol-4-yl%25255D-%2525281H-indol-2-yl%252529methanone%252B%252528CH5183284%25252FDebio%252B1347%252529%25252C%252BAn%252BOrally%252BAvailable%252Band%252BSelective%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B%252528FGFR%252529%252BInhibitor%26aulast%3DEbiike%26aufirst%3DHirosato%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01082016%26date%3D29112016%26date%3D08122016%26date%3D07112016%26volume%3D59%26issue%3D23%26spage%3D10586%26epage%3D10600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Jun  Fan</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Fanwang  Meng</span>, <span class="hlFld-ContribAuthor ">Yuming  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6690-6708. <a href="https://doi.org/10.1021/acs.jmedchem.6b00056" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00056%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525285%2525E2%252580%2525B2-Substituted%252529-Benzimidazole-5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-1H-indazoles%252Bas%252BPotent%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DYan%26aufirst%3DWei%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13012016%26date%3D06072016%26date%3D28072016%26date%3D27062016%26volume%3D59%26issue%3D14%26spage%3D6690%26epage%3D6708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Yixuan  Li</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Yiming  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (6)
                                     , 629-634. <a href="https://doi.org/10.1021/acsmedchemlett.6b00066" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00066%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BSubstituted%252B1H-Pyrazolo%25255B3%25252C4-b%25255Dpyridine%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BFGFR%252BKinase%252BInhibitors%26aulast%3DZhao%26aufirst%3DBin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12022016%26date%3D20042016%26date%3D28042016%26date%3D09062016%26date%3D20042016%26volume%3D7%26issue%3D6%26spage%3D629%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenbo  Yu</span>, <span class="hlFld-ContribAuthor ">Sirish Kaushik  Lakkaraju</span>, <span class="hlFld-ContribAuthor ">E. Prabhu  Raman</span>, <span class="hlFld-ContribAuthor ">Lei  Fang</span>, and <span class="hlFld-ContribAuthor ">Alexander D.  MacKerell, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling Using Site-Identification by Ligand Competitive Saturation (SILCS) with Multiple Probe Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (2)
                                     , 407-420. <a href="https://doi.org/10.1021/ci500691p" title="DOI URL">https://doi.org/10.1021/ci500691p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500691p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500691p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPharmacophore%252BModeling%252BUsing%252BSite-Identification%252Bby%252BLigand%252BCompetitive%252BSaturation%252B%252528SILCS%252529%252Bwith%252BMultiple%252BProbe%252BMolecules%26aulast%3DYu%26aufirst%3DWenbo%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D19112014%26date%3D06022015%26date%3D23022015%26date%3D26012015%26volume%3D55%26issue%3D2%26spage%3D407%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang-Tao  Li</span>, <span class="hlFld-ContribAuthor ">Li-Xia  Wang</span>, <span class="hlFld-ContribAuthor ">De-Xian  Wang</span>, <span class="hlFld-ContribAuthor ">Liang  Zhao</span>, and <span class="hlFld-ContribAuthor ">Mei-Xiang  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Resolution, Structure, and Racemization of Inherently Chiral 1,3-Alternate Azacalix[4]pyrimidines: Quantification of Conformation Mobility. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (5)
                                     , 2178-2188. <a href="https://doi.org/10.1021/jo500054v" title="DOI URL">https://doi.org/10.1021/jo500054v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo500054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo500054v%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%25252C%252BResolution%25252C%252BStructure%25252C%252Band%252BRacemization%252Bof%252BInherently%252BChiral%252B1%25252C3-Alternate%252BAzacalix%25255B4%25255Dpyrimidines%25253A%252BQuantification%252Bof%252BConformation%252BMobility%26aulast%3DLi%26aufirst%3DJiang-Tao%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D09012014%26date%3D13022014%26date%3D07032014%26date%3D10022014%26volume%3D79%26issue%3D5%26spage%3D2178%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Klein</span>, <span class="hlFld-ContribAuthor ">Julie  Tucker</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Richard A.  Norman</span>, and <span class="hlFld-ContribAuthor ">Alexander L.  Breeze</span>  . </span><span class="cited-content_cbyCitation_article-title">FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (2)
                                     , 166-171. <a href="https://doi.org/10.1021/ml4004205" title="DOI URL">https://doi.org/10.1021/ml4004205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4004205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4004205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFGFR1%252BKinase%252BInhibitors%25253A%252BClose%252BRegioisomers%252BAdopt%252BDivergent%252BBinding%252BModes%252Band%252BDisplay%252BDistinct%252BBiophysical%252BSignatures%26aulast%3DKlein%26aufirst%3DTobias%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19102013%26date%3D06122013%26date%3D16122013%26date%3D13022014%26date%3D06122013%26volume%3D5%26issue%3D2%26spage%3D166%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina V.  Vinogradova</span>, <span class="hlFld-ContribAuthor ">Brett P.  Fors</span>, and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Cross-Coupling of Aryl Chlorides and Triflates with Sodium Cyanate: A Practical Synthesis of Unsymmetrical Ureas. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (27)
                                     , 11132-11135. <a href="https://doi.org/10.1021/ja305212v" title="DOI URL">https://doi.org/10.1021/ja305212v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja305212v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja305212v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPalladium-Catalyzed%252BCross-Coupling%252Bof%252BAryl%252BChlorides%252Band%252BTriflates%252Bwith%252BSodium%252BCyanate%25253A%252BA%252BPractical%252BSynthesis%252Bof%252BUnsymmetrical%252BUreas%26aulast%3DVinogradova%26aufirst%3DEkaterina%2BV.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D29052012%26date%3D29062012%26date%3D11072012%26date%3D20062012%26volume%3D134%26issue%3D27%26spage%3D11132%26epage%3D11135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gamal A.E.  Mostafa</span>, <span class="hlFld-ContribAuthor ">Adnan A.  Kadi</span>, <span class="hlFld-ContribAuthor ">Najla  AlMasoud</span>, <span class="hlFld-ContribAuthor ">Mohamed W.  Attwa</span>, <span class="hlFld-ContribAuthor ">Nasser S.  Al-Shakliah</span>, <span class="hlFld-ContribAuthor ">Haitham  AlRabiah</span>. </span><span class="cited-content_cbyCitation_article-title">LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2021,</strong> <em>1179 </em>, 122806. <a href="https://doi.org/10.1016/j.jchromb.2021.122806" title="DOI URL">https://doi.org/10.1016/j.jchromb.2021.122806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2021.122806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2021.122806%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DLC-MS%25252FMS%252Bmethod%252Bfor%252Bthe%252Bquantification%252Bof%252Bthe%252Banti-cancer%252Bagent%252Binfigratinib%25253A%252BApplication%252Bfor%252Bestimation%252Bof%252Bmetabolic%252Bstability%252Bin%252Bhuman%252Bliver%252Bmicrosomes%26aulast%3DMostafa%26aufirst%3DGamal%2BA.E.%26date%3D2021%26volume%3D1179%26spage%3D122806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milind  Javle</span>, <span class="hlFld-ContribAuthor ">Sameek  Roychowdhury</span>, <span class="hlFld-ContribAuthor ">Robin Kate  Kelley</span>, <span class="hlFld-ContribAuthor ">Saeed  Sadeghi</span>, <span class="hlFld-ContribAuthor ">Teresa  Macarulla</span>, <span class="hlFld-ContribAuthor ">Karl Heinz  Weiss</span>, <span class="hlFld-ContribAuthor ">Dirk-Thomas  Waldschmidt</span>, <span class="hlFld-ContribAuthor ">Lipika  Goyal</span>, <span class="hlFld-ContribAuthor ">Ivan  Borbath</span>, <span class="hlFld-ContribAuthor ">Anthony  El-Khoueiry</span>, <span class="hlFld-ContribAuthor ">Mitesh J  Borad</span>, <span class="hlFld-ContribAuthor ">Wei Peng  Yong</span>, <span class="hlFld-ContribAuthor ">Philip A  Philip</span>, <span class="hlFld-ContribAuthor ">Michael  Bitzer</span>, <span class="hlFld-ContribAuthor ">Surbpong  Tanasanvimon</span>, <span class="hlFld-ContribAuthor ">Ai  Li</span>, <span class="hlFld-ContribAuthor ">Amit  Pande</span>, <span class="hlFld-ContribAuthor ">Harris S  Soifer</span>, <span class="hlFld-ContribAuthor ">Stacie Peacock  Shepherd</span>, <span class="hlFld-ContribAuthor ">Susan  Moran</span>, <span class="hlFld-ContribAuthor ">Andrew X  Zhu</span>, <span class="hlFld-ContribAuthor ">Tanios S  Bekaii-Saab</span>, <span class="hlFld-ContribAuthor ">Ghassan K  Abou-Alfa</span>. </span><span class="cited-content_cbyCitation_article-title">Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Gastroenterology & Hepatology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.1016/S2468-1253(21)00196-5" title="DOI URL">https://doi.org/10.1016/S2468-1253(21)00196-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2468-1253(21)00196-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2468-1253%2821%2900196-5%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DInfigratinib%252B%252528BGJ398%252529%252Bin%252Bpreviously%252Btreated%252Bpatients%252Bwith%252Badvanced%252Bor%252Bmetastatic%252Bcholangiocarcinoma%252Bwith%252BFGFR2%252Bfusions%252Bor%252Brearrangements%25253A%252Bmature%252Bresults%252Bfrom%252Ba%252Bmulticentre%25252C%252Bopen-label%25252C%252Bsingle-arm%25252C%252Bphase%252B2%252Bstudy%26aulast%3DJavle%26aufirst%3DMilind%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David Wai Meng  Tai</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Aldo  Prawira</span>, <span class="hlFld-ContribAuthor ">Rebecca Zhi Wen  Ho</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Hepatology International</span><span> <strong>2021,</strong> <em>67 </em><a href="https://doi.org/10.1007/s12072-021-10212-8" title="DOI URL">https://doi.org/10.1007/s12072-021-10212-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12072-021-10212-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12072-021-10212-8%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%2520International%26atitle%3DTargeted%252Binhibition%252Bof%252BFGF19%25252FFGFR%252Bcascade%252Bimproves%252Bantitumor%252Bimmunity%252Band%252Bresponse%252Brate%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DTai%26aufirst%3DDavid%2BWai%2BMeng%26date%3D2021%26date%3D2021%26volume%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Qibiao  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Henning</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (29)
                                     , 16041-16047. <a href="https://doi.org/10.1002/ange.202101328" title="DOI URL">https://doi.org/10.1002/ange.202101328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202101328%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDegrader%252Bfor%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%25252F2%26aulast%3DDu%26aufirst%3DGuangyan%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D29%26spage%3D16041%26epage%3D16047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Qibiao  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Henning</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (29)
                                     , 15905-15911. <a href="https://doi.org/10.1002/anie.202101328" title="DOI URL">https://doi.org/10.1002/anie.202101328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202101328%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDegrader%252Bfor%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%25252F2%26aulast%3DDu%26aufirst%3DGuangyan%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D29%26spage%3D15905%26epage%3D15911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  DeSalvo</span>, <span class="hlFld-ContribAuthor ">Yuguang  Ban</span>, <span class="hlFld-ContribAuthor ">Luyuan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaodian  Sun</span>, <span class="hlFld-ContribAuthor ">Zhijie  Jiang</span>, <span class="hlFld-ContribAuthor ">Darcy A.  Kerr</span>, <span class="hlFld-ContribAuthor ">Mahsa  Khanlari</span>, <span class="hlFld-ContribAuthor ">Maria  Boulina</span>, <span class="hlFld-ContribAuthor ">Mario R.  Capecchi</span>, <span class="hlFld-ContribAuthor ">Juha M.  Partanen</span>, <span class="hlFld-ContribAuthor ">Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Tadashi  Kondo</span>, <span class="hlFld-ContribAuthor ">David M.  Ornitz</span>, <span class="hlFld-ContribAuthor ">Jonathan C.  Trent</span>, <span class="hlFld-ContribAuthor ">Josiane E.  Eid</span>. </span><span class="cited-content_cbyCitation_article-title">ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2021,</strong> <em>131 </em>
                                    (13)
                                     <a href="https://doi.org/10.1172/JCI141908" title="DOI URL">https://doi.org/10.1172/JCI141908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI141908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI141908%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DETV4%252Band%252BETV5%252Bdrive%252Bsynovial%252Bsarcoma%252Bthrough%252Bcell%252Bcycle%252Band%252BDUX4%252Bembryonic%252Bpathway%252Bcontrol%26aulast%3DDeSalvo%26aufirst%3DJoanna%26date%3D2021%26date%3D2021%26volume%3D131%26issue%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Casey  Ah-Cann</span>, <span class="hlFld-ContribAuthor ">Verena C.  Wimmer</span>, <span class="hlFld-ContribAuthor ">Clare E.  Weeden</span>, <span class="hlFld-ContribAuthor ">Claire  Marceaux</span>, <span class="hlFld-ContribAuthor ">Charity W.  Law</span>, <span class="hlFld-ContribAuthor ">Laura  Galvis</span>, <span class="hlFld-ContribAuthor ">Caitlin E.  Filby</span>, <span class="hlFld-ContribAuthor ">Joy  Liu</span>, <span class="hlFld-ContribAuthor ">Kelsey  Breslin</span>, <span class="hlFld-ContribAuthor ">Tracy  Willson</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Ritchie</span>, <span class="hlFld-ContribAuthor ">Marnie E.  Blewitt</span>, <span class="hlFld-ContribAuthor ">Marie-Liesse  Asselin-Labat</span>. </span><span class="cited-content_cbyCitation_article-title">A functional genetic screen identifies aurora kinase b as an essential regulator of Sox9-positive mouse embryonic lung progenitor cells. </span><span class="cited-content_cbyCitation_journal-name">Development</span><span> <strong>2021,</strong> <em>148 </em>
                                    (13)
                                     <a href="https://doi.org/10.1242/dev.199543" title="DOI URL">https://doi.org/10.1242/dev.199543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/dev.199543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fdev.199543%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopment%26atitle%3DA%252Bfunctional%252Bgenetic%252Bscreen%252Bidentifies%252Baurora%252Bkinase%252Bb%252Bas%252Ban%252Bessential%252Bregulator%252Bof%252BSox9-positive%252Bmouse%252Bembryonic%252Blung%252Bprogenitor%252Bcells%26aulast%3DAh-Cann%26aufirst%3DCasey%26date%3D2021%26date%3D2021%26volume%3D148%26issue%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie  Bolcaen</span>, <span class="hlFld-ContribAuthor ">Shankari  Nair</span>, <span class="hlFld-ContribAuthor ">Cathryn  Driver</span>, <span class="hlFld-ContribAuthor ">Tebatso  Boshomane</span>, <span class="hlFld-ContribAuthor ">Thomas  Ebenhan</span>, <span class="hlFld-ContribAuthor ">Charlot  Vandevoorde</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (7)
                                     , 626. <a href="https://doi.org/10.3390/ph14070626" title="DOI URL">https://doi.org/10.3390/ph14070626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14070626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14070626%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DNovel%252BReceptor%252BTyrosine%252BKinase%252BPathway%252BInhibitors%252Bfor%252BTargeted%252BRadionuclide%252BTherapy%252Bof%252BGlioblastoma%26aulast%3DBolcaen%26aufirst%3DJulie%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D7%26spage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aldo  Prawira</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Rebecca Zhi Wen  Ho</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>. </span><span class="cited-content_cbyCitation_article-title">Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2021,</strong> <em>68 </em><a href="https://doi.org/10.1007/s00432-021-03703-6" title="DOI URL">https://doi.org/10.1007/s00432-021-03703-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-021-03703-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-021-03703-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DUpregulation%252Bof%252Bthe%252BErbB%252Bfamily%252Bby%252BEZH2%252Bin%252Bhepatocellular%252Bcarcinoma%252Bconfers%252Bresistance%252Bto%252BFGFR%252Binhibitor%26aulast%3DPrawira%26aufirst%3DAldo%26date%3D2021%26date%3D2021%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingping  Su</span>, <span class="hlFld-ContribAuthor ">Zhihao  Liu</span>, <span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Xiuli  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Hanyun  Que</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Yiwen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 1
              H
              -pyrrolo[2,3-
              b
              ]pyridine derivatives as potent fibroblast growth factor receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (34)
                                     , 20651-20661. <a href="https://doi.org/10.1039/D1RA02660G" title="DOI URL">https://doi.org/10.1039/D1RA02660G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA02660G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA02660G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1%252BH%252B-pyrrolo%25255B2%25252C3-%252Bb%252B%25255Dpyridine%252Bderivatives%252Bas%252Bpotent%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%26aulast%3DSu%26aufirst%3DXingping%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D34%26spage%3D20651%26epage%3D20661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Zehui  Hou</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Zhuomin  Yu</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Liang</span>, <span class="hlFld-ContribAuthor ">Shuang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2021,</strong> <em>377 </em>
                                    (3)
                                     , 358-367. <a href="https://doi.org/10.1124/jpet.121.000518" title="DOI URL">https://doi.org/10.1124/jpet.121.000518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.121.000518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.121.000518%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3Dcirc-Keratin%252B6c%252BPromotes%252BMalignant%252BProgression%252Band%252BImmune%252BEvasion%252Bof%252BColorectal%252BCancer%252Bthrough%252BmicroRNA-485-3p%25252FProgrammed%252BCell%252BDeath%252BReceptor%252BLigand%252B1%252BAxis%26aulast%3DJiang%26aufirst%3DZhipeng%26date%3D2021%26date%3D2021%26volume%3D377%26issue%3D3%26spage%3D358%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingxiang  Lin</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Qian</span>, <span class="hlFld-ContribAuthor ">William J.  Jusko</span>, <span class="hlFld-ContribAuthor ">Donald E.  Mager</span>, <span class="hlFld-ContribAuthor ">Wen Wee  Ma</span>, <span class="hlFld-ContribAuthor ">Robert M.  Straubinger</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2021,</strong> <em>377 </em>
                                    (3)
                                     , 370-384. <a href="https://doi.org/10.1124/jpet.120.000412" title="DOI URL">https://doi.org/10.1124/jpet.120.000412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.120.000412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.120.000412%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DSynergistic%252BPharmacodynamic%252BEffects%252Bof%252BGemcitabine%252Band%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%252Bon%252BPancreatic%252BCancer%252BCell%252BCycle%252BKinetics%252Band%252BProliferation%26aulast%3DLin%26aufirst%3DQingxiang%26date%3D2021%26date%3D2021%26volume%3D377%26issue%3D3%26spage%3D370%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandru  Nita</span>, <span class="hlFld-ContribAuthor ">Sara P.  Abraham</span>, <span class="hlFld-ContribAuthor ">Pavel  Krejci</span>, <span class="hlFld-ContribAuthor ">Michaela  Bosakova</span>. </span><span class="cited-content_cbyCitation_article-title">Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1445. <a href="https://doi.org/10.3390/cells10061445" title="DOI URL">https://doi.org/10.3390/cells10061445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10061445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10061445%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DOncogenic%252BFGFR%252BFusions%252BProduce%252BCentrosome%252Band%252BCilia%252BDefects%252Bby%252BEctopic%252BSignaling%26aulast%3DNita%26aufirst%3DAlexandru%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Hubert</span>, <span class="hlFld-ContribAuthor ">Zohair  Selmani</span>, <span class="hlFld-ContribAuthor ">Yohann  Loriot</span>, <span class="hlFld-ContribAuthor ">Antoine  Thiery-Vuillemin</span>. </span><span class="cited-content_cbyCitation_article-title">FGFR alterations in urothelial carcinoma: Picking the right target. </span><span class="cited-content_cbyCitation_journal-name">Bulletin du Cancer</span><span> <strong>2021,</strong> <em>108 </em>
                                    (6)
                                     , 566-570. <a href="https://doi.org/10.1016/j.bulcan.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.bulcan.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bulcan.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bulcan.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520du%2520Cancer%26atitle%3DFGFR%252Balterations%252Bin%252Burothelial%252Bcarcinoma%25253A%252BPicking%252Bthe%252Bright%252Btarget%26aulast%3DHubert%26aufirst%3DPaul%26date%3D2021%26volume%3D108%26issue%3D6%26spage%3D566%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Rizzo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicina</span><span> <strong>2021,</strong> <em>57 </em>
                                    (5)
                                     , 458. <a href="https://doi.org/10.3390/medicina57050458" title="DOI URL">https://doi.org/10.3390/medicina57050458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/medicina57050458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmedicina57050458%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicina%26atitle%3DTargeted%252BTherapies%252Bin%252BAdvanced%252BCholangiocarcinoma%25253A%252BA%252BFocus%252Bon%252BFGFR%252BInhibitors%26aulast%3DRizzo%26aufirst%3DAlessandro%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D5%26spage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin‐Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen‐Jun  Xue</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Li</span>, <span class="hlFld-ContribAuthor ">Ru  Dong</span>, <span class="hlFld-ContribAuthor ">Ming‐Tao  Li</span>, <span class="hlFld-ContribAuthor ">Li‐Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4,6‐Disubstituted Pyrimidine Derivatives as Novel Dual VEGFR2/FGFR1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2021,</strong> <em>18 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/cbdv.202100095" title="DOI URL">https://doi.org/10.1002/cbdv.202100095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202100095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202100095%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDiscovery%252Bof%252B4%25252C6%2525E2%252580%252590Disubstituted%252BPyrimidine%252BDerivatives%252Bas%252BNovel%252BDual%252BVEGFR2%25252FFGFR1%252BInhibitors%26aulast%3DZhang%26aufirst%3DJin%25E2%2580%2590Yang%26date%3D2021%26date%3D2021%26volume%3D18%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David K.  Lau</span>, <span class="hlFld-ContribAuthor ">Ian Y.  Luk</span>, <span class="hlFld-ContribAuthor ">Laura J.  Jenkins</span>, <span class="hlFld-ContribAuthor ">Andrew  Martin</span>, <span class="hlFld-ContribAuthor ">David S.  Williams</span>, <span class="hlFld-ContribAuthor ">Kael L.  Schoffer</span>, <span class="hlFld-ContribAuthor ">Fiona  Chionh</span>, <span class="hlFld-ContribAuthor ">Michael  Buchert</span>, <span class="hlFld-ContribAuthor ">Katrin  Sjoquist</span>, <span class="hlFld-ContribAuthor ">Alex  Boussioutas</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Hayes</span>, <span class="hlFld-ContribAuthor ">Matthias  Ernst</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Weickhardt</span>, <span class="hlFld-ContribAuthor ">Nick  Pavlakis</span>, <span class="hlFld-ContribAuthor ">Niall C.  Tebbutt</span>, <span class="hlFld-ContribAuthor ">John M.  Mariadason</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2021,</strong> <em>20 </em>
                                    (4)
                                     , 704-715. <a href="https://doi.org/10.1158/1535-7163.MCT-20-0836" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-20-0836</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-20-0836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-20-0836%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DRapid%252BResistance%252Bof%252BFGFR-driven%252BGastric%252BCancers%252Bto%252BRegorafenib%252Band%252BTargeted%252BFGFR%252BInhibitors%252Bcan%252Bbe%252BOvercome%252Bby%252BParallel%252BInhibition%252Bof%252BMEK%26aulast%3DLau%26aufirst%3DDavid%2BK.%26date%3D2021%26date%3D2021%26volume%3D20%26issue%3D4%26spage%3D704%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dingding  Gao</span>, <span class="hlFld-ContribAuthor ">Nan  Jin</span>, <span class="hlFld-ContribAuthor ">Yixian  Fu</span>, <span class="hlFld-ContribAuthor ">Yueyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Yujie  Wang</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Yuehong  Chen</span>, <span class="hlFld-ContribAuthor ">Mingming  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xiao</span>, <span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Yingxia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113333. <a href="https://doi.org/10.1016/j.ejmech.2021.113333" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113333%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdrug%252Bdesign%252Bof%252Bbenzothiazole-based%252Bderivatives%252Bas%252Bpotent%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%252Bsignaling%252Bpathway%252Binhibitors%26aulast%3DGao%26aufirst%3DDingding%26date%3D2021%26volume%3D216%26spage%3D113333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lipika  Goyal</span>, <span class="hlFld-ContribAuthor ">Sarinya  Kongpetch</span>, <span class="hlFld-ContribAuthor ">Valerie E.  Crolley</span>, <span class="hlFld-ContribAuthor ">John  Bridgewater</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting FGFR inhibition in cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Treatment Reviews</span><span> <strong>2021,</strong> <em>95 </em>, 102170. <a href="https://doi.org/10.1016/j.ctrv.2021.102170" title="DOI URL">https://doi.org/10.1016/j.ctrv.2021.102170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ctrv.2021.102170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ctrv.2021.102170%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Treatment%2520Reviews%26atitle%3DTargeting%252BFGFR%252Binhibition%252Bin%252Bcholangiocarcinoma%26aulast%3DGoyal%26aufirst%3DLipika%26date%3D2021%26volume%3D95%26spage%3D102170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rei  Noguchi</span>, <span class="hlFld-ContribAuthor ">Yuki  Yoshimatsu</span>, <span class="hlFld-ContribAuthor ">Akane  Sei</span>, <span class="hlFld-ContribAuthor ">Kaoru  Hirabayashi</span>, <span class="hlFld-ContribAuthor ">Iwao  Ozawa</span>, <span class="hlFld-ContribAuthor ">Kazutaka  Kikuta</span>, <span class="hlFld-ContribAuthor ">Tadashi  Kondo</span>. </span><span class="cited-content_cbyCitation_article-title">Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma. </span><span class="cited-content_cbyCitation_journal-name">Human Cell</span><span> <strong>2021,</strong> <em>34 </em>
                                    (2)
                                     , 667-674. <a href="https://doi.org/10.1007/s13577-020-00454-3" title="DOI URL">https://doi.org/10.1007/s13577-020-00454-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13577-020-00454-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13577-020-00454-3%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Cell%26atitle%3DEstablishment%252Band%252Bcharacterization%252Bof%252BNCC-MLPS1-C1%25253A%252Ba%252Bnovel%252Bpatient-derived%252Bcell%252Bline%252Bof%252Bmyxoid%252Bliposarcoma%26aulast%3DNoguchi%26aufirst%3DRei%26date%3D2021%26date%3D2020%26volume%3D34%26issue%3D2%26spage%3D667%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaowei  Wu</span>, <span class="hlFld-ContribAuthor ">Mengdi  Dai</span>, <span class="hlFld-ContribAuthor ">Rongrong  Cui</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Chunpu  Li</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Jihui  Zhao</span>, <span class="hlFld-ContribAuthor ">Bao  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Dan  Feng</span>, <span class="hlFld-ContribAuthor ">Tianbiao  Yang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 781-794. <a href="https://doi.org/10.1016/j.apsb.2020.09.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyridazinone%252Bderivatives%252Bas%252Bcovalent%252BFGFR%252Binhibitors%26aulast%3DWu%26aufirst%3DXiaowei%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D781%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikumi  Kuriwaki</span>, <span class="hlFld-ContribAuthor ">Minoru  Kameda</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Iikubo</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Hisamichi</span>, <span class="hlFld-ContribAuthor ">Yuichiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Shigetoshi  Kikuchi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Moritomo</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kondoh</span>, <span class="hlFld-ContribAuthor ">Tadashi  Terasaka</span>, <span class="hlFld-ContribAuthor ">Yasushi  Amano</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Tateishi</span>, <span class="hlFld-ContribAuthor ">Yuka  Echizen</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Iwai</span>, <span class="hlFld-ContribAuthor ">Atsushi  Noda</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Tomiyama</span>, <span class="hlFld-ContribAuthor ">Taisuke  Nakazawa</span>, <span class="hlFld-ContribAuthor ">Masaaki  Hirano</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>33 </em>, 116019. <a href="https://doi.org/10.1016/j.bmc.2021.116019" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure-activity%252Brelationships%252Bof%252Bpyrimidine%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bactive%252BFGFR3%252Binhibitors%252Bwith%252Bboth%252Bincreased%252Bsystemic%252Bexposure%252Band%252Benhanced%252Bin%252Bvitro%252Bpotency%26aulast%3DKuriwaki%26aufirst%3DIkumi%26date%3D2021%26volume%3D33%26spage%3D116019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohong  Pu</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Jing  Cai</span>, <span class="hlFld-ContribAuthor ">Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Yao  Fu</span>, <span class="hlFld-ContribAuthor ">Xiangshan  Fan</span>, <span class="hlFld-ContribAuthor ">Hongyan  Wu</span>, <span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Yudong  Qiu</span>, <span class="hlFld-ContribAuthor ">Shen  Yue</span>. </span><span class="cited-content_cbyCitation_article-title">Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     <a href="https://doi.org/10.1038/s41419-021-03548-4" title="DOI URL">https://doi.org/10.1038/s41419-021-03548-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-021-03548-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-021-03548-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DTyping%252BFGFR2%252Btranslocation%252Bdetermines%252Bthe%252Bresponse%252Bto%252Btargeted%252Btherapy%252Bof%252Bintrahepatic%252Bcholangiocarcinomas%26aulast%3DPu%26aufirst%3DXiaohong%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolu  Chen</span>, <span class="hlFld-ContribAuthor ">Yanan  Liu</span>, <span class="hlFld-ContribAuthor ">Liting  Zhang</span>, <span class="hlFld-ContribAuthor ">Daoxing  Chen</span>, <span class="hlFld-ContribAuthor ">Zhaojun  Dong</span>, <span class="hlFld-ContribAuthor ">Chengguang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Qinqin  Xia</span>, <span class="hlFld-ContribAuthor ">Jianzhang  Wu</span>, <span class="hlFld-ContribAuthor ">Yongheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zheng</span>, <span class="hlFld-ContribAuthor ">Yuepiao  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113219. <a href="https://doi.org/10.1016/j.ejmech.2021.113219" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113219%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bindazole%252Bderivatives%252Bas%252Bselective%252Band%252Bpotent%252BFGFR4%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BFGF19-driven%252Bhepatocellular%252Bcancer%26aulast%3DChen%26aufirst%3DXiaolu%26date%3D2021%26volume%3D214%26spage%3D113219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anh  Tran</span>, <span class="hlFld-ContribAuthor ">Tong San  Koh</span>, <span class="hlFld-ContribAuthor ">Aldo  Prawira</span>, <span class="hlFld-ContribAuthor ">Rebecca Zhi Wen  Ho</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Thanh Chung  Vu</span>, <span class="hlFld-ContribAuthor ">Septian  Hartano</span>, <span class="hlFld-ContribAuthor ">Xing Qi  Teo</span>, <span class="hlFld-ContribAuthor ">Way Cherng  Chen</span>, <span class="hlFld-ContribAuthor ">Philip  Lee</span>, <span class="hlFld-ContribAuthor ">Choon Hua  Thng</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 70-83. <a href="https://doi.org/10.1007/s11307-020-01531-7" title="DOI URL">https://doi.org/10.1007/s11307-020-01531-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-020-01531-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-020-01531-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DDynamic%252BContrast-Enhanced%252BMagnetic%252BResonance%252BImaging%252Bas%252BImaging%252BBiomarker%252Bfor%252BVascular%252BNormalization%252BEffect%252Bof%252BInfigratinib%252Bin%252BHigh-FGFR-Expressing%252BHepatocellular%252BCarcinoma%252BXenografts%26aulast%3DTran%26aufirst%3DAnh%26date%3D2021%26date%3D2020%26volume%3D23%26issue%3D1%26spage%3D70%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Rezzola</span>, <span class="hlFld-ContribAuthor ">Jessica  Guerra</span>, <span class="hlFld-ContribAuthor ">Adwaid Manu  Krishna Chandran</span>, <span class="hlFld-ContribAuthor ">Alessandra  Loda</span>, <span class="hlFld-ContribAuthor ">Anna  Cancarini</span>, <span class="hlFld-ContribAuthor ">Piergiuseppe  Sacristani</span>, <span class="hlFld-ContribAuthor ">Francesco  Semeraro</span>, <span class="hlFld-ContribAuthor ">Marco  Presta</span>. </span><span class="cited-content_cbyCitation_article-title">VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (4)
                                     , 2179. <a href="https://doi.org/10.3390/ijms22042179" title="DOI URL">https://doi.org/10.3390/ijms22042179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22042179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22042179%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DVEGF-Independent%252BActivation%252Bof%252BM%2525C3%2525BCller%252BCells%252Bby%252Bthe%252BVitreous%252Bfrom%252BProliferative%252BDiabetic%252BRetinopathy%252BPatients%26aulast%3DRezzola%26aufirst%3DSara%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D4%26spage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario E.  Lacouture</span>, <span class="hlFld-ContribAuthor ">Vincent  Sibaud</span>, <span class="hlFld-ContribAuthor ">Milan J.  Anadkat</span>, <span class="hlFld-ContribAuthor ">Benjamin  Kaffenberger</span>, <span class="hlFld-ContribAuthor ">Jonathan  Leventhal</span>, <span class="hlFld-ContribAuthor ">Kathleen  Guindon</span>, <span class="hlFld-ContribAuthor ">Ghassan  Abou‐Alfa</span>. </span><span class="cited-content_cbyCitation_article-title">Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines. </span><span class="cited-content_cbyCitation_journal-name">The Oncologist</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/onco.13552" title="DOI URL">https://doi.org/10.1002/onco.13552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/onco.13552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fonco.13552%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Oncologist%26atitle%3DDermatologic%252BAdverse%252BEvents%252BAssociated%252Bwith%252BSelective%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%25253A%252BOverview%25252C%252BPrevention%25252C%252Band%252BManagement%252BGuidelines%26aulast%3DLacouture%26aufirst%3DMario%2BE.%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdellah  Yamani</span>, <span class="hlFld-ContribAuthor ">Daria  Zdżalik-Bielecka</span>, <span class="hlFld-ContribAuthor ">Joanna  Lipner</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Stańczak</span>, <span class="hlFld-ContribAuthor ">Natalia  Piórkowska</span>, <span class="hlFld-ContribAuthor ">Paulina Seweryna  Stańczak</span>, <span class="hlFld-ContribAuthor ">Patrycja  Olejkowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Hucz-Kalitowska</span>, <span class="hlFld-ContribAuthor ">Marta  Magdycz</span>, <span class="hlFld-ContribAuthor ">Karolina  Dzwonek</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Dubiel</span>, <span class="hlFld-ContribAuthor ">Monika  Lamparska-Przybysz</span>, <span class="hlFld-ContribAuthor ">Delfina  Popiel</span>, <span class="hlFld-ContribAuthor ">Jerzy  Pieczykolan</span>, <span class="hlFld-ContribAuthor ">Maciej  Wieczorek</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1–3). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112990. <a href="https://doi.org/10.1016/j.ejmech.2020.112990" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112990%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bpyrazole-benzimidazole%252BCPL304110%25252C%252Bas%252Ba%252Bpotent%252Band%252Bselective%252Binhibitor%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptors%252BFGFR%252B%2525281%2525E2%252580%2525933%252529%26aulast%3DYamani%26aufirst%3DAbdellah%26date%3D2021%26volume%3D210%26spage%3D112990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwei  Yang</span>, <span class="hlFld-ContribAuthor ">Yongkun  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview. </span><span class="cited-content_cbyCitation_journal-name">OncoTargets and Therapy</span><span> <strong>2021,</strong> <em>Volume 14 </em>, 1341-1366. <a href="https://doi.org/10.2147/OTT.S297643" title="DOI URL">https://doi.org/10.2147/OTT.S297643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/OTT.S297643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FOTT.S297643%26sid%3Dliteratum%253Aachs%26jtitle%3DOncoTargets%2520and%2520Therapy%26atitle%3DPromising%252BMolecular%252BTargets%252Bfor%252Bthe%252BTargeted%252BTherapy%252Bof%252BBiliary%252BTract%252BCancers%25253A%252BAn%252BOverview%26aulast%3DYang%26aufirst%3DWenwei%26date%3D2021%26date%3D2021%26volume%3DVolume%252014%26spage%3D1341%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Alhalabi</span>, <span class="hlFld-ContribAuthor ">Jianjun  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Medical Treatment with Targeted Therapy for Metastatic Urothelial Bladder Carcinoma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 199-209. <a href="https://doi.org/10.1007/978-3-030-71509-0_16" title="DOI URL">https://doi.org/10.1007/978-3-030-71509-0_16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-71509-0_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-71509-0_16%26sid%3Dliteratum%253Aachs%26atitle%3DMedical%252BTreatment%252Bwith%252BTargeted%252BTherapy%252Bfor%252BMetastatic%252BUrothelial%252BBladder%252BCarcinoma%26aulast%3DAlhalabi%26aufirst%3DOmar%26date%3D2021%26date%3D2021%26spage%3D199%26epage%3D209%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DUrinary%252BBladder%252BPathology%26aulast%3DZhou%26aufirst%3DHaijun%26date%3D2021%26volume%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasar  Ahmed</span>, <span class="hlFld-ContribAuthor ">Raza  Khan</span>, <span class="hlFld-ContribAuthor ">Mary  O’Reilly</span>, <span class="hlFld-ContribAuthor ">Shane  O’Sulivan</span>, <span class="hlFld-ContribAuthor ">Thamir  Mahgoub</span>. </span><span class="cited-content_cbyCitation_article-title">FGFR inhibitors: Emerging treatments in advanced or metastatic cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Current Oncology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     , 22. <a href="https://doi.org/10.4103/jco.jco_45_20" title="DOI URL">https://doi.org/10.4103/jco.jco_45_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/jco.jco_45_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2Fjco.jco_45_20%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Current%2520Oncology%26atitle%3DFGFR%252Binhibitors%25253A%252BEmerging%252Btreatments%252Bin%252Badvanced%252Bor%252Bmetastatic%252Bcholangiocarcinoma%26aulast%3DAhmed%26aufirst%3DYasar%26date%3D2021%26volume%3D4%26issue%3D1%26spage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline  Copeland</span>, <span class="hlFld-ContribAuthor ">Marcos  Simoes-Costa</span>. </span><span class="cited-content_cbyCitation_article-title">Post-transcriptional tuning of FGF signaling mediates neural crest induction. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2020,</strong> <em>117 </em>
                                    (52)
                                     , 33305-33316. <a href="https://doi.org/10.1073/pnas.2009997117" title="DOI URL">https://doi.org/10.1073/pnas.2009997117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2009997117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2009997117%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPost-transcriptional%252Btuning%252Bof%252BFGF%252Bsignaling%252Bmediates%252Bneural%252Bcrest%252Binduction%26aulast%3DCopeland%26aufirst%3DJacqueline%26date%3D2020%26date%3D2020%26volume%3D117%26issue%3D52%26spage%3D33305%26epage%3D33316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomonori  Ozaki</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Yuki  Iimori</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Takeshita</span>, <span class="hlFld-ContribAuthor ">Yukiko  Yamagishi</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Masazumi  Kamohara</span>, <span class="hlFld-ContribAuthor ">Kaori  Fujita</span>, <span class="hlFld-ContribAuthor ">Masayuki  Tanahashi</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Tsumaki</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-77345-y" title="DOI URL">https://doi.org/10.1038/s41598-020-77345-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-77345-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-77345-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DEvaluation%252Bof%252BFGFR%252Binhibitor%252BASP5878%252Bas%252Ba%252Bdrug%252Bcandidate%252Bfor%252Bachondroplasia%26aulast%3DOzaki%26aufirst%3DTomonori%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  Domenichini</span>, <span class="hlFld-ContribAuthor ">Ilaria  Casari</span>, <span class="hlFld-ContribAuthor ">Peter V.  Simpson</span>, <span class="hlFld-ContribAuthor ">Nima Maheshkumar  Desai</span>, <span class="hlFld-ContribAuthor ">Lingfeng  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher  Dustin</span>, <span class="hlFld-ContribAuthor ">Jeanne S.  Edmands</span>, <span class="hlFld-ContribAuthor ">Albert  van der Vliet</span>, <span class="hlFld-ContribAuthor ">Moosa  Mohammadi</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Massi</span>, <span class="hlFld-ContribAuthor ">Marco  Falasca</span>. </span><span class="cited-content_cbyCitation_article-title">Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signalling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2020,</strong> <em>39 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-020-01777-7" title="DOI URL">https://doi.org/10.1186/s13046-020-01777-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-020-01777-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-020-01777-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DRhenium%252BN-heterocyclic%252Bcarbene%252Bcomplexes%252Bblock%252Bgrowth%252Bof%252Baggressive%252Bcancers%252Bby%252Binhibiting%252BFGFR-%252Band%252BSRC-mediated%252Bsignalling%26aulast%3DDomenichini%26aufirst%3DAlice%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Ardizzone</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Scuderi</span>, <span class="hlFld-ContribAuthor ">Dario  Giuffrida</span>, <span class="hlFld-ContribAuthor ">Cristina  Colarossi</span>, <span class="hlFld-ContribAuthor ">Caterina  Puglisi</span>, <span class="hlFld-ContribAuthor ">Michela  Campolo</span>, <span class="hlFld-ContribAuthor ">Salvatore  Cuzzocrea</span>, <span class="hlFld-ContribAuthor ">Emanuela  Esposito</span>, <span class="hlFld-ContribAuthor ">Irene  Paterniti</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (12)
                                     , 3825. <a href="https://doi.org/10.3390/cancers12123825" title="DOI URL">https://doi.org/10.3390/cancers12123825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12123825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12123825%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DRole%252Bof%252BFibroblast%252BGrowth%252BFactors%252BReceptors%252B%252528FGFRs%252529%252Bin%252BBrain%252BTumors%25252C%252BFocus%252Bon%252BAstrocytoma%252Band%252BGlioblastoma%26aulast%3DArdizzone%26aufirst%3DAlessio%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D12%26spage%3D3825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Thanh Chung  Vu</span>, <span class="hlFld-ContribAuthor ">Rebecca Zhi Wen  Ho</span>, <span class="hlFld-ContribAuthor ">Aldo  Prawira</span>, <span class="hlFld-ContribAuthor ">Lingzhi  Wang</span>, <span class="hlFld-ContribAuthor ">Boon Cher  Goh</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>. </span><span class="cited-content_cbyCitation_article-title">Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (24)
                                     , 9405. <a href="https://doi.org/10.3390/ijms21249405" title="DOI URL">https://doi.org/10.3390/ijms21249405</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21249405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21249405%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBevacizumab%252BAugments%252Bthe%252BAntitumor%252BEfficacy%252Bof%252BInfigratinib%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DLe%26aufirst%3DThi%2BBich%2BUyen%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D24%26spage%3D9405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Niefang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation: 5-amino-1H-pyrazole-1- carbonyl derivatives as FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (11)
                                     , 1330-1341. <a href="https://doi.org/10.2174/1570180817999200608140628" title="DOI URL">https://doi.org/10.2174/1570180817999200608140628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180817999200608140628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180817999200608140628%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%25253A%252B5-amino-1H-pyrazole-1-%252Bcarbonyl%252Bderivatives%252Bas%252BFGFR%252BInhibitors%26aulast%3DZhang%26aufirst%3DYan%26date%3D2020%26volume%3D17%26issue%3D11%26spage%3D1330%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas  Barrows</span>, <span class="hlFld-ContribAuthor ">Lijuan  Feng</span>, <span class="hlFld-ContribAuthor ">Thomas S.  Carroll</span>, <span class="hlFld-ContribAuthor ">C. David  Allis</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2020,</strong> <em>117 </em>
                                    (41)
                                     , 25732-25741. <a href="https://doi.org/10.1073/pnas.2008017117" title="DOI URL">https://doi.org/10.1073/pnas.2008017117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2008017117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2008017117%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DLoss%252Bof%252BUTX%25252FKDM6A%252Band%252Bthe%252Bactivation%252Bof%252BFGFR3%252Bconverge%252Bto%252Bregulate%252Bdifferentiation%252Bgene-expression%252Bprograms%252Bin%252Bbladder%252Bcancer%26aulast%3DBarrows%26aufirst%3DDouglas%26date%3D2020%26date%3D2020%26volume%3D117%26issue%3D41%26spage%3D25732%26epage%3D25741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin M.  Levine</span>, <span class="hlFld-ContribAuthor ">Kai  Ding</span>, <span class="hlFld-ContribAuthor ">Lyuqin  Chen</span>, <span class="hlFld-ContribAuthor ">Steffi  Oesterreich</span>. </span><span class="cited-content_cbyCitation_article-title">FGFR4: A promising therapeutic target for breast cancer and other solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>214 </em>, 107590. <a href="https://doi.org/10.1016/j.pharmthera.2020.107590" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107590%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DFGFR4%25253A%252BA%252Bpromising%252Btherapeutic%252Btarget%252Bfor%252Bbreast%252Bcancer%252Band%252Bother%252Bsolid%252Btumors%26aulast%3DLevine%26aufirst%3DKevin%2BM.%26date%3D2020%26volume%3D214%26spage%3D107590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shalini  Makawita</span>, <span class="hlFld-ContribAuthor ">Ghassan  K Abou-Alfa</span>, <span class="hlFld-ContribAuthor ">Sameek  Roychowdhury</span>, <span class="hlFld-ContribAuthor ">Saeed  Sadeghi</span>, <span class="hlFld-ContribAuthor ">Ivan  Borbath</span>, <span class="hlFld-ContribAuthor ">Lipika  Goyal</span>, <span class="hlFld-ContribAuthor ">Allen  Cohn</span>, <span class="hlFld-ContribAuthor ">Angela  Lamarca</span>, <span class="hlFld-ContribAuthor ">Do-Youn  Oh</span>, <span class="hlFld-ContribAuthor ">Teresa  Macarulla</span>, <span class="hlFld-ContribAuthor ">Rachna  T Shroff</span>, <span class="hlFld-ContribAuthor ">Michael  Howland</span>, <span class="hlFld-ContribAuthor ">Ai  Li</span>, <span class="hlFld-ContribAuthor ">Terry  Cho</span>, <span class="hlFld-ContribAuthor ">Amit  Pande</span>, <span class="hlFld-ContribAuthor ">Milind  Javle</span>. </span><span class="cited-content_cbyCitation_article-title">Infigratinib in patients with advanced cholangiocarcinoma with
              FGFR2
              gene fusions/translocations: the PROOF 301 trial. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (30)
                                     , 2375-2384. <a href="https://doi.org/10.2217/fon-2020-0299" title="DOI URL">https://doi.org/10.2217/fon-2020-0299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2020-0299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2020-0299%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DInfigratinib%252Bin%252Bpatients%252Bwith%252Badvanced%252Bcholangiocarcinoma%252Bwith%252BFGFR2%252Bgene%252Bfusions%25252Ftranslocations%25253A%252Bthe%252BPROOF%252B301%252Btrial%26aulast%3DMakawita%26aufirst%3DShalini%26date%3D2020%26volume%3D16%26issue%3D30%26spage%3D2375%26epage%3D2384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junghwa  Choi</span>, <span class="hlFld-ContribAuthor ">Jee Young  Sung</span>, <span class="hlFld-ContribAuthor ">Saerom  Lee</span>, <span class="hlFld-ContribAuthor ">Jungyoen  Yoo</span>, <span class="hlFld-ContribAuthor ">Christopher  Rongo</span>, <span class="hlFld-ContribAuthor ">Yong-Nyun  Kim</span>, <span class="hlFld-ContribAuthor ">Jaegal  Shim</span>. </span><span class="cited-content_cbyCitation_article-title">Rab8 and Rabin8-Mediated Tumor Formation by Hyperactivated EGFR Signaling via FGFR Signaling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7770. <a href="https://doi.org/10.3390/ijms21207770" title="DOI URL">https://doi.org/10.3390/ijms21207770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207770%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRab8%252Band%252BRabin8-Mediated%252BTumor%252BFormation%252Bby%252BHyperactivated%252BEGFR%252BSignaling%252Bvia%252BFGFR%252BSignaling%26aulast%3DChoi%26aufirst%3DJunghwa%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luigi  Maddaluno</span>, <span class="hlFld-ContribAuthor ">Corinne  Urwyler</span>, <span class="hlFld-ContribAuthor ">Theresa  Rauschendorfer</span>, <span class="hlFld-ContribAuthor ">Michael  Meyer</span>, <span class="hlFld-ContribAuthor ">Debora  Stefanova</span>, <span class="hlFld-ContribAuthor ">Roman  Spörri</span>, <span class="hlFld-ContribAuthor ">Mateusz  Wietecha</span>, <span class="hlFld-ContribAuthor ">Luca  Ferrarese</span>, <span class="hlFld-ContribAuthor ">Diana  Stoycheva</span>, <span class="hlFld-ContribAuthor ">Daniela  Bender</span>, <span class="hlFld-ContribAuthor ">Nick  Li</span>, <span class="hlFld-ContribAuthor ">Gerhard  Strittmatter</span>, <span class="hlFld-ContribAuthor ">Khondokar  Nasirujjaman</span>, <span class="hlFld-ContribAuthor ">Hans‐Dietmar  Beer</span>, <span class="hlFld-ContribAuthor ">Peter  Staeheli</span>, <span class="hlFld-ContribAuthor ">Eberhard  Hildt</span>, <span class="hlFld-ContribAuthor ">Annette  Oxenius</span>, <span class="hlFld-ContribAuthor ">Sabine  Werner</span>. </span><span class="cited-content_cbyCitation_article-title">Antagonism of interferon signaling by fibroblast growth factors promotes viral replication. </span><span class="cited-content_cbyCitation_journal-name">EMBO Molecular Medicine</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     <a href="https://doi.org/10.15252/emmm.201911793" title="DOI URL">https://doi.org/10.15252/emmm.201911793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/emmm.201911793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Femmm.201911793%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520Molecular%2520Medicine%26atitle%3DAntagonism%252Bof%252Binterferon%252Bsignaling%252Bby%252Bfibroblast%252Bgrowth%252Bfactors%252Bpromotes%252Bviral%252Breplication%26aulast%3DMaddaluno%26aufirst%3DLuigi%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakob  Paur</span>, <span class="hlFld-ContribAuthor ">Maximilian  Valler</span>, <span class="hlFld-ContribAuthor ">Rebecca  Sienel</span>, <span class="hlFld-ContribAuthor ">Karin  Taxauer</span>, <span class="hlFld-ContribAuthor ">Klaus  Holzmann</span>, <span class="hlFld-ContribAuthor ">Brigitte  Marian</span>, <span class="hlFld-ContribAuthor ">Andreas  Unterberger</span>, <span class="hlFld-ContribAuthor ">Thomas  Mohr</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, <span class="hlFld-ContribAuthor ">Andja  Gvozdenovich</span>, <span class="hlFld-ContribAuthor ">Johannes  Schimming</span>, <span class="hlFld-ContribAuthor ">Michael  Grusch</span>, <span class="hlFld-ContribAuthor ">Bettina  Grasl‐Kraupp</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Liver International</span><span> <strong>2020,</strong> <em>40 </em>
                                    (9)
                                     , 2279-2290. <a href="https://doi.org/10.1111/liv.14505" title="DOI URL">https://doi.org/10.1111/liv.14505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/liv.14505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fliv.14505%26sid%3Dliteratum%253Aachs%26jtitle%3DLiver%2520International%26atitle%3DInteraction%252Bof%252BFGF9%252Bwith%252BFGFR3%2525E2%252580%252590IIIb%25252FIIIc%25252C%252Ba%252Bputative%252Bdriver%252Bof%252Bgrowth%252Band%252Baggressive%252Bbehaviour%252Bof%252Bhepatocellular%252Bcarcinoma%26aulast%3DPaur%26aufirst%3DJakob%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D9%26spage%3D2279%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shun  Morizumi</span>, <span class="hlFld-ContribAuthor ">Seidai  Sato</span>, <span class="hlFld-ContribAuthor ">Kazuya  Koyama</span>, <span class="hlFld-ContribAuthor ">Hiroyasu  Okazaki</span>, <span class="hlFld-ContribAuthor ">Yajuan  Chen</span>, <span class="hlFld-ContribAuthor ">Hisatsugu  Goto</span>, <span class="hlFld-ContribAuthor ">Kozo  Kagawa</span>, <span class="hlFld-ContribAuthor ">Hirohisa  Ogawa</span>, <span class="hlFld-ContribAuthor ">Haruka  Nishimura</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kawano</span>, <span class="hlFld-ContribAuthor ">Yuko  Toyoda</span>, <span class="hlFld-ContribAuthor ">Hisanori  Uehara</span>, <span class="hlFld-ContribAuthor ">Yasuhiko  Nishioka</span>. </span><span class="cited-content_cbyCitation_article-title">Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory Cell and Molecular Biology</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 317-326. <a href="https://doi.org/10.1165/rcmb.2019-0090OC" title="DOI URL">https://doi.org/10.1165/rcmb.2019-0090OC</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1165/rcmb.2019-0090OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1165%2Frcmb.2019-0090OC%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520Cell%2520and%2520Molecular%2520Biology%26atitle%3DBlockade%252Bof%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptors%252BMediates%252BBidirectional%252BEffects%252Bin%252BLung%252BFibrosis%26aulast%3DMorizumi%26aufirst%3DShun%26date%3D2020%26volume%3D63%26issue%3D3%26spage%3D317%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y.  Takashi</span>, <span class="hlFld-ContribAuthor ">S.  Fukumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphate-sensing and regulatory mechanism of FGF23 production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Endocrinological Investigation</span><span> <strong>2020,</strong> <em>43 </em>
                                    (7)
                                     , 877-883. <a href="https://doi.org/10.1007/s40618-020-01205-9" title="DOI URL">https://doi.org/10.1007/s40618-020-01205-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40618-020-01205-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40618-020-01205-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Endocrinological%2520Investigation%26atitle%3DPhosphate-sensing%252Band%252Bregulatory%252Bmechanism%252Bof%252BFGF23%252Bproduction%26aulast%3DTakashi%26aufirst%3DY.%26date%3D2020%26date%3D2020%26volume%3D43%26issue%3D7%26spage%3D877%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuichi  Takashi</span>, <span class="hlFld-ContribAuthor ">Seiji  Fukumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast growth factor receptor as a potential candidate for phosphate sensing. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Nephrology & Hypertension</span><span> <strong>2020,</strong> <em>29 </em>
                                    (4)
                                     , 446-452. <a href="https://doi.org/10.1097/MNH.0000000000000618" title="DOI URL">https://doi.org/10.1097/MNH.0000000000000618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MNH.0000000000000618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMNH.0000000000000618%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Nephrology%2520%2526%2520Hypertension%26atitle%3DFibroblast%252Bgrowth%252Bfactor%252Breceptor%252Bas%252Ba%252Bpotential%252Bcandidate%252Bfor%252Bphosphate%252Bsensing%26aulast%3DTakashi%26aufirst%3DYuichi%26date%3D2020%26volume%3D29%26issue%3D4%26spage%3D446%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chelsea K.  Osterman</span>, <span class="hlFld-ContribAuthor ">Matthew I.  Milowsky</span>. </span><span class="cited-content_cbyCitation_article-title">Searching for the perfect combination of drug, disease, genetic alteration, and screening test to maximize FGFR inhibition in urothelial cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer</span><span> <strong>2020,</strong> <em>126 </em>
                                    (11)
                                     , 2588-2591. <a href="https://doi.org/10.1002/cncr.32804" title="DOI URL">https://doi.org/10.1002/cncr.32804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cncr.32804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcncr.32804%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%26atitle%3DSearching%252Bfor%252Bthe%252Bperfect%252Bcombination%252Bof%252Bdrug%25252C%252Bdisease%25252C%252Bgenetic%252Balteration%25252C%252Band%252Bscreening%252Btest%252Bto%252Bmaximize%252BFGFR%252Binhibition%252Bin%252Burothelial%252Bcancer%26aulast%3DOsterman%26aufirst%3DChelsea%2BK.%26date%3D2020%26date%3D2020%26volume%3D126%26issue%3D11%26spage%3D2588%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ikumi  Kuriwaki</span>, <span class="hlFld-ContribAuthor ">Minoru  Kameda</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Hisamichi</span>, <span class="hlFld-ContribAuthor ">Shigetoshi  Kikuchi</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Iikubo</span>, <span class="hlFld-ContribAuthor ">Yuichiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Moritomo</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kondoh</span>, <span class="hlFld-ContribAuthor ">Yasushi  Amano</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Tateishi</span>, <span class="hlFld-ContribAuthor ">Yuka  Echizen</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Iwai</span>, <span class="hlFld-ContribAuthor ">Atsushi  Noda</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Tomiyama</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masaaki  Hirano</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 115453. <a href="https://doi.org/10.1016/j.bmc.2020.115453" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115453%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdrug%252Bdesign%252Bof%252B1%25252C3%25252C5-triazine%252Band%252Bpyrimidine%252Bderivatives%252Bas%252Bnovel%252BFGFR3%252Binhibitors%252Bwith%252Bhigh%252Bselectivity%252Bover%252BVEGFR2%26aulast%3DKuriwaki%26aufirst%3DIkumi%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D115453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadia Carvalho  Lima</span>, <span class="hlFld-ContribAuthor ">Eliza  Atkinson</span>, <span class="hlFld-ContribAuthor ">Tom D.  Bunney</span>, <span class="hlFld-ContribAuthor ">Matilda  Katan</span>, <span class="hlFld-ContribAuthor ">Paul H.  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (9)
                                     , 3214. <a href="https://doi.org/10.3390/ijms21093214" title="DOI URL">https://doi.org/10.3390/ijms21093214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21093214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21093214%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252Bthe%252BSrc%252BPathway%252BEnhances%252Bthe%252BEfficacy%252Bof%252BSelective%252BFGFR%252BInhibitors%252Bin%252BUrothelial%252BCancers%252Bwith%252BFGFR3%252BAlterations%26aulast%3DLima%26aufirst%3DNadia%2BCarvalho%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D9%26spage%3D3214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hermann AM  Mucke</span>. </span><span class="cited-content_cbyCitation_article-title">Patent highlights October–November 2019. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2020,</strong> <em>9 </em>
                                    (2)
                                     , 33-40. <a href="https://doi.org/10.4155/ppa-2020-0003" title="DOI URL">https://doi.org/10.4155/ppa-2020-0003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2020-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2020-0003%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DPatent%252Bhighlights%252BOctober%2525E2%252580%252593November%252B2019%26aulast%3DMucke%26aufirst%3DHermann%2BAM%26date%3D2020%26volume%3D9%26issue%3D2%26spage%3D33%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Rzęsikowska</span>, <span class="hlFld-ContribAuthor ">Mateusz  Jabłoński</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>. </span><span class="cited-content_cbyCitation_article-title">Flat or angular? The impact of the nitrogen atom hybridization on the docking results for arylpiperazine derivatives as an example. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (2)
                                     , 823-829. <a href="https://doi.org/10.1007/s11224-019-01469-9" title="DOI URL">https://doi.org/10.1007/s11224-019-01469-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-019-01469-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-019-01469-9%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DFlat%252Bor%252Bangular%25253F%252BThe%252Bimpact%252Bof%252Bthe%252Bnitrogen%252Batom%252Bhybridization%252Bon%252Bthe%252Bdocking%252Bresults%252Bfor%252Barylpiperazine%252Bderivatives%252Bas%252Ban%252Bexample%26aulast%3DRz%25C4%2599sikowska%26aufirst%3DKatarzyna%26date%3D2020%26date%3D2019%26volume%3D31%26issue%3D2%26spage%3D823%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdulaziz B.  Hamid</span>, <span class="hlFld-ContribAuthor ">Ruben C.  Petreaca</span>. </span><span class="cited-content_cbyCitation_article-title">Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 927. <a href="https://doi.org/10.3390/cancers12040927" title="DOI URL">https://doi.org/10.3390/cancers12040927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12040927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12040927%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSecondary%252BResistant%252BMutations%252Bto%252BSmall%252BMolecule%252BInhibitors%252Bin%252BCancer%252BCells%26aulast%3DHamid%26aufirst%3DAbdulaziz%2BB.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriyuki  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Yutaka  Hashimoto</span>, <span class="hlFld-ContribAuthor ">Naoko  Yasue</span>, <span class="hlFld-ContribAuthor ">Makoto  Suzuki</span>, <span class="hlFld-ContribAuthor ">Ileana M.  Cristea</span>, <span class="hlFld-ContribAuthor ">Naoto  Ueno</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanical Stress Regulates Epithelial Tissue Integrity and Stiffness through the FGFR/Erk2 Signaling Pathway during Embryogenesis. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 3875-3888.e3. <a href="https://doi.org/10.1016/j.celrep.2020.02.074" title="DOI URL">https://doi.org/10.1016/j.celrep.2020.02.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2020.02.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2020.02.074%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DMechanical%252BStress%252BRegulates%252BEpithelial%252BTissue%252BIntegrity%252Band%252BStiffness%252Bthrough%252Bthe%252BFGFR%25252FErk2%252BSignaling%252BPathway%252Bduring%252BEmbryogenesis%26aulast%3DKinoshita%26aufirst%3DNoriyuki%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D3875%26epage%3D3888.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zixin  Xie</span>, <span class="hlFld-ContribAuthor ">Kaiqi  Wu</span>, <span class="hlFld-ContribAuthor ">Yuexuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yaqian  Pan</span>, <span class="hlFld-ContribAuthor ">Bo  Chen</span>, <span class="hlFld-ContribAuthor ">Donghua  Cheng</span>, <span class="hlFld-ContribAuthor ">Suwei  Pan</span>, <span class="hlFld-ContribAuthor ">Taoning  Guo</span>, <span class="hlFld-ContribAuthor ">Xuze  Du</span>, <span class="hlFld-ContribAuthor ">Longcheng  Fang</span>, <span class="hlFld-ContribAuthor ">Xuebao  Wang</span>, <span class="hlFld-ContribAuthor ">Faqing  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111943. <a href="https://doi.org/10.1016/j.ejmech.2019.111943" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111943%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4%25252C6-pyrimidinediamine%252Bderivatives%252Bas%252Bnovel%252Bdual%252BEGFR%25252FFGFR%252Binhibitors%252Baimed%252BEGFR%25252FFGFR1-positive%252BNSCLC%26aulast%3DXie%26aufirst%3DZixin%26date%3D2020%26volume%3D187%26spage%3D111943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyan  Shen</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Paul S.  Cohen</span>, <span class="hlFld-ContribAuthor ">Gongqin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Biphasic Mathematical Model of Cell–Drug Interaction That Separates Target-Specific and Off-Target Inhibition and Suggests Potent Targeted Drug Combinations for Multi-Driver Colorectal Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 436. <a href="https://doi.org/10.3390/cancers12020436" title="DOI URL">https://doi.org/10.3390/cancers12020436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12020436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12020436%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DBiphasic%252BMathematical%252BModel%252Bof%252BCell%2525E2%252580%252593Drug%252BInteraction%252BThat%252BSeparates%252BTarget-Specific%252Band%252BOff-Target%252BInhibition%252Band%252BSuggests%252BPotent%252BTargeted%252BDrug%252BCombinations%252Bfor%252BMulti-Driver%252BColorectal%252BCancer%252BCells%26aulast%3DShen%26aufirst%3DJinyan%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Ronghui  Du</span>, <span class="hlFld-ContribAuthor ">Guilherme Rodrigo  Reis Monteiro dos Santos</span>, <span class="hlFld-ContribAuthor ">Revital  Yefidoff-Freedman</span>, <span class="hlFld-ContribAuthor ">Andrew  Bohm</span>, <span class="hlFld-ContribAuthor ">Jose  Halperin</span>, <span class="hlFld-ContribAuthor ">Michael  Chorev</span>, <span class="hlFld-ContribAuthor ">Bertal H.  Aktas</span>. </span><span class="cited-content_cbyCitation_article-title">New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111973. <a href="https://doi.org/10.1016/j.ejmech.2019.111973" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111973%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bactivators%252Bof%252BeIF2%2525CE%2525B1%252BKinase%252BHeme-Regulated%252BInhibitor%252B%252528HRI%252529%252Bwith%252Bimproved%252Bbiophysical%252Bproperties%26aulast%3DZhang%26aufirst%3DQingwen%26date%3D2020%26volume%3D187%26spage%3D111973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Xiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Tian  Xie</span>, <span class="hlFld-ContribAuthor ">San-Ke  Yang</span>, <span class="hlFld-ContribAuthor ">Xian-Jin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel C-N Migration Rearrangement Based on N-F Compounds for the Synthesis of
              N
              -Alkyl Diaryl Ureas. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (4)
                                     , 437-445. <a href="https://doi.org/10.1002/ejoc.201901602" title="DOI URL">https://doi.org/10.1002/ejoc.201901602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901602%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BNovel%252BC-N%252BMigration%252BRearrangement%252BBased%252Bon%252BN-F%252BCompounds%252Bfor%252Bthe%252BSynthesis%252Bof%252BN%252B-Alkyl%252BDiaryl%252BUreas%26aulast%3DZhao%26aufirst%3DYi-Xiao%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D4%26spage%3D437%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 265-281. <a href="https://doi.org/10.18632/oncotarget.27435" title="DOI URL">https://doi.org/10.18632/oncotarget.27435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27435%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DResistance%252Bto%252Ballosteric%252BSHP2%252Binhibition%252Bin%252BFGFR-driven%252Bcancers%252Bthrough%252Brapid%252Bfeedback%252Bactivation%252Bof%252BFGFR%26aulast%3DLu%26aufirst%3DHengyu%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D3%26spage%3D265%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Wu-Chen  Xie</span>, <span class="hlFld-ContribAuthor ">Si-Ping  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in the development of novel, selective and potent FGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111884. <a href="https://doi.org/10.1016/j.ejmech.2019.111884" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111884%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Bthe%252Bdevelopment%252Bof%252Bnovel%25252C%252Bselective%252Band%252Bpotent%252BFGFR%252Binhibitors%26aulast%3DLiu%26aufirst%3DFeng-Tao%26date%3D2020%26volume%3D186%26spage%3D111884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>151 </em>, 104567. <a href="https://doi.org/10.1016/j.phrs.2019.104567" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104567%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DThe%252Brole%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B%252528FGFR%252529%252Bprotein-tyrosine%252Bkinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bcancers%252Bincluding%252Bthose%252Bof%252Bthe%252Burinary%252Bbladder%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2020%26volume%3D151%26spage%3D104567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Wen</span>, <span class="hlFld-ContribAuthor ">Lina  Gao</span>, <span class="hlFld-ContribAuthor ">Liang  Gao</span>, <span class="hlFld-ContribAuthor ">Fengjun  He</span>, <span class="hlFld-ContribAuthor ">Jingxian  Zhou</span>, <span class="hlFld-ContribAuthor ">Junwei  Wang</span>, <span class="hlFld-ContribAuthor ">Rupeng  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Chen</span>, <span class="hlFld-ContribAuthor ">Di  Kang</span>, <span class="hlFld-ContribAuthor ">Lihong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 1
              H
              -1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors
              via
              fragment-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 72-84. <a href="https://doi.org/10.1080/14756366.2019.1673745" title="DOI URL">https://doi.org/10.1080/14756366.2019.1673745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1673745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1673745%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B1%252BH%252B-1%25252C2%25252C4-triazole%25252C%252Bbenzothiazole%252Band%252Bindazole-based%252Bderivatives%252Bas%252Bpotent%252BFGFR1%252Binhibitors%252Bvia%252Bfragment-based%252Bvirtual%252Bscreening%26aulast%3DLiu%26aufirst%3DJian%26date%3D2020%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Marseglia</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Riccardo  Castelli</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast growth factor receptor inhibitors: patent review (2015–2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 965-977. <a href="https://doi.org/10.1080/13543776.2019.1688300" title="DOI URL">https://doi.org/10.1080/13543776.2019.1688300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1688300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1688300%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFibroblast%252Bgrowth%252Bfactor%252Breceptor%252Binhibitors%25253A%252Bpatent%252Breview%252B%2525282015%2525E2%252580%2525932019%252529%26aulast%3DMarseglia%26aufirst%3DGiuseppe%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D965%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Meiju  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2019,</strong> <em>59 </em>, 3-22. <a href="https://doi.org/10.1016/j.semcancer.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.semcancer.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DReceptor%252Btyrosine%252Bkinases%252Bin%252BPI3K%252Bsignaling%25253A%252BThe%252Btherapeutic%252Btargets%252Bin%252Bcancer%26aulast%3DJiang%26aufirst%3DWei%26date%3D2019%26volume%3D59%26spage%3D3%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathane Santanna  Felix</span>, <span class="hlFld-ContribAuthor ">Lucas  Mendonça</span>, <span class="hlFld-ContribAuthor ">Cassia Lisboa  Braga</span>, <span class="hlFld-ContribAuthor ">Jaqueline Soares  Silva</span>, <span class="hlFld-ContribAuthor ">Cynthia dos Santos  Samary</span>, <span class="hlFld-ContribAuthor ">Juliana Borges  Vieira</span>, <span class="hlFld-ContribAuthor ">Fernanda  Cruz</span>, <span class="hlFld-ContribAuthor ">Nazareth de Novaes  Rocha</span>, <span class="hlFld-ContribAuthor ">Gisele  Zapata‐Sudo</span>, <span class="hlFld-ContribAuthor ">Patricia Rieken Macedo  Rocco</span>, <span class="hlFld-ContribAuthor ">Pedro Leme  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of the FGF receptor‐1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (23)
                                     , 4462-4473. <a href="https://doi.org/10.1111/bph.14807" title="DOI URL">https://doi.org/10.1111/bph.14807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14807%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DEffects%252Bof%252Bthe%252BFGF%252Breceptor%2525E2%252580%2525901%252Binhibitor%25252C%252Binfigratinib%25252C%252Bwith%252Bor%252Bwithout%252Bsildenafil%25252C%252Bin%252Bexperimental%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DFelix%26aufirst%3DNathane%2BSantanna%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D23%26spage%3D4462%26epage%3D4473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Weiss</span>, <span class="hlFld-ContribAuthor ">Flavia  Adler</span>, <span class="hlFld-ContribAuthor ">Alexandra  Buhles</span>, <span class="hlFld-ContribAuthor ">Christelle  Stamm</span>, <span class="hlFld-ContribAuthor ">Robin A.  Fairhurst</span>, <span class="hlFld-ContribAuthor ">Michael  Kiffe</span>, <span class="hlFld-ContribAuthor ">Dario  Sterker</span>, <span class="hlFld-ContribAuthor ">Mario  Centeleghe</span>, <span class="hlFld-ContribAuthor ">Markus  Wartmann</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Kinyamu-Akunda</span>, <span class="hlFld-ContribAuthor ">Heiko S.  Schadt</span>, <span class="hlFld-ContribAuthor ">Philippe  Couttet</span>, <span class="hlFld-ContribAuthor ">Armin  Wolf</span>, <span class="hlFld-ContribAuthor ">Youzhen  Wang</span>, <span class="hlFld-ContribAuthor ">Patrizia  Barzaghi-Rinaudo</span>, <span class="hlFld-ContribAuthor ">Masato  Murakami</span>, <span class="hlFld-ContribAuthor ">Audrey  Kauffmann</span>, <span class="hlFld-ContribAuthor ">Thomas  Knoepfel</span>, <span class="hlFld-ContribAuthor ">Nicole  Buschmann</span>, <span class="hlFld-ContribAuthor ">Catherine  Leblanc</span>, <span class="hlFld-ContribAuthor ">Robert  Mah</span>, <span class="hlFld-ContribAuthor ">Pascal  Furet</span>, <span class="hlFld-ContribAuthor ">Jutta  Blank</span>, <span class="hlFld-ContribAuthor ">Francesco  Hofmann</span>, <span class="hlFld-ContribAuthor ">William R.  Sellers</span>, <span class="hlFld-ContribAuthor ">Diana  Graus Porta</span>. </span><span class="cited-content_cbyCitation_article-title">FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (12)
                                     , 2194-2206. <a href="https://doi.org/10.1158/1535-7163.MCT-18-1291" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-1291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-1291%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DFGF401%25252C%252BA%252BFirst-In-Class%252BHighly%252BSelective%252Band%252BPotent%252BFGFR4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BFGF19-Driven%252BHepatocellular%252BCancer%26aulast%3DWeiss%26aufirst%3DAndreas%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D12%26spage%3D2194%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>, <span class="hlFld-ContribAuthor ">Hongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Steven  Kovats</span>, <span class="hlFld-ContribAuthor ">Roberto  Velazquez</span>, <span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Bhavesh  Pant</span>, <span class="hlFld-ContribAuthor ">Matthew  Shirley</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Meyer</span>, <span class="hlFld-ContribAuthor ">Minying  Pu</span>, <span class="hlFld-ContribAuthor ">Joanne  Lim</span>, <span class="hlFld-ContribAuthor ">Michael  Fleming</span>, <span class="hlFld-ContribAuthor ">LeighAnn  Alexander</span>, <span class="hlFld-ContribAuthor ">Ali  Farsidjani</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Susan  Moody</span>, <span class="hlFld-ContribAuthor ">Serena J.  Silver</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Darrin D.  Stuart</span>, <span class="hlFld-ContribAuthor ">Tinya J.  Abrams</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Juliet  Williams</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Silvia  Goldoni</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (12)
                                     , 2368-2380. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0170" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0170%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTumor%252BIntrinsic%252BEfficacy%252Bby%252BSHP2%252Band%252BRTK%252BInhibitors%252Bin%252BKRAS-Mutant%252BCancers%26aulast%3DHao%26aufirst%3DHuai-Xiang%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D12%26spage%3D2368%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakub  Sumbal</span>, <span class="hlFld-ContribAuthor ">Zuzana  Koledova</span>. </span><span class="cited-content_cbyCitation_article-title">FGF signaling in mammary gland fibroblasts regulates multiple fibroblast functions and mammary epithelial morphogenesis. </span><span class="cited-content_cbyCitation_journal-name">Development</span><span> <strong>2019,</strong> <em>146 </em>
                                    (23)
                                     <a href="https://doi.org/10.1242/dev.185306" title="DOI URL">https://doi.org/10.1242/dev.185306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/dev.185306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fdev.185306%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopment%26atitle%3DFGF%252Bsignaling%252Bin%252Bmammary%252Bgland%252Bfibroblasts%252Bregulates%252Bmultiple%252Bfibroblast%252Bfunctions%252Band%252Bmammary%252Bepithelial%252Bmorphogenesis%26aulast%3DSumbal%26aufirst%3DJakub%26date%3D2019%26date%3D2019%26volume%3D146%26issue%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvia  Grünewald</span>, <span class="hlFld-ContribAuthor ">Oliver  Politz</span>, <span class="hlFld-ContribAuthor ">Sebastian  Bender</span>, <span class="hlFld-ContribAuthor ">Mélanie  Héroult</span>, <span class="hlFld-ContribAuthor ">Klemens  Lustig</span>, <span class="hlFld-ContribAuthor ">Uwe  Thuss</span>, <span class="hlFld-ContribAuthor ">Christoph  Kneip</span>, <span class="hlFld-ContribAuthor ">Charlotte  Kopitz</span>, <span class="hlFld-ContribAuthor ">Dieter  Zopf</span>, <span class="hlFld-ContribAuthor ">Marie‐Pierre  Collin</span>, <span class="hlFld-ContribAuthor ">Ulf  Boemer</span>, <span class="hlFld-ContribAuthor ">Stuart  Ince</span>, <span class="hlFld-ContribAuthor ">Peter  Ellinghaus</span>, <span class="hlFld-ContribAuthor ">Dominik  Mumberg</span>, <span class="hlFld-ContribAuthor ">Holger  Hess‐Stumpp</span>, <span class="hlFld-ContribAuthor ">Karl  Ziegelbauer</span>. </span><span class="cited-content_cbyCitation_article-title">Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2019,</strong> <em>145 </em>
                                    (5)
                                     , 1346-1357. <a href="https://doi.org/10.1002/ijc.32224" title="DOI URL">https://doi.org/10.1002/ijc.32224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.32224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.32224%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DRogaratinib%25253A%252BA%252Bpotent%252Band%252Bselective%252Bpan%2525E2%252580%252590FGFR%252Binhibitor%252Bwith%252Bbroad%252Bantitumor%252Bactivity%252Bin%252BFGFR%2525E2%252580%252590overexpressing%252Bpreclinical%252Bcancer%252Bmodels%26aulast%3DGr%25C3%25BCnewald%26aufirst%3DSylvia%26date%3D2019%26date%3D2019%26volume%3D145%26issue%3D5%26spage%3D1346%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sana  Raoof</span>, <span class="hlFld-ContribAuthor ">Iain J.  Mulford</span>, <span class="hlFld-ContribAuthor ">Heidie  Frisco-Cabanos</span>, <span class="hlFld-ContribAuthor ">Varuna  Nangia</span>, <span class="hlFld-ContribAuthor ">Daria  Timonina</span>, <span class="hlFld-ContribAuthor ">Emma  Labrot</span>, <span class="hlFld-ContribAuthor ">Nafeeza  Hafeez</span>, <span class="hlFld-ContribAuthor ">Samantha J.  Bilton</span>, <span class="hlFld-ContribAuthor ">Yotam  Drier</span>, <span class="hlFld-ContribAuthor ">Fei  Ji</span>, <span class="hlFld-ContribAuthor ">Max  Greenberg</span>, <span class="hlFld-ContribAuthor ">August  Williams</span>, <span class="hlFld-ContribAuthor ">Krystina  Kattermann</span>, <span class="hlFld-ContribAuthor ">Leah  Damon</span>, <span class="hlFld-ContribAuthor ">Sosathya  Sovath</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Rakiec</span>, <span class="hlFld-ContribAuthor ">Joshua M.  Korn</span>, <span class="hlFld-ContribAuthor ">David A.  Ruddy</span>, <span class="hlFld-ContribAuthor ">Cyril H.  Benes</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Zofia  Piotrowska</span>, <span class="hlFld-ContribAuthor ">Lecia V.  Sequist</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Niederst</span>, <span class="hlFld-ContribAuthor ">Jordi  Barretina</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Aaron N.  Hata</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2019,</strong> <em>38 </em>
                                    (37)
                                     , 6399-6413. <a href="https://doi.org/10.1038/s41388-019-0887-2" title="DOI URL">https://doi.org/10.1038/s41388-019-0887-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-019-0887-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-019-0887-2%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DTargeting%252BFGFR%252Bovercomes%252BEMT-mediated%252Bresistance%252Bin%252BEGFR%252Bmutant%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DRaoof%26aufirst%3DSana%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D37%26spage%3D6399%26epage%3D6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Marco  Gizzi</span>, <span class="hlFld-ContribAuthor ">Ratislav  Bahleda</span>, <span class="hlFld-ContribAuthor ">Yohann  Loriot</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Development of FGFR3 Inhibitors for the Treatment of Urothelial Cancer. </span><span class="cited-content_cbyCitation_journal-name">Bladder Cancer</span><span> <strong>2019,</strong> <em>5 </em>
                                    (2)
                                     , 87-102. <a href="https://doi.org/10.3233/BLC-180205" title="DOI URL">https://doi.org/10.3233/BLC-180205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/BLC-180205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FBLC-180205%26sid%3Dliteratum%253Aachs%26jtitle%3DBladder%2520Cancer%26atitle%3DClinical%252BDevelopment%252Bof%252BFGFR3%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BUrothelial%252BCancer%26aulast%3DIbrahim%26aufirst%3DTony%26date%3D2019%26volume%3D5%26issue%3D2%26spage%3D87%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pino  Bordignon</span>, <span class="hlFld-ContribAuthor ">Giulia  Bottoni</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Xu</span>, <span class="hlFld-ContribAuthor ">Alma S.  Popescu</span>, <span class="hlFld-ContribAuthor ">Zinnia  Truan</span>, <span class="hlFld-ContribAuthor ">Emmanuella  Guenova</span>, <span class="hlFld-ContribAuthor ">Lukas  Kofler</span>, <span class="hlFld-ContribAuthor ">Paris  Jafari</span>, <span class="hlFld-ContribAuthor ">Paola  Ostano</span>, <span class="hlFld-ContribAuthor ">Martin  Röcken</span>, <span class="hlFld-ContribAuthor ">Victor  Neel</span>, <span class="hlFld-ContribAuthor ">G. Paolo  Dotto</span>. </span><span class="cited-content_cbyCitation_article-title">Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>28 </em>
                                    (9)
                                     , 2358-2372.e6. <a href="https://doi.org/10.1016/j.celrep.2019.07.092" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.07.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.07.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.07.092%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DDualism%252Bof%252BFGF%252Band%252BTGF-%2525CE%2525B2%252BSignaling%252Bin%252BHeterogeneous%252BCancer-Associated%252BFibroblast%252BActivation%252Bwith%252BETV1%252Bas%252Ba%252BCritical%252BDeterminant%26aulast%3DBordignon%26aufirst%3DPino%26date%3D2019%26volume%3D28%26issue%3D9%26spage%3D2358%26epage%3D2372.e6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lipika  Goyal</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Leah Y.  Liu</span>, <span class="hlFld-ContribAuthor ">Ferran  Fece de la Cruz</span>, <span class="hlFld-ContribAuthor ">Jochen K.  Lennerz</span>, <span class="hlFld-ContribAuthor ">Srivatsan  Raghavan</span>, <span class="hlFld-ContribAuthor ">Ignaty  Leschiner</span>, <span class="hlFld-ContribAuthor ">Liudmila  Elagina</span>, <span class="hlFld-ContribAuthor ">Giulia  Siravegna</span>, <span class="hlFld-ContribAuthor ">Raymond W.S.  Ng</span>, <span class="hlFld-ContribAuthor ">Phuong  Vu</span>, <span class="hlFld-ContribAuthor ">Krushna C.  Patra</span>, <span class="hlFld-ContribAuthor ">Supriya K.  Saha</span>, <span class="hlFld-ContribAuthor ">Raul N.  Uppot</span>, <span class="hlFld-ContribAuthor ">Ron  Arellano</span>, <span class="hlFld-ContribAuthor ">Stephanie  Reyes</span>, <span class="hlFld-ContribAuthor ">Takeshi  Sagara</span>, <span class="hlFld-ContribAuthor ">Sachie  Otsuki</span>, <span class="hlFld-ContribAuthor ">Brandon  Nadres</span>, <span class="hlFld-ContribAuthor ">Heather A.  Shahzade</span>, <span class="hlFld-ContribAuthor ">Ipsita  Dey-Guha</span>, <span class="hlFld-ContribAuthor ">Isobel J.  Fetter</span>, <span class="hlFld-ContribAuthor ">Islam  Baiev</span>, <span class="hlFld-ContribAuthor ">Emily E.  Van Seventer</span>, <span class="hlFld-ContribAuthor ">Janet E.  Murphy</span>, <span class="hlFld-ContribAuthor ">Cristina R.  Ferrone</span>, <span class="hlFld-ContribAuthor ">Kenneth K.  Tanabe</span>, <span class="hlFld-ContribAuthor ">Vikram  Deshpande</span>, <span class="hlFld-ContribAuthor ">James J.  Harding</span>, <span class="hlFld-ContribAuthor ">Rona  Yaeger</span>, <span class="hlFld-ContribAuthor ">Robin K.  Kelley</span>, <span class="hlFld-ContribAuthor ">Alberto  Bardelli</span>, <span class="hlFld-ContribAuthor ">A. John  Iafrate</span>, <span class="hlFld-ContribAuthor ">William C.  Hahn</span>, <span class="hlFld-ContribAuthor ">Cyril H.  Benes</span>, <span class="hlFld-ContribAuthor ">David T.  Ting</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Hirai</span>, <span class="hlFld-ContribAuthor ">Gad  Getz</span>, <span class="hlFld-ContribAuthor ">Dejan  Juric</span>, <span class="hlFld-ContribAuthor ">Andrew X.  Zhu</span>, <span class="hlFld-ContribAuthor ">Ryan B.  Corcoran</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>. </span><span class="cited-content_cbyCitation_article-title">TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2019,</strong> <em>9 </em>
                                    (8)
                                     , 1064-1079. <a href="https://doi.org/10.1158/2159-8290.CD-19-0182" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-19-0182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-19-0182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-19-0182%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DTAS-120%252BOvercomes%252BResistance%252Bto%252BATP-Competitive%252BFGFR%252BInhibitors%252Bin%252BPatients%252Bwith%252BFGFR2%252BFusion%2525E2%252580%252593Positive%252BIntrahepatic%252BCholangiocarcinoma%26aulast%3DGoyal%26aufirst%3DLipika%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D8%26spage%3D1064%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>, <span class="hlFld-ContribAuthor ">Fanie R.  Van Heerden</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the distinct mechanistic binding and activity of 5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-3-(5-(4-methylpiperazin-1-yl)-1
              H
              -benzo[
              d
              ]imidazol-2-yl)-1
              H
              -indazole enantiomers against FGFR1. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2019,</strong> <em>21 </em>
                                    (27)
                                     , 15120-15132. <a href="https://doi.org/10.1039/C9CP02112D" title="DOI URL">https://doi.org/10.1039/C9CP02112D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP02112D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP02112D%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DRevealing%252Bthe%252Bdistinct%252Bmechanistic%252Bbinding%252Band%252Bactivity%252Bof%252B5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-3-%2525285-%2525284-methylpiperazin-1-yl%252529-1%252BH%252B-benzo%25255B%252Bd%252B%25255Dimidazol-2-yl%252529-1%252BH%252B-indazole%252Benantiomers%252Bagainst%252BFGFR1%26aulast%3DFarrokhzadeh%26aufirst%3DAbdolkarim%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D27%26spage%3D15120%26epage%3D15132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Roberto  Velazquez</span>, <span class="hlFld-ContribAuthor ">Hongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Lukas Manuel  Dunkl</span>, <span class="hlFld-ContribAuthor ">Malika  Kazic-Legueux</span>, <span class="hlFld-ContribAuthor ">Anne  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Eric  Billy</span>, <span class="hlFld-ContribAuthor ">Eusebio  Manchado</span>, <span class="hlFld-ContribAuthor ">Saskia M.  Brachmann</span>, <span class="hlFld-ContribAuthor ">Susan E.  Moody</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (7)
                                     , 1323-1334. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0852" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0852%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSHP2%252BInhibition%252BOvercomes%252BRTK-Mediated%252BPathway%252BReactivation%252Bin%252BKRAS-Mutant%252BTumors%252BTreated%252Bwith%252BMEK%252BInhibitors%26aulast%3DLu%26aufirst%3DHengyu%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D7%26spage%3D1323%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuichi  Takashi</span>, <span class="hlFld-ContribAuthor ">Hidetaka  Kosako</span>, <span class="hlFld-ContribAuthor ">Shun  Sawatsubashi</span>, <span class="hlFld-ContribAuthor ">Yuka  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Ito</span>, <span class="hlFld-ContribAuthor ">Maria K.  Tsoumpra</span>, <span class="hlFld-ContribAuthor ">Masaomi  Nangaku</span>, <span class="hlFld-ContribAuthor ">Masahiro  Abe</span>, <span class="hlFld-ContribAuthor ">Munehide  Matsuhisa</span>, <span class="hlFld-ContribAuthor ">Shigeaki  Kato</span>, <span class="hlFld-ContribAuthor ">Toshio  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Seiji  Fukumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (23)
                                     , 11418-11427. <a href="https://doi.org/10.1073/pnas.1815166116" title="DOI URL">https://doi.org/10.1073/pnas.1815166116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1815166116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1815166116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DActivation%252Bof%252Bunliganded%252BFGF%252Breceptor%252Bby%252Bextracellular%252Bphosphate%252Bpotentiates%252Bproteolytic%252Bprotection%252Bof%252BFGF23%252Bby%252Bits%252BO-glycosylation%26aulast%3DTakashi%26aufirst%3DYuichi%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D23%26spage%3D11418%26epage%3D11427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuyan  Dai</span>, <span class="hlFld-ContribAuthor ">Zhan  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhuchu  Chen</span>, <span class="hlFld-ContribAuthor ">Guangyu  Xu</span>, <span class="hlFld-ContribAuthor ">Yongheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (6)
                                     , 614. <a href="https://doi.org/10.3390/cells8060614" title="DOI URL">https://doi.org/10.3390/cells8060614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8060614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8060614%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DFibroblast%252BGrowth%252BFactor%252BReceptors%252B%252528FGFRs%252529%25253A%252BStructures%252Band%252BSmall%252BMolecule%252BInhibitors%26aulast%3DDai%26aufirst%3DShuyan%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D6%26spage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Avick Kumar  Ghosh</span>, <span class="hlFld-ContribAuthor ">Indranil  Samanta</span>, <span class="hlFld-ContribAuthor ">Anushree  Mondal</span>, <span class="hlFld-ContribAuthor ">Wenshe Ray  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Inhibition in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 889-906. <a href="https://doi.org/10.1002/cmdc.201900107" title="DOI URL">https://doi.org/10.1002/cmdc.201900107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900107%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCovalent%252BInhibition%252Bin%252BDrug%252BDiscovery%26aulast%3DGhosh%26aufirst%3DAvick%2BKumar%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D889%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Alhalabi</span>, <span class="hlFld-ContribAuthor ">Hind  Rafei</span>, <span class="hlFld-ContribAuthor ">Amishi  Shah</span>, <span class="hlFld-ContribAuthor ">Arlene  Siefker-Radtke</span>, <span class="hlFld-ContribAuthor ">Matthew  Campbell</span>, <span class="hlFld-ContribAuthor ">Jianjun  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting advanced urothelial carcinoma-developing strategies. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Oncology</span><span> <strong>2019,</strong> <em>31 </em>
                                    (3)
                                     , 207-215. <a href="https://doi.org/10.1097/CCO.0000000000000532" title="DOI URL">https://doi.org/10.1097/CCO.0000000000000532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CCO.0000000000000532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCCO.0000000000000532%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Oncology%26atitle%3DTargeting%252Badvanced%252Burothelial%252Bcarcinoma-developing%252Bstrategies%26aulast%3DAlhalabi%26aufirst%3DOmar%26date%3D2019%26volume%3D31%26issue%3D3%26spage%3D207%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Chun-Han  Chen</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel 7
              H
              -pyrrolo-[2,3-
              d
              ]pyrimidine derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (9)
                                     , 959-974. <a href="https://doi.org/10.4155/fmc-2018-0564" title="DOI URL">https://doi.org/10.4155/fmc-2018-0564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0564%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B7%252BH%252B-pyrrolo-%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYi-Min%26date%3D2019%26volume%3D11%26issue%3D9%26spage%3D959%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Behzad  Jafari</span>, <span class="hlFld-ContribAuthor ">Maryam  Hamzeh-Mivehroud</span>, <span class="hlFld-ContribAuthor ">Michael B.  Morris</span>, <span class="hlFld-ContribAuthor ">Siavoush  Dastmalchi</span>. </span><span class="cited-content_cbyCitation_article-title">Exploitation of phage display for the development of anti-cancer agents targeting fibroblast growth factor signaling pathways: New strategies to tackle an old challenge. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2019,</strong> <em>46 </em>, 54-65. <a href="https://doi.org/10.1016/j.cytogfr.2019.03.002" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2019.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2019.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2019.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DExploitation%252Bof%252Bphage%252Bdisplay%252Bfor%252Bthe%252Bdevelopment%252Bof%252Banti-cancer%252Bagents%252Btargeting%252Bfibroblast%252Bgrowth%252Bfactor%252Bsignaling%252Bpathways%25253A%252BNew%252Bstrategies%252Bto%252Btackle%252Ban%252Bold%252Bchallenge%26aulast%3DJafari%26aufirst%3DBehzad%26date%3D2019%26volume%3D46%26spage%3D54%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm2006222&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm2006222%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-20%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=281&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of nonspecific FGFR inhibitors in clinical development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Pseudo ring concept applied to the design of the <i>N</i>-pyrimidin-4-yl-urea motif. (B) Prototype compound <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structure of compound <b>3</b> (PD173074).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Growth kinetics of orthotopically growing RT112/luc1 bladder cancer cells. Tumor burden was monitored by measuring light emission after intravenous injection of <span class="smallcaps smallerCapital">d</span>-luciferin. Representative Xenogen IVIS images from 1, 5, 13, 22, 29, and 34 days after inoculation. One animal (top right in each frame) was inoculated subcutaneously for comparison. The pseudocolor gradient of each image has been adjusted to the same scale (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Orthotopically growing RT112/luc1 bladder tumors dissected 34 days after inoculation. Left: Three tumor-filled bladders dissected from RT112/luc1 bladder tumor carrying mice. A noninoculated normal bladder (WT) is shown for comparison. Right: Histology of a representative tumor invading through the bladder wall.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tumors were established in female HsdNpa: Athymic Nude-nu  mice by orthotopic inoculation of 5 × 10<sup>5</sup> cells per animal. Daily treatment with compound <b>1h</b> administered orally as a suspension in PEG300/D5W (2:1, v/v) at 0, 10, and 30 mg/kg was initiated 14 days after inoculation. (A) Light emission from tumor bearing animals during 12 days treatment as a measure of tumor burden. (B) Body weight measurements during the treatment. Data are presented as means ± SEM *<i>p</i> < 0.05; ANOVA post hoc Dunnett’s versus vehicle treated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Antitumor activity of compound <b>1h</b> against RT112 human bladder cancer xenografts implanted subcutaneously in immuno-compromised, female Rowett rats. (B) Body weight measurements during the treatment. Data are presented as means ± SEM *<i>p</i> < 0.05, ***<i>p</i> < 0.001; ANOVA post hoc Dunnett’s versus vehicle treated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. RT112 xenograft tumors were dissected at the indicated time points postdosing (<i>n</i> = 4), lysed, and analyzed by Western blot for concentration of <b>1h</b>, FRS2 Tyr-phosphorylation (pFRS2), and MAPK activation (pMAPK). Protein loading was monitored by analyzing the lysates for total FRS2 protein, total MAPK protein, or β-tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of <b>1h</b> treatment on the capsule weight and Tie-2 levels in bFGF (A) or VEGF (B) containing porous chambers implanted subcutaneously in the flank of FVB mice. Animals were treated orally either with <b>1h</b> at 10, 30, and 50 mg/kg or vehicle (NMP/PEG300 10%, 5 mL/kg) starting 4–6 h before implantation of the chambers and daily for 3 additional days. Values are mean ± SEM *<i>p</i> < 0.05, statistical significance of inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Binding model of <b>1h</b> to the FGFR3 kinase domain homology model showing interacting residues. Hydrogen bonds are indicated by turquoise dashes. (B) Summary of the interactions of <b>1h</b> within the ATP binding site of FGFR3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. X-ray structure of the <b>1h</b>–FGFR1 complex (RCSB ID: rcsb067881. PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI">3TT0</a>). Hydrogen bonds are indicated by pale cyan circles.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of <i>N</i>-Aryl-<i>N</i>′-pyrimidin-4-yl Ureas<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>NH<sub>2</sub>, 25% NH<sub>3</sub> in H<sub>2</sub>O, 33% MeNH<sub>2</sub> in EtOH or 70% EtNH<sub>2</sub> in H<sub>2</sub>O, <i>i</i>-PrOH, RT; (b) R<sub>2</sub>NH<sub>2</sub> (<b>8</b>–<b>15</b>), CH<sub>3</sub>COOH/H<sub>2</sub>O, 100 °C or 4 N HCl in dioxane, 150 °C; (c) 20% COCl<sub>2</sub> in toluene, dioxane, reflux; (d) toluene, 70 °C or reflux.</p></p></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of anilines <b>8</b>, <b>10</b>, <b>15</b>, and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Anilines <b>9</b>, <b>11</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (A) (a) 80 °C, 15 h (89%); (b) Raney Ni, H<sub>2</sub>, MeOH, 25 °C, 7 h (98%). (B) (a) NaOH, DMF, 75 °C, 2 h (92%). (C) (a) (<i>t</i>-Bu)<sub>3</sub>P, Pd(PhCN)<sub>2</sub>Cl<sub>2</sub>, CuI, dioxane, 25 °C, 22 h (90%); (b) 10% Pd on carbon, H<sub>2</sub>, EtOH, 25 °C, 22 h (68%). (D) (a) H<sub>2</sub>SO<sub>4</sub>, HNO<sub>3</sub>, CH<sub>3</sub>COOH (47%); (b) CH<sub>3</sub>CHO, Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, 5 °C, 1 h (70%); (c) 10% Pd on carbon, H<sub>2</sub>, EtOH, 25 °C, 3 h (33%). (E) (a) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 15 h (100%); (b) Raney Ni, H<sub>2</sub>, MeOH, 25 °C, 5 h (84%).</p></p></figure><figure data-id="sch3" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Anilines <b>27</b> and <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) acetic anhydride, toluene, 25 °C (97%); (b) sodium chlorate, acetic acid, 32% HCl (in H<sub>2</sub>O), 0 °C (47%); (c) SO<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, 0 °C (58%); (d) 2 N KOH, ethanol (<b>27</b>, 100%; <b>30</b>, 92%).</p></p></figure><figure data-id="sch4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/medium/jm-2011-006222_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aniline <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-20/jm2006222/production/images/large/jm-2011-006222_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2006222&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) dimethyl sulfate, KOH, acetone, 25 °C (91%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Beenken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span> </span><span class="NLM_article-title">The FGF family: biology, pathophysiology and therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=235-253&author=A.+Beenkenauthor=M.+Mohammadi&title=The+FGF+family%3A+biology%2C+pathophysiology+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeenken%26aufirst%3DA.%26aulast%3DMohammadi%26aufirst%3DM.%26atitle%3DThe%2520FGF%2520family%253A%2520biology%252C%2520pathophysiology%2520and%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D235%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Turner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grose, R.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor signalling: from development to cancer</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1038%2Fnrc2780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=20094046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Gktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=116-129&author=N.+Turnerauthor=R.+Grose&title=Fibroblast+growth+factor+signalling%3A+from+development+to+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor signalling: from development to cancer</span></div><div class="casAuthors">Turner, Nicholas; Grose, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fibroblast growth factors (FGFs) and their receptors control a wide range of biol. functions, regulating cellular proliferation, survival, migration and differentiation.  Although targeting FGF signalling as a cancer therapeutic target has lagged behind that of other receptor tyrosine kinases, there is now substantial evidence for the importance of FGF signalling in the pathogenesis of diverse tumor types, and clin. reagents that specifically target the FGFs or FGF receptors are being developed.  Although FGF signalling can drive tumorigenesis, in different contexts FGF signalling can mediate tumor protective functions; the identification of the mechanisms that underlie these differential effects will be important to understand how FGF signalling can be most appropriately therapeutically targeted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUBfz6uAu97bVg90H21EOLACvtfcHk0litXRUYMeYnZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Gktg%253D%253D&md5=7963bc75c149981560dffc8d91b4aaf1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2780%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DN.%26aulast%3DGrose%26aufirst%3DR.%26atitle%3DFibroblast%2520growth%2520factor%2520signalling%253A%2520from%2520development%2520to%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D116%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Walz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt-Graeff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hehlmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, A.</span><span> </span><span class="NLM_article-title">The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1005-1009&author=C.+Walzauthor=A.+Chaseauthor=C.+Schochauthor=A.+Weisserauthor=F.+Schlegelauthor=A.+Hochhausauthor=R.+Fuchsauthor=A.+Schmitt-Graeffauthor=R.+Hehlmannauthor=N.+C.+P.+Crossauthor=A.+Reiter&title=The+t%288%3B17%29%28p11%3Bq23%29+in+the+8p11+myeloproliferative+syndrome+fuses+MYO18A+to+FGFR1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalz%26aufirst%3DC.%26aulast%3DChase%26aufirst%3DA.%26aulast%3DSchoch%26aufirst%3DC.%26aulast%3DWeisser%26aufirst%3DA.%26aulast%3DSchlegel%26aufirst%3DF.%26aulast%3DHochhaus%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DR.%26aulast%3DSchmitt-Graeff%26aufirst%3DA.%26aulast%3DHehlmann%26aufirst%3DR.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26aulast%3DReiter%26aufirst%3DA.%26atitle%3DThe%2520t%25288%253B17%2529%2528p11%253Bq23%2529%2520in%2520the%25208p11%2520myeloproliferative%2520syndrome%2520fuses%2520MYO18A%2520to%2520FGFR1%26jtitle%3DLeukemia%26date%3D2005%26volume%3D19%26spage%3D1005%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Belloni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trubia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapinassi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuciforo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo-Coco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, P. P.</span><span> </span><span class="NLM_article-title">8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.20144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=15609342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Cnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=320-325&author=E.+Belloniauthor=M.+Trubiaauthor=P.+Gaspariniauthor=C.+Micucciauthor=C.+Tapinassiauthor=S.+Confalonieriauthor=P.+Nuciforoauthor=B.+Martinoauthor=F.+Lo-Cocoauthor=P.+G.+Pelicciauthor=P.+P.+Di+Fiore&title=8p11+myeloproliferative+syndrome+with+a+novel+t%287%3B8%29+translocation+leading+to+fusion+of+the+FGFR1+and+TIF1+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes</span></div><div class="casAuthors">Belloni, Elena; Trubia, Maurizio; Gasparini, Patrizia; Micucci, Carla; Tapinassi, Cinzia; Confalonieri, Stefano; Nuciforo, Paolo; Martino, Bruno; Lo-Coco, Francesco; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-325</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">8P11 myeloproliferative syndrome (EMS) is a clin.-pathol. entity characterized by rearrangements involving the FGFR1 gene, which encodes a receptor tyrosine kinase.  These rearrangements invariably lead to aberrant fusion proteins in which the kinase activity is constitutively turned on, with resulting oncogenic properties.  In this article, authors describe a new translocation in EMS, t(7;8)(q34;p11), in which the FGFR1 gene is fused to a previously unidentified partner, the TIF1 gene.  Authors show that both the TIF1-FGFR1 and FGFR1-TIF1 fusion proteins have the potential to be translated as a result of the translocation.  Thus, these data extend the involvement of FGFR1 in EMS and lend support to the concept that there is a precise correlation between genotype and phenotype in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJAFwc0c3bmbVg90H21EOLACvtfcHk0lgwUq6Q8N1BOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Cnsb8%253D&md5=10eed7238eb11f51f1de9a926058aa0d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20144%26sid%3Dliteratum%253Aachs%26aulast%3DBelloni%26aufirst%3DE.%26aulast%3DTrubia%26aufirst%3DM.%26aulast%3DGasparini%26aufirst%3DP.%26aulast%3DMicucci%26aufirst%3DC.%26aulast%3DTapinassi%26aufirst%3DC.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DNuciforo%26aufirst%3DP.%26aulast%3DMartino%26aufirst%3DB.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26aulast%3DDi%2BFiore%26aufirst%3DP.%2BP.%26atitle%3D8p11%2520myeloproliferative%2520syndrome%2520with%2520a%2520novel%2520t%25287%253B8%2529%2520translocation%2520leading%2520to%2520fusion%2520of%2520the%2520FGFR1%2520and%2520TIF1%2520genes%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2005%26volume%3D42%26spage%3D320%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Roumiantsev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitri, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asiedu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span> </span><span class="NLM_article-title">Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=287-298&author=S.+Roumiantsevauthor=D.+S.+Krauseauthor=C.+A.+Neumannauthor=C.+A.+Dimitriauthor=F.+Asieduauthor=N.+C.+P.+Crossauthor=R.+A.+Van+Etten&title=Distinct+stem+cell+myeloproliferative%2FT+lymphoma+syndromes+induced+by+ZNF198-FGFR1+and+BCR-FGFR1+fusion+genes+from+8p11+translocations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoumiantsev%26aufirst%3DS.%26aulast%3DKrause%26aufirst%3DD.%2BS.%26aulast%3DNeumann%26aufirst%3DC.%2BA.%26aulast%3DDimitri%26aufirst%3DC.%2BA.%26aulast%3DAsiedu%26aufirst%3DF.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26atitle%3DDistinct%2520stem%2520cell%2520myeloproliferative%252FT%2520lymphoma%2520syndromes%2520induced%2520by%2520ZNF198-FGFR1%2520and%2520BCR-FGFR1%2520fusion%2520genes%2520from%25208p11%2520translocations%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D287%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Grand, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscier, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span> </span><span class="NLM_article-title">Identification of a novel gene, FGFR10P2, fused to FGFR1 in 8p11 myeloproliferative syndrome</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.20023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=15034873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslCqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=78-83&author=E.+K.+Grandauthor=F.+H.+Grandauthor=A.+J.+Chaseauthor=F.+M.+Rossauthor=M.+M.+Corcoranauthor=D.+G.+Oscierauthor=N.+C.+P.+Cross&title=Identification+of+a+novel+gene%2C+FGFR10P2%2C+fused+to+FGFR1+in+8p11+myeloproliferative+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel gene, FGFR10P2, fused to FGFR1 in 8p11 myeloproliferative syndrome</span></div><div class="casAuthors">Grand, Effie K.; Grand, Francis H.; Chase, Andrew J.; Ross, Fiona M.; Corcoran, Martin M.; Oscier, David G.; Cross, Nicholas C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-83</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The 8p11 myeloproliferative syndrome (EMS) is an aggressive hematol. malignancy caused by the fusion of diverse partner genes to fibroblast growth factor receptor 1 (FGFR1).  The partner proteins promote dimerization and ligand-independent activation of FGFR1-encoded tyrosine kinase, deregulating hemopoiesis in a manner analogous to BCR-ABL in chronic myeloid leukemia.  Here, the authors describe the identification of a new FGFR1 fusion gene in a patient who presented with T-cell lymphoblastic lymphoma in conjunction with an acquired ins(12;8)(p11;p11p22).  Initial FISH anal. and Southern :blotting confirmed that FGFR1 was disrupted.  Using 5'-RACE PCR, we identified part of a novel gene, FGFR1OP, at chromosome band 12p11 that was fused to exon 9 of FGFR1.  FGFR1OP2 is predicted to be translated into an evolutionarily conserved protein contg. coiled-coil domains but no other recognizable motifs.  The presence of the chimeric gene was confirmed by RT-PCR, genomic DNA PCR, and FISH.  These data further support the central role of deregulated FGFR1 in the pathogenesis of EMS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMM7rk-elQQLVg90H21EOLACvtfcHk0lgwUq6Q8N1BOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslCqtL0%253D&md5=dd9d52bfb44a018bbc898699bb09bc65</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20023%26sid%3Dliteratum%253Aachs%26aulast%3DGrand%26aufirst%3DE.%2BK.%26aulast%3DGrand%26aufirst%3DF.%2BH.%26aulast%3DChase%26aufirst%3DA.%2BJ.%26aulast%3DRoss%26aufirst%3DF.%2BM.%26aulast%3DCorcoran%26aufirst%3DM.%2BM.%26aulast%3DOscier%26aufirst%3DD.%2BG.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26atitle%3DIdentification%2520of%2520a%2520novel%2520gene%252C%2520FGFR10P2%252C%2520fused%2520to%2520FGFR1%2520in%25208p11%2520myeloproliferative%2520syndrome%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2004%26volume%3D40%26spage%3D78%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sohal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mould, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welborn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montefusco, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinclair, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Den Berg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanstraelen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, N. C. P.</span><span> </span><span class="NLM_article-title">Identification of four new translocations involving FGFRI in myeloid disorders</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.1177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=11550283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnt1Skt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=155-163&author=J.+Sohalauthor=A.+Chaseauthor=S.+Mouldauthor=M.+Corcoranauthor=D.+Oscierauthor=S.+Iqbalauthor=S.+Parkerauthor=J.+Welbornauthor=R.+I.+Harrisauthor=G.+Martinelliauthor=V.+Montefuscoauthor=P.+Sinclairauthor=B.+S.+Wilkinsauthor=H.+Van+Den+Bergauthor=D.+Vanstraelenauthor=J.+M.+Goldmanauthor=N.+C.+P.+Cross&title=Identification+of+four+new+translocations+involving+FGFRI+in+myeloid+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of four new translocations involving FGFRI in myeloid disorders</span></div><div class="casAuthors">Sohal, Jastinder; Chase, Andrew; Mould, Sarah; Corcoran, Martin; Oscier, David; Iqbal, Sameena; Parker, Sally; Welborn, Jeanna; Harris, Richard I.; Martinelli, Giovanni; Montefusco, Vittorio; Sinclair, Paul; Wilkins, Bridget S.; Van Den Berg, Henk; Vanstraelen, Danny; Goldman, John M.; Cross, Nicholas C. P.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The 8p11 myeloproliferative syndrome (EMS) is assocd. with three translocations, t(8;13)(p11;q12), t(8;9)(p11;q33), and t(6;8)(q27;p11), that fuse unrelated genes (ZNF198, CEP110, and FOP, resp.) to the entire tyrosine kinase domain of FGFRI.  In all cases thus far examd. (n = 10), the t(8;13) results in an identical mRNA fusion between ZNF198 exon 17 and FGFRI exon 9.  To det. if consistent fusions are also seen in the variant translocations, the authors performed RT-PCR on four cases and sequenced the products.  For two patients with a t(8;9), the authors found that CEP110 exon 15 was fused to FGFRI exon 9.  For two patients with a t(6;8), the authors found that FOP exon 5 (n = 1) or exon 7 (n = 1) was fused to FGFRI exon 9.  To det. if FGFRI might be involved in other myeloid disorders with translocations of 8p, the authors developed a two-color FISH assay using two differentially labeled PAC clones that flank FGFRI.  Disruption of this gene was indicated in a patient with a t(8;17)(p11;q25) and Ph-neg. chronic myeloid leukemia in assocn. with systemic malignant mast cell disease, a patient with acute myeloid leukemia with a t(8;11)(p11;p15), and two cases with T-cell lymphoma, myeloproliferative disorder, and marrow eosinophilia with a t(8;12)(p11;q15) and ins(12;8)(p11;p11p21), resp.  For the patient with the t(8;11), the chromosome 11 breakpoint was detd. to be in the vicinity of NUP98.  The authors conclude that 1) all mRNA fusions in EMS result in splicing to FGFRI exon 9 but breakpoints in FOP are variable, 2) two-color FISH can identify patients with EMS, and 3) the t(8;17)(p11;q25).  T(8;11)(p11;p15), t(8;12)(p11;q15), and ins(12;8)(p11;p11p21) are novel karyotypic changes that most likely involve FGFRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6aAENbhw7LVg90H21EOLACvtfcHk0lgwUq6Q8N1BOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnt1Skt7g%253D&md5=2303ea2f1ccacce9f3ebce78b1e72242</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fgcc.1177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.1177%26sid%3Dliteratum%253Aachs%26aulast%3DSohal%26aufirst%3DJ.%26aulast%3DChase%26aufirst%3DA.%26aulast%3DMould%26aufirst%3DS.%26aulast%3DCorcoran%26aufirst%3DM.%26aulast%3DOscier%26aufirst%3DD.%26aulast%3DIqbal%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DS.%26aulast%3DWelborn%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DR.%2BI.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DMontefusco%26aufirst%3DV.%26aulast%3DSinclair%26aufirst%3DP.%26aulast%3DWilkins%26aufirst%3DB.%2BS.%26aulast%3DVan%2BDen%2BBerg%26aufirst%3DH.%26aulast%3DVanstraelen%26aufirst%3DD.%26aulast%3DGoldman%26aufirst%3DJ.%2BM.%26aulast%3DCross%26aufirst%3DN.%2BC.%2BP.%26atitle%3DIdentification%2520of%2520four%2520new%2520translocations%2520involving%2520FGFRI%2520in%2520myeloid%2520disorders%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2001%26volume%3D32%26spage%3D155%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Popovici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ollendorff, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaffanet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guasch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacrot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pebusque, M.-J.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">5712</span><span class="NLM_x">–</span> <span class="NLM_lpage">5717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=5712-5717&author=C.+Popoviciauthor=J.+Adelaideauthor=V.+Ollendorffauthor=M.+Chaffanetauthor=G.+Guaschauthor=M.+Jacrotauthor=D.+Lerouxauthor=D.+Birnbaumauthor=M.-J.+Pebusque&title=Fibroblast+growth+factor+receptor+1+is+fused+to+FIM+in+stem-cell+myeloproliferative+disorder+with+t%288%3B13%29%28p12%3Bq12%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici%26aufirst%3DC.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DOllendorff%26aufirst%3DV.%26aulast%3DChaffanet%26aufirst%3DM.%26aulast%3DGuasch%26aufirst%3DG.%26aulast%3DJacrot%26aufirst%3DM.%26aulast%3DLeroux%26aufirst%3DD.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DPebusque%26aufirst%3DM.-J.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25201%2520is%2520fused%2520to%2520FIM%2520in%2520stem-cell%2520myeloproliferative%2520disorder%2520with%2520t%25288%253B13%2529%2528p12%253Bq12%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D5712%26epage%3D5717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Regenass, U; Caravatti, G.; Fredenhagen, A.; Wacker, O.</span>Patent WO9532975,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Regenass%2C+U%3B+Caravatti%2C+G.%3B+Fredenhagen%2C+A.%3B+Wacker%2C+O.Patent+WO9532975%2C+1995."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRegenass%26aufirst%3DU%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadleigh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duclos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelsperger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerji, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">14479</span><span class="NLM_x">–</span> <span class="NLM_lpage">14484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=14479-14484&author=J.+Chenauthor=D.+J.+DeAngeloauthor=J.+L.+Kutokauthor=I.+R.+Williamsauthor=B.+H.+Leeauthor=M.+Wadleighauthor=N.+Duclosauthor=S.+Cohenauthor=J.+Adelspergerauthor=R.+Okabeauthor=A.+Coburnauthor=I.+Galinskyauthor=B.+Huntlyauthor=P.+S.+Cohenauthor=T.+Meyerauthor=D.+Fabbroauthor=J.+Roeselauthor=L.+Banerjiauthor=J.+D.+Griffinauthor=S.+Xiaoauthor=J.+A.+Fletcherauthor=R.+M.+Stoneauthor=D.+G.+Gilliland&title=PKC412+inhibits+the+zinc+finger+198-fibroblast+growth+factor+receptor+1+fusion+tyrosine+kinase+and+is+active+in+treatment+of+stem+cell+myeloproliferative+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DWadleigh%26aufirst%3DM.%26aulast%3DDuclos%26aufirst%3DN.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DAdelsperger%26aufirst%3DJ.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DCoburn%26aufirst%3DA.%26aulast%3DGalinsky%26aufirst%3DI.%26aulast%3DHuntly%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DP.%2BS.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DRoesel%26aufirst%3DJ.%26aulast%3DBanerji%26aufirst%3DL.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DPKC412%2520inhibits%2520the%2520zinc%2520finger%2520198-fibroblast%2520growth%2520factor%2520receptor%25201%2520fusion%2520tyrosine%2520kinase%2520and%2520is%2520active%2520in%2520treatment%2520of%2520stem%2520cell%2520myeloproliferative%2520disorder%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D14479%26epage%3D14484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Yagasaki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murohashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniwaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, M.</span><span> </span><span class="NLM_article-title">Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8371</span><span class="NLM_x">–</span> <span class="NLM_lpage">8374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8371-8374&author=F.+Yagasakiauthor=D.+Wakaoauthor=Y.+Yokoyamaauthor=Y.+Uchidaauthor=I.+Murohashiauthor=H.+Kayanoauthor=M.+Taniwakiauthor=A.+Matsudaauthor=M.+Bessho&title=Fusion+of+ETV6+to+fibroblast+growth+factor+receptor+3+in+peripheral+T-cell+lymphoma+with+a+t%284%3B12%29%28p16%3Bp13%29+chromosomal+translocation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYagasaki%26aufirst%3DF.%26aulast%3DWakao%26aufirst%3DD.%26aulast%3DYokoyama%26aufirst%3DY.%26aulast%3DUchida%26aufirst%3DY.%26aulast%3DMurohashi%26aufirst%3DI.%26aulast%3DKayano%26aufirst%3DH.%26aulast%3DTaniwaki%26aufirst%3DM.%26aulast%3DMatsuda%26aufirst%3DA.%26aulast%3DBessho%26aufirst%3DM.%26atitle%3DFusion%2520of%2520ETV6%2520to%2520fibroblast%2520growth%2520factor%2520receptor%25203%2520in%2520peripheral%2520T-cell%2520lymphoma%2520with%2520a%2520t%25284%253B12%2529%2528p16%253Bp13%2529%2520chromosomal%2520translocation%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8371%26epage%3D8374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brents, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrock, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ried, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehl, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergsagel, P. L.</span><span> </span><span class="NLM_article-title">Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1038%2Fng0797-260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=9207791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK2sXktFGjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=260-264&author=M.+Chesiauthor=E.+Nardiniauthor=L.+A.+Brentsauthor=E.+Schrockauthor=T.+Riedauthor=W.+M.+Kuehlauthor=P.+L.+Bergsagel&title=Frequent+translocation+t%284%3B14%29%28p16.3%3Bq32.3%29+in+multiple+myeloma+is+associated+with+increased+expression+and+activating+mutations+of+fibroblast+growth+factor+receptor+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3</span></div><div class="casAuthors">Chesi, Marta; Nardini, Elena; Brents, Leslie A.; Schrock, Evelin; Ried, Thomas; Kuehl, W. Michael; Bergsagel, P. Leif</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">260-264</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Dysregulation of oncogenes by translocation to the IgH locus (14q32) is a seminal event in the pathogenesis of B-cell tumors.  In multiple myeloma (MM), translocations to the IgH locus have been reported at an incidence of 20-60%.  For most translocations, the partner chromosome is unknown (14q+); for the others, a diverse array of chromosomal partners have been identified, with 11q13 (cyclin D1) the only chromosome that is frequently involved.  Recently, we developed a Southern-blot assay that detects translocation breakpoint fragments in most MM tumors, including those with no translocation detected by conventional karyotyping.  In a continuing anal. of translocations in 21 myeloma cell lines and primary tumors, we show that the novel, karyotypically silent translocation t(4;14)(p16.3;q32.3) is present in five lines and at least three of ten primary tumors.  The chromosome-4 breakpoints are clustered in a 70-kb region centromeric to the fibroblast growth factor receptor 3 gene (FGFR3), the apparent dysregulated oncogene.  Two lines and one primary tumor with this translocation selectively express an FGFR3 allele contg. activating mutations identified previously in thanatophoric dwarfism.  We propose that after the t(4;14) translocation, somatic mutation during tumor progression frequently generates an FGFR3 protein that is active in the absence of ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojH58PJMxq5bVg90H21EOLACvtfcHk0lgFcrLHtk8UJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFGjsrc%253D&md5=edb81448dfdac30ce0be3b67686bd5b6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fng0797-260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0797-260%26sid%3Dliteratum%253Aachs%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DNardini%26aufirst%3DE.%26aulast%3DBrents%26aufirst%3DL.%2BA.%26aulast%3DSchrock%26aufirst%3DE.%26aulast%3DRied%26aufirst%3DT.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26atitle%3DFrequent%2520translocation%2520t%25284%253B14%2529%2528p16.3%253Bq32.3%2529%2520in%2520multiple%2520myeloma%2520is%2520associated%2520with%2520increased%2520expression%2520and%2520activating%2520mutations%2520of%2520fibroblast%2520growth%2520factor%2520receptor%25203%26jtitle%3DNature%2520Genet.%26date%3D1997%26volume%3D16%26spage%3D260%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Richelda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronchetti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viggiano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiolo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, A.</span><span> </span><span class="NLM_article-title">A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">4062</span><span class="NLM_x">–</span> <span class="NLM_lpage">4070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=4062-4070&author=R.+Richeldaauthor=D.+Ronchettiauthor=L.+Baldiniauthor=L.+Croauthor=L.+Viggianoauthor=R.+Marzellaauthor=M.+Rocchiauthor=T.+Otsukiauthor=L.+Lombardiauthor=A.+T.+Maioloauthor=A.+Neri&title=A+novel+chromosomal+translocation+t%284%3B14%29%28p16.3%3Bq32%29+in+multiple+myeloma+involves+the+fibroblast+growth-factor+receptor+3+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichelda%26aufirst%3DR.%26aulast%3DRonchetti%26aufirst%3DD.%26aulast%3DBaldini%26aufirst%3DL.%26aulast%3DCro%26aufirst%3DL.%26aulast%3DViggiano%26aufirst%3DL.%26aulast%3DMarzella%26aufirst%3DR.%26aulast%3DRocchi%26aufirst%3DM.%26aulast%3DOtsuki%26aufirst%3DT.%26aulast%3DLombardi%26aufirst%3DL.%26aulast%3DMaiolo%26aufirst%3DA.%2BT.%26aulast%3DNeri%26aufirst%3DA.%26atitle%3DA%2520novel%2520chromosomal%2520translocation%2520t%25284%253B14%2529%2528p16.3%253Bq32%2529%2520in%2520multiple%2520myeloma%2520involves%2520the%2520fibroblast%2520growth-factor%2520receptor%25203%2520gene%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D4062%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Intini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maiolo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, A.</span><span> </span><span class="NLM_article-title">Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1046%2Fj.1365-2141.2001.02957.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=11529856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVyhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2001&pages=362-364&author=D.+Intiniauthor=L.+Baldiniauthor=S.+Fabrisauthor=L.+Lombardiauthor=G.+Ciceriauthor=A.+T.+Maioloauthor=A.+Neri&title=Analysis+of+FGFR3+gene+mutations+in+multiple+myeloma+patients+with+t%284%3B14%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)</span></div><div class="casAuthors">Intini, Daniela; Baldini, Luca; Fabris, Sonia; Lombardi, Luigia; Ciceri, Gabriella; Maiolo, Anna Teresa; Neri, Antonino</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">362-364</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The t(4;14)(p16.3;q32) in multiple myeloma (MM) leads to an apparent deregulation of the FGFR3 and WHSC1/MMSET genes.  FGFR3 mutations, known to be assocd. with genetic skeletal disorders, have also been identified in a few cases of MM (mainly cell lines) with t(4;14).  We investigated FGFR3 mutations in a series of 53 MM cases; 11 cases with t(4;14) and FGFR3 overexpression were analyzed using reverse transcription polymerase chain reaction, while the remaining cases were studied at DNA level.  The Arg248Cys mutation, which is assocd. with some lethal forms of skeletal disorders, was found in one case with t(4;14).  Our results indicate that FGFR3 mutations occur in only a small fraction of MM cases with t(4;14).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRMVl9Xjk57Vg90H21EOLACvtfcHk0lh0ywvlltUXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVyhu7o%253D&md5=66b3052d3f7a6909381b35cc8bb49cab</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2141.2001.02957.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2141.2001.02957.x%26sid%3Dliteratum%253Aachs%26aulast%3DIntini%26aufirst%3DD.%26aulast%3DBaldini%26aufirst%3DL.%26aulast%3DFabris%26aufirst%3DS.%26aulast%3DLombardi%26aufirst%3DL.%26aulast%3DCiceri%26aufirst%3DG.%26aulast%3DMaiolo%26aufirst%3DA.%2BT.%26aulast%3DNeri%26aufirst%3DA.%26atitle%3DAnalysis%2520of%2520FGFR3%2520gene%2520mutations%2520in%2520multiple%2520myeloma%2520patients%2520with%2520t%25284%253B14%2529%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2001%26volume%3D114%26spage%3D362%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cappellen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Medina, S. G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre-Garau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radvanyi, F.</span><span> </span><span class="NLM_article-title">Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10471491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=18-20&author=D.+Cappellenauthor=C.+De+Oliveiraauthor=D.+Ricolauthor=S.+G.+D.+De+Medinaauthor=J.+Bourdinauthor=X.+Sastre-Garauauthor=D.+Chopinauthor=J.+P.+Thieryauthor=F.+Radvanyi&title=Frequent+activating+mutations+of+FGFR3+in+human+bladder+and+cervix+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas</span></div><div class="casAuthors">Cappellen, David; De Oliveira, Catherine; Ricol, David; De Medina, Sixtina Gil Diez; Bourdin, Jerome; Sastre-Garau, Xavier; Chopin, Dominique; Thiery, Jean Paul; Radvanyi, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-20</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The authors assessed transcript levels of the two FGFR3 variants, FGFR3b and FGFR3c, by semi-quant. PCR in 76 primary bladder carcinomas, 6 normal urothelial, 29 primary cervical carcinomas, and 6 normal cervical epithelia.  As expected, the FGFR3b variant was the only form expressed in both malignant and non malignant epithelial tissues.  PCR-SSCP anal. of the coding region of FGFR3 on reverse-transcribed RNA from a representative subset of 26 bladder and 12 cervix tumor samples was performed.  The sequences of abnormally migrating bands revealed single nucleotide substitutions in 9 of 26 bladder carcinomas, and 3 of 12 cervix carcinomas.  These same changes were obsd. in corresponding tumor genomic sequences.  Matched constitutional DNA, available in the nine bladder tumor cases with mutations, contained wild-type sequences, demonstrating the somatic nature of these mutations.  FGFR3 missense somatic mutations identified include R248C, S249C, G372C, and K652E.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYzbQ2LS6my7Vg90H21EOLACvtfcHk0lh0ywvlltUXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWhs7s%253D&md5=2873c55650dd0179ea565c2f981b0a5d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCappellen%26aufirst%3DD.%26aulast%3DDe%2BOliveira%26aufirst%3DC.%26aulast%3DRicol%26aufirst%3DD.%26aulast%3DDe%2BMedina%26aufirst%3DS.%2BG.%2BD.%26aulast%3DBourdin%26aufirst%3DJ.%26aulast%3DSastre-Garau%26aufirst%3DX.%26aulast%3DChopin%26aufirst%3DD.%26aulast%3DThiery%26aufirst%3DJ.%2BP.%26aulast%3DRadvanyi%26aufirst%3DF.%26atitle%3DFrequent%2520activating%2520mutations%2520of%2520FGFR3%2520in%2520human%2520bladder%2520and%2520cervix%2520carcinomas%26jtitle%3DNature%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D18%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Billerey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubriot-Lorton, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil Diez de Medina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Rhijn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bralet, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefrere-Belda, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahaye, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafrani, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Kwast, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radvanyi, F.</span><span> </span><span class="NLM_article-title">Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1955</span><span class="NLM_x">–</span> <span class="NLM_lpage">1959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2FS0002-9440%2810%2964665-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=11395371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFyksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1955-1959&author=C.+Billereyauthor=D.+Chopinauthor=M.-H.+Aubriot-Lortonauthor=D.+Ricolauthor=S.+Gil+Diez+de+Medinaauthor=B.+Van+Rhijnauthor=M.-P.+Braletauthor=M.-A.+Lefrere-Beldaauthor=J.-B.+Lahayeauthor=C.+C.+Abbouauthor=J.+Bonaventureauthor=E.+S.+Zafraniauthor=T.+Van+Der+Kwastauthor=J.+P.+Thieryauthor=F.+Radvanyi&title=Frequent+FGFR3+mutations+in+papillary+non-invasive+bladder+%28pTa%29+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors</span></div><div class="casAuthors">Billerey, Claude; Chopin, Dominique; Aubriot-Lorton, Marie-Helene; Ricol, David; Gil Diez de Medina, Sixtina; Van Rhijn, Bas; Bralet, Marie-Pierre; Lefrere-Belda, Marie-Aude; Lahaye, Jean-Baptiste; Abbou, Claude C.; Bonaventure, Jacky; Zafrani, Elie Serge; Van Der Kwast, Theo; Thiery, Jean Paul; Radvanyi, Francois</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1955-1959</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The authors recently identified activating mutations of fibroblast growth factor receptor 3 (FGFR3) in bladder carcinoma.  In this study they assessed the incidence of FGFR3 mutations in a series of 132 bladder carcinomas: 20 carcinoma in situ (CIS), 50 pTa, 19 pT1, and 43 pT2-4.  All 48 mutations identified were identical to the germinal activating mutations that cause thanatophoric dysplasia, a lethal form of dwarfism.  The S249C mutation, found in 33 of the 48 mutated tumors, was the most common.  The frequency of mutations was higher in pTa tumors (37 of 50, 74%) than in CIS (0 of 20, 0%; P < 0.0001), pT1 (4 of 19, 21%; P < 0.0001) and pT2-4 tumors (7 of 43, 16%; P < 0.0001).  FGFR3 mutations were detected in 27 of 32 (84%) G1, 16 of 29 (55%) G2, and 5 of 71 (7%) G3 tumors.  This assocn. between FGFR3 mutations and low grade was highly significant (P < 0.0001).  FGFR3 is the first gene found to be mutated at a high frequency in pTa tumors.  The absence of FGFR3 mutations in CIS and the low frequency of FGFR3 mutations in pT1 and pT2-4 tumors are consistent with the model of bladder tumor progression in which the most common precursor of pT1 and pT2-4 tumors is CIS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cEtqTlSTK7Vg90H21EOLACvtfcHk0lh0ywvlltUXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFyksLg%253D&md5=d721e057bb97ab766c990b803cb3a874</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2964665-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252964665-2%26sid%3Dliteratum%253Aachs%26aulast%3DBillerey%26aufirst%3DC.%26aulast%3DChopin%26aufirst%3DD.%26aulast%3DAubriot-Lorton%26aufirst%3DM.-H.%26aulast%3DRicol%26aufirst%3DD.%26aulast%3DGil%2BDiez%2Bde%2BMedina%26aufirst%3DS.%26aulast%3DVan%2BRhijn%26aufirst%3DB.%26aulast%3DBralet%26aufirst%3DM.-P.%26aulast%3DLefrere-Belda%26aufirst%3DM.-A.%26aulast%3DLahaye%26aufirst%3DJ.-B.%26aulast%3DAbbou%26aufirst%3DC.%2BC.%26aulast%3DBonaventure%26aufirst%3DJ.%26aulast%3DZafrani%26aufirst%3DE.%2BS.%26aulast%3DVan%2BDer%2BKwast%26aufirst%3DT.%26aulast%3DThiery%26aufirst%3DJ.%2BP.%26aulast%3DRadvanyi%26aufirst%3DF.%26atitle%3DFrequent%2520FGFR3%2520mutations%2520in%2520papillary%2520non-invasive%2520bladder%2520%2528pTa%2529%2520tumors%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2001%26volume%3D158%26spage%3D1955%26epage%3D1959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gomez-Roman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saenz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escuredo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santa Cruz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junquera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez Banos, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Brea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esparza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Val-Bernal, J. F.</span><span> </span><span class="NLM_article-title">Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=15701828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=459-465&author=J.+J.+Gomez-Romanauthor=P.+Saenzauthor=J.+Cuevas+Gonzalezauthor=K.+Escuredoauthor=S.+Santa+Cruzauthor=C.+Junqueraauthor=L.+Simonauthor=A.+Martinezauthor=J.+L.+Gutierrez+Banosauthor=M.+Lopez-Breaauthor=C.+Esparzaauthor=J.+F.+Val-Bernal&title=Fibroblast+growth+factor+receptor+3+is+overexpressed+in+urinary+tract+carcinomas+and+modulates+the+neoplastic+cell+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth</span></div><div class="casAuthors">Gomez-Roman, J. Javier; Saenz, Pilar; Cuevas Gonzalez, Jorge; Escuredo, Kepa; Santa Cruz, Simon; Junquera, Corina; Simon, Laureano; Martinez, Antonio; Gutierrez Banos, J. Luis; Lopez-Brea, Marta; Esparza, Clara; Val-Bernal, J. Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">459-465</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Fibroblast growth factor receptor 3 (FGFR3) mutations have been assocd. with achondroplastic syndromes and urinary bladder carcinomas.  Here we describe changes in FGFR3 mRNA and protein expression in transitional carcinomas and det. the effect of monoclonal antibodies against FGFR3 in RT-112 cell line proliferation.  We used microarray tools to evaluate FGFR3 mRNA expression in 22 urinary bladder carcinomas at different stages (noninvasive pTa, lamina propria invasive pT1, and muscular invasive pT2) and 7 nonneoplastic tissue controls.  FGFR3 protein expression was evaluated by Western blotting in 15 different carcinomas and 3 nonneoplastic controls.  Two hundred thirty-seven urinary bladder and renal pelvis carcinomas and 21 neg. controls were tested on tissue microarrays by immunohistochem.  The effect on cell proliferation in the RT-112 bladder cancer cell line of monoclonal antibodies against FGFR3 was also evaluated.  Overexpression of FGFR3 mRNA was found in pTa and pT1 stage carcinomas (fold change >8) and in pT2 carcinomas (fold change >4).  Nonneoplastic urinary bladder samples do not express FGFR3 protein.  However, 83% of pTa, 100% of pT1, and 50% of pT2 carcinomas expressed FGFR3 as detd. by Western blotting.  By immunohistochem., FGFR3 was pos. in 71.4% of pTa, 72% of pT1, and 49.2% of pT2 cases as well as 61.5% of upper urinary tract carcinomas.  Proliferation of the RT-112 cell line was inhibited with monoclonal antibodies against FGFR3.  FGFR3 seems to play an important role in transitional cell carcinoma development.  Our results suggest that FGFR3 antagonists could be developed as possible therapeutics for treatment of urinary tract carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoykdI_zOzaobVg90H21EOLACvtfcHk0lip6Kmu1gV0JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWgtrY%253D&md5=4f877dd65a2af3c9203174b6b98a751c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Roman%26aufirst%3DJ.%2BJ.%26aulast%3DSaenz%26aufirst%3DP.%26aulast%3DCuevas%2BGonzalez%26aufirst%3DJ.%26aulast%3DEscuredo%26aufirst%3DK.%26aulast%3DSanta%2BCruz%26aufirst%3DS.%26aulast%3DJunquera%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DL.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGutierrez%2BBanos%26aufirst%3DJ.%2BL.%26aulast%3DLopez-Brea%26aufirst%3DM.%26aulast%3DEsparza%26aufirst%3DC.%26aulast%3DVal-Bernal%26aufirst%3DJ.%2BF.%26atitle%3DFibroblast%2520growth%2520factor%2520receptor%25203%2520is%2520overexpressed%2520in%2520urinary%2520tract%2520carcinomas%2520and%2520modulates%2520the%2520neoplastic%2520cell%2520growth%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D459%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Jang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. G.</span><span> </span><span class="NLM_article-title">Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3541</span><span class="NLM_x">–</span> <span class="NLM_lpage">3543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=3541-3543&author=J.+H.+Jangauthor=K.+H.+Shinauthor=J.+G.+Park&title=Mutations+in+fibroblast+growth+factor+receptor+2+and+fibroblast+growth+factor+receptor+3+genes+associated+with+human+gastric+and+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DJ.%2BH.%26aulast%3DShin%26aufirst%3DK.%2BH.%26aulast%3DPark%26aufirst%3DJ.%2BG.%26atitle%3DMutations%2520in%2520fibroblast%2520growth%2520factor%2520receptor%25202%2520and%2520fibroblast%2520growth%2520factor%2520receptor%25203%2520genes%2520associated%2520with%2520human%2520gastric%2520and%2520colorectal%2520cancers%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D3541%26epage%3D3543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokote, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saijo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishio, K.</span><span> </span><span class="NLM_article-title">AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3051</span><span class="NLM_x">–</span> <span class="NLM_lpage">3057</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1158%2F1078-0432.CCR-06-2743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17505008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1KrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3051-3057&author=M.+Takedaauthor=T.+Araoauthor=H.+Yokoteauthor=T.+Komatsuauthor=K.+Yanagiharaauthor=H.+Sasakiauthor=Y.+Yamadaauthor=T+Tamuraauthor=K.+Fukuokaauthor=H.+Kimuraauthor=N.+Saijoauthor=K.+Nishio&title=AZD2171+shows+potent+antitumor+activity+against+gastric+cancer+over-expressing+fibroblast+growth+factor+receptor+2%2Fkeratinocyte+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor</span></div><div class="casAuthors">Takeda, Masayuki; Arao, Tokuzo; Yokote, Hideyuki; Komatsu, Teruo; Yanagihara, Kazuyoshi; Sasaki, Hiroki; Yamada, Yasuhide; Tamura, Tomohide; Fukuoka, Kazuya; Kimura, Hiroshi; Saijo, Nagahiro; Nishio, Kazuto</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3051-3057</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">AZD2171 is an oral, highly potent, and selective vascular endothelial growth factor signaling inhibitor that inhibits all vascular endothelial growth factor receptor tyrosine kinases.  The purpose of this study was to investigate the activity of AZD2171 in gastric cancer.  We examd. the antitumor effect of AZD2171 on the eight gastric cancer cell lines in vitro and in vivo.  AZD2171 directly inhibited the growth of two gastric cancer cell lines (KATO-III and OCUM2M), with an IC50 of 0.15 and 0.37 μmol/L, resp., more potently than the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib.  Reverse transcription-PCR expts. and immunoblotting revealed that sensitive cell lines dominantly expressed COOH terminus-truncated fibroblast growth factor receptor 2 (FGFR2) splicing variants that were constitutively phosphorylated and spontaneously dimerized.  AZD2171 completely inhibited the phosphorylation of FGFR2 and downstream signaling proteins (FRS2, AKT, and mitogen-activated protein kinase) in sensitive cell lines at a 10-fold lower concn. (0.1 μmol/L) than in the other cell lines.  An in vitro kinase assay showed that AZD2171 inhibited kinase activity of immunopptd. FGFR2 with submicromolar Ki values (∼0.05 μmol/L).  Finally, we assessed the antitumor activity of AZD2171 in human gastric tumor xenograft models in mice.  Oral administration of AZD2171 (1.5 or 6 mg/kg/d) significantly and dose-dependently inhibited tumor growth in mice bearing KATO-III and OCUM2M tumor xenografts.  AZD2171 exerted potent antitumor activity against gastric cancer xenografts overexpressing FGFR2.  The results of these preclin. studies indicate that AZD2171 may provide clin. benefit in patients with certain types of gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0qvLkeUog7LVg90H21EOLACvtfcHk0lip6Kmu1gV0JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1KrtLs%253D&md5=015f1e899f602818fd92f9d2679e5db7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2743%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DArao%26aufirst%3DT.%26aulast%3DYokote%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DT.%26aulast%3DYanagihara%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTamura%26aufirst%3DT%26aulast%3DFukuoka%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DSaijo%26aufirst%3DN.%26aulast%3DNishio%26aufirst%3DK.%26atitle%3DAZD2171%2520shows%2520potent%2520antitumor%2520activity%2520against%2520gastric%2520cancer%2520over-expressing%2520fibroblast%2520growth%2520factor%2520receptor%25202%252Fkeratinocyte%2520growth%2520factor%2520receptor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3051%26epage%3D3057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorenstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span> </span><span class="NLM_article-title">FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 Signaling for Growth and Survival</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2340</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2340-2348&author=K.+Kuniiauthor=L.+Davisauthor=J.+Gorensteinauthor=H.+Hatchauthor=M.+Yashiroauthor=A.+Di+Baccoauthor=C.+Elbiauthor=B.+Lutterbach&title=FGFR2-amplified+gastric+cancer+cell+lines+require+FGFR2+and+Erbb3+Signaling+for+Growth+and+Survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DGorenstein%26aufirst%3DJ.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DYashiro%26aufirst%3DM.%26aulast%3DDi%2BBacco%26aufirst%3DA.%26aulast%3DElbi%26aufirst%3DC.%26aulast%3DLutterbach%26aufirst%3DB.%26atitle%3DFGFR2-amplified%2520gastric%2520cancer%2520cell%2520lines%2520require%2520FGFR2%2520and%2520Erbb3%2520Signaling%2520for%2520Growth%2520and%2520Survival%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2340%26epage%3D2348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pollock, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartside, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dejeza, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallon, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodfellow, P. J.</span><span> </span><span class="NLM_article-title">Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">7158</span><span class="NLM_x">–</span> <span class="NLM_lpage">7162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=7158-7162&author=P.+M.+Pollockauthor=M.+G.+Gartsideauthor=L.+C.+Dejezaauthor=M.+A.+Powellauthor=M.+A.+Mallonauthor=H.+Daviesauthor=M.+Mohammadiauthor=P.+A.+Futrealauthor=M.+R.+Strattonauthor=J.+M.+Trentauthor=P.+J.+Goodfellow&title=Frequent+activating+FGFR2+mutations+in+endometrial+carcinomas+parallel+germline+mutations+associated+with+craniosynostosis+and+skeletal+dysplasia+syndromes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollock%26aufirst%3DP.%2BM.%26aulast%3DGartside%26aufirst%3DM.%2BG.%26aulast%3DDejeza%26aufirst%3DL.%2BC.%26aulast%3DPowell%26aufirst%3DM.%2BA.%26aulast%3DMallon%26aufirst%3DM.%2BA.%26aulast%3DDavies%26aufirst%3DH.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DFutreal%26aufirst%3DP.%2BA.%26aulast%3DStratton%26aufirst%3DM.%2BR.%26aulast%3DTrent%26aufirst%3DJ.%2BM.%26aulast%3DGoodfellow%26aufirst%3DP.%2BJ.%26atitle%3DFrequent%2520activating%2520FGFR2%2520mutations%2520in%2520endometrial%2520carcinomas%2520parallel%2520germline%2520mutations%2520associated%2520with%2520craniosynostosis%2520and%2520skeletal%2520dysplasia%2520syndromes%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D7158%26epage%3D7162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Weiss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sos, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zander, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuckmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soltermann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöttle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leenders, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabow, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Querings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heukamp, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balke-Want, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansén, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baessmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmüller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainer, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brambilla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorimier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brustugun, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel-Riedel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sänger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timens, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sietsma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunnissen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heideman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappuzzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligorio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernestus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoelben, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nürnberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. K.</span><span> </span><span class="NLM_article-title">Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1126%2Fscitranslmed.3001451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFWisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=62-93&author=J.+M.+Weissauthor=M.+L.+Sosauthor=D.+Seidelauthor=M.+Peiferauthor=T.+Zanderauthor=J.+M.+Heuckmannauthor=R.+T.+Ullrichauthor=R.+Menonauthor=S.+Maierauthor=A.+Soltermannauthor=H.+Mochauthor=P.+Wagenerauthor=F.+Fischerauthor=S.+Heynckauthor=M.+Kokerauthor=J.+Sch%C3%B6ttleauthor=F.+Leendersauthor=F.+Gablerauthor=I.+Dabowauthor=S.+Queringsauthor=L.+C.+Heukampauthor=H.+Balke-Wantauthor=S.+Ans%C3%A9nauthor=D.+Rauhauthor=I.+Baessmannauthor=J.+Altm%C3%BCllerauthor=Z.+Wainerauthor=M.+Conronauthor=G.+Wrightauthor=O.+Russellauthor=B.+Solomonauthor=E.+Brambillaauthor=C.+Brambillaauthor=P.+Lorimierauthor=S.+Sollbergauthor=O.+T.+Brustugunauthor=W.+Engel-Riedelauthor=C.+Ludwigauthor=I.+Petersenauthor=J.+S%C3%A4ngerauthor=J.+Clementauthor=H.+Groenauthor=W.+Timensauthor=H.+Sietsmaauthor=E.+Thunnissenauthor=E.+Smitauthor=D.+Heidemanauthor=F.+Cappuzzoauthor=C.+Ligorioauthor=S.+Damianiauthor=M.+Hallekauthor=R.+Beroukhimauthor=W.+Paoauthor=B.+Kleblauthor=M.+Baumannauthor=R.+Buettnerauthor=K.+Ernestusauthor=E.+Stoelbenauthor=J.+Wolfauthor=P.+N%C3%BCrnbergauthor=S.+Pernerauthor=R.+K.+Thomas&title=Frequent+and+Focal+FGFR1+Amplification+Associates+with+Therapeutically+Tractable+FGFR1+Dependency+in+Squamous+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer</span></div><div class="casAuthors">Weiss, Jonathan; Sos, Martin L.; Seidel, Danila; Peifer, Martin; Zander, Thomas; Heuckmann, Johannes M.; Ullrich, Roland T.; Menon, Roopika; Maier, Sebastian; Soltermann, Alex; Moch, Holger; Wagener, Patrick; Fischer, Florian; Heynck, Stefanie; Koker, Mirjam; Schoettle, Jakob; Leenders, Frauke; Gabler, Franziska; Dabow, Ines; Querings, Silvia; Heukamp, Lukas C.; Balke-Want, Hyatt; Ansen, Sascha; Rauh, Daniel; Baessmann, Ingelore; Altmueller, Janine; Wainer, Zoe; Conron, Matthew; Wright, Gavin; Russell, Prudence; Solomon, Ben; Brambilla, Elisabeth; Brambilla, Christian; Lorimier, Philippe; Sollberg, Steinar; Brustugun, Odd Terje; Engel-Riedel, Walburga; Ludwig, Corinna; Petersen, Iver; Saenger, Joerg; Clement, Joachim; Groen, Harry; Timens, Wim; Sietsma, Hannie; Thunnissen, Erik; Smit, Egbert; Heideman, Danielle; Cappuzzo, Federico; Ligorio, Claudia; Damiani, Stefania; Hallek, Michael; Beroukhim, Rameen; Pao, William; Klebl, Bert; Baumann, Matthias; Buettner, Reinhard; Ernestus, Karen; Stoelben, Erich; Wolf, Juergen; Nuernberg, Peter; Perner, Sven; Thomas, Roman K.</div><div class="citationInfo"><span class="NLM_cas:title">Science Translational Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">62</span>),
    <span class="NLM_cas:pages">62ra93</span>CODEN:
                <span class="NLM_cas:coden">STMCBQ</span>;
        ISSN:<span class="NLM_cas:issn">1946-6242</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Lung cancer remains one of the leading causes of cancer-related death in developed countries.  Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to treatment by epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) inhibition, resp., squamous cell lung cancer currently lacks therapeutically exploitable genetic alterations.  We conducted a systematic search in a set of 232 lung cancer specimens for genetic alterations that were therapeutically amenable and then performed high-resoln. gene copy no. analyses.  We identified frequent and focal fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell lung cancer (n = 155), but not in other lung cancer subtypes, and, by fluorescence in situ hybridization, confirmed the presence of FGFR1 amplifications in an independent cohort of squamous cell lung cancer samples (22% of cases).  Using cell-based screening with the FGFR inhibitor PD173074 in a large (n = 83) panel of lung cancer cell lines, we demonstrated that this compd. inhibited growth and induced apoptosis specifically in those lung cancer cells carrying amplified FGFR1.  We validated the FGFR1 dependence of FGFR1-amplified cell lines by FGFR1 knockdown and by ectopic expression of an FGFR1-resistant allele (FGFR1V561M), which rescued FGFR1-amplified cells from PD173074-mediated cytotoxicity.  Finally, we showed that inhibition of FGFR1 with a small mol. led to significant tumor shrinkage in vivo.  Thus, focal FGFR1 amplification is common in squamous cell lung cancer and assocd. with tumor growth and survival, suggesting that FGFR inhibitors may be a viable therapeutic option in this cohort of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9iQRgbnlWiLVg90H21EOLACvtfcHk0lhOCIefkqZoJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFWisLc%253D&md5=1d088ffa078b4bf37ee43100d91fee6e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001451%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%2BM.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DSeidel%26aufirst%3DD.%26aulast%3DPeifer%26aufirst%3DM.%26aulast%3DZander%26aufirst%3DT.%26aulast%3DHeuckmann%26aufirst%3DJ.%2BM.%26aulast%3DUllrich%26aufirst%3DR.%2BT.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DMaier%26aufirst%3DS.%26aulast%3DSoltermann%26aufirst%3DA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DWagener%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DF.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3DKoker%26aufirst%3DM.%26aulast%3DSch%25C3%25B6ttle%26aufirst%3DJ.%26aulast%3DLeenders%26aufirst%3DF.%26aulast%3DGabler%26aufirst%3DF.%26aulast%3DDabow%26aufirst%3DI.%26aulast%3DQuerings%26aufirst%3DS.%26aulast%3DHeukamp%26aufirst%3DL.%2BC.%26aulast%3DBalke-Want%26aufirst%3DH.%26aulast%3DAns%25C3%25A9n%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DBaessmann%26aufirst%3DI.%26aulast%3DAltm%25C3%25BCller%26aufirst%3DJ.%26aulast%3DWainer%26aufirst%3DZ.%26aulast%3DConron%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DRussell%26aufirst%3DO.%26aulast%3DSolomon%26aufirst%3DB.%26aulast%3DBrambilla%26aufirst%3DE.%26aulast%3DBrambilla%26aufirst%3DC.%26aulast%3DLorimier%26aufirst%3DP.%26aulast%3DSollberg%26aufirst%3DS.%26aulast%3DBrustugun%26aufirst%3DO.%2BT.%26aulast%3DEngel-Riedel%26aufirst%3DW.%26aulast%3DLudwig%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DI.%26aulast%3DS%25C3%25A4nger%26aufirst%3DJ.%26aulast%3DClement%26aufirst%3DJ.%26aulast%3DGroen%26aufirst%3DH.%26aulast%3DTimens%26aufirst%3DW.%26aulast%3DSietsma%26aufirst%3DH.%26aulast%3DThunnissen%26aufirst%3DE.%26aulast%3DSmit%26aufirst%3DE.%26aulast%3DHeideman%26aufirst%3DD.%26aulast%3DCappuzzo%26aufirst%3DF.%26aulast%3DLigorio%26aufirst%3DC.%26aulast%3DDamiani%26aufirst%3DS.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DM.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DErnestus%26aufirst%3DK.%26aulast%3DStoelben%26aufirst%3DE.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DN%25C3%25BCrnberg%26aufirst%3DP.%26aulast%3DPerner%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26atitle%3DFrequent%2520and%2520Focal%2520FGFR1%2520Amplification%2520Associates%2520with%2520Therapeutically%2520Tractable%2520FGFR1%2520Dependency%2520in%2520Squamous%2520Cell%2520Lung%2520Cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D62%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarrio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dexter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iravani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenwick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardisson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6652</span><span class="NLM_x">–</span> <span class="NLM_lpage">6662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1158%2F1078-0432.CCR-06-1164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17121884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1elsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=6652-6662&author=J.+S.+Reis-Filhoauthor=P.+T.+Simpsonauthor=N.+C.+Turnerauthor=M.+B.+Lambrosauthor=C.+Jonesauthor=A.+Mackayauthor=A.+Grigoriadisauthor=D.+Sarrioauthor=K.+Savageauthor=T.+Dexterauthor=M.+Iravaniauthor=K.+Fenwickauthor=B.+Weberauthor=D.+Hardissonauthor=F.+C.+Schmittauthor=J.+Palaciosauthor=S.+R.+Lakhaniauthor=A.+Ashworth&title=FGFR1+emerges+as+a+potential+therapeutic+target+for+lobular+breast+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">FGFR1 Emerges as a potential therapeutic target for lobular breast crcinomas</span></div><div class="casAuthors">Reis-Filho, Jorge Sergio; Simpson, Pete T.; Turner, Nicholas C.; Lambros, Maryou Ballo; Jones, Chris; Mackay, Alan; Grigoriadis, Anita; Sarrio, David; Savage, Kay; Dexter, Tim; Iravani, Marjan; Fenwick, Kerry; Weber, Barbara; Hardisson, David; Schmitt, Fernando Carlos; Palacios, Jose; Lakhani, Sunil R.; Ashworth, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6652-6662</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Classic lobular carcinomas (CLC) account for 10% to 15% of all breast cancers.  At the genetic level, CLCs show recurrent phys. loss of chromosome16q coupled with the lack of E-cadherin (CDH1 gene) expression.  However, little is known about the putative therapeutic targets for these tumors.  The aim of this study was to characterize CLCs at the mol. genetic level and identify putative therapeutic targets.  We subjected 13 cases of CLC to a comprehensive mol. anal. including immunohistochem. for E-cadherin, estrogen and progesterone receptors, HER2/neu and p53; high-resoln. comparative genomic hybridization (HR-CGH); microarray-based CGH (aCGH); and fluorescent and chromogenic in situ hybridization for CCND1 and FGFR1.  All cases lacked the expression of E-cadherin, p53, and HER2, and all but one case was pos. for estrogen receptors.  HR-CGH revealed recurrent gains on 1q and losses on 16q (both, 85%). aCGH showed a good agreement with but higher resoln. and sensitivity than HR-CGH.  Recurrent, high level gains at 11q13 (CCND1) and 8p12-p11.2 were identified in seven and six cases, resp., and were validated with in situ hybridization.  Examn. of aCGH and the gene expression profile data of the cell lines, MDA-MB-134 and ZR-75-1, which harbor distinct gains of 8p12-p11.2, identified FGFR1 as a putative amplicon driver of 8p12-p11.2 amplification in MDA-MB-134.  Inhibition of FGFR1 expression using small interfering RNA or a small-mol. chem. inhibitor showed that FGFR1 signaling contributes to the survival of MDA-MB-134 cells.  The findings suggest that receptor FGFR1 inhibitors may be useful as therapeutics in a subset of CLCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3HfEguTUcVbVg90H21EOLACvtfcHk0lhEGAcennTjkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1elsL%252FO&md5=3b036c4129974b6386214ede47292d73</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1164%26sid%3Dliteratum%253Aachs%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DSimpson%26aufirst%3DP.%2BT.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DSarrio%26aufirst%3DD.%26aulast%3DSavage%26aufirst%3DK.%26aulast%3DDexter%26aufirst%3DT.%26aulast%3DIravani%26aufirst%3DM.%26aulast%3DFenwick%26aufirst%3DK.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DHardisson%26aufirst%3DD.%26aulast%3DSchmitt%26aufirst%3DF.%2BC.%26aulast%3DPalacios%26aufirst%3DJ.%26aulast%3DLakhani%26aufirst%3DS.%2BR.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFGFR1%2520emerges%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520lobular%2520breast%2520carcinomas%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D6652%26epage%3D6662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Penault-Llorca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deLapeyriere, O.</span><span> </span><span class="NLM_article-title">Expression of FGF and FGF receptor genes in human breast cancer</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.2910610205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7705943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1995&pages=170-176&author=F.+Penault-Llorcaauthor=F.+Bertucciauthor=J.+Adelaideauthor=P.+Parcauthor=F.+Coulierauthor=J.+Jacquemierauthor=D.+Birnbaumauthor=O.+deLapeyriere&title=Expression+of+FGF+and+FGF+receptor+genes+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of FGF and FGF receptor genes in human breast cancer</span></div><div class="casAuthors">Penault-Llorca, Frederique; Bertucci, Francois; Adelaiede, Jose; Parc, Patricia; Coulier, Francois; Jacquemier, Jocelyne; Birnbaum, Daniel; DeLapeyriere, Odile</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-6</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The family of FGF growth factors is involved in several biol. processes and might play an important role in tumorigenesis.  The authors have studied the resp. expression of 8 of the 9 characterized FGF genes, and of the 4 known FGF receptor genes, in a panel of 10 tumor-cell lines and 103 breast-tumor samples, using RT-PCR and Northern-blot analyses.  FGF1 and FGF2 were expressed in almost all samples, whereas expression of FGF5, FGF6, FGF7 and FGF9 was more restricted.  FGFR1, FGFR2, and FGFR4 were expressed at high levels in resp. 22%, 4%, and 32% of tumors.  FGFR3 expression was not detected.  The transcript encoding an FGFR1 isoform with 2 Ig-like domains was the most prevalent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM4Ndkn4BdcLVg90H21EOLACvtfcHk0lhEGAcennTjkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsVCmt7g%253D&md5=ce0eda6c49f3504d032c36d6cfb805e5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910610205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910610205%26sid%3Dliteratum%253Aachs%26aulast%3DPenault-Llorca%26aufirst%3DF.%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DParc%26aufirst%3DP.%26aulast%3DCoulier%26aufirst%3DF.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DdeLapeyriere%26aufirst%3DO.%26atitle%3DExpression%2520of%2520FGF%2520and%2520FGF%2520receptor%2520genes%2520in%2520human%2520breast%2520cancer%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1995%26volume%3D61%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penault-Llorca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deLapeyriere, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span> </span><span class="NLM_article-title">Expression of the FGFR1 gene in human breast-carcinoma cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.2910590314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7927944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fht1yqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=373-378&author=J.+Jacquemierauthor=J.+Adelaideauthor=P.+Parcauthor=F.+Penault-Llorcaauthor=J.+Plancheauthor=O.+deLapeyriereauthor=D.+Birnbaum&title=Expression+of+the+FGFR1+gene+in+human+breast-carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the FGFR1 gene in human breast-carcinoma cells</span></div><div class="casAuthors">Jacquemier J; Adelaide J; Parc P; Penault-Llorca F; Planche J; deLapeyriere O; Birnbaum D</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-8</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Fibroblast growth factors (FGF) constitute a family of at least 9 members which act through high-affinity tyrosine-kinase receptors encoded by 4 distinct genes.  In humans, the FGFR1 gene is located in chromosomal region 8p12.  Its amplification and expression were examined in a panel of 110 breast carcinoma samples by Southern- and Northern-blot analyses.  FGFR1 was amplified in 9% and overexpressed in about 15% of the tumors studied.  In situ hybridization experiments were performed on tissue sections of normal breast and tumors with a high level of FGFR1 expression.  In both normal and tumoral tissues, FGFR1 RNA was detected in the epithelial cells.  Overexpression of FGFR1 seems to be associated with small, well-differentiated diploid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj08CCzyP00w5nADWVYHg1fW6udTcc2eaiaDpPD3_6q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fht1yqtw%253D%253D&md5=28a3af0a2b6fb24f844e5dce70eb0d18</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910590314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910590314%26sid%3Dliteratum%253Aachs%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DParc%26aufirst%3DP.%26aulast%3DPenault-Llorca%26aufirst%3DF.%26aulast%3DPlanche%26aufirst%3DJ.%26aulast%3DdeLapeyriere%26aufirst%3DO.%26aulast%3DBirnbaum%26aufirst%3DD.%26atitle%3DExpression%2520of%2520the%2520FGFR1%2520gene%2520in%2520human%2520breast-carcinoma%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1994%26volume%3D59%26spage%3D373%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jaakkola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmikangas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyrhonen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtovirta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevanlinna, H.</span><span> </span><span class="NLM_article-title">Amplification of fgfr4 gene in human breast and gynecological cancers</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">378</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.2910540305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=8099571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK3sXmt1aqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1993&pages=378-382&author=S.+Jaakkolaauthor=P.+Salmikangasauthor=S.+Nylundauthor=J.+Partanenauthor=E.+Armstrongauthor=S.+Pyrhonenauthor=P.+Lehtovirtaauthor=H.+Nevanlinna&title=Amplification+of+fgfr4+gene+in+human+breast+and+gynecological+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of fgfr4 gene in human breast and gynecological cancers</span></div><div class="casAuthors">Jaakkola, Susanna; Salmikangas, Paula; Nylund, Stella; Partanen, Juha; Armstrong, Elina; Pyrhonen, Seppo; Lehtovirta, Pentti; Nevanlinna, Heli</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">378-82</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The authors have investigated gene amplification of fibroblast growth factor receptor-4 (FGFR4) gene in 30 primary breast tumor samples and 15 gynecol. tumor samples.  Ten percent of the breast tumors showed 2- to 4-fold amplification.  Amplification was found more frequently in estrogen- and progesterone-receptor-pos. tumors and in tumors with high lymph-node involvement.  Breast tumor samples were also analyzed for the amplification of fgfr4 and erbB2 genes and the chromosome 11q13 located genes hst1/int2/bcl1/sea.  ErbB2 gene was amplified 2- to 13-fold in 13% of the cases, but no amplification of int2/hst1/bcl1/sea amplicon was found.  Gynecol. tumors were also analyzed for the amplification of fgfr4 and fgfr3 genes and for int2 and hst1 oncogenes.  Eleven of the 15 gynecol. tumors were ovarian neoplasms including 2 benign tumors; the remainder comprised 1 ovarian metastasis of breast cancer; I endometrial cancer; 1 uterine leiomyosarcoma and 1 carcinosarcoma of the fallopian tube.  In gynecol. tumors, fgfr4 gene was found to be amplified in 2 ovarian tumors.  Amplification of hstI was found in 1 benign ovarian tumor.  Thus, the fgfr4 gene may be involved in breast and ovarian tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF8SaHJN93yLVg90H21EOLACvtfcHk0livBwOIgIds0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmt1aqu70%253D&md5=6109469c784e655644ddc8ed3106bf1b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910540305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910540305%26sid%3Dliteratum%253Aachs%26aulast%3DJaakkola%26aufirst%3DS.%26aulast%3DSalmikangas%26aufirst%3DP.%26aulast%3DNylund%26aufirst%3DS.%26aulast%3DPartanen%26aufirst%3DJ.%26aulast%3DArmstrong%26aufirst%3DE.%26aulast%3DPyrhonen%26aufirst%3DS.%26aulast%3DLehtovirta%26aufirst%3DP.%26aulast%3DNevanlinna%26aufirst%3DH.%26atitle%3DAmplification%2520of%2520fgfr4%2520gene%2520in%2520human%2520breast%2520and%2520gynecological%2520cancers%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1993%26volume%3D54%26spage%3D378%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Theillet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelaide, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louason, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet-Dorion, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsaros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sismondi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudray, P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers</span> <span class="citation_source-journal">Genes, Chromosomes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fgcc.2870070407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7692948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK2cXhs1Shtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=219-226&author=C.+Theilletauthor=J.+Adelaideauthor=G.+Louasonauthor=F.+Bonnet-Dorionauthor=J.+Jacquemierauthor=J.+Adnaneauthor=M.+Longyauthor=D.+Katsarosauthor=P.+Sismondiauthor=P.+Gaudray&title=FGFRI+and+PLAT+genes+and+DNA+amplification+at+8p12+in+breast+and+ovarian+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers</span></div><div class="casAuthors">Theillet, Charles; Adelaide, Jose; Louason, Genevieve; Bonnet-Dorion, Francoise; Jacquemier, Jocelyne; Adnane, Jalila; Longy, Michel; Katsaros, Dionisi; Sismondi, Piero; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-26</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    </div><div class="casAbstract">Several chromosomal regions are found to be consistently amplified in human breast cancers.  For two of these regions, 8p 12 and 10q26, the authors previously reported the amplification of genes encoding FGF receptors, FGFRI/FLG and FGFR2/BEK, in about 12% of breast tumors.  The PLAT gene, encoding the tissue-type plasminogen activator, is also located close to or within the 8p 12 region.  In the present study, the authors show that both FGFRI and PLAT can be amplified in breast as well as ovarian carcinomas.  FGFRI amplification was detected in 14.5% of breast and 7.8% of ovarian tumors, whereas PLAT was found to be amplified in 15.6% and 19.4% of the tumors, resp.  Each gene could be amplified independently of the other.  These data raised the question of which gene is selected for amplification at 8p 12.  In most cases, the levels of expression of FGFRI and PLAT in breast tumors were comparable to their level of expression in normal mammary tissue.  However, FGFRI was expressed above the normal level in a certain no. of cases.  This gene could be a good candidate as "driver" of the 8p12 amplification, but it cannot account for all complex mol. events taking place in this region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKI0BCYkSi_bVg90H21EOLACvtfcHk0livBwOIgIds0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhs1Shtrs%253D&md5=d8eaa381591a324bd7d42e8a50a075b4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fgcc.2870070407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.2870070407%26sid%3Dliteratum%253Aachs%26aulast%3DTheillet%26aufirst%3DC.%26aulast%3DAdelaide%26aufirst%3DJ.%26aulast%3DLouason%26aufirst%3DG.%26aulast%3DBonnet-Dorion%26aufirst%3DF.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DAdnane%26aufirst%3DJ.%26aulast%3DLongy%26aufirst%3DM.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DSismondi%26aufirst%3DP.%26aulast%3DGaudray%26aufirst%3DP.%26atitle%3DFGFRI%2520and%2520PLAT%2520genes%2520and%2520DNA%2520amplification%2520at%25208p12%2520in%2520breast%2520and%2520ovarian%2520cancers%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D1993%26volume%3D7%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Adnane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionne, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanteur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theillet, C.</span><span> </span><span class="NLM_article-title">BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=659-663&author=J.+Adnaneauthor=P.+Gaudrayauthor=C.+A.+Dionneauthor=G.+Crumleyauthor=M.+Jayeauthor=J.+Schlessingerauthor=P.+Jeanteurauthor=D.+Birnbaumauthor=C.+Theillet&title=BEK+and+FLG%2C+two+receptors+to+members+of+the+FGF+family%2C+are+amplified+in+subsets+of+human+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdnane%26aufirst%3DJ.%26aulast%3DGaudray%26aufirst%3DP.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26aulast%3DCrumley%26aufirst%3DG.%26aulast%3DJaye%26aufirst%3DM.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DJeanteur%26aufirst%3DP.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DTheillet%26aufirst%3DC.%26atitle%3DBEK%2520and%2520FLG%252C%2520two%2520receptors%2520to%2520members%2520of%2520the%2520FGF%2520family%252C%2520are%2520amplified%2520in%2520subsets%2520of%2520human%2520breast%2520cancers%26jtitle%3DOncogene%26date%3D1991%26volume%3D6%26spage%3D659%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Elsheikh, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grainge, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span> </span><span class="NLM_article-title">FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">R23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=R23&author=S.+E.+Elsheikhauthor=A.+R.+Greenauthor=M.+B.+K.+Lambrosauthor=N.+C.+Turnerauthor=M.+J.+Graingeauthor=D.+Poweauthor=I.+O.+Ellisauthor=J.+S.+Reis-Filho&title=FGFR1+amplification+in+breast+carcinomas%3A+a+chromogenic+in+situ+hybridisation+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElsheikh%26aufirst%3DS.%2BE.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DLambros%26aufirst%3DM.%2BB.%2BK.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DGrainge%26aufirst%3DM.%2BJ.%26aulast%3DPowe%26aufirst%3DD.%26aulast%3DEllis%26aufirst%3DI.%2BO.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26atitle%3DFGFR1%2520amplification%2520in%2520breast%2520carcinomas%253A%2520a%2520chromogenic%2520in%2520situ%2520hybridisation%2520analysis%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2007%26volume%3D9%26spage%3DR23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Valladares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia Hernandez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamanca Gomez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curiel-Quezada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrigal-Bujaidar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sierra Martinez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenas Aranda, D. J.</span><span> </span><span class="NLM_article-title">Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women</span> <span class="citation_source-journal">Cancer Genet. Cytogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2Fj.cancergencyto.2006.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17011986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWqtrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2006&pages=147-151&author=A.+Valladaresauthor=N.+Garcia+Hernandezauthor=F.+Salamanca+Gomezauthor=E.+Curiel-Quezadaauthor=E.+Madrigal-Bujaidarauthor=M.+D.+Vergaraauthor=M.+Sierra+Martinezauthor=D.+J.+Arenas+Aranda&title=Genetic+expression+profiles+and+chromosomal+alterations+in+sporadic+breast+cancer+in+Mexican+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women</span></div><div class="casAuthors">Valladares, Adan; Garcia Hernandez, Normand; Salamanca Gomez, Fabio; Curiel-Quezada, Everardo; Madrigal-Bujaidar, Eduardo; Vergara, Ma. Dolores; Sierra Martinez, Monica; Arenas Aranda, Diego J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Genetics and Cytogenetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-151</span>CODEN:
                <span class="NLM_cas:coden">CGCYDF</span>;
        ISSN:<span class="NLM_cas:issn">0165-4608</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Breast cancer is the second-leading cause of death among Mexican women >35 years of age.  At the mol. level, changes in many genetic pathways have been reported to be assocd. with this neoplasm.  To analyze these changes, we detd. gene expression profiles and chromosomal structural alterations in tumors from Mexican women.  We obtained mRNA to identify expression profiles with microarray technol., and DNA to det. amplifications and deletions, in 10 fresh sporadic breast tumor biopsies without treatment, as well as in 10 nonaffected breast tissues.  Expression profiles were compared with genetic changes obsd. by comparative genomic hybridization (CGH).  We compared the expression profiles against the structural alterations from the studied genes by means of microarrays; at least 17 of these genes correlated with DNA copy no. alterations.  We found that the following genes were overexpressed: LAMC1, PCTK3, CCNC, CCND1, FGF3, PCTK2, L1CAM, BGN, and PLXNB3 (alias PLEXR).  Underexpressed genes included CASP9, FGR, TP73, HSPG2, and ERCC1; genes turned off included FRAP1, EPHA2 (previously ECK), IL12A, E2F5, TNFRSF10B, TNFRSF10A, EFNB3, and BCL2.  The results will allow us, in the near future, to outline genes that could serve as diagnostic, prognostic, or target therapy markers for the Mexican population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmHhQPSzIowrVg90H21EOLACvtfcHk0lg_hqVzeAAP9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWqtrvM&md5=61cefaa234d059279b82b169ebba0bbe</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergencyto.2006.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergencyto.2006.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DValladares%26aufirst%3DA.%26aulast%3DGarcia%2BHernandez%26aufirst%3DN.%26aulast%3DSalamanca%2BGomez%26aufirst%3DF.%26aulast%3DCuriel-Quezada%26aufirst%3DE.%26aulast%3DMadrigal-Bujaidar%26aufirst%3DE.%26aulast%3DVergara%26aufirst%3DM.%2BD.%26aulast%3DSierra%2BMartinez%26aufirst%3DM.%26aulast%3DArenas%2BAranda%26aufirst%3DD.%2BJ.%26atitle%3DGenetic%2520expression%2520profiles%2520and%2520chromosomal%2520alterations%2520in%2520sporadic%2520breast%2520cancer%2520in%2520Mexican%2520women%26jtitle%3DCancer%2520Genet.%2520Cytogenet.%26date%3D2006%26volume%3D170%26spage%3D147%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Fioravanti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappelletti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coradini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miodini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fronzo, G.</span><span> </span><span class="NLM_article-title">int-2 oncogene amplification and prognosis in node-negative breast carcinoma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2F%28SICI%291097-0215%2819971219%2974%3A6%3C620%3A%3AAID-IJC11%3E3.0.CO%3B2-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=9421359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A280%3ADyaK1c%252FotFOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1997&pages=620-624&author=L.+Fioravantiauthor=V.+Cappellettiauthor=D.+Coradiniauthor=P.+Miodiniauthor=G.+Borsaniauthor=M.+G.+Daidoneauthor=G.+Di+Fronzo&title=int-2+oncogene+amplification+and+prognosis+in+node-negative+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">int-2 oncogene amplification and prognosis in node-negative breast carcinoma</span></div><div class="casAuthors">Fioravanti L; Cappelletti V; Coradini D; Miodini P; Borsani G; Daidone M G; Di Fronzo G</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-4</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The role of int-2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node-negative primary breast cancers given first-line local-regional treatments until relapse and with a median follow-up of 65 months.  Tumours had been previously characterised for oestrogen (ER) and progesterone receptor (PgR) status and proliferative activity (3H-thymidine labelling index).  Amplification of the int-2 oncogene occurred in 18% of cases and was significantly related to the presence of hormone receptors and to menopausal status or age, but not to proliferative status.  Patients with tumours exhibiting int-2 amplification had a lower probability of disease-free survival than patients with non-amplified tumours and frequently developed local-regional recurrence.  Disease-free survival analysis, adjusted for the prognostic contribution provided by tumour size, steroid receptors and proliferative rate, indicated that the association between int-2 amplification and risk of relapse was maintained and remained constant even in the presence of the other co-variates.  Interestingly, int-2 amplification was a further prognostic discriminant within subsets of patients with a putatively good (i.e., tumour size <20 mm, ER+ and PgR+) or poor prognosis (i.e., high labelling index).  Our exploratory study suggests that within node-negative patients, int-2 amplification could be a valuable and independent prognosticator, useful to identify patients at high risk of local-regional recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAFFsDZPhrMEg6wdEZmT2rfW6udTcc2eahejzycSfpMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c%252FotFOisA%253D%253D&md5=deffd5e262f0abb1097675c56aeb8147</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819971219%2974%3A6%3C620%3A%3AAID-IJC11%3E3.0.CO%3B2-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819971219%252974%253A6%253C620%253A%253AAID-IJC11%253E3.0.CO%253B2-9%26sid%3Dliteratum%253Aachs%26aulast%3DFioravanti%26aufirst%3DL.%26aulast%3DCappelletti%26aufirst%3DV.%26aulast%3DCoradini%26aufirst%3DD.%26aulast%3DMiodini%26aufirst%3DP.%26aulast%3DBorsani%26aufirst%3DG.%26aulast%3DDaidone%26aufirst%3DM.%2BG.%26aulast%3DDi%2BFronzo%26aufirst%3DG.%26atitle%3Dint-2%2520oncogene%2520amplification%2520and%2520prognosis%2520in%2520node-negative%2520breast%2520carcinoma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1997%26volume%3D74%26spage%3D620%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaul, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsfall, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musgrove, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshadri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span> </span><span class="NLM_article-title">EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1617</span><span class="NLM_x">–</span> <span class="NLM_lpage">1623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=1617-1623&author=R.+Huiauthor=D.+H.+Campbellauthor=C.+S.+L.+Leeauthor=K.+McCaulauthor=D.+J.+Horsfallauthor=E.+A.+Musgroveauthor=R.+J.+Dalyauthor=R.+Seshadriauthor=R.+L.+Sutherland&title=EMS1+amplification+can+occur+independently+of+CCND1+or+INT-2+amplification+at+11q13+and+may+identify+different+phenotypes+in+primary+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DD.%2BH.%26aulast%3DLee%26aufirst%3DC.%2BS.%2BL.%26aulast%3DMcCaul%26aufirst%3DK.%26aulast%3DHorsfall%26aufirst%3DD.%2BJ.%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DSeshadri%26aufirst%3DR.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26atitle%3DEMS1%2520amplification%2520can%2520occur%2520independently%2520of%2520CCND1%2520or%2520INT-2%2520amplification%2520at%252011q13%2520and%2520may%2520identify%2520different%2520phenotypes%2520in%2520primary%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D1997%26volume%3D15%26spage%3D1617%26epage%3D1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Berns, E. M. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foekens, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Staveren, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Putten, W. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Koning, H. Y. W. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portengen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klijn, J. G. M.</span><span> </span><span class="NLM_article-title">Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=1995&pages=11-18&author=E.+M.+J.+J.+Bernsauthor=J.+A.+Foekensauthor=I.+L.+van+Staverenauthor=W.+L.+J.+van+Puttenauthor=H.+Y.+W.+C.+M.+de+Koningauthor=H.+Portengenauthor=J.+G.+M.+Klijn&title=Oncogene+amplification+and+prognosis+in+breast+cancer%3A+relationship+with+systemic+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerns%26aufirst%3DE.%2BM.%2BJ.%2BJ.%26aulast%3DFoekens%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2BStaveren%26aufirst%3DI.%2BL.%26aulast%3Dvan%2BPutten%26aufirst%3DW.%2BL.%2BJ.%26aulast%3Dde%2BKoning%26aufirst%3DH.%2BY.%2BW.%2BC.%2BM.%26aulast%3DPortengen%26aufirst%3DH.%26aulast%3DKlijn%26aufirst%3DJ.%2BG.%2BM.%26atitle%3DOncogene%2520amplification%2520and%2520prognosis%2520in%2520breast%2520cancer%253A%2520relationship%2520with%2520systemic%2520treatment%26jtitle%3DGene%26date%3D1995%26volume%3D159%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Mayr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanitz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderegg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthardt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohrs, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, J.</span><span> </span><span class="NLM_article-title">Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays</span> <span class="citation_source-journal">Am. J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1309%2FN6X5MB24BP42KP20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=16753589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFWisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=101-109&author=D.+Mayrauthor=V.+Kanitzauthor=B.+Andereggauthor=B.+Luthardtauthor=J.+Engelauthor=U.+Lohrsauthor=G.+Amannauthor=J.+Diebold&title=Analysis+of+gene+amplification+and+prognostic+markers+in+ovarian+cancer+using+comparative+genomic+hybridization+for+microarrays+and+immunohistochemical+analysis+for+tissue+microarrays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays</span></div><div class="casAuthors">Mayr, Doris; Kanitz, Veronika; Anderegg, Birgit; Luthardt, Beate; Engel, Jutta; Lohrs, Udo; Amann, Gudrun; Diebold, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-109</span>CODEN:
                <span class="NLM_cas:coden">AJCPAI</span>;
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Pathology</span>)
        </div><div class="casAbstract">To identify oncogens amplification involved in ovarian carcinogenesis, we studied 21 ovarian carcinomas and 5 serous borderline tumors using conventional comparative genomic hybridization (CGH) and CGH to a genomic DNA microarray.  Immunohistochem. anal. of the proteins encoded by the genes that were amplified frequently (FGF3/4, FGFR1, CCNE1, PAK1, JUNB, and MDM2) was performed on a tissue microarray comprising 254 cases of ovarian neoplasms.  Regarding histol. type, characteristic patterns of copy no. changes were revealed.  They correlated with histol. tumor type and with intratumoral heterogeneity.  Gain of FGF3/4 and CCNE1 was found in all serous carcinomas.  Endometrioid carcinomas most frequently showed gain of JUNB (83%), KRAS2 (67%), MYCN (50%), ESR (50%), and CCND2 (50%).  Of the serous borderline tumors, 80% harbored amplification of FGFR1 and MDM2 and a 75% gain of PIK3CA.  Only CCNE1 immunoreactivity was significantly correlated with CGH results (P < .05) and postoperative survival (P < .05).  Microarray-based genomic anal. in combination with immunohistochem. anal. was found to be a powerful technique for identification of clin. relevant gene amplification in human ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSaV-Jzj09aLVg90H21EOLACvtfcHk0liCBJjbFNBZ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFWisb4%253D&md5=5612e9b0a96e4a2c7ce08a05acf44d00</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1309%2FN6X5MB24BP42KP20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252FN6X5MB24BP42KP20%26sid%3Dliteratum%253Aachs%26aulast%3DMayr%26aufirst%3DD.%26aulast%3DKanitz%26aufirst%3DV.%26aulast%3DAnderegg%26aufirst%3DB.%26aulast%3DLuthardt%26aufirst%3DB.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DLohrs%26aufirst%3DU.%26aulast%3DAmann%26aufirst%3DG.%26aulast%3DDiebold%26aufirst%3DJ.%26atitle%3DAnalysis%2520of%2520gene%2520amplification%2520and%2520prognostic%2520markers%2520in%2520ovarian%2520cancer%2520using%2520comparative%2520genomic%2520hybridization%2520for%2520microarrays%2520and%2520immunohistochemical%2520analysis%2520for%2520tissue%2520microarrays%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2006%26volume%3D126%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Seki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, T.</span><span> </span><span class="NLM_article-title">Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10853025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksV2ru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2000&pages=103-106&author=A.+Sekiauthor=M.+Yoshinouchiauthor=N.+Sekiauthor=J.+Kodamaauthor=Y.+Miyagiauthor=T.+Kudo&title=Detection+of+c-erbB-2+and+FGF-3+%28INT-2%29+gene+amplification+in+epithelial+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer</span></div><div class="casAuthors">Seki, Akihiko; Yoshinouchi, Mitsuo; Seki, Noriko; Kodama, Junichi; Miyagi, Yasunari; Kudo, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-106</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">We examd. gene amplifications of the c-erbB-2 and FGF-3 gene in 48 epithelial ovarian cancers by differential PCR and addressed their assocn. with clinico-pathol. features including clin. outcome.  Overall, 25.0 and 20.8% of ovarian cancers displayed amplified c-erbB-2 or FGF-3 gene, resp.  Amplification of the c-erbB-2 gene was significantly assocd. with particular histol. cell types, higher histol. grade, and low levels of serous CA125.  However, there was no correlation between c-erbB-2 gene amplification and patient outcome.  No correlation was obsd. between FGF-3 gene amplification and any clinicopathol. features including overall survival.  These findings suggested that c-erbB-2 or FGF-3 gene amplification might be one of the oncogenic events implicated in the development of ovarian cancers, yet is not a useful prognostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwoWQcmp_GU7Vg90H21EOLACvtfcHk0liCBJjbFNBZ8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksV2ru7o%253D&md5=eaf374a5551ed5f62987506ad0266fff</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeki%26aufirst%3DA.%26aulast%3DYoshinouchi%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DKodama%26aufirst%3DJ.%26aulast%3DMiyagi%26aufirst%3DY.%26aulast%3DKudo%26aufirst%3DT.%26atitle%3DDetection%2520of%2520c-erbB-2%2520and%2520FGF-3%2520%2528INT-2%2529%2520gene%2520amplification%2520in%2520epithelial%2520ovarian%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2000%26volume%3D17%26spage%3D103%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rubin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etkind, P.</span><span> </span><span class="NLM_article-title">Amplification of the Int-2 gene in head and neck squamous cell carcinoma</span> <span class="citation_source-journal">J. Laryngol. Otol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=7876747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A280%3ADyaK2M7ot1Sisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1995&pages=72-76&author=J.+S.+Rubinauthor=L.+Qiuauthor=P.+Etkind&title=Amplification+of+the+Int-2+gene+in+head+and+neck+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Amplification of the Int-2 gene in head and neck squamous cell carcinoma</span></div><div class="casAuthors">Rubin J S; Qiu L; Etkind P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of laryngology and otology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-6</span>
        ISSN:<span class="NLM_cas:issn">0022-2151</span>.
    </div><div class="casAbstract">Cellular oncogenes have been implicated in head and neck cancer development since 1986.  More recently interest has focused on chromosome 11q13; oncogenes therein undergoing ongoing investigation include Bcl-1/Prad-1, Hst-1 and Int-2.  Our laboratory has studied the Int-2 oncogene for several years, primarily in the breast.  This paper presents our investigations of Int-2 in the head and neck.  Thirty-four paraffin-embedded primary squamous cell carcinomas were studied for Int-2 gene amplification using a carefully controlled method of sequence quantification by DNA dot blots.  Amplification, mostly low level, was identified in 62 per cent of samples studied.  No clinical correlation to amplification could be found.  Further studies are underway looking for evidence of expression of Int-2 in fresh tissues and for amplification and expression of other oncogenes on this amplicon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN78q5fDugwBfKb6ELK8t0fW6udTcc2eb55RYxodozVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7ot1Sisw%253D%253D&md5=91de349c313d4985ea76ece9a99562c2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DEtkind%26aufirst%3DP.%26atitle%3DAmplification%2520of%2520the%2520Int-2%2520gene%2520in%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DJ.%2520Laryngol.%2520Otol.%26date%3D1995%26volume%3D109%26spage%3D72%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, J. S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, X.-Y.</span><span> </span><span class="NLM_article-title">Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2Fj.canlet.2006.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=17215076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2ks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2007&pages=36-42&author=L.+Huauthor=J.+S.+T.+Shamauthor=D.+Xieauthor=J.-M.+Wenauthor=W.-S.+Wangauthor=Y.+Wangauthor=X.-Y.+Guan&title=Up-regulation+of+fibroblast+growth+factor+3+is+associated+with+tumor+metastasis+and+recurrence+in+human+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma</span></div><div class="casAuthors">Hu, Liang; Sham, Jonathan S. T.; Xie, Dan; Wen, Jian-Ming; Wang, Wei-Sheng; Wang, Yi; Guan, Xin-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-42</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently, we established a hepatocellular carcinoma (HCC) cell line (named H4-M) from a metastatic HCC tumor.  In H4-M, a marker chromosome contg. a homogeneously staining region (hsr) was identified by cytogenetic anal.  The hsr was characterized by chromosome microdissection and the result showed that the hsr was composed of DNA sequence from 11q13.  Oncogenes CCND1 and FGF3 were localized within the complicon and overexpressions of CCND1 and FGF3 were confirmed by Northern blot anal.  Clin. significance of FGF3 overexpression was studied by immunohistochem. (IHC) using an HCC tissue microarray (TMA) contg. 60 pairs of primary/metastatic HCCs and 30 pairs of primary/recurrent HCCs.  TMA study showed that overexpression of FGF3 was significantly assocd. with HCC metastasis and recurrence (p < 0.01) , suggesting that up-regulation of FGF3 may play an important role in HCC metastasis and recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMvXmjWrs7XbVg90H21EOLACvtfcHk0lgz07dzhBkydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2ks7s%253D&md5=4f5ed1eb2b83f5f867f9083a7b892051</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSham%26aufirst%3DJ.%2BS.%2BT.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DJ.-M.%26aulast%3DWang%26aufirst%3DW.-S.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGuan%26aufirst%3DX.-Y.%26atitle%3DUp-regulation%2520of%2520fibroblast%2520growth%2520factor%25203%2520is%2520associated%2520with%2520tumor%2520metastasis%2520and%2520recurrence%2520in%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D252%26spage%3D36%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tsou, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsen, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, S. F.</span><span> </span><span class="NLM_article-title">Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=331-340&author=A.+P.+Tsouauthor=K.+M.+Wuauthor=T.+Y.+Tsenauthor=C.+W.+Chiauthor=J.+H.+Chiuauthor=W.+Y.+Luiauthor=C.+P.+Huauthor=C.+Changauthor=C.+K.+Chouauthor=S.+F.+Tsai&title=Parallel+hybridization+analysis+of+multiple+protein+kinase+genes%3A+identification+of+gene+expression+patterns+characteristic+of+human+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DA.%2BP.%26aulast%3DWu%26aufirst%3DK.%2BM.%26aulast%3DTsen%26aufirst%3DT.%2BY.%26aulast%3DChi%26aufirst%3DC.%2BW.%26aulast%3DChiu%26aufirst%3DJ.%2BH.%26aulast%3DLui%26aufirst%3DW.%2BY.%26aulast%3DHu%26aufirst%3DC.%2BP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DC.%2BK.%26aulast%3DTsai%26aufirst%3DS.%2BF.%26atitle%3DParallel%2520hybridization%2520analysis%2520of%2520multiple%2520protein%2520kinase%2520genes%253A%2520identification%2520of%2520gene%2520expression%2520patterns%2520characteristic%2520of%2520human%2520hepatocellular%2520carcinoma%26jtitle%3DGenomics%26date%3D1998%26volume%3D50%26spage%3D331%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gerald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colbatzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handschuh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann-Lintz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4466</span><span class="NLM_x">–</span> <span class="NLM_lpage">4480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4466-4480&author=J.+Geraldauthor=A.+Heckelauthor=F.+Colbatzkyauthor=S.+Handschuhauthor=J.+Kleyauthor=T.+Lehmann-Lintzauthor=R.+Lotzauthor=U.+Tontsch-Gruntauthor=R.+Walterauthor=F.+Hilberg&title=Design%2C+Synthesis%2C+and+Evaluation+of+Indolinones+as+Triple+Angiokinase+Inhibitors+and+the+Discovery+of+a+Highly+Specific+6-Methoxycarbonyl-Substituted+Indolinone+%28BIBF+1120%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerald%26aufirst%3DJ.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3DColbatzky%26aufirst%3DF.%26aulast%3DHandschuh%26aufirst%3DS.%26aulast%3DKley%26aufirst%3DJ.%26aulast%3DLehmann-Lintz%26aufirst%3DT.%26aulast%3DLotz%26aufirst%3DR.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DHilberg%26aufirst%3DF.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluation%2520of%2520Indolinones%2520as%2520Triple%2520Angiokinase%2520Inhibitors%2520and%2520the%2520Discovery%2520of%2520a%2520Highly%2520Specific%25206-Methoxycarbonyl-Substituted%2520Indolinone%2520%2528BIBF%25201120%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4466%26epage%3D4480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Renhowe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shafer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machajewski, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jazan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonios-McCrea, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapointe, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menezes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aardalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vora, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernette-Hammond, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. L.</span><span> </span><span class="NLM_article-title">Design, Structure–Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800790t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=278-292&author=P.+A.+Renhoweauthor=S.+Pecchiauthor=C.+M.+Shaferauthor=T.+D.+Machajewskiauthor=E.+M.+Jazanauthor=C.+Taylorauthor=W.+Antonios-McCreaauthor=C.+M.+McBrideauthor=K.+Frazierauthor=M.+Wiesmannauthor=G.+R.+Lapointeauthor=P.+H.+Feuchtauthor=R.+L.+Warneauthor=C.+C.+Heiseauthor=D.+Menezesauthor=K.+Aardalenauthor=H.+Yeauthor=M.+Heauthor=V.+Leauthor=J.+Voraauthor=J.+M.+Jansenauthor=M.+E.+Wernette-Hammondauthor=A.+L.+Harris&title=Design%2C+Structure%E2%80%93Activity+Relationships+and+in+Vivo+Characterization+of+4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones%3A+A+Novel+Class+of+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm800790t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800790t%26sid%3Dliteratum%253Aachs%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26aulast%3DPecchi%26aufirst%3DS.%26aulast%3DShafer%26aufirst%3DC.%2BM.%26aulast%3DMachajewski%26aufirst%3DT.%2BD.%26aulast%3DJazan%26aufirst%3DE.%2BM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DAntonios-McCrea%26aufirst%3DW.%26aulast%3DMcBride%26aufirst%3DC.%2BM.%26aulast%3DFrazier%26aufirst%3DK.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DLapointe%26aufirst%3DG.%2BR.%26aulast%3DFeucht%26aufirst%3DP.%2BH.%26aulast%3DWarne%26aufirst%3DR.%2BL.%26aulast%3DHeise%26aufirst%3DC.%2BC.%26aulast%3DMenezes%26aufirst%3DD.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DV.%26aulast%3DVora%26aufirst%3DJ.%26aulast%3DJansen%26aufirst%3DJ.%2BM.%26aulast%3DWernette-Hammond%26aufirst%3DM.%2BE.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DDesign%252C%2520Structure%25E2%2580%2593Activity%2520Relationships%2520and%2520in%2520Vivo%2520Characterization%2520of%25204-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones%253A%2520A%2520Novel%2520Class%2520of%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D278%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaseelan, R.,  Sr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span> </span><span class="NLM_article-title">Discovery and preclinical studies of (<i>R</i>)-1-(4-(4-fluoro-2-methyl-1<i>H</i>-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propanol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2143</span><span class="NLM_x">–</span> <span class="NLM_lpage">2146</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051106d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2143-2146&author=R.+S.+Bhideauthor=Z.-W.+Caiauthor=Y.-Z.+Zhangauthor=L.+Qianauthor=D.+Weiauthor=S.+Barbosaauthor=L.+J.+Lombardoauthor=R.+M.+Borzilleriauthor=X.+Zhengauthor=L.+I.+Wuauthor=J.+C.+Barrishauthor=S.-H.+Kimauthor=K.+Leavittauthor=A.+Mathurauthor=L.+Leithauthor=S.+Chaoauthor=B.+Wautletauthor=S.+Mortilloauthor=R.+Jayaseelanauthor=D.+Kukralauthor=J.+Huntauthor=A.+Kamathauthor=A.+Furaauthor=V.+Vyasauthor=P.+Maratheauthor=C.+D%E2%80%99Arienzoauthor=G.+Derbinauthor=J.+Fargnoli&title=Discovery+and+preclinical+studies+of+%28R%29-1-%284-%284-fluoro-2-methyl-1H-indol-5-yloxy%29-5-methylpyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-6-yloxy%29propanol+%28BMS-540215%29%2C+an+in+vivo+active+potent+VEGFR-2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm051106d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051106d%26sid%3Dliteratum%253Aachs%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DZhang%26aufirst%3DY.-Z.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DBarbosa%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BI.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DLeavitt%26aufirst%3DK.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJayaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DJ.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDerbin%26aufirst%3DG.%26aulast%3DFargnoli%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520studies%2520of%2520%2528R%2529-1-%25284-%25284-fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propanol%2520%2528BMS-540215%2529%252C%2520an%2520in%2520vivo%2520active%2520potent%2520VEGFR-2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2143%26epage%3D2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Hennequin, L. F. A.; Ple, P.; Stokes, E. S. E.; Mckerrecher, D.</span><span> </span><span class="NLM_article-title">Quinazoline derivatives as angiogenesis inhibitors</span>. Patent WO2000047212,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=L.+F.+A.+Hennequin&author=P.+Ple&author=E.+S.+E.+Stokes&author=D.+Mckerrecher&title=Quinazoline+derivatives+as+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%2BA.%26atitle%3DQuinazoline%2520derivatives%2520as%2520angiogenesis%2520inhibitors%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wedge, S. R.; K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brave, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffey, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilburn, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richmond, G. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadsworth, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigley, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurgensmeier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, D. J.</span><span> </span><span class="NLM_article-title">AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=4389-4400&author=S.+R.%3B+K.+J.+Wedgeauthor=L.+F.+Hennequinauthor=P.+J.+Valentineauthor=S.+T.+Barryauthor=S.+R.+Braveauthor=N.+R.+Smithauthor=N.+H.+Jamesauthor=M.+Dukesauthor=J.+O.+Curwenauthor=R.+Chesterauthor=J.+A.+Jacksonauthor=S.+J.+Boffeyauthor=L.+L.+Kilburnauthor=S.+Barnettauthor=G.+H.+P.+Richmondauthor=P.+F.+Wadsworthauthor=M.+Walkerauthor=A.+L.+Bigleyauthor=S.+T.+Taylorauthor=L.+Cooperauthor=S.+Beckauthor=J.+M.+Jurgensmeierauthor=D.+J.+Ogilvie&title=AZD2171%3A+a+highly+potent%2C+orally+bioavailable%2C+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%253B%2BK.%2BJ.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DValentine%26aufirst%3DP.%2BJ.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DBrave%26aufirst%3DS.%2BR.%26aulast%3DSmith%26aufirst%3DN.%2BR.%26aulast%3DJames%26aufirst%3DN.%2BH.%26aulast%3DDukes%26aufirst%3DM.%26aulast%3DCurwen%26aufirst%3DJ.%2BO.%26aulast%3DChester%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DJ.%2BA.%26aulast%3DBoffey%26aufirst%3DS.%2BJ.%26aulast%3DKilburn%26aufirst%3DL.%2BL.%26aulast%3DBarnett%26aufirst%3DS.%26aulast%3DRichmond%26aufirst%3DG.%2BH.%2BP.%26aulast%3DWadsworth%26aufirst%3DP.%2BF.%26aulast%3DWalker%26aufirst%3DM.%26aulast%3DBigley%26aufirst%3DA.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%2BT.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DJurgensmeier%26aufirst%3DJ.%2BM.%26aulast%3DOgilvie%26aufirst%3DD.%2BJ.%26atitle%3DAZD2171%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D4389%26epage%3D4400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Moussy, A.; Kinet, J.-P.</span><span> </span><span class="NLM_article-title">Use of dual C-KIT/FGFR3 inhibitors for treating multiple myeloma</span>. Patent WO2007026251,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Moussy&author=J.-P.+Kinet&title=Use+of+dual+C-KIT%2FFGFR3+inhibitors+for+treating+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoussy%26aufirst%3DA.%26atitle%3DUse%2520of%2520dual%2520C-KIT%252FFGFR3%2520inhibitors%2520for%2520treating%2520multiple%2520myeloma%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawver, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Cho.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5120</span><span class="NLM_x">–</span> <span class="NLM_lpage">5130</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5120-5130&author=L.+Sunauthor=N.+Tranauthor=C.+Liangauthor=F.+Tangauthor=A.+Riceauthor=R.+Schreckauthor=K.+Waltzauthor=L.+K.+Shawverauthor=G.+McMahonauthor=Cho.+Tang&title=Design%2C+Synthesis%2C+and+Evaluations+of+Substituted+3-%5B%283-+or+4-Carboxyethylpyrrol-2-yl%29methylidenyl%5Dindolin-2-ones+as+Inhibitors+of+VEGF%2C+FGF%2C+and+PDGF+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm9904295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904295%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DA.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DWaltz%26aufirst%3DK.%26aulast%3DShawver%26aufirst%3DL.%2BK.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DCho.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Evaluations%2520of%2520Substituted%25203-%255B%25283-%2520or%25204-Carboxyethylpyrrol-2-yl%2529methylidenyl%255Dindolin-2-ones%2520as%2520Inhibitors%2520of%2520VEGF%252C%2520FGF%252C%2520and%2520PDGF%2520Receptor%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5120%26epage%3D5130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Huang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentini, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broudy, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commodore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narasimhan, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohemmad, Q. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuliucci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span> </span><span class="NLM_article-title">Discovery of 3-[2-(Imidazo[1,2-<i>b</i>]pyridazin-3-yl)ethynyl]-4-methyl-<i>N</i>-[4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl]benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region–Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4719</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100395q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4701-4719&author=W.-S.+Huangauthor=C.+A.+Metcalfauthor=R.+Sundaramoorthiauthor=Y.+Wangauthor=D.+Zouauthor=R.+M.+Thomasauthor=X.+Zhuauthor=L.+Caiauthor=D.+Wenauthor=S.+Liuauthor=J.+Romeroauthor=J.+Qiauthor=I.+Chenauthor=G.+Bandaauthor=S.+P.+Lentiniauthor=S.+Dasauthor=Q.+Xuauthor=J.+Keatsauthor=F.+Wangauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+T.+Snodgrassauthor=M.+I.+Broudyauthor=K.+Russianauthor=T.+Zhouauthor=L.+Commodoreauthor=N.+I.+Narasimhanauthor=Q.+K.+Mohemmadauthor=J.+Iuliucciauthor=V.+M.+Riveraauthor=D.+C.+Dalgarnoauthor=T.+K.+Sawyerauthor=T.+Clacksonauthor=W.+C.+Shakespeare&title=Discovery+of+3-%5B2-%28Imidazo%5B1%2C2-b%5Dpyridazin-3-yl%29ethynyl%5D-4-methyl-N-%5B4-%28%284-methylpiperazin-1-yl%29methyl%29-3-%28trifluoromethyl%29phenyl%5Dbenzamide+%28AP24534%29%2C+a+Potent%2C+Orally+Active+Pan-Inhibitor+of+Breakpoint+Cluster+Region%E2%80%93Abelson+%28BCR-ABL%29+Kinase+Including+the+T315I+Gatekeeper+Mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100395q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100395q%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DBanda%26aufirst%3DG.%26aulast%3DLentini%26aufirst%3DS.%2BP.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DSnodgrass%26aufirst%3DJ.%2BT.%26aulast%3DBroudy%26aufirst%3DM.%2BI.%26aulast%3DRussian%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DNarasimhan%26aufirst%3DN.%2BI.%26aulast%3DMohemmad%26aufirst%3DQ.%2BK.%26aulast%3DIuliucci%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26atitle%3DDiscovery%2520of%25203-%255B2-%2528Imidazo%255B1%252C2-b%255Dpyridazin-3-yl%2529ethynyl%255D-4-methyl-N-%255B4-%2528%25284-methylpiperazin-1-yl%2529methyl%2529-3-%2528trifluoromethyl%2529phenyl%255Dbenzamide%2520%2528AP24534%2529%252C%2520a%2520Potent%252C%2520Orally%2520Active%2520Pan-Inhibitor%2520of%2520Breakpoint%2520Cluster%2520Region%25E2%2580%2593Abelson%2520%2528BCR-ABL%2529%2520Kinase%2520Including%2520the%2520T315I%2520Gatekeeper%2520Mutant%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4701%26epage%3D4719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Funahashi, Y.; Tsuruoka, A.; Matsukura, M.; Haneda, T.; Fukuda, Y.; Kamata, J.; Takahashi, K.; Matsushima, T.; Miyazaki, K.; Nomoto, K.; Watanabe, T.; Obaishi, H.; Yamaguchi, A.; Suzuki, S.; Nakamura, K.; Mimura, F.; Yamamoto, Y.; Matsui, J.; Matsui, K.; Yoshiba, T.; Suzuki, Y.; Arimoto, I.</span><span> </span><span class="NLM_article-title">Nitrogenous aromatic ring compounds</span>. Patent WO2002032872,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=Y.+Funahashi&author=A.+Tsuruoka&author=M.+Matsukura&author=T.+Haneda&author=Y.+Fukuda&author=J.+Kamata&author=K.+Takahashi&author=T.+Matsushima&author=K.+Miyazaki&author=K.+Nomoto&author=T.+Watanabe&author=H.+Obaishi&author=A.+Yamaguchi&author=S.+Suzuki&author=K.+Nakamura&author=F.+Mimura&author=Y.+Yamamoto&author=J.+Matsui&author=K.+Matsui&author=T.+Yoshiba&author=Y.+Suzuki&author=I.+Arimoto&title=Nitrogenous+aromatic+ring+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFunahashi%26aufirst%3DY.%26atitle%3DNitrogenous%2520aromatic%2520ring%2520compounds%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Matsui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uenaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, M.</span><span> </span><span class="NLM_article-title">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1002%2Fijc.23131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2007&pages=664-671&author=J.+Matsuiauthor=Y.+Yamamotoauthor=Y.+Funahashiauthor=A.+Tsuruokaauthor=T.+Watanabeauthor=T.+Wakabayashiauthor=T.+Uenakaauthor=M.+Asada&title=E7080%2C+a+novel+inhibitor+that+targets+multiple+kinases%2C+has+potent+antitumor+activities+against+stem+cell+factor+producing+human+small+cell+lung+cancer+H146%2C+based+on+angiogenesis+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition</span></div><div class="casAuthors">Matsui, Junji; Yamamoto, Yuji; Funahashi, Yasuhiro; Tsuruoka, Akihiko; Watanabe, Tatsuo; Wakabayashi, Toshiaki; Uenaka, Toshimitsu; Asada, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">664-671</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">E7080 is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.  In this study, we show the inhibitory activity of E7080 against SCF-induced angiogenesis in vitro and tumor growth of SCF-producing human small cell lung carcinoma H146 cells in vivo.  E7080 inhibits SCF-driven tube formation of HUVEC, which express SCF receptor, KIT at the IC50 value of 5.2 nM and it was almost identical for VEGF-driven one (IC50 = 5.1 nM).  To assess the role of SCF/KIT signaling in tumor angiogenesis, we evaluated the effect of imatinib, a selective KIT kinase inhibitor, on tumor growth of H146 cells in nude mice.  Imatinib did not show the potent antitumor activity in vitro (IC50 = 2,200 nM), because H146 cells did not express KIT.  However, oral administration of imatinib at 160 mg/kg clearly slowed tumor growth of H146 cells in nude mice, accompanied by decreased microvessel d.  Oral administration of E7080 inhibited tumor growth of H146 cells at doses of 30 and 100 mg/kg in a dose-dependent manner and caused tumor regression at 100 mg/kg.  While anti-VEGF antibody also slowed tumor growth, it did not cause tumor regression.  These results indicate that KIT signaling has a role in tumor angiogenesis of SCF-producing H146 cells, and E7080 causes regression of H146 tumors as a result of antiangiogenic activity mediated by inhibition of both KIT and VEGF receptor signaling.  E7080 may provide therapeutic benefits in the treatment of SCF-producing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPTQ6ba_AUe7Vg90H21EOLACvtfcHk0ljx7YnDwwwtsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeltg%253D%253D&md5=6e9eb70f79fe324167a0b87efadfe563</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fijc.23131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.23131%26sid%3Dliteratum%253Aachs%26aulast%3DMatsui%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DFunahashi%26aufirst%3DY.%26aulast%3DTsuruoka%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DT.%26aulast%3DUenaka%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DM.%26atitle%3DE7080%252C%2520a%2520novel%2520inhibitor%2520that%2520targets%2520multiple%2520kinases%252C%2520has%2520potent%2520antitumor%2520activities%2520against%2520stem%2520cell%2520factor%2520producing%2520human%2520small%2520cell%2520lung%2520cancer%2520H146%252C%2520based%2520on%2520angiogenesis%2520inhibition%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D122%26spage%3D664%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><div class="note"><p class="first last">During the preparation of this manuscript, AstraZeneca disclosed the FGFR inhibitor AZD4547</p></div>.<span class="NLM_contrib-group">Gavine, P. R.; Mooney, L.; Kilgour, E.; Thomas, A. P.; Al-Kadhimi, K.; Beck, S.; Coleman, T.; Baker, D.; Mellor, M. J.; Brooks, A. N.; Klinowska, T.</span><span> </span><span class="NLM_article-title">Characterization of AZD4547: An orally bioavailable, potent and selective inhibitor of FGFR tyrosine kinases 1, 2 and 3</span>. <span class="NLM_conf-name">American Association for Cancer Research (AACR) 102nd Annual Meeting</span>, <span class="NLM_conf-loc">Orlando, FL</span>, <span class="NLM_conf-date">April 2–6, 2011</span>, <div class="note"><p class="first last">Abstract 3568</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=During+the+preparation+of+this+manuscript%2C+AstraZeneca+disclosed+the+FGFR+inhibitor+AZD4547.Gavine%2C+P.+R.%3B+Mooney%2C+L.%3B+Kilgour%2C+E.%3B+Thomas%2C+A.+P.%3B+Al-Kadhimi%2C+K.%3B+Beck%2C+S.%3B+Coleman%2C+T.%3B+Baker%2C+D.%3B+Mellor%2C+M.+J.%3B+Brooks%2C+A.+N.%3B+Klinowska%2C+T.+Characterization+of+AZD4547%3A+An+orally+bioavailable%2C+potent+and+selective+inhibitor+of+FGFR+tyrosine+kinases+1%2C+2+and+3.+American+Association+for+Cancer+Research+%28AACR%29+102nd+Annual+Meeting%2C+Orlando%2C+FL%2C+April+2%E2%80%936%2C+2011%2C+Abstract+3568."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGavine%26aufirst%3DP.%2BR.%26atitle%3DCharacterization%2520of%2520AZD4547%253A%2520An%2520orally%2520bioavailable%252C%2520potent%2520and%2520selective%2520inhibitor%2520of%2520FGFR%2520tyrosine%2520kinases%25201%252C%25202%2520and%25203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guagnano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Entry into a new class of protein kinase inhibitors by pseudo ring design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=897-900&author=P.+Furetauthor=G.+Caravattiauthor=V.+Guagnanoauthor=M.+Langauthor=T.+Meyerauthor=J.+Schoepfer&title=Entry+into+a+new+class+of+protein+kinase+inhibitors+by+pseudo+ring+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DGuagnano%26aufirst%3DV.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DEntry%2520into%2520a%2520new%2520class%2520of%2520protein%2520kinase%2520inhibitors%2520by%2520pseudo%2520ring%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D897%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="note"><p class="first last">The kinase domains of FGFR2, FGFR3 and FGFR4 have a sequence identity to that of FGFR1 of 87%, 84%, and 75%, respectively. In the ATP binding site, all the residues are conserved within the different isoforms with the exception of two of them located in the hinge region and corresponding to FGFR3 residues Y557 and A559. In FGFR1 and FGFR2, Y557 is conserved while it is mutated into a cysteine in FGFR4. A559 is conserved in FGFR4 but is a serine in FGFR1 and FGFR2. The latter residue points towards the exterior of the ATP pocket and cannot make contact with inhibitors. In contrast, Y557 and its cysteine equivalent in FGFR4 can make van der Waals contacts with inhibitors.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Thompson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoon, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationships of Soluble 7-Substituted 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridin-2-amines and Related Ureas as Dual Inhibitors of the Fibroblast Growth Factor Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4628</span><span class="NLM_x">–</span> <span class="NLM_lpage">4653</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0500931" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4628-4653&author=A.+M.+Thompsonauthor=A.+M.+Delaneyauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=T.+A.+Spoonauthor=S.+M.+Creanauthor=H.+D.+H.+Showalterauthor=W.+A.+Denny&title=Synthesis+and+Structure%E2%80%93Activity+Relationships+of+Soluble+7-Substituted+3-%283%2C5-Dimethoxyphenyl%29-1%2C6-naphthyridin-2-amines+and+Related+Ureas+as+Dual+Inhibitors+of+the+Fibroblast+Growth+Factor+Receptor-1+and+Vascular+Endothelial+Growth+Factor+Receptor-2+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0500931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500931%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BM.%26aulast%3DDelaney%26aufirst%3DA.%2BM.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DSpoon%26aufirst%3DT.%2BA.%26aulast%3DCrean%26aufirst%3DS.%2BM.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520Soluble%25207-Substituted%25203-%25283%252C5-Dimethoxyphenyl%2529-1%252C6-naphthyridin-2-amines%2520and%2520Related%2520Ureas%2520as%2520Dual%2520Inhibitors%2520of%2520the%2520Fibroblast%2520Growth%2520Factor%2520Receptor-1%2520and%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4628%26epage%3D4653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamby, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseenkova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span> </span><span class="NLM_article-title">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5896</span><span class="NLM_x">–</span> <span class="NLM_lpage">5904</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1093%2Femboj%2F17.20.5896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=9774334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=5896-5904&author=M.+Mohammadiauthor=S.+Froumauthor=J.+M.+Hambyauthor=M.+C.+Schroederauthor=R.+L.+Panekauthor=G.+H.+Luauthor=A.+V.+Eliseenkovaauthor=D.+Greenauthor=J.+Schlessingerauthor=S.+R.+Hubbard&title=Crystal+structure+of+an+angiogenesis+inhibitor+bound+to+the+FGF+receptor+tyrosine+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain</span></div><div class="casAuthors">Mohammadi, Moosa; Froum, Scott; Hamby, James M.; Schroeder, Mel C.; Panek, Robert L.; Lu, Gina H.; Eliseenkova, Anna V.; Green, David; Schlessinger, Joseph; Hubbard, Stevan R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5896-5904</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is an essential physiol. process in development, yet also plays a major role in the progression of human diseases such as diabetic retinopathy, atherosclerosis and cancer.  The effects of the most potent angiogenic factors, vascular endothelial growth factor (VEGF), angiopoietin and fibroblast growth factor (FGF) are mediated through cell surface receptors that possess intrinsic protein tyrosine kinase activity.  In this report, the authors describe a synthetic compd. of the pyrido[2,3-d]pyrimidine class, designated PD 173074, that selectively inhibits the tyrosine kinase activities of the FGF and VEGF receptors.  The authors show that systemic administration of PD 173074 in mice can effectively block angiogenesis induced by either FGF or VEGF with no apparent toxicity.  To elucidate the determinants of selectivity, the authors have detd. the crystal structure of PD 173074 in complex with the tyrosine kinase domain of FGF receptor 1 at 2.5 Å resoln.  A high degree of surface complementarity between PD 173074 and the hydrophobic, ATP-binding pocket of FGF receptor 1 underlies the potency and selectivity of this inhibitor.  PD 173074 is thus a promising candidate for a therapeutic angiogenesis inhibitor to be used in the treatment of cancer and other diseases whose progression is dependent upon new blood vessel formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4zdEklzyMx7Vg90H21EOLACvtfcHk0lhQTdU_MI8eug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnt1Cmurs%253D&md5=a76b085ddc9d352878a2c6bc9d1cd6ff</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.20.5896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.20.5896%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DFroum%26aufirst%3DS.%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DEliseenkova%26aufirst%3DA.%2BV.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26atitle%3DCrystal%2520structure%2520of%2520an%2520angiogenesis%2520inhibitor%2520bound%2520to%2520the%2520FGF%2520receptor%2520tyrosine%2520kinase%2520domain%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D5896%26epage%3D5904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ong, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadari, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lax, I.</span><span> </span><span class="NLM_article-title">FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1128%2FMCB.20.3.979-989.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10629055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Snuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=979-989&author=S.+H.+Ongauthor=G.+R.+Guyauthor=Y.+R.+Hadariauthor=S.+Laksauthor=N.+Gotohauthor=J.+Schlessingerauthor=I.+Lax&title=FRS2+proteins+recruit+intracellular+signaling+pathways+by+binding+to+diverse+targets+on+fibroblast+growth+factor+and+nerve+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors</span></div><div class="casAuthors">Ong, S. H.; Guy, G. R.; Hadari, Y. R.; Laks, S.; Gotoh, N.; Schlessinger, J.; Lax, I.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">979-989</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The docking protein FRS2 was implicated in the transmission of extracellular signals from the fibroblast growth factor (FGF) or nerve growth factor (NGF) receptors to the Ras/mitogen-activated protein kinase signaling cascade.  The two members of the FRS2 family, FRS2α and FRS2β, are structurally very similar.  Each is composed of an N-terminal myristoylation signal, a phosphotyrosine-binding (PTB) domain, and a C-terminal tail contg. multiple binding sites for the SH2 domains of the adapter protein Grb2 and the protein tyrosine phosphatase Shp2.  The PTB domains of both the α and β isoforms of FRS2 bind directly to the FGF or NGF receptors.  The PTB domains of the FRS2 proteins bind to a highly conserved sequence in the juxtamembrane region of FGFR1.  While FGFR1 interacts with FRS2 constitutively, independent of ligand stimulation and tyrosine phosphorylation, NGF receptor (TrkA) binding to FRS2 is strongly dependent on receptor activation.  Complex formation with TrkA is dependent on phosphorylation of Y490, a canonical PTB domain binding site that also functions as a binding site for Shc (NPXpY).  Using deletion and alanine scanning mutagenesis as well as peptide competition assays, the authors demonstrate that the PTB domains of the FRS2 proteins specifically recognize two different primary structures in two different receptors in a phosphorylation-dependent or -independent manner.  In addn., NGF-induced tyrosine phosphorylation of FRS2α is diminished in cells that overexpress a kinase-inactive mutant of FGFR1.  This expt. suggests that FGFR1 may regulate signaling via NGF receptors by sequestering a common key element which both receptors utilize for transmitting their signals.  The multiple interactions mediated by FRS2 appear to play an important role in target selection and in defining the specificity of several families of receptor tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorUBiLcOTfcbVg90H21EOLACvtfcHk0lhQTdU_MI8eug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Snuw%253D%253D&md5=c87b5e18ba3b12a836070ea2378e2593</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.3.979-989.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.3.979-989.2000%26sid%3Dliteratum%253Aachs%26aulast%3DOng%26aufirst%3DS.%2BH.%26aulast%3DGuy%26aufirst%3DG.%2BR.%26aulast%3DHadari%26aufirst%3DY.%2BR.%26aulast%3DLaks%26aufirst%3DS.%26aulast%3DGotoh%26aufirst%3DN.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DLax%26aufirst%3DI.%26atitle%3DFRS2%2520proteins%2520recruit%2520intracellular%2520signaling%2520pathways%2520by%2520binding%2520to%2520diverse%2520targets%2520on%2520fibroblast%2520growth%2520factor%2520and%2520nerve%2520growth%2520factor%2520receptors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D979%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Mohamadi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, N. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caufield, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Still, W. C.</span><span> </span><span class="NLM_article-title">MacroModel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1990&pages=440-467&author=F.+Mohamadiauthor=N.+G.+J.+Richardsauthor=W.+C.+Guidaauthor=R.+Liskampauthor=M.+Liptonauthor=C.+Caufieldauthor=G.+Changauthor=T.+Hendricksonauthor=W.+C.+Still&title=MacroModel%E2%80%94an+integrated+software+system+for+modeling+organic+and+bioorganic+molecules+using+molecular+mechanics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMohamadi%26aufirst%3DF.%26aulast%3DRichards%26aufirst%3DN.%2BG.%2BJ.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DLiskamp%26aufirst%3DR.%26aulast%3DLipton%26aufirst%3DM.%26aulast%3DCaufield%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHendrickson%26aufirst%3DT.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DMacroModel%25E2%2580%2594an%2520integrated%2520software%2520system%2520for%2520modeling%2520organic%2520and%2520bioorganic%2520molecules%2520using%2520molecular%2520mechanics%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1990%26volume%3D11%26spage%3D440%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, B.</span><span> </span><span class="NLM_article-title">The SWISS-PROT protein sequence data bank: current status</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3578</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=3578-3580&author=A.+Bairochauthor=B.+Boeckmann&title=The+SWISS-PROT+protein+sequence+data+bank%3A+current+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DBoeckmann%26aufirst%3DB.%26atitle%3DThe%2520SWISS-PROT%2520protein%2520sequence%2520data%2520bank%253A%2520current%2520status%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D3578%26epage%3D3580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Notredame, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D.; G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heringa, J.</span><span> </span><span class="NLM_article-title">T-Coffee: A novel method for fast and accurate multiple sequence alignment</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1006%2Fjmbi.2000.4042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=10964570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVGntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2000&pages=205-217&author=C.+Notredameauthor=D.%3B+G.+Higginsauthor=J.+Heringa&title=T-Coffee%3A+A+novel+method+for+fast+and+accurate+multiple+sequence+alignment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">T-Coffee: A Novel Method for Fast and Accurate Multiple Sequence Alignment</span></div><div class="casAuthors">Notredame, Cedric; Higgins, Desmond G.; Heringa, Jaap</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-217</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">We describe a new method (T-Coffee) for multiple sequence alignment that provides a dramatic improvement in accuracy with a modest sacrifice in speed as compared to the most commonly used alternatives.  The method is broadly based on the popular progressive approach to multiple alignment but avoids the most serious pitfalls caused by the greedy nature of this algorithm.  With T-Coffee we pre-process a data set of all pair-wise alignments between the sequences.  This provides us with a library of alignment information that can be used to guide the progressive alignment.  Intermediate alignments are then based not only on the sequences to be aligned next but also on how all of the sequences align with each other.  This alignment information can be derived from heterogeneous sources such as a mixt. of alignment programs and/or structure superposition.  Here, we illustrate the power of the approach by using a combination of local and global pair-wise alignments to generate the library.  The resulting alignments are significantly more reliable, as detd. by comparison with a set of 141 test cases, than any of the popular alternatives that we tried.  The improvement, esp. clear with the more difficult test cases, is always visible, regardless of the phylogenetic spread of the sequences in the tests.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraooGHJVZRYrVg90H21EOLACvtfcHk0liLyDScCcm4DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVGntr8%253D&md5=62c7b0c4e224acf1b172810571d5755d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2000.4042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2000.4042%26sid%3Dliteratum%253Aachs%26aulast%3DNotredame%26aufirst%3DC.%26aulast%3DHiggins%26aufirst%3DD.%253B%2BG.%26aulast%3DHeringa%26aufirst%3DJ.%26atitle%3DT-Coffee%253A%2520A%2520novel%2520method%2520for%2520fast%2520and%2520accurate%2520multiple%2520sequence%2520alignment%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D302%26spage%3D205%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Vriend, G.</span><span> </span><span class="NLM_article-title">WHAT IF: A molecular modeling and drug design program</span> <span class="citation_source-journal">J. Mol. Graphics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2006222&amp;key=10.1016%2F0263-7855%2890%2980070-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm2006222&amp;key=2268628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2006222&amp;key=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1990&pages=52-56&author=G.+Vriend&title=WHAT+IF%3A+A+molecular+modeling+and+drug+design+program"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">WHAT IF:  a molecular modeling and drug design program</span></div><div class="casAuthors">Vriend, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-6, 29</span>CODEN:
                <span class="NLM_cas:coden">JMGRDV</span>;
        ISSN:<span class="NLM_cas:issn">0263-7855</span>.
    </div><div class="casAbstract">A FORTRAN 77 computer program has been written to aid with macromol. modeling and drug design.  Called WHAT IF, it provides an intelligent and flexible environment for displaying, manipulating, and analyzing small mols., proteins, nucleic acids, and their interactions.  A relational protein structure database is incorporated to be queried.  The program is suitable for most common crystallog. work.  The menu-driven operation of WHAT IF, combined with the use of default values wherever user input is required, makes it very easy to use for a novice user while keeping full flexibility for more sophisticated studies.  Although there are not too many unique features in WHAT IF, the fact that everything is integrated in one program makes if a unique tool for many purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ64OrfsqnR7Vg90H21EOLACvtfcHk0liLyDScCcm4DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFGksL8%253D&md5=a764dc42ba008577f0076092ab4e6024</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0263-7855%2890%2980070-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0263-7855%252890%252980070-V%26sid%3Dliteratum%253Aachs%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DWHAT%2520IF%253A%2520A%2520molecular%2520modeling%2520and%2520drug%2520design%2520program%26jtitle%3DJ.%2520Mol.%2520Graphics%26date%3D1990%26volume%3D8%26spage%3D52%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bailey, S.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr, Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">D50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D50&publication_year=1994&pages=760-763&author=S.+Bailey&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DS.%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3DD50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-ref60_1"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, P.; Roversi, P.; Sharff, A.; Smart, O.; Vonrhein, C.; Woman, T.</span>Buster 2.9; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, UK</span><span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=P.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+Smart&author=C.+Vonrhein&author=T.+Woman&title=Buster+2.9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref60_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%25202.9%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FGI','PDB','2FGI'); return false;">PDB: 3TT0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/jm2006222">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48076"></div></div></div></div></div><hr /></hr><p class="last">Experimental details (including analytical data) for the final compounds <b>1a</b>–<b>g</b>, <b>1i</b>–<b>n</b>, and intermediates <b>5</b>, <b>7</b>, <b>11</b>–<b>14</b>, <b>16</b>–<b>18</b>, <b>20</b>–<b>25</b>, <b>27</b>, <b>29</b>, <b>32</b>–<b>35</b>, <b>37</b>; complete data set of Tables <a class="ref showTableEvent internalNav" href="#tbl4">4</a>–<a class="ref showTableEvent internalNav" href="#tbl5">5</a>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2006222/suppl_file/jm2006222_si_001.pdf">jm2006222_si_001.pdf (254.94 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2006222&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm2006222%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-20%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2006222" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995fbe79d43db8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
